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1 Introduction 
1.1 The era of bacterial infectious diseases has just begun 
Bacterial infections often resulted in death before World War II. In 1848, 60 % of death were 
caused by infectious diseases in England (Cutler et al., 2006) and 80 % of patients infected 
with Staphylococcus aureus died in the early 1940s (Deurenberg and Stobberingh, 2008). 
After Koch and Pasteur gained first insights into the principles of bacterial infections 
proposed as the germ theory in the second half of the 19th century (Lederberg, 2000), first 
substances with antimicrobial activity were detected in the begin of the 20th century: 
Salvarsan was used for syphilis treatment since 1910 and prontosil was employed for general 
purposes since 1935 (Kingston, 2000). The first antibiotics according to today‘s definition 
were applied during World War II. In 1937, sulfonamides were employed to treat 
streptococcal infections and in 1942, penicillin was applied against e.g. tetanus, gas 
gangrene and wound infections (Manring et al., 2009; Davies and Davies, 2010). 
Streptomycin was introduced in 1944 to treat patients suffering from tuberculosis (Davies 
and Davies, 2010). With the development of the first semi-synthetic β-lactam antibiotic 
methicillin in 1959 and the isolation or development of several other antibiotics like 
cephalosporins, macrolides or fluorochinolones, the age of infectious diseases caused by 
bacteria seemed to be successfully overcome (Davies and Davies, 2010).  
This was unfortunately not the case: First pathogens being resistant against the applied 
antibiotics were observed only a few years after the respective antibiotic was employed for 
clinical treatments (Davies and Davies, 2010; Deurenberg and Stobberingh, 2008). 
Subsequently, resistant strains were found in hospitals and were also established in the 
community (Goossens and Sprenger, 1998; Deurenberg and Stobberingh, 2008). The 
accumulation of resistances against several classes of antibiotics in one organism lead to the 
development of nosocomial superbugs like multidrug-resistant strains of S. aureus, 
Mycobacterium tuberculosis or Pseudomonas aeruginosa (Davies and Davies, 2010). 
Infections with these bacteria resulted in increased mortality and morbidity, in elongated 
hospitalization and also in increased health care costs (Cosgrove, 2006). Since the beginning 
of the 21st century, the bacterial membrane targeting lipopeptide daptomycin was employed 
to treat infections caused by multi-resistant gram positive bacteria (Enoch et al., 2007). 
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Unfortunately, daptomycin resistant S. aureus strains were observed recently (Baltz, 2009; 
Friedman et al., 2006). 
Infections caused by highly-resistant bacteria represent only one aspect of the problem 
today: In developing countries and in crisis regions, many people die due to infectious 
diseases promoted by malnutrition, poor sanitation, climate changes or insufficient medical 
supply often additionally complicated by emerging antimicrobial resistances (Wilson, 1995; 
Byarugaba, 2004). For example, 2.7 million people died due to tuberculosis and 8.1 million 
were worldwide infected in 1993 (Dobson and Carper, 1996). Therefore, the era of bacterial 
infections has only just begun.  
 
 
1.2 The opportunistic pathogen Pseudomonas aeruginosa 
P. aeruginosa is a ubiquitous gram negative bacterium found in coastal marine habitats, soil 
and swamp. It was also isolated from animals and plants. Due to its ability to form biofilms 
on wet surfaces, it can grow on rocks and is found in almost every environment (Stover et 
al., 2000; van Delden and Iglewski, 1998; Hancock, 1998). This is facilitated by its versatile 
and flexible metabolism concerning e.g. carbon source utilization, growth in the presence or 
absence of oxygen and denitrification (Oberhardt et al., 2008). 
P. aeruginosa is able to infect humans as opportunistic pathogen by colonializing burn 
wounds or catheters inserted into urinary tracts or respiration systems (Stover et al., 2000). 
It is the most common gram negative nosocomial pathogen with 10 – 15 % nosocomial 
infections worldwide and provides a wide variety of virulence factors (van Delden and 
Iglewski, 1998; Strateva and Yordanov, 2009). It is related to hospital-acquired acute 
infections of surgical wounds (8 %), bloodstreams (10 %), urinary tracts (12 %) and 
pneumonia (16 %) of immunocompetent patients. Nosocomial P. aeruginosa infections of 
intubated, immunocompetent patients exhibit a death rate of 38 %. Instead, community-
acquired infections of immunocompetent humans are rare. For immunocomprimized 
patients, P. aeruginosa infections are fatal: Pneumonia and septicemia resulted in 30 % 
deaths and AIDS patients died due to P. aeruginosa infections with a rate of 50 % (van 
Delden and Iglewski, 1998). 
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The treatment of P. aeruginosa infections is challenging due to its high intrinsic resistance 
and its ability to acquire resistance mechanisms (Breidenstein et al., 2011; Hancock, 1998; 
Strateva and Yordanov, 2009). Especially in patients suffering from cystic fibrosis producing 
high viscous mucus, P. aeruginosa infections are often chronically established (Gaspar et al., 
2013; Callaghan and McClean, 2012). 
 
1.2.1 Antibiotic resistance of P. aeruginosa 
In general, bacteria become resistant mainly by two conventional mechanisms called 
acquired and adaptive resistance. Acquired (also called genetic) resistance results from the 
uptake of specific resistance genes by horizontal gene transfer and from mutations leading 
to increased expression or de-repression of efflux pump components and other resistance 
related systems or due to target site modifications. This kind of resistance mechanism is 
genetically encoded and is therefore inherited to daughter cells. Instead, adaptive resistance 
is induced by the presence of an antibiotic or by environmental stresses. Resistance related 
genes become upregulated and the bacterium is less susceptible to specific compounds. 
When the stimulus is removed, the adaptive resistance is lost and is therefore uninheritable 
(Breidenstein et al., 2011; Hancock, 1998). 
Beside these conventional types of resistance, P. aeruginosa exhibits a special, high intrinsic 
resistance against antibiotics like aminoglycosides, fluorochinolones or β-lactams mainly 
provided by three different systems. First, P. aeruginosa possesses an outer membrane with 
very low permeability (12 – 100x less compared to E. coli; Hancock, 1998). Outer membranes 
are regarded as selective, molecular sieves. Hydrophilic compounds pass this barrier by 
diffusing through water filled channels of porins. The size of the hydrophilic compounds is 
limited by porin channel sizes and their uptake is restricted by the low quantity of porins in 
the outer membrane of P. aeruginosa. Furthermore, antibiotics are taken up by specific 
porins or self-promoted ways. Alternatively, hydrophobic compounds can pass the outer 
membrane bilayer (Breidenstein et al., 2011; Hancock, 1998). The second aspect of 
P. aeruginosa intrinsic resistance is the rapid efflux of accumulated antibiotics. Efflux pumps 
with wide substrate specificity, especially the resistance-nodulation-division efflux systems 
MexAB-OprM and MexXY-OprM, are constitutively expressed and export harmful antibiotics. 
Additionally, representing the third part of intrinsic resistance, P. aeruginosa exhibits a 
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chromosomally encoded β-lactamase which is constitutively expressed and confers 
resistance against a wide variety of β-lactam-type antibiotics (Breidenstein et al., 2011; 
Strateva and Yordanov, 2009; Hancock, 1998). 
 
1.2.2 Cystic fibrosis and P. aeruginosa infection 
Cystic fibrosis is an inheritable disease and is caused by mutations affecting the cystic fibrosis 
transmembrane conductance regulator (CFTR) localized in epithelial cells. The defective 
CFTR influences the function of several organs like the gastrointestinal tract, the pancreas, 
the liver and particularly the respiratory system (Gaspar et al., 2013). In lung epithelial cells, 
the CFTR mediated chloride secretion into the airways is decreased. Consequently, the 
sodium absorption from the airway liquid is increased resulting in depletion of airway 
surface liquid, mucus dehydration and volume reduction. The increased mucus viscosity 
impairs the mucociliary clearance normally exporting contaminated mucus. Purulent sputum 
is accumulated resulting in chronic infections of cystic fibrosis patients (Gaspar et al., 2013; 
Callaghan and McClean, 2012). The surface liquid pH of cystic fibrosis lung epithelial cells 
was found acidified due to the impaired bicarbonate ion secretion by CFTR (Coakley et al., 
2003). Additionally, acidification of infection sites was proposed as a general aspect of 
inflammation (Simmen et al., 1994). 
When the cystic fibrosis lung becomes infected by a non-mucoid P. aeruginosa, the 
bacterium penetrates the nutrient rich mucus due to its flagellar activity and secrets high 
amounts of virulence factors. By the time, virulence factor secretion is reduced and 
P. aeruginosa forms biofilms protective against antimicrobial compounds and phagocytosis. 
Mutations are accumulated often resulting in the increased production of the 
exopolysaccharide alginate representing a physical barrier against host defense components 
(Gaspar et al., 2013; Callaghan and McClean, 2012; Schobert and Jahn, 2010; van Delden and 
Iglewski, 1998; Breidenstein et al., 2011). In viscous mucus, oxygen becomes limited and 
P. aeruginosa adapts to microaerophilic or anaerobic conditions by changing its physiology. 
It uses denitrification or special types of fermentation being accompanied by a diminished 
antibiotic sensitivity to antimicrobial compounds (Schobert and Jahn, 2010; Callaghan and 
McClean, 2012). 
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Chronic P. aeruginosa infections are associated with a decline in lung function. 54 % of cystic 
fibrosis patients are infected with P. aeruginosa being most prominent in adults (80 %), 
whereas S. aureus is the main pathogen in children (approximately 80 %) (Gaspar et al., 
2013). Microbial communities within the lung mucus include also anaerobic bacteria and 
evolve with the patient’s age. Mostly, chronic P. aeruginosa infections cannot be eradicated 
by any therapy (Gaspar et al., 2013; Schobert and Jahn, 2010). Therefore, the understanding 
of P. aeruginosa processes resulting in increased antibiotic tolerance and the subsequent 
development of new antimicrobials are highly important. 
 
 
1.3 Prokaryotic cell envelopes and compounds 
Prokaryotes can be divided in different classes according to their cell envelope architecture 
and components. These are summarized in the following sections focusing on bacterial 
membranes. 
 
1.3.1 Different prokaryotic cell envelopes 
The prokaryotic cytoplasm is surrounded by the cytoplasmic membrane separating the cell 
from its environment consisting of a phospholipid bilayer with inserted membrane proteins. 
Transport across the membrane is highly selective and energy generating processes 
depending on the proton motive force are located there. Membranes are highly variable 
structures described initially by the fluid mosaic model (Madigan and Martinko, 2009). 
Cytoplasmic membranes are surrounded by stabilizing structures: Gram positive bacteria 
exhibit a massive peptidoglycan layer containing teichonic and teichuronic acids. In contrast, 
gram negative bacteria provide a thin peptidoglycan layer but also an additional outer 
membrane separating the peptidoglycan harboring periplasmic space from the environment. 
The outer membrane consists of an inner phospholipid leaflet and an outer 
lipopolysaccharide leaflet. Archaea do not possess peptidoglycan but their membranes are 
also surrounded by stabilizing structures consisting of pseudopeptidoglycan, other poly-
saccharides or proteinogenic structures forming the S-layer (Madigan and Martinko, 2009).  
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1.3.2 Phospholipids 
Prokaryotic phospholipids share a common basic amphiphilic structure. They consist of a 
glycerol backbone coupled to two hydrophobic side chains and a phosphate group and differ 
in their hydrophilic head groups (Koga, 2011).  
Bacterial phospholipids are synthesized based on the precursor phosphatidic acid (PA) which 
is synthesized as follows: A fatty acid is transferred to the 1-position of glycerol-3-phosphate 
by the glycerol-3-phosphate acyltransferase PlsB or alternatively in a two-step process by 
PlsX and PlsY yielding lysophosphatidic acid (1-acyl-glycerol-3-phosphate). Subsequently, a 
second fatty acid is coupled to the remaining hydroxyl group of lysophosphatidic acid by the 
1-acyl-glycerol-3-phosphate acyltransferase PlsC yielding the phospholipid precursor PA 
(Zhang and Rock, 2008; Geiger et al., 2010b; Geiger et al., 2010a). Saturated fatty acids are 
predominantly found in the 1-position, whereas unsaturated fatty acids are often located in 
the 2-position (Dowhan, 1997). The hydrophilic phosphate group of PA is coupled to several 
other hydrophilic molecules resulting in diversified phospholipids as summarized in Figure 1 
based on selected reviews (Zhang and Rock, 2008; Geiger et al., 2010a; Geiger et al., 2010b). 
The phospholipid synthesis was proposed to be located at the inner leaflet of the 
cytoplasmic membrane (Cronan, 2003). Initially, PA is activated using cytidine triphosphate 
(CTP) resulting in cytidine diphosphate-diacylglycerol (CDP-DAG) representing the central 
intermediate of phospholipid synthesis. The zwitterionic phosphatidylserine (PS) is 
synthesized by replacing cytidine monophosphate (CMP) with L-serine by the phosphatidyl-
serine synthase. PS is further converted to the zwitterionic phosphatidylethanolamine (PE) 
by the phosphatidylserine decarboxylase by releasing CO2. CDP-DAG is also the basis for the 
anionic phosphatidylglycerol (PG) synthesis using glycerol-3-phosphate via the intermediate 
phosphatidylglycerol phosphate by phosphatidylglycerol phosphate synthase and 
phosphatidylglycerol phosphate phosphatase. Two PG molecules are condensed by the 
cardiolipin synthase yielding the anionic diphosphatidylglycerol (DPG, also named 
cardiolipin). PE, PG and DPG are the major phospholipids of many bacteria. E.g. Escherichia 
coli contains 70 – 80 % PE, 15 – 20 % PG and up to 5 % DPG (Huijbregts et al., 2000).  
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Figure 1: Diversification of phospholipid head groups (according to Geiger et al., 2010a) 
Bacterial phospholipids possessing different polar head groups are synthesized based on a 
common ancestor. One reaction pathway results in the formation of phosphatidylserine, 
phosphatidylethanolamine and phosphatidylcholine, whereas phosphatidylglycerol, diphos-
phatidylglycerol and aminoacyl-phosphatidylglycerols are synthesized in a second pathway. 
A third branch leads to the formation of phosphatidylinositol.  
Phospholipid synthesizing enzymes are underlined. aa: amino acid, CMP: cytidine 
monophosphate, CTP: cytidine triphosphate, PPi: pyrophosphate, R:  amino acid side chain, R1-4: 
fatty acid residues, SAH: S-adenosyl homocysteine, SAM: S-adenosyl methionine. See scheme for 
further abbreviations. 
phosphatidic acid (PA) 
cytidine diphosphate-diacylglycerol (CDP-DAG)
phosphatidylserine (PS)
phosphatidylethanolamine (PE)
phosphatidylglycerol phosphate
phosphatidylglycerol (PG)
diphosphatidylglycerol (DPG)
aminoacyl-phosphatidylglycerol (aaPG)
CTP
PPi
CDP-diglyceride
synthase
phosphatidylinositol (PI)
serine
CMP phosphatidylserine
synthase
glycerol-3-phosphate
CMP
CMP
myo-inositol
phosphatidylglycerol
phosphate synthase
phosphatidylinositol
synthase
phosphatidylserine
decarboxylase
CO2
phosphatidylglycerol phosphate
phosphatase
Pi
phosphatidylcholine (PC)
3 SAM
3 SAH
phospholipid
N-methyltransferase
PG
glycerol
cardiolipin
synthase
aminoacyl-
phosphatidylglycerol
synthase
aa-tRNAaa
tRNAaa
choline
CMP
phosphatidylcholine
synthase
Introduction -8-  
Additionally, several bacteria provide phospholipids with other modified head groups: The 
zwitterionic phosphatidylcholine (PC) present in only 10 % of the bacteria (Geiger et al., 
2010b) is synthesized by two different pathways: First, PE is methylated threefold by 
phospholipid N-methyltransferase using S-adenosyl methionine (SAM). Alternatively, PC is 
directly obtained by the condensation of CDP-DAG with choline catalyzed by the 
phosphatidylcholine synthase. The anionic phosphatidylinositol (PI) rarely found in bacteria 
is synthesized by CDP-DAG condensation with myo-inositol promoted by the 
phosphatidylinositol synthase e.g. in M. tuberculosis (Geiger et al., 2010b). The formation of 
aminoacyl-phosphatidylglycerol (aaPG) by the transfer of an amino acid to PG by an 
aminoacyl-phosphatidylglycerol synthase (aaPGS) is also a process restricted to certain 
bacterial species. The charge characteristic of this molecule depends on the employed amino 
acid (Zhang and Rock, 2008; Geiger et al., 2010b; Geiger et al., 2010a; Roy, 2009). Several 
bacteria like Bacillus subtilis synthesize glucosylated diacylglycerols by transferring up to four 
uridine diphosphate-activated glucose molecules to diacylglycerol (Geiger et al., 2010b). 
Other lipids like sphingolipids and steroids or hopanoids are rarely found in bacteria (Geiger 
et al., 2010b) and not further discussed here.  
Different bacterial phospholipids have distinct functions in cellular processes. E.g. anionic 
phospholipids are involved in DNA replication initiation, the control of cell division and 
protein translocation. PE is necessary for the accurate topology of certain membrane 
proteins (Geiger et al., 2010b; Dowhan, 1997). Phospholipids have been found to aggregate 
to lipid microdomains and rafts localizing and compartmentalizing distinct membrane 
proteins and processes. E.g. DPG and PE enriched domains were located together with 
several phospholipid synthases in bacterial septal membranes (Dowhan and Bogdanov, 
2002; Matsumoto et al., 2006; Barák and Muchová, 2013). The aaPGs confer resistance 
against several antimicrobial compounds (Geiger et al., 2010b) as further described in detail 
in following chapters. 
Phospholipids are degraded by phospholipases cleaving specifically the ester bonds of the 
fatty acyl side chains or the phosphodiesterbond of the hydrophilic part with varying 
specificities (Schmiel and Miller, 1999; Ramrakhiani and Chand, 2011). Most bacterial 
phospholipases are secreted for phosphate and carbon source acquisition. Additionally, they 
act as virulence factors by degrading host phospholipids and destabilizing host membranes 
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resulting in tissue destruction during infection (Schmiel and Miller, 1999). Instead, eukaryotic 
phospholipases are mainly employed in lipid metabolism and signal transduction processes 
but are also components of e.g. snake venoms (Schmiel and Miller, 1999; Ramrakhiani and 
Chand, 2011). 
Archaeal phospholipids provide a glycerol-1-phosphate backbone which is sequentially 
linked to geranylgeranyl side chains yielding archaetidic acid (in analogy to PA). CTP 
activation results in CDP-archaeol (in analogy to CDP-DAG) and archaetidylserine, 
archaetidylglycerol and archaetidylinositol are proposed to be synthesized analogously to 
bacterial pathways because homologous enzymes were identified in archaea by sequence 
analysis. The unsaturated geranylgeranyl side chains are hydrogenated during phospholipid 
synthesis using nicotinamide adenine dinucleotide (NADH) resulting in saturated isoprenoid 
residues predominant in archaeal lipids (Koga, 2010; Koga, 2011). 
 
1.3.3 Membrane proteins and protein secretion 
Proteins are integrated into membranes or are associated with membranes. Extracyto-
plasmatic proteins are transported across the membrane employing the same machineries 
(Dalbey et al., 2011). They are necessary for solute transport, signal transduction, energy 
production, cell-to-cell signaling, membrane biogenesis and several other processes 
(Dowhan and Bogdanov, 2009). Basic principles of membrane protein insertion and protein 
transfer across cytoplasmic membranes in bacteria are summarized. 
Proteins represent the second major class of membrane components comprising 20 – 30 % 
of total cellular proteins (Dalbey et al., 2011). Integral cytoplasmic membrane proteins 
consist of several α-helices inserted into the membrane by a highly conserved process 
present in bacteria, archaea and eukaryotes (Natale et al., 2008). After translation of the first 
amino acids, the nascent peptide chain emerges from the ribosome. The N-terminal located 
signal sequence with an average length of 20 amino acids (Natale et al., 2008) provides a 
hydrophobic core region which is bound by the signal recognition particle (SRP) consisting of 
a 4.5 S RNA molecule and the Ffh protein binding guanosine triphosphate (GTP). The SRP 
directs the ribosome to the membrane and binds to the membrane associated FtsY receptor 
also providing GTP. After SRP-FtsY complex formation, the nascent protein chain is 
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transferred to the SecYEG translocon, GTP is hydrolyzed and subsequently, SRP and FtsY 
dissociate (Dalbey et al., 2011). Transmembrane helices of the nascent peptide chain are 
inserted co-translationally into the membrane by leaving the translocon laterally and 
cytoplasmic and extracytoplasmic domains are released into the respective compartment. 
Membrane insertion processes might be assisted by the YidC insertase (Dalbey et al., 2011). 
The transport of the nascent peptide chain into and through the translocon is promoted by 
the cytoplasmic adenosine triphosphate (ATP) hydrolyzing motor protein SecA and also by 
the proton motive force (Dalbey et al., 2011; Natale et al., 2008). 
Several factors influencing the topology of membrane proteins are encoded within the 
proteinogenic amino acid sequence. The signal sequence, the position of charged amino 
acids and the hydrophobicity of transmembrane domains determine the topology together 
with factors directly associated with the translocation process (YidC) (Dalbey et al., 2011; 
Bogdanov et al., 2009; Dowhan and Bogdanov, 2009). The most prominent initial membrane 
protein topology determinant is the localization of positively and negatively charged 
residues within the cytoplasmic and periplasmic loops of the integral membrane protein 
according to the ‘positive-inside’ rule. It describes the preferred localization of positively 
charged amino acid residues in cytoplasmic loops but the molecular basics are not solved in 
detail (Dalbey et al., 2011; Bogdanov et al., 2009; Dowhan and Bogdanov, 2009). This type of 
orientation determination is also observed for proteins with a single membrane-spanning 
helix (Dalbey et al., 2011). The final membrane topology is additionally influenced by the 
interaction of membrane helices and extramembrane domains and especially by the 
biophysical properties of phospholipids surrounding the membrane protein. This was 
demonstrated by analyzing the PE-dependent topology of the E. coli lactose permease LacY 
(Dalbey et al., 2011; von Heijne, 2006; Bogdanov et al., 2009; Dowhan and Bogdanov, 2009). 
Proteins are transported across the membrane and secreted into the periplasm (gram 
negatives) or to the extracellular space (gram positives) employing the same SecYEG 
translocon. During translation, the nascent peptide chain is bound by several copies of the 
cytoplasmic chaperone SecB maintaining the protein in an unfolded state. After translation, 
SecB interacts with SecA transferring the substrate protein to the SecYEG translocon and the 
protein is transported across the membrane mediated by the ATP-dependent SecA. SecB is 
not present in all bacteria but its function might be replaced by general chaperones (Natale 
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et al., 2008). In gram negative bacteria, periplasmic proteins are folded by periplasmic 
chaperones and disulfide-bonds are introduced by the redox-active Dsb-system well-
elucidated in E. coli. Related compounds were also detected in gram positives (Kadokura and 
Beckwith, 2010).  
Alternatively, proteins are transported across the membrane after translation and protein 
folding using the TatABC machinery. For this, the protein provides an N-terminal secretion 
signal sequence exhibiting two arginine residues. Most Tat-secreted proteins contain redox-
active co-factors available only in the cytoplasm e.g. respiratory chain proteins. In contrast 
to the Sec-pathway, the Tat-machinery is driven solely by proton motive force (Dalbey et al., 
2011; Holland, 2004; Natale et al., 2008). 
Proteins designated for environmental release like nutrient degrading enzymes and 
virulence factors are secreted by gram positive bacteria employing the systems presented 
above. In gram negatives, proteins are secreted either in a two-step process combining the 
Sec- and Tat-machineries with outer membrane channels, e.g. by secretion systems type II 
and V, or in one-step processes spanning the whole bacterial envelope, e.g. by secretion 
systems type I and III (Holland, 2004; Bleves et al., 2010; Filloux, 2011). 
 
1.3.4 Bacterial membrane homeostasis 
The barrier function of bacterial membranes depends on the characteristics of their 
phospholipids which are altered to adapt the cell in response to changing environmental 
conditions like temperature, osmolarity, salinity, pH or to defend antimicrobial compounds 
(Zhang and Rock, 2008). Phospholipid adaptation is obtained by linking more/minor 
unsaturated cis-fatty acids or iso/anteiso-branched fatty acids determining the membrane 
viscosity to the glycerol backbone. Additionally, the fatty acid side chains of existing 
phospholipids are modified by introducing cis-double bonds by desaturases (Martinez et al., 
2010; Zhang and Rock, 2008). These side chains can be further converted into cyclopropane 
structures employing SAM. Alternatively, some bacteria can transform cis-fatty acids 
irreversible into their trans-isomers exhibiting nearly saturated fatty acid characteristics 
(Zhang and Rock, 2008). By elevating the ratio of unsaturated to saturated fatty acids, 
membrane fluidity and permeability are increased e.g. in response to decreasing 
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temperatures. In contrast, high amounts of saturated fatty acids result in a closely packed, 
highly ordered phospholipid architecture associated with low fluidity and low permeability. 
In addition to the fatty acid alteration, the phospholipid head group composition is altered 
to balance the ratio of neutral or zwitterionic phospholipids to anionic ones regulating 
membrane associated processes (Zhang and Rock, 2008). For several bacteria, the formation 
of aaPG from PG in response to acidic pH conditions resulting in altered membrane surface 
charges was described and associated with antibiotic resistance (Roy, 2009). 
 
 
1.4 Aminoacyl esters of PG: synthesis and impact 
PG modification by aminoacylation was first described about 50 years ago (MacFarlane, 
1962; Lennarz et al., 1966). Up to now, several organisms containing aaPG molecules were 
identified (Dare and Ibba, 2012; Roy, 2009) and many of them are associated with 
eukaryotes as pathogens, symbionts or commensals (Geiger et al., 2010a). 
 
1.4.1 Aminoacylated PG variants 
Aminoacylated PG is present in membranes of different bacteria. Most prominent is the 
utilization of L-lysine for PG modification, followed by L-alanine, but the use of several other 
amino acids was also observed (Dare and Ibba, 2012; Roy, 2009). The structures of the 
resulting lysyl-phosphatidylglycerol (L-PG) and alanyl-phosphatidylglycerol (A-PG) are 
presented in Figure 2.  
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A specific amino acid is transferred by the respective aaPGS from its corresponding tRNA to 
the 2’ or the 3’ hydroxyl group of PG (Dare and Ibba, 2012; Klein et al., 2009). The migration 
of the amino acid moiety between the 2’ and the 3’ position was observed in vitro (Tocanne 
et al., 1974a). Due to the addition of L-lysine to the anionic PG, the resulting L-PG is carrying 
a positive net charge resulting in altered membrane surface charge characteristics. In 
contrast, the utilization of L-alanine yields to the zwitterionic A-PG (Roy, 2009; Klein et al., 
2009). Based on in vitro experiments it was proposed that the hydrophilic head groups of 
both L-PG and A-PG do not prefer an elongated conformation. Instead, loop structures 
resulting from intramolecular salt bridge formation were postulated (Tocanne et al., 1974b; 
Tocanne et al., 1974c; Sacre et al., 1977). It was assumed that the formation of aaPG 
molecules (e.g. 6 % A-PG in P. aeruginosa and 45 % L-PG in S. aureus; Klein et al., 2009; 
Slavetinsky et al., 2012) allows for the optimal fine-tuning of membrane properties like 
fluidity and phospholipid head group interaction (Tocanne et al., 1974b; Tocanne et al., 
1974c; Sacre et al., 1977; Dare and Ibba, 2012; Roy, 2009).  
 
 
lysyl-phosphatidylglycerol (L-PG)
alanyl-phosphatidylglycerol (A-PG)
Figure 2: Structures of aminoacylated PG variants 
L-PG and A-PG are synthesized by transferring the respective amino acid from its corresponding 
tRNA to the 3’ hydroxyl group of PG (Roy, 2009). Alternatively, the respective amino acid might be 
coupled to the 2’ hydroxyl group (not shown). 
R1 and R2: fatty acid side chains. 
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1.4.2 AaPG synthesizing enzymes 
For almost 50 years, not only the existence of aaPG molecules but also the involvement of 
aminoacylated tRNAs in PG modification had been identified (MacFarlane, 1962; Lennarz et 
al., 1966). The preparation of the S. aureus aaPGS enzyme by solvent extraction had been 
described (Nesbitt and Lennarz, 1968). In 2001, the S. aureus aaPGS (also termed MprF; 
multiple peptide resistance factor) was reinvestigated due to the observed association to the 
resistance of S. aureus to components of the host innate immune system (Peschel et al., 
2001). This was the starting point for the investigation of several other aaPGS enzymes (for 
review, see Roy, 2009). These investigations resulted in the following model of the domain 
architecture of aaPGS enzymes and their enzymatic mechanism (Figure 3). 
 
 
AaPGS enzymes provide two domains with different functions and are localized in the 
cytoplasmic membrane of bacteria (Roy, 2009; Klein et al., 2009; Ernst et al., 2009; 
Slavetinsky et al., 2012). The highly conserved, cytoplasmic C-terminal domain (Figure 3, 
dark gray) transfers an amino acid from its tRNA to a hydroxyl group of the phospholipid PG 
yielding aaPG and the respective tRNA. The key amino acid residues for catalysis were 
identified within this domain in an extended mutagenesis study of all highly conserved 
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Figure 3: AaPG synthesis mediated by aaPGS enzymes 
AaPGS enzymes consist of a highly conserved, cytoplasmic C-terminal domain (dark gray enzyme 
domain) catalyzing the synthesis of aaPG by transferring an amino acid from its tRNA to a hydroxyl 
group of the phospholipid PG (dark gray lipid). The hydrophobic N-terminal flippase domain (light 
gray) consists of a varying number of transmembrane helices and translocates the aaPG across 
the cytoplasmic membrane (see text for references). 
AaPG: aminoacyl-phosphatidylglycerol, aaPGS: aaPG synthase, PG: phosphatidylglycerol, R: amino 
acid side chain. 
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amino acid residues of the P. aeruginosa enzyme (Hebecker et al., 2011). The synthesis of 
aaPG was observed to be catalyzed by the C-terminal domains of the P. aeruginosa A-PGS 
and the Clostridium perfringens lysyl-phosphatidylglycerol synthase (L-PGS) devoid of any 
N-terminal helices (Hebecker et al., 2011; Roy and Ibba, 2009; Ernst et al., 2009). However, 
the S. aureus C-terminal enzyme domain catalyzes the aminoacylation of PG only in the 
presence of specific transmembrane helices (Ernst et al., 2009; Slavetinsky et al., 2012). 
In an extended study, Hebecker and coworkers elucidated the substrate recognition of the 
water soluble, C-terminal alanyl-phosphatidylglycerol synthase (A-PGS) domain of 
P. aeruginosa (Hebecker et al., 2011): The PG substrate is recognized by the A-PGS mainly 
due to its polar head group. In contrast, the architecture of the fatty acid side chains is of 
minor importance as observed by maintained catalysis even in the absence of one fatty acid. 
The substrate recognition of the aminoacyl-tRNA substrate was investigated using several 
aminoacylated tRNA derivatives including alanylated ribonucleic microhelices. The study 
revealed that only five terminal base pairings of the amino acid acceptor stem are necessary 
for effective substrate recognition. Instead, the architecture of the tRNA bound amino acid is 
the determinant for the substrate recognition (Roy and Ibba, 2008b; Hebecker et al., 2011). 
On the basis of site-directed mutagenesis experiments, an enzymatic mechanism was 
proposed for the P. aeruginosa A-PGS: The nucleophilic hydroxyl group of PG attacks the 
enzymatically activated ester bond linking the amino acid to the tRNA without the 
involvement of a covalent enzyme-substrate intermediate (Hebecker et al., 2011).  
The second domain of aaPGS enzymes, the hydrophobic N-terminal domain (Figure 3, light 
gray), consists of 4 to 14 transmembrane helices showing a low level of sequence 
conservation (Roy, 2009). It was shown that this part of the protein is responsible for the 
translocation of synthesized aaPG from the inner to the outer leaflet of the cytoplasmic 
membrane. The S. aureus and C. perfringens flippase domains exhibit relaxed substrate 
specificity as indicated by the observed flipping of A-PG and L-PG in the presence of a 
chimeric aaPGS enzyme (Ernst et al., 2009; Slavetinsky et al., 2012). AaPG translocation is 
essential for the observed resistance of S. aureus to antimicrobial substances (Slavetinsky et 
al., 2012; Ernst et al., 2009). However, some aaPGS enzymes are devoid of this flippase 
domain (Roy and Ibba, 2009) and aaPG translocation might be processed by phospholipid 
flippases with broad substrate spectra (Ernst and Peschel, 2011). Since A-PG was also 
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detected in the outer membrane of P. aeruginosa, an aaPGS independent transfer of A-PG 
from the outer leaflet of the inner membrane to the inner leaflet of the outer membrane 
was proposed (Klein et al., 2009).  
In most organisms, a single aaPGS homologous gene was identified. However, the gram 
positive C. perfringens provides two homologs identified as an A-PGS and an L-PGS, 
respectively (Roy and Ibba, 2008b). In contrast, aaPGS enzymes from B. subtilis, Enterococcus 
faecium and Enterococcus faecalis were identified to accept at least two aminoacyl-tRNA 
substrates (Roy and Ibba, 2009; Bao et al., 2012). Interestingly, for the Listeria 
monocytogenes L-PGS enzyme, the modification of PG with lysine and in parallel the 
presence of lysyl-DPG was observed (Thedieck et al., 2006).  
 
1.4.3 AaPG related physiology and antibiotic resistance 
AaPG deficient strains of several bacteria did not show a growth phenotype (Peschel et al., 
2001; Klein et al., 2009; Thedieck et al., 2006) and the membrane proteome of the S. aureus 
deletion mutant strain was not dramatically altered (Sievers et al., 2010). However, for 
aaPGS defective strains of S. aureus, M. tuberculosis and L. monocytogenes, a reduced 
virulence was observed in vivo (Peschel et al., 2001; Maloney et al., 2009; Thedieck et al., 
2006) and an L-PGS deficient Rhizobium tropici strain showed a reduced nodulation 
efficiency (Vinuesa et al., 2003). 
The S. aureus L-PGS (also termed MprF) was identified by a screening approach searching for 
factors mediating the bacterial resistance against antimicrobial peptides of the host innate 
immune system. L-PGS deficient strains devoid of any L-PG were found significantly more 
susceptible to cationic defensins, protegrins and other antimicrobial peptides of different 
origin when compared to the respective control strains (Peschel et al., 2001). Cationic 
antimicrobial peptides (CAMPs) provide an amphipathic architecture containing positively 
charged amino acid residues and providing hydrophobic surfaces and they are part of the 
innate defense mechanisms of various organisms (Zasloff, 2002). They have been proposed 
to interact with anionic phospholipid head groups, thereby disrupting the membrane 
integrity and in some cases pore formation followed by membrane depolarization was 
assumed (Zasloff, 2002; Peschel and Sahl, 2006). During evolution, bacteria established 
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several mechanisms to cope with CAMPs. One of these mechanisms is the specific 
aminoacylation of PG (Peschel and Sahl, 2006; Koprivnjak and Peschel, 2011). Based on the 
results obtained for the L-PGS deficient S. aureus strain, the ‘charge repulsion’ model 
schematically presented in Figure 4 was proposed by A. Peschel and coworkers as a potential 
mechanism of L-PG mediated resistance against CAMPs (Peschel et al., 2001).  
 
 
In bacterial strains which provide a negatively charged membrane surface due to anionic 
phospholipids like PG, positively charged CAMPs interact with the anionic head groups which 
result in a disordered membrane structure. In contrast, L-PG containing membranes provide 
a more positively charged surface resulting in the repulsion of CAMPs and leading to the 
observed CAMP resistance (Peschel et al., 2001). However, recent results indicate a more 
complex L-PG mediated CAMP or daptomycin resistance mechanism. The anionic lipopeptide 
antibiotic daptomycin represents a CAMP when it is complexed with calcium ions (Bayer et 
al., 2013). In vitro studies with artificial membranes revealed that CAMP repulsion cannot be 
correlated directly to the L-PG content of the membrane (Bayer et al., 2013). Other reports 
emphasize rather a reduced anionic phospholipid content than an increased aaPG level for 
the observed CAMP resistance in S. aureus, B. subtilis and P. aeruginosa (Mishra et al., 
2012a; Hachmann et al., 2011; Conrad and Gilleland, 1981). Furthermore, the substitution of 
Figure 4: Scheme of the ‘charge repulsion’ mechanism (according to Peschel et al., 2001) 
The proposed ‘charge repulsion’ model describes the interaction of CAMPs with S. aureus 
membranes in the presence and in the absence of L-PG (Peschel et al., 2001). 
A. Positively charged CAMPs interact with negatively charged phospholipid head groups, attach 
to the membrane surface and disrupt the membrane order.  
B. The presence of the cationic phospholipid L-PG prevents the CAMP interaction which results 
in the CAMP resistance of S. aureus.  
Dark gray: anionic phospholipids, middle gray: zwitterionic and uncharged phospholipids, light 
gray: cationic L-PG. CAMP: cationic antimicrobial peptide, L-PG: lysyl-phosphatidylglycerol.  
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the cationic L-PG by the zwitterionic A-PG in S. aureus membranes resulted in a comparable 
resistance phenotype. This indicates that a simple repulsion is not sufficient to explain the 
observed effects further supporting the ‘PG reduction’ hypothesis (Bayer et al., 2013; 
Slavetinsky et al., 2012). AaPG formation was also associated with the resistance of different 
pathogens against daptomycin, oxacillin, methicillin, polymyxins and nisin (Hachmann et al., 
2009; Komatsuzawa et al., 2001; Nishi et al., 2004; Bao et al., 2012; Jones et al., 2008). 
Moreover, A-PG production was related to the increased resistance of P. aeruginosa against 
the CAMP protamine, the β-lactam cefsulodin, the heavy metal ion chromium(III) and 
osmotic stress conditions induced by lactate (Klein et al., 2009). Especially in the context of 
P. aeruginosa containing up to 6 % A-PG, both postulated CAMP resistance mechanisms 
(‘charge repulsion’ and ‘PG reduction’) do not explain the observed resistance phenotypes. 
Membrane permeability and fluidity alterations or an influence of A-PG on membrane 
protein function and activity are also discussed in the literature (Klein et al., 2009; Roy et al., 
2009). Furthermore, the consequences of parallel synthesis of different aaPGs described for 
several bacteria have not been elucidated in detail. Although the synthesis of A-PG in an 
L-PG deficient S. aureus strain resulted in comparable daptomycin resistance phenotypes 
(Slavetinsky et al., 2012), it is not clear if this is also the case for bacteria synthesizing low 
amounts of aaPG or for gram negative bacteria showing a completely different cell envelope 
architecture.  
 
1.4.4 Regulation of aaPG synthesis 
For several aaPGS synthesizing bacteria like S. aureus and P. aeruginosa, increased aaPG 
amounts were detected under acidic conditions while the growth of the respective aaPGS 
defective strains was not affected (Houtsmuller and van Deenen, 1965; Klein et al., 2009; 
Sohlenkamp et al., 2007; Vinuesa et al., 2003; op den Kamp et al., 1969; Minnikin and 
Abdolrahimzadeh, 1974). In contrast, a transposon mutagenesis study identified an aaPGS 
homolog essential for the growth of R. tropici in acidic environments (Vinuesa et al., 2003). 
Promoter sequences located upstream of the aaPGS encoding genes of P. aeruginosa and 
R. tropici were identified and the upregulation of the aaPG synthesis under acidic growth 
conditions was demonstrated (Klein et al., 2009; Vinuesa et al., 2003). To date, the 
underlying regulatory system has not been characterized. 
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In S. aureus, the GraRS two component system sensing specific antimicrobial peptides was 
identified to increase the expression of the L-PGS. However, this system only responds to 
very specific compounds and has not the ability to sense antimicrobial peptides in general 
(Yang et al., 2012). In L. monocytogenes, the expression of the L-PGS is regulated by the 
VirSR two component system for which the induction of cell envelope stress response genes 
was demonstrated. However, the signal that activates the VirSR system has not been 
identified (Roy, 2009).  
The extracytoplasmic functioning sigma factor σ22 of P. aeruginosa regulates the expression 
of various genes in response to cell wall stresses and controls the synthesis of alginate in 
mucoid strains associated with lung infections. The A-PGS was identified as a component of 
the σ22 regulon and it was further demonstrated that the stress response system was also 
affected in A-PGS defective strains. In this context, an essential role of A-PG was concluded. 
However, the molecular details are not resolved yet (Wood and Ohman, 2012). 
 
1.4.5 AaPGS enzymes are encoded in a potential operon in gram negative 
bacteria 
In many aaPG synthesizing gram negatives, the aaPGS encoding gene is located upstream of 
a second gene. In P. aeruginosa, the respective orf PA0919 is separated from the A-PGS 
encoding orf PA0920 by one single base pair. PA0919 homologous genes like acvB of 
Agrobacterium tumefaciens and atvA (acid tolerance and virulence) of R. tropici were 
previously detected (Vinuesa et al., 2003). First, acvB was identified by a transposon 
mutagenesis study screening for virulence defective A. tumefaciens strains (Wirawan et al., 
1993). Further investigation also revealed the VirJ protein in A. tumefaciens which is highly 
homologous to the AcvB protein (Pan et al., 1995). Cellular fractionation analysis identified 
AcvB and VirJ in the periplasm of A. tumefaciens (Kang et al., 1994; Pan et al., 1995). Due to 
the affected virulence it was proposed that AcvB/VirJ is a periplasmic component of the 
A. tumefaciens type IV secretion system (Pantoja et al., 2002). 
Vinuesa and coworkers identified that AcvB of A. tumefaciens and AtvA of R. tropici are 
relevant for bacterial growth under acidic conditions (Vinuesa et al., 2003). Bioinformatic 
analyses revealed a serine containing lipase active site sequence motif (LIPASE_SER motif) 
within the sequence of the R. tropici AtvA. The substitution of the specific active site serine 
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to alanine resulted in an acid sensitive phenotype indicating the relevance of this specific 
serine for the function of AtvA. Due to the obtained results it was proposed that AtvA might 
be a member of an as yet unidentified class of lipolytic enzymes (Vinuesa et al., 2003). It was 
speculated that high L-PG amounts might not be detectable in R. tropici due to the proposed 
lipolytic function of AtvA (Sohlenkamp et al., 2007). However, up to now the characterization 
of an AcvB/AtvA homolog has not been reported.  
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1.5 Aim of this study 
Under various stress conditions several pathogenic bacteria have the ability to modify the 
phospholipid PG mainly with lysine or alanine yielding the cationic L-PG or the zwitterionic 
A-PG. This reaction is mediated by aaPGS enzymes showing different aminoacyl-tRNA 
specificities (Ernst and Peschel, 2011). AaPGS deficient strains exhibited an increased 
susceptibility to host innate immune system components and to several antibiotics. 
Therefore, the inhibition of aaPGS enzymes was proposed as a promising strategy to treat 
bacterial infections (Ernst and Peschel, 2011). The first part of this study is dealing with the 
identification of the aminoacyl-tRNA substrate specificity of several as yet uncharacterized 
aaPGS enzymes. These results will then allow for the characterization of potential 
determinants of the aminoacyl-tRNA substrate specificity and also for the analysis of the 
evolutionary origin of A-PG and L-PG synthesis.  
To date, it is not clear if L-PG and A-PG synthesis results in comparable resistance 
phenotypes as indicated by results obtained for the gram positive model organism S. aureus 
(Slavetinsky et al., 2012) or if these molecules result in different physiological consequences 
possibly depending on the respective host. To address this question, an A-PGS deficient 
mutant strain of the gram negative model organism P. aeruginosa had to be complemented 
with various aaPGS enzymes to generate strains with artificially altered membrane 
composition. The obtained strains had to be characterized phenotypically to figure out the 
specific impact of the respective aaPG in the P. aeruginosa model system. Furthermore, the 
response of the A-PGS promoter to several antimicrobial compounds had to be investigated 
to analyze the A-PG homeostasis under antimicrobial stress conditions. 
AaPGS enzymes are encoded in combination with a second protein with a proposed lipolytic 
function in gram negative bacteria (Vinuesa et al., 2003). In P. aeruginosa, this protein is 
encoded by orf PA0919 whose function had to be elucidated in the present study. For this, a 
PA0919 deficient mutant had to be constructed and to be characterized with respect to 
growth phenotype, lipid composition and susceptibility to antimicrobials. Furthermore, the 
protein had to be analyzed biochemically after recombinant production and purification 
concerning its substrate specificity. Therefore, an appropriate in vitro activity assay had to be 
developed. Besides this, the cellular localization of the PA0919 protein in P. aeruginosa had 
to be elucidated. 
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2 Materials and methods 
2.1 Materials 
Instruments, chemicals, bacterial strains, plasmids and oligodeoxynucleotides employed in 
this study are summarized in the following sections. 
 
2.1.1 Instruments 
Instruments used in this study are summarized in Table 1. 
 
Table 1: Instruments 
Instrument Model Manufacturer 
agarose gel electrophoresis 
chamber 
Agagel Biometra 
agarose gel documentation DeVision G system Decon Science Tec 
autoclave LVSA 50/70 Zirbus 
blotting apparatus Trans-Blot® SD system Bio-Rad 
Trans-Blot® TurboTM system Bio-Rad 
centrifuge Avanti® J-E Beckman Coulter 
Megafuge Heraeus® 
Minispin® Eppendorf 
OptimaTM L-90K ultracentrifuge with 
rotors SW 40 Ti or 70.1 Ti 
Beckman Coulter 
cell disruptor FastPrep® MP Biomedicals 
fluorescence spectrometer LS50B PerkinElmer 
FPLC ÄKTApurifierTM GE Healthcare 
French® Press French® Pressure Cell Press Polytec 
French® Press cell French® Pressure Cell SLM Aminco 
lyophilization Lyovac GT2 Finn-Aqua 
magnetic stirrer KM02 basic IKA Werke 
microplate incubator  OmniLog® Biology 
PHMP-4 Grant bio 
microplate reader Model 680 Bio-Rad 
photometer NanoDrop PEQLAB Biotechnologie 
Ultrospec 2000 Amersham Pharmacia 
Ultrospec 2100pro Amersham Pharmacia 
pH determination CG 842 Schott 
pipettes 
 
0.5 – 10 µL Reference Eppendorf 
2 – 20 µL Reference Eppendorf 
10 – 100 µL Reference Eppendorf 
50 – 200 µL Reference Eppendorf 
100 – 1000 µL Reference Eppendorf 
LAB-Mate 10 mL ABI Med 
20 – 200 µL Transferpette®-8 Brand 
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Instrument Model Manufacturer 
power supply PowerPac300 Bio-Rad 
SDS-PAGE Mini-Protean IIITM Bio-Rad 
shaker 3020 GFL 
TR-150 Infors 
scintillation counter Tri-Carb® 2900TR PerkinElmer 
thermocycler Tpersonal Biometra 
C1000™ Thermal Cycler Bio-Rad 
thermomixer Thermomixer compact Eppendorf 
UV-Vis spectrometer V-650 Jasco 
vortex REAX2000 Heidolph 
water purification Milli-Q system Millipore 
X-ray film processor Optimax® Protec® 
 
 
2.1.2 Chemicals, enzymes and appliance 
Chemicals and enzymes used in this study are summarized in Table 2. Unspecified chemicals 
were obtained from Fluka, Roth, Riedel-de Haen, Roche and Sigma-Aldrich (quality grade 
p.a.). Kits and appliances are indicated in Table 3. 
 
Table 2: Chemicals and enzymes 
Application Product Manufacturer 
antibodies and 
accessory 
5-bromo-4-chloro-3-indolyl phosphate (BCIP) Sigma-Aldrich 
nitrotetrazolium blue (NBT) Sigma-Aldrich 
Strep-Tactin® AP conjugate IBA 
antimicrobial 
compounds employed 
for susceptibility tests 
ampicillin Roth 
benzethonium chloride Sigma-Aldrich 
cefsulodin Sigma-Aldrich 
daptomycin Novartis 
domiphen bromide Sigma-Aldrich 
methicillin Sigma-Aldrich 
nisin Sigma-Aldrich 
oxacillin Sigma-Aldrich 
poly-L-lysine Sigma-Aldrich 
polymyxin B Sigma-Aldrich 
polymyxin E Sigma-Aldrich 
protamine sulfate Sigma-Aldrich 
vancomycin Roth 
14C-labeled compounds [1-14C]-L-alanine Moravec Biochemicals 
[U-14C]-L-lysine Moravec Biochemicals 
chemicals adenosine triphosphate (ATP) Sigma-Aldrich 
L-alanine Sigma-Aldrich 
avidin Calbiochem® 
bovine serume albumin Roth 
Bradford reagent Sigma-Aldrich 
 -25- Materials and methods 
Application Product Manufacturer 
chemicals (continued) cOmplete protease inhibitor cocktail Roche 
creatine phosphate Sigma-Aldrich 
desthiobiotin IBA 
deoxynucleotide triphosphate (dNTP) mix New England Biolabs 
GelStar™ Nucleic Acid Gel Stain Lonza 
isopropyl-β-D-thiogalactopyranoside (IPTG) GERBU 
molybdatophosphoric acid Roth 
ninhydrin spray solution Merck 
OptiPhase HighSafe 2 PerkinElmer 
PBS-Tween® tablets Medicago 
phenylmethylsulfonyl fluoride (PMSF) Sigma-Aldrich 
Redox Dye Mix A Biolog 
Strep-tag® regeneration buffer IBA 
Nα-tosyl-L-lysine chloromethyl ketone (TLCK) Sigma-Aldrich 
chromogenic 
compounds 
Ala-ONp Bachem 
Gly-ONp Bachem 
Ac-Gly-ONp Bachem 
Boc-Ala-ONp Bachem 
Ala-pNA Bachem 
4-nitrophenol butyrate Sigma-Aldrich 
4-nitrophenol acetate Sigma-Aldrich 
4-nitrophenol phosphate Sigma-Aldrich 
2-nitrophenyl-β-D-galactopyranoside (ONPG) Roth 
enzymes creatine phosphate kinase Sigma-Aldrich 
DNase I, RNase free ambion® 
lysozyme (from chicken egg white) Fluka 
Phusion® High-Fidelity DNA-Polymerase Thermo Fisher Scientific 
restriction endonucleases New England Biolabs 
RNase A Invitrogen 
Taq DNA Polymerase New England Biolabs 
T4 DNA Ligase New England Biolabs 
media components BactoTM Proteose Peptone no. 3 BD 
BactoTM Tryptone BD 
BactoTM Soytone BD 
Casamino acids Roth 
IF-0 medium Biolog 
IF-10a medium Biolog 
markers GeneRulerTM DNA Ladder Mix Thermo Fisher Scientific 
RNA Molecular Weight Marker I,  
DIG-labeled, 0.3 – 6.9 kb 
Roche 
PageRulerTM Prestained Protein Ladder Thermo Fisher Scientific 
Unstained Protein Molecular Weight Marker Thermo Fisher Scientific 
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Table 3: Kits and appliances 
Application Product Manufacturer 
kits QIAquick PCR Purification Kit Qiagen 
QIAquick Gel Extraction Kit Qiagen 
QuikChange® II Site-Directed Mutagenesis Kit Stratagene 
microplate appliance gas permeable membrane  
(Breath-EasyTM sealing membrane) 
Diversified Biotech 
microplates, 96-well flat bottom  
(No. 82.1581.001) 
Sarstedt 
Phenotype MicroArrayTM plates PM9 – PM20 Biolog 
protein purification Amicon® Ultra-0.5 device Merck 
dialysis tubing membrane visking  
(molecular weight cutoff: 14 kDa) 
Roth 
Poly-Prep chromatography columns  
(0.8 x 4 cm) 
BioRad 
Protino® Ni-NTA agarose Macherey-Nagel 
Strep-Tactin® Superflow® high capacity resin IBA 
Superdex 200 5/150 GL column GE Healthcare 
radioactivity analysis exposure cassette K 20 – 25 cm Bio-Rad 
scintillation vials (PE-LD), 20 mL A. Hartenstein 
X-ray film Fuji Super RX BEMA 
others pH indicator test stripes  
(pH Fix 2.0 – 9.0 and 4.5 – 10.0) 
Macherey-Nagel 
PVDF membrane, pore size 0.45 µm Millipore, Merck 
sterile filters (Ø 0.2 µm) Sarstedt 
thin-layer chromatography plates  
(Alugram®SIL G/UV254) 
Macherey-Nagel 
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2.1.3 Strains and plasmids 
Table 4 lists the bacterial strains used in this study and Table 5 summarizes the employed 
plasmids. 
 
Table 4: Bacterial strains 
Strain Genotype Reference 
Escherichia coli 
BL21 (λDE3) B F- dcm ompT hsdS(rB
- mB
-) gal λ(DE3) Stratagene 
Studier et al., 1990 
DH10B F- mcrA Δ(mrr-hsdRMS-mcrBC) ΔlacX74 
Φ80lacZΔM15 recA1 endA1 araΔ139 
Δ(ara-leu)7697 galU galK λ- rpsL nupG 
(Strr) 
Invitrogen 
Grant et al., 1990 
RosettaTM(λDE3)pLys F– ompT hsdSB(rB
– mB
–) gal dcm (DE3) 
pLysSRARE (Cmr) 
Novagen® 
TOP10 F- mcrA Δ(mrr-hsdRMS-mcrBC) ΔlacX74 
Φ80lacZΔM15 recA1 araΔ139 Δ(ara-
leu)7697 galU galK rpsL endA1 nupG 
(Strr) 
Invitrogen 
ST18 S17 λ-pir ΔhemA Thoma and 
Schobert, 2009 
Pseudomonas aeruginosa PAO1 and MPAO1 derivatives 
PAO1 wild-type Stover et al., 2000 
PAO1 ΔPA0920 markerless deletion mutant of orf 
PA0920 from P. aeruginosa PAO1 
Lorenzo, 2006 
Klein et al., 2009 
PAO1 ΔSacomp PAO1 ΔPA0920 attB::(PPA0920-SamprF-
trrnB); complementation of PAO1 
ΔPA0920 by the integration of the mprF 
gene (Sa113) from S. aureus NCTC 8352, 
controlled by the PPA0920 promoter, into 
the attB site 
this work 
PAO1 ΔBscomp PAO1 ΔPA0920 attB::(PPA0920-BsmprF-
trrnB); complementation of PAO1 
ΔPA0920 by the integration of the mprF 
gene (BSU08425) from B. subtilis subsp. 
subtilis str. 168, controlled by the PPA0920 
promoter, into the attB site 
this work 
PAO1 ΔEfcomp PAO1 ΔPA0920 attB::(PPA0920-EfmprF-
trrnB); complementation of PAO1 
ΔPA0920 by the integration of the 
aaPGS2 gene (gi:69249189) from 
E. faecium DO, controlled by the PPA0920 
promoter, into the attB site 
this work 
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Strain Genotype Reference 
PAO1 ΔPacomp PAO1 ΔPA0920 attB::(PPA0920-PA0920-
trrnB); complementation of PAO1 
ΔPA0920 by the integration of orf 
PA0920 from P. aeruginosa PAO1, 
controlled by the PPA0920 promoter, into 
the attB site 
this work 
PAO1 ΔPa-aa543-881comp PAO1 ΔPA0920 attB::(PPA0920-PA0920-
aa543-881-trrnB); complementation of 
PAO1 ΔPA0920 by the integration of the 
coding sequence for amino acids 543 – 
881 of orf PA0920 from P. aeruginosa 
PAO1, controlled by the PPA0920 
promoter, into the attB site 
this work 
PAO1 ΔPA0919 markerless deletion mutant of orf 
PA0919 from P. aeruginosa PAO1 
Groenewold, 2011 
PAO1 ΔPA0919/PPA0919-PA0919-T  
(Δ19 P19-19) 
PAO1 ΔPA0919 attB::(PPA0919-PA0919-
trrnB); complementation of PAO1 
ΔPA0919 by the integration of orf 
PA0919 from P. aeruginosa PAO1, 
controlled by the PPA0919 promoter, into 
the attB site 
this work 
PAO1 ΔPA0919/PPA0920-PA0919-T  
(Δ19 P20-19) 
PAO1 ΔPA0919 attB::(PPA0920-PA0919-
trrnB); complementation of PAO1 
ΔPA0919 by the integration of orf 
PA0919 from P. aeruginosa PAO1, 
controlled by the PPA0920 promoter, into 
the attB site 
this work 
PAO1 ΔPA0919/PPA0919-T  
(Δ19 P19) 
PAO1 ΔPA0919 attB::(PPA0919-trrnB); 
derivative of PAO1 ΔPA0919 containing 
the PPA0919 promoter within the attB site 
this work 
PAO1 ΔPA0919/PPA0920-T  
(Δ19 P20) 
PAO1 ΔPA0919 attB::(PPA0920-trrnB); 
derivative of PAO1 ΔPA0919 containing 
the PPA0920 promoter within the attB site 
this work 
PAO1 ΔPA0919/PPA0919-PA0919-
Strep-T  
(Δ19 19) 
PAO1 ΔPA0919 attB::(PPA0919-PA0919-
Strep-trrnB); complementation of PAO1 
ΔPA0919 by the integration of orf 
PA0919 from P. aeruginosa PAO1, 
C-terminally fused to a Strep-tag II 
coding sequence, controlled by the 
PPA0919 promoter, into the attB site 
this work 
PAO1 ΔPA0919/PPA0919-PA0919-
Δaa1-34-Strep-T  
(Δ19 1935-427) 
PAO1 ΔPA0919 attB::(PPA0919-PA0919-
Δaa1-34-Strep-trrnB); complementation 
of PAO1 ΔPA0919 by the integration of 
the coding sequence for amino acids 
35 – 427 of orf PA0919 from P. aerugi-
nosa PAO1, C-terminally fused to a 
Strep-tag II coding sequence, controlled 
by the PPA0919 promoter, into the attB 
site 
this work 
PAO1 ΔPA0919 pUCP20T 
(Δ19 pUC) 
PAO1 ΔPA0919 containing the empty 
pUCP20T vector, Cbr 
this work 
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Strain Genotype Reference 
PAO1 ΔPA0919 pUCP20T/PPA0919-
PA0919-Strep 
(Δ19 pUC/19) 
PAO1 ΔPA0919 containing vector 
pUCP20T/PPA0919-PA0919-Strep, Cb
r; 
complementation of PAO1 ΔPA0919 by 
the pUCP20T-encoded orf PA0919 from 
P. aeruginosa PAO1, C-terminally fused 
to a Strep-tag II coding sequence, 
controlled by the PPA0919 promoter 
this work 
PAO1 ΔPA0919 pUCP20T/PPA0919-
PA0919-Δaa1-34-Strep 
(Δ19 pUC/1935-427) 
PAO1 ΔPA0919 containing vector 
pUCP20T/PPA0919-PA0919-Δaa1-34-Strep, 
Cbr; complementation of PAO1 
ΔPA0919 by the pUCP20T-encoded 
coding sequence for amino acids 35 –
427 of orf PA0919 from P. aeruginosa 
PAO1, C-terminally fused to a Strep-tag 
II coding sequence, controlled by the 
PPA0919 promoter 
this work 
PAO1 KS11 PAO1 attB::(mini-CTX2-lacZ); PAO1 
containing the lacZ reporter gene 
without any promoter in the attB site 
Schreiber et al., 
2006 
PAO1-PPA0920-lacZ PAO1 attB::(PPA0920-lacZ); PAO1 con-
taining the PPA0920 promoter fragment 
fused to the lacZ reporter gene in the 
attB site 
Klein et al., 2009 
Spier, 2007 
PAO1 PPA0919-430-lacZ PAO1 attB::(PPA0919-430-lacZ); PAO1 
containing a 430 bp PPA0919 promoter 
fragment fused to the lacZ reporter 
gene in the attB site 
this work 
PAO1 PPA0919-206-lacZ PAO1 attB::(PPA0919-206-lacZ); PAO1 
containing a 206 bp PPA0919 promoter 
fragment fused to the lacZ reporter 
gene in the attB site 
this work 
PAO1 PPA0919-140-lacZ PAO1 attB::(PPA0919-140-lacZ); PAO1 
containing a 140 bp PPA0919 promoter 
fragment fused to the lacZ reporter 
gene in the attB site 
this work 
MPAO1 wild-type Jacobs et al., 2003 
MPAO1 17368 mutant of MPAO1 with transposon 
ISlacZ/hah inserted at base position 711 
of orf PA0919 
Jacobs et al., 2003 
MPAO1 53595 mutant of MPAO1 with transposon 
ISphoA/hah inserted at base position 
532 of orf PA0919 
Jacobs et al., 2003 
Others 
Bacillus licheniformis  
ATCC 14580 
wild-type (DSM 13) Veith et al., 2004 
Bacillus thuringiensis  
serovar Berliner ATCC 10792 
wild-type (DSM 2046) German Collection 
of Microorganisms 
and Cell Cultures 
(DSMZ) 
Bacillus subtilis  
subsp. subtilis str. 168 
wild-type Kunst et al., 1997 
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Strain Genotype Reference 
Burkholderia phymatum  
STM 815 
wild-type (DSM 17167) DSMZ 
Kineococcus radiotolerans 
SRS 30216 
wild-type (DSM 14245) Bagwell et al., 2008 
Phillips et al., 2002 
Methanosarcina barkeri  
str. Fusaro ATCC 29787 
wild-type Maeder et al., 2006 
Paenibacillus polymyxa  
ATCC 842 
wild-type (DSM 36) Jeong et al., 2011 
Pseudomonas aeruginosa  
UCBPP-PA14 
wild-type Lee et al., 2006 
Pseudomonas putida KT2440 wild-type Nelson et al., 2002 
Streptococcus salivarius  
subsp. thermophilus ATCC 19258 
wild-type (DSM 20617) DSMZ 
 
 
Table 5: Plasmids 
Insert sequences introduced into the respective vector were verified by sequencing.  
Plasmid Description Reference 
pBAD-His-A E. coli recombinant protein production vector, 
L(+)-arabinose-inducible expression system, 
N-terminal His6-tag, Ap
r 
Invitrogen 
pBAD-His-A/A2435 pBAD-His-A containing orf Mbar_A2435 from 
M. barkeri ATCC 29787 cloned into XhoI site, Apr 
S. Hebecker, 
unpublished 
pBAD-His-A/Bp4019 pBAD-His-A containing orf Bphy_4019 from 
B. phymatum STM 815 cloned into XhoI/HindIII 
site, Apr 
this work 
pBAD-His-A/Bthur0008_13400 pBAD-His-A containing orf Bthur0008_13400 
from B. thuringiensis ATCC 10792 cloned into 
XhoI/KpnI site, Apr 
this work 
pBAD-His-A/Krad4555 pBAD-His-A containing orf Krad_4555 from 
K. radiotolerans SRS 30216 cloned into 
SacI/HindIII site, Apr 
S. Hebecker, 
unpublished 
pBAD-His-A/Ppoly_aaPGS pBAD-His-A containing aaPGS coding sequence 
from P. polymyxa ATCC 842 cloned into 
SacI/KpnI site, Apr 
this work 
pGEX-6P-1 E. coli recombinant protein production vector, 
Ptac promoter, N-terminal GST-tag, PreScission 
protease specific cleavage site, Apr 
GE Healthcare 
pGEX-6P-1/StMprFΔaa1-503 pGEX-6P-1 containing coding sequence of 
amino acids 504 – 851 of S. thermophilus ATCC 
19258 aaPGS, cloned into BamHI/XhoI site, Apr 
Jäger, 2011 
pGEX-6P-1/YfiXΔaa1-518 pGEX-6P-1 containing coding sequence of 
amino acids 519 – 850 of B. licheniformis ATCC 
14580 YfiX, cloned into BamHI/XhoI site, Apr 
Jäger, 2011 
mini-CTX2 chromosomal integration vector for 
P. aeruginosa, Tetr 
Hoang et al., 
2000 
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Plasmid Description Reference 
mini-CTX2-PTC mini-CTX2 containing the promoter-terminator-
construct (PTC) fragment: native PPA0920 
promoter (187 bp) followed by a linker 
(containing SphI and BamHI sites) and the rrnB 
terminator sequence (158 bp; Invitrogen) 
cloned into SacI/HindIII site, Tetr 
this work 
mini-CTX2-P-SamprF-T mini-CTX2-PTC vector containing mprF (Sa113) 
from S. aureus NCTC 8325 cloned into 
SphI/BamHI site, Tetr 
this work 
mini-CTX2-P-BsmprF-T mini-CTX2-PTC vector containing mprF 
(BSU08425) from B. subtilis subsp. subtilis str. 
168 cloned into SphI/BamHI site, Tetr 
this work 
mini-CTX2-P-EfmprF-T mini-CTX2-PTC vector containing aaPGS2 coding 
sequence (gi:69249189) from E. faecium DO 
cloned into SphI/BamHI site, Tetr 
this work 
mini-CTX2-P-PA0920-T mini-CTX2-PTC vector containing orf PA0920 
(A-PGS) from P. aeruginosa PAO1 cloned into 
SphI/BamHI site, Tetr 
this work 
mini-CTX2- 
P-PA0920-aa543-881-T 
mini-CTX2-PTC vector containing sequence 
encoding A-PGS amino acids 543 – 881 (PA0920 
C-terminal domain) from P. aeruginosa PAO1 
cloned into SphI/BamHI site, Tetr 
this work 
mini-CTX2-PPA0920-PA0919-T mini-CTX2-PTC derivative containing the native 
PPA0920 promoter (187 bp upstream of orf 
PA0920) followed by orf PA0919, inserted into 
SacI/BamHI site, Tetr 
this work 
mini-CTX2-PPA0919-PA0919-T mini-CTX2-PTC derivative containing the native 
PPA0919 promoter (430 bp upstream of orf 
PA0919) followed by orf PA0919, inserted into 
SacI/BamHI site, Tetr 
this work 
mini-CTX2-PPA0919-T  mini-CTX2-PTC derivative containing the native 
PPA0919 promoter (430 bp upstream of orf 
PA0919) inserted into SacI/BamHI site, Tetr  
this work  
mini-CTX2-PPA0919-PA0919-
Strep-T 
mini-CTX2-PTC derivative containing the native 
PPA0919 promoter (430 bp upstream of orf 
PA0919) followed by orf PA0919, fused to a 
Strep-tag II coding sequence, inserted into 
SacI/BamHI site, Tetr 
this work 
mini-CTX2-PPA0919-PA0919- 
Δaa1-34-Strep-T 
mini-CTX2-PPA0919-PA0919-Strep-T derivative, 
PA0919 secretion signal sequence (amino acids 
1 – 34) removed, inserted into SacI/BamHI site, 
Tetr 
this work 
pUCP20T E. coli – P. aeruginosa shuttle vector, Cbr Schweizer et 
al., 1996 
pUCP20T/PPA0919-PA0919- 
Strep 
pUCP20T derivative containing the native PPA0919 
promoter (430 bp upstream of orf PA0919) 
followed by orf PA0919, fused to a Strep-tag II 
coding sequence, inserted into KpnI/BamHI site, 
Cbr 
this work 
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Plasmid Description Reference 
pUCP20T/PPA0919-PA0919- 
Δaa1-34-Strep 
pUCP20T/PPA0919-PA0919-Strep derivative, 
PA0919 secretion signal sequence (amino acids 
1 – 34) removed, inserted into KpnI/BamHI site, 
Cbr 
this work 
mini-CTX-lacZ chromosomal integration vector for 
P. aeruginosa carrying a promoter-less lacZ, Tetr 
Becher and 
Schweizer, 
2000 
mini-CTX-PPA0919-430-lacZ mini-CTX-lacZ derivative containing the 430 bp 
PPA0919 promoter fragment upstream of orf 
PA0919 inserted into KpnI/BamHI site, Tetr 
this work 
mini-CTX-PPA0919-206-lacZ mini-CTX-lacZ derivative containing the 206 bp 
PPA0919 promoter fragment upstream of orf 
PA0919 inserted into KpnI/BamHI site, Tetr 
this work 
mini-CTX-PPA0919-140-lacZ mini-CTX-lacZ derivative containing the 140 bp 
PPA0919 promoter fragment upstream of orf 
PA0919 inserted into KpnI/BamHI site, Tetr 
this work 
pPS858 source of gentamicin resistance cassette, Apr, 
Gmr 
Hoang et al., 
1998 
pEX18Ap gene replacement vector with multiple cloning 
site from pUC18, oriT+, sacB+, Apr 
Hoang et al., 
1998 
pEX18Ap/ΔPA0919 pEX18Ap derivative with 438 bp upstream 
sequence of orf PA0919, gentamicin resistance 
cassette of pPS858 (flanked by BamHI sites) and 
673 bp downstream of orf PA0919, inserted 
into KpnI/HindIII site, Apr, Gmr 
Groenewold, 
2011 
pFLP2 source of FLP recombinase, Apr Hoang et al., 
1998 
pET22b(+) vector for recombinant protein production in 
E. coli, provides a T7 promoter, a PelB secretion 
signal sequence and a C-terminal His6-tag, Ap
r 
Merck 
pET22b(+)/BAS1375Δaa1-527 pET22b(+) derivative encoding for amino acids 
528 – 861 of B. anthracis BAS1375, sequence 
optimized for E. coli coding usage, cloned into 
NdeI/XhoI site, Apr 
Jäger, 2011 
pET22b(+)PA0919 pET22b(+) derivative encoding for amino acids 
35 – 427 of orf PA0919 from P. aeruginosa, 
cloned into NcoI/HindIII site, employed for 
expression of PA0919 fused to PelB sequence 
(N-terminal) and His6-tag (C-terminal), Ap
r 
this work 
pET22b(+)Strep pET22b(+) derivative providing a C-terminal 
Strep-tag II, cloned into HindIII/XhoI site, Apr 
T. Nicke, 
unpublished 
pET22b(+)PA0919-Strep pET22b(+)Strep derivative encoding amino acids 
35 – 427 of orf PA0919 from P. aeruginosa, 
cloned into NcoI/HindIII site, employed for 
expression of PA0919 fused to PelB sequence 
(N-terminal) and Strep-tag II (C-terminal), Apr 
this work 
pET22b(+)PA0919-S240A-
Strep 
pET22b(+)PA0919-Strep derivative, amino acid 
serine 240 changed to alanine, Apr 
this work 
pET22b(+)PA0919-S307A-
Strep 
pET22b(+)PA0919-Strep derivative, amino acid 
serine 307 changed to alanine, Apr 
this work 
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Plasmid Description Reference 
pET22b(+)PA0919-H401A-
Strep 
pET22b(+)PA0919-Strep derivative, amino acid 
histidine 401 changed to alanine, Apr 
this work 
pET28b(+)PA0903 E. coli expression vector pET22b(+) carrying orf 
PA0903 (P. aeruginosa alanyl-tRNA synthetase) 
cloned into NdeI/BamHI site, T7 promoter, 
N-terminal His6-tag, Kan
r 
Hebecker et 
al., 2011 
 
 
2.1.4 Oligodeoxynucleotides 
Oligodeoxynucleotides employed for cloning are summarized in Table 6, whereas oligo-
deoxynucleotides used for sequencing purposes are listed in Table 7. 
 
Table 6: Oligodeoxynucleotides for cloning purposes 
Restriction sites are indicated by bold letters, nucleotides inserted for reading frame compliance 
are highlighted gray. Specifically indicated primers were taken from: 1 Jäger, 2011; 2 Groenewold, 
2011; 3 T. Nicke, unpublished. 
Promoter-terminator construct restriction sites are indicated in bold letters (SacI, SphI, BamHI, 
HindIII; in the given order). Promoter (between SacI and SphI) and terminator (between BamHI 
and HindIII) sequences are italicized and separated by a linker sequence (between SphI and 
BamHI).  
No. Name Sequence (5’-3’) 
1 Bp4019XhoIfw GATACTCGAGATGTCTGACCATCCCCGCTC 
2 Bp4019HindIIIrv TCGTATAAGCTTTCATGAACGCCGGCCCCCTG 
3 BthuXhoIfw CCAGTACTCGAGATGTCGTTTTCATGG 
4 BthuKpnIrv CGTTGAGGTACCCTAAGAATTTAGCTG 
5 4555KrSacIfw GATAGAGCTCGTGCTCGGTGACCGGATCCTC 
6 4555KrHindIIIrv TCGTATAAGCTTTCAGCTGTGGACGACCCCGC 
7 Mbar2435XhoIfw GCTATCTCGAGATGACAGACAAAGGAAG 
8 Mbar2435XhoIrv GCTATCTCGAGTCAGGTGAGTTCTTCGG 
9 Paeni1SacIfw GGAGGTGAGCTCATGAAWTCWAATCACAAACCG 
10 Paeni1KpnIrv GGTTGTGGTACCTTAGTCCGAGCGTTTGG 
111 BaNdeI22fw GCGCCATATGAATCGTTATCGTAATGAATTTC 
121 BaXhoI22rv GGGGCTCGAGGCTATTTTTGCGTTTAC 
131 StBamHIGexfwG GCGCGGATCCAGAGTTTTGGCACCTCGTAAG 
141 StXhoIGexrv GGGGCTCGAGTTACTTCCAAAGACGTCTTTTC 
151 BlBamHIGexfw GCGCGGATCCAACAGGAAAACGAAAGAG 
161 BlXhoIGexrv GGGGCTCGAGTCATTTCGTTCTCCTTCC 
17 miniSphSafw CGAGGCGCATGCAGATGAATCAGGAAG 
18 miniBamSarv GGCGCCGGATCCTTATTTGTGACGTATTACAC 
19 miniSphBsfw CCGGCGGCATGCTGATTAAAAAGAATGC 
20 miniBamBsrv CGGCGGGGATCCTTAGACGGAGTCTTTTTTGC 
21 miniSphEffw GGGCCCGCATGCAGGTGATTTATTTGTTAAAAAATACC 
22 miniBamEfrv GCGCGCGGATCCATACTTTCTTCGTATC 
23 miniSphPaflfw GTTATAGCATGCGCACCGACGCTCC 
24 miniSphPalfw GAATTAGCATGCGCGCGGCACC 
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No. Name Sequence (5’-3’) 
25 miniBamPalrv GCACTGGGATCCTCAGCGTTTCACCAATC 
262 KoPCR1PA0919Kpn-fw GCAATGGGTACCGCATCGCCATCGTC 
272 KoPCR1PA0919Bam-rv CGTTCAGGATCCATCAGCGTTTCACC 
282 KoPCR2PA0919Bam-fw GGTAATGGATCCTCGCGATCAAGCTCTC 
292 KoPCR2PA0919Hind-rv GGTTGCAAGCTTGTCGCGGCTGAC 
30 pPA0919SacIfw GATAACGAGCTCATCGTCCGCCACCAG 
31 PA0919BamHIrv GCATAAGGATCCTCAGGCGTCGGGAGC 
32 PA0919SphIfw CCAAGAGCATGCTGATGTCTGTCGTGAAACG 
33 pPA0919lacZKpnIfw CATCATGGTACCATCGTCCGCCACCAG 
34 pPA0919lacZKpnI+35fw GCATAGGGTACCGTTGACCCAGC 
35 pPA0919lacZKpnIshortfw GCATAGGGTACCGCGACGCTTCAAG 
363 A AGCTTCTCAGCGCTTGGAGCCACCCGCAGTTCGAAAAATAATAAC
TGCAGC 
373 B TCGAGCTGCAGTTATTATTTTTCGAACTGCGGGTGGCTCCAAGCG
CTGAGA 
38 PA0919deltaAS1-34NcoIfw GAATCACCATGGCGAAACTGGAAGCCCTGGAC 
39 PA0919HindIIIrv GATAGCAAGCTTGGCGTCGGGAGCGTTCTC 
40 PA0919_S240A_fw CACCCTGTTCTATGCCGGCGACGGCGG 
41 PA0919_S240A_rv CCGCCGTCGCCGGCATAGAACAGGGTG 
42 PA0919_S307A_fw CCTGGCCGGCTACGCCTTCGGCGCTGAC 
43 PA0919_S307A_rv GTCAGCGCCGAAGGCGTAGCCGGCCAGG 
44 PA0919_H401A_fw CTGCCGGGCGGCGCCCACTTCGACGAG 
45 PA0919_H401_rv CTCGTCGAAGTGGGCGCCGCCCGGCAG 
46 pPA0919Kpnlocal-fw CCTAAGGGTACCATCGTCCGCCACCAGG 
47 PA0919StrepII-Bam-rv GCAAGTGGATCCTTATTATTTTTCGAACTGCGGGTGGCTCCAAGC
GCTGAGAATCTTGGCGTCGGGAGC 
48 1_deltaPA0919AS1-34fw GGATTGGTGAAACGCTGATATGAAACTGGAAGCCCTGG 
49 1_deltaPA0919AS1-34rv CCAGGGCTTCCAGTTTCATATCAGCGTTTCACCAATCC 
promoter-terminator construct GAGCTCGCTGAACCATCGCTGAACGAATACCAGCAAATGGCCTTC
GGCCACTTCGCCGACGCAACTCCTGCAAAACCCGGCGGTCTTCTCC
CTGTGACAGGACGCCGCCCCGCACAGAAAAAATCTGCTGCGACCA
CTTGGGAACTCGCCCGAGAGGCCATACTCTGTCGCGCAAATTCCC
ATGAGGTGGCGCATGCGACTATCGGTGGATCCTGCCTGGCGGCA
GTAGCGCGGTGGTCCCACCTGACCCCATGCCGAACTCAGAAGTGA
AACGCCGTAGCGCCGATGGTAGTGTGGGGTCTCCCCATGCGAGA
GTAGGGAACTGCCAGGCATCAAATAAAACGAAAGGCTCAGTCGA
AAGACTGGGCCTTAAGCTT 
The construct was employed to integrate the sequences of the 
PPA0920 promoter and the rrnB terminator (flanked by 
designated restriction sites) into the mini-CTX2 vector. 
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Table 7:  Oligodeoxynucleotides employed for sequencing 
Specifically indicated primers were taken from: 1 Lorenzo, 2006; 2 Jäger, 2011; 3 Spier, 2007; 
4 S. Hebecker, unpublished; 5 primer collection AK Jahn; 6 standard primer from GATC Biotech 
(Konstanz, Germany). 
No. Name Sequence (5’-3’) 
1 pBADfw GATTAGCGGATCCTACCTG 
21 pBAD_r_seq GATTTAATCTGTATCAGG 
3 pBADBthufw GCGTATATGTCATTGCTGC 
4 pBADBthu2fw CTTATCGGAATATTAGACACGAG 
5 pBADBthu3fw GGAATTGATGTTGAAGAAACG 
6 pBADBphyfw CATCGAGCAGATCCTGCTGG 
7 pBADBphy2fw GCGCTCGTTCTGATGACTG 
8 pBADBphy3fw GACGCTGGGTCTCGCTGTC 
9 pBADMbarfw CCCTGCTTCATGTCCTTGTG 
10 pBADPpolyfw GTGCTGGATGCTCACCCATGG 
11 pBADPpolyrv CCAGCCGAGTGAATATCC 
122,5 pGEX-6P-1 fw CCTCCAAAATCGGATCTG  
132,5 pGEX-6P-1 rv CACCGTCATCACCGAAAC  
142,6 pGEX-5 fw CTGGCAAGCCACGTTTGG  
152,6 pGEX-3 rv GGAGCTGCATGTGTCAGAG  
162,6 T7 fw TAATACGACTCACTATAGGG  
172 T7 term rv CGTTTAGAGGCCCCAAG 
182 pET-RP rv CTAGTTATTGCTCAGCGG 
193 oNB-51 CTCAGCCCGAAGCCGGTGTT 
203 oNB-53 GAAATCCGGCTGTTGCCCTG 
21 SeqSa1fw GTAGCAATCACATTGTATC 
22 SeqSa1rv GAATAACAAGCGATGCC 
23 SeqSa2fw GGATTGTACTGCACTTTAG 
24 SeqSa3fw GACGGAAATCACTTAACG 
25 SeqSa4fw GCGAGGAGATTATTAATCAG 
26 SeqSa5fw GGCTAGATAATCGTCAG 
27 SeqSa6fw CCGAATTGGGAACCAC 
28 SeqBs1fw GTCATTCAAACGTACGC 
29 SeqBs1rv CGCAGTGAGTACTTCAGGAC 
30 SeqBs2fw CGCATATATTGGAGCTTCAG 
31 SeqBs3fw GTTATACCGCACATTCC 
32 SeqBs4fw GCGTCTTGCTGCGTTTC 
33 SeqBs5fw GAAGGGATTCTCGCTCG 
34 SeqBs6fw GAGTGGCGAGGGAAATAC 
35 SeqEf1fw CCACCTAGGACTGTTC 
36 SeqEf1rv GCATTAGTCCGCTTTTCC 
37 SeqEf2fw CGGCGGTCTATATTTTCC 
38 SeqEf3fw GTACTTTCTGCCACTATCC 
39 SeqEf4fw GGCCATCATCGCTGTTAG 
40 SeqEf5fw GTCTTACAACCACCATTTTC 
41 SeqEf6fw CTGGGTCTCACGTTATAC 
421 SPA0920-1850r GAATTGCCAGATCAGTTC 
431 SPA0920-1420r GAAGGGTACTTCCATCAG 
441 SPA0920-950r ATCAAGCGGTACAAGAGC 
451 SPA0920-410r GGGAATACAGTCGGTAGC 
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No. Name Sequence (5’-3’) 
461 SPA0920-2360r CTTGTAGTGGAGGATGAG 
474 Sp1MprFHisf GACGCTTCAAGGACAAGTTC  
484 Sp2MprFHisf CTTCTTCCGCATCGCCATC  
49 SeqPafl1rv GATCAGCCGGATGCGTTGTG 
50 miniCTX2rrnBrv GGCAGTTCCCTACTCTCGC 
51 PA0919_2rv GACCTCGAGTACCGGCAG 
526 pET-24a GGGTTATGCTAGTTATTGCTCAG  
536 M13-FP TGTAAAACGACGGCCAGT  
546 M13-RP CAGGAAACAGCTATGACC  
 
 
 
2.2 Sterilization, media and additives 
Sterilization conditions, media and additives employed in this study are summarized in the 
following sections. 
 
2.2.1 Sterilization 
Media and subjects were vapor sterilized using 121 °C and 1 bar excess pressure for 20 min. 
Temperature sensitive solutions were filtrated employing a filter pore width of 0.2 µm. 
 
2.2.2 LB medium 
All bacterial strains (except Streptococcus thermophilus; see Jäger, 2011) were cultivated in 
Luria Bertani medium (LB; Sambrook and Russell, 2001) unless indicated otherwise. 
 LB medium tryptone 10 g/L 
  yeast extract 5 g/L 
  NaCl 5 g/L 
Solid medium was obtained by adding 15 g/L agar-agar previous to sterilization. 
 
2.2.3 AB medium 
AB medium without citrate (Heydorn et al., 2000) supplemented with glucose was employed 
to cultivate P. aeruginosa PAO1, P. aeruginosa PA14 and Pseudomonas putida. The addition 
of an appropriate phosphate buffer resulted in modified AB medium adjusted to a specific 
pH value. The resulting AB medium showed a pH value that was increased by 0.3 units when 
compared to the employed A10 solution. 
 -37- Materials and methods 
 AB medium A10 100 mL/L 
  1 M D(+)-glucose 20 mL/L 
  14 mg/mL FeSO4 x 7 H2O 0.5 mL/L 
  trace elements 1 mL/L 
  1 M MgCl2 1 mL/L 
  1 M CaCl2 0.1 mL/L 
All components were prepared as stock solutions. A10 solutions, MgCl2 and CaCl2 were 
sterilized by autoclaving and glucose, FeSO4 and trace elements were filtrated for 
sterilization. 
 A10 solution pH 7.0 pH 6.0 pH 5.0 pH 4.0 
  (NH4)2SO4 20 g/L 20 g/L 20 g/L 20 g/L 
  Na2HPO4 300 mM 62.5 mM 20 mM 1 mM 
  KH2PO4 150 mM 387.5 mM 430 mM 449 mM 
 trace elements CaSO4 x 2 H2O 200 mg/L 
  FeSO4 x 7 H2O 200 mg/L 
  MgSO4 x H2O 20 mg/L 
  CuSO4 x 5 H2O 20 mg/L 
  ZnSO4 x 5 H2O 20 mg/L 
  Na2MoO4 x H2O 10 mg/L 
  H3BO3 5 mg/L 
 
2.2.4 SMM 
B. subtilis, Bacillus thuringiensis, Bacillus licheniformis and Paenibacillus polymyxa were 
cultivated in Spizizen’s minimal medium (SMM; Harwood and Cutting, 1990). 
 SMM medium SMM basis 880 mL/L 
  10x SMM mixture 100 mL/L 
  100x SMM trace elements 10 mL/L 
  10 % Casamino acids 10 mL/L 
The ingredients were prepared and sterilized. SMM basis was prepared with a pH of 7.0. If 
other pH values were requested, SMM basis was adjusted using 85 % phosphoric acid. SMM 
basis and Casamino acids solutions were autoclaved, whereas 10x SMM mixture and 100x 
SMM trace elements were filtrated for sterilization. 
 SMM basis pH 7.0 (NH4)2SO4 17 mM 
  K2HPO4 91 mM 
  KH2PO4 50 mM 
  trisodium citrate x 2 H2O 4 mM 
  MgSO4 x 7 H2O 0.9 mM 
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 10x SMM mixture L-phenylalanine 3 mM 
  L-tryptophan 2.5 mM 
  thiamine chloride x HCl 15 µM 
  D(+)-glucose x H2O 500 mM 
  sodium pyruvate 500 mM 
 100x SMM trace elements CaCl2 x 2 H2O 5.4 mM 
  FeCl2 x 4 H2O 5.75 mM 
  MnCl2 x 4 H2O 0.5 mM 
  ZnCl2 1.25 mM 
  CuCl2 x 2 H2O 0.25 mM 
  CoCl2 x 6 H2O 0.25 mM 
  Na2MoO4 x 2 H2O 0.25 mM 
 
2.2.5 R2A medium 
For the cultivation of Burkholderia phymatum, Reasoner’s 2A medium (R2A; Reasoner and 
Geldreich, 1985) was used. If solid medium was needed, 15 g/L agar-agar was added before 
autoclaving. 
 R2A medium yeast extract 0.5 g/L 
  BactoTM Proteose Peptone no. 3 0.5 g/L 
  Casamino acids 0.5 g/L 
  D(+)-glucose 0.5 g/L 
  soluble starch 0.5 g/L 
  sodium pyruvate 0.3 g/L 
  K2HPO4 0.3 g/L 
  MgSO4 x 7 H2O 0.05 g/L 
 
2.2.6 TSB medium 
S. thermophilus was cultivated in trypticase soy broth medium (TSB; Yousef and Carlstrom, 
2003) supplemented with 0.3 % yeast extract (Jäger, 2011). For the preparation of solid 
medium, 15 g/L agar-agar was added before vapor sterilization. 
 TSB medium yeast extract 3 g/L 
  BactoTM Tryptone 17 g/L 
  BactoTM Soytone 3 g/L 
  D(+)-glucose x H2O 2.5 g/L 
  NaCl 5 g/L 
  K2HPO4 2.5 g/L 
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2.2.7 Additives 
Media additives were prepared as concentrated solutions, sterilized by filtration and stored 
at –20 °C. For E. coli and P. aeruginosa, different final concentrations were used. Additives 
were dissolved in water if no solvent is indicated (Table 8).  
 
Table 8: Media additives  
Media additive Stock solution Final concentration 
E. coli P. aeruginosa 
5-aminolevulinic acid (ALA) 50 mg/mL 50 µg/mL – 
ampicillin (Ap) 100 mg/mL 100 µg/mL – 
carbenicillin (Cb) 100 mg/mL 100 µg/mL 250 µg/mL 
chloramphenicol (Cm) 34 mg/mL (ethanol) 34 µg/mL – 
gentamicin (Gm) 10 mg/mL 10 µg/mL 50 µg/mL 
kanamycin (Kan) 30 mg/mL 30 µg/mL – 
tetracycline (Tet) 12.5 mg/mL 12.5 µg/mL 80 µg/mL 
isopropyl-β-D-thiogalactopyranoside 
(IPTG) 
0.5 M 25 – 300 µM – 
L(+)-arabinose 20 % (w/v) 0.2 – 2.0 % (w/v) – 
D(+)-sucrose 50 % (w/v) – 5 % (w/v) 
 
 
 
2.3 Microbiological procedures 
Bacterial cells were cultivated and stored as summarized in the following chapters.  
 
2.3.1 Cultivation of bacterial cells  
Bacterial cells were grown at 37 °C (B. phymatum: 30 °C) and 200 rpm (S. thermophilus: 
without shaking, Jäger, 2011). Pre-cultures (5 – 100 mL of the respective medium 
supplemented with the respective antibiotics, in baffled flasks) were inoculated using a 
single colony from a plate culture or a glycerol stock culture and cultivated overnight 
(S. thermophilus: for 3 d; Jäger, 2011). 
Plate cultures were prepared by plating a bacterial cell suspension (5 – 100 µL) or by 
streaking cells with an inoculating loop and were incubated overnight (S. thermophilus: for 
3 – 5 d; Jäger, 2011). 
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2.3.2 Determination of cell density 
For the determination of liquid bacterial cell culture densities, the optical density (OD) at 
578 nm was determined photometrically. An OD578 of 1 represents a cell culture density of 
approximately 1 x 109 cells per mL (Sambrook and Russell, 2001). 
 
2.3.3 Storage of bacteria 
For long term storage, glycerol cultures (20 % (w/v)) were prepared by mixing a bacterial 
overnight culture with the appropriate amount of 80 % (w/v) sterile glycerol. Cultures were 
stored at –80 °C (Sambrook and Russell, 2001). 
 
2.3.4 Cultivation of E. coli for recombinant protein production 
For the production of recombinant protein in E. coli, 500 mL LB medium (in baffled flasks) 
were inoculated (1:100, v/v) employing a pre-culture and incubated at 37 °C and 200 rpm 
until a specific culture turbidity was reached. Protein production was induced by IPTG or 
L(+)-arabinose and cells were further incubated (for additive concentrations and cultivation 
specifications, see the respective method and section 2.2.7). 
 
2.3.5 Determination of P. aeruginosa growth phenotypes  
Growth phenotypes of P. aeruginosa strains were determined using AB medium at pH 7.3 
and pH 5.3 (Heydorn et al., 2000). Pre-cultures (AB medium pH 7.3, supplemented with the 
respective antibiotics) were inoculated using a single colony from a plate culture and 
incubated at 37 °C and 200 rpm overnight. Main cultures (60 mL AB medium in baffled flasks 
supplemented with the respective antibiotics) were inoculated to an OD578 of 0.05 and 
cultured at 37 °C and 200 rpm. Growth was monitored by measuring the OD578 at distinct 
time points.  
 
 
2.4 Molecular biological methods 
The molecular biological techniques employed for the preparation of competent E. coli cells, 
transformation as well as DNA extraction, purification, amplification, cloning and 
manipulation are summarized in the following sections. Moreover, procedures used for 
P. aeruginosa deletion mutant strain construction and complementation techniques are 
presented. 
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2.4.1 Preparation of CaCl2 competent E. coli cells 
100 mL LB medium (in baffled flasks, with additives if required) were inoculated using an 
overnight pre-culture in a ratio of 1:100 (v/v) and cultured at 37 °C and 200 rpm. When the 
culture density had reached an OD578 of 0.6 – 0.8, cells were harvested by centrifugation 
(3’000 x g, 10 min, 4 °C). After washing with 10 mL cold CaCl2 solution, the cells were 
suspended in 1 mL of the same solution and stored at –80 °C in aliquots of 50 – 200 µL 
(Sambrook and Russell, 2001). 
 CaCl2 solution CaCl2 0.1 M 
  glycerol 10 % (w/v) 
 
2.4.2 Preparation of RbCl competent E. coli cells 
RbCl competent E. coli cells were prepared according to Engler et al., 2008. After inoculation 
of 500 mL LB medium (in baffled flasks, with additives if required) in a ratio of 1:100 (v/v) 
using an overnight pre-culture, the cells were cultivated at 37 °C and 200 rpm to a culture 
density of OD578 = 0.5. The cells were harvested (3’000 x g, 10 min, 4 °C), suspended in cold 
TFB-I solution and incubated on ice for 5 min. After sedimentation (4’500 x g, 10 min, 4 °C), 
the cells were suspended in 2 – 3 mL cold TFB-II buffer, incubated on ice for 1 h and stored 
at –80 °C in aliquots of 50 – 200 µL. 
 TFB-I potassium acetate 30 mM 
  CaCl2 10 mM 
  MnCl2 50 mM 
  RbCl 100 mM 
  glycerol 15 % (w/v) 
  adjusted to pH 5.8 with acetic acid, sterilized by filtration 
 TFB-II piperazine-N,N’-bis(2-ethanesulfonic acid) 
  (PIPES)-HCl pH 6.5 10 mM 
  CaCl2 75 mM 
  RbCl 10 mM 
  glycerol 15 % (w/v) 
  adjusted to pH 6.5 with KOH, sterilized by filtration 
 
2.4.3 Transformation of competent E. coli cells by heat shock 
50 – 100 µL competent E. coli cells were mixed with 1 – 10 µL plasmid solution (50 µg/mL) 
and incubated on ice for 20 min. The heat shock was performed at 42 °C for 45 sec and 
subsequently, the cells were incubated on ice for 2 min. After suspending in 250 – 500 µL LB 
medium, the cells were incubated at 37 °C and 300 rpm for 1 h. For the selection of 
transformed clones, an appropriate amount of cells was plated on LB agar plates containing 
the respective antibiotics and incubated at 37 °C overnight (Sambrook and Russell, 2001).  
Materials and methods -42-  
2.4.4 Extraction of plasmid DNA 
Two different protocols were used to extract plasmid DNA from bacteria: The first provides 
highly purified plasmid DNA, whereas the second procedure is time-saving and results in 
high amounts of plasmid DNA. All centrifugation steps were performed at room temperature 
(RT) and 11’000 x g unless indicated otherwise. 
To obtain highly purified plasmid DNA, plasmid containing E. coli cells were grown as 
overnight cultures in LB medium supplemented with the respective antibiotics. The cells 
were harvested (4 mL culture, 5 min), suspended in 150 µL GTE buffer and incubated for 
2 min. 300 µL NaOH/SDS were added to lyse the cells and the sample was mixed carefully by 
inverting the tube. After incubation for 5 min, 225 µL sodium acetate were added, the 
sample was mixed and incubated for 5 min. Denatured proteins and insoluble cell 
compounds were separated by centrifugation for 5 min and the plasmid DNA was 
precipitated by adding 600 µL isopropanol to the supernatant. The plasmid DNA was 
sedimented for 10 min, solved in 200 µL TES buffer containing 3 µL RNase A and incubated at 
37 °C for 30 min. For plasmid DNA extraction, the sample was mixed with 200 µL CPI and 
centrifuged for 3 min. The upper, aqueous phase containing the plasmid DNA was removed, 
mixed with 400 µL 100 % ethanol and incubated for 5 min. After centrifugation for 15 min, 
the sedimented DNA was washed with 500 µL 70 % ethanol, dried at 50 °C, dissolved in 50 µL 
dH2O and stored at –20 °C (Sambrook and Russell, 2001). 
To obtain high amounts of plasmid DNA, 4 mL of an E. coli overnight culture were harvested 
and the cell sediment was suspended in 300 µL buffer P1. 300 µL NaOH/SDS were added and 
mixed by inverting the tube. Proteins were denatured by the addition of 300 µL potassium 
acetate and separated together with cell debris by centrifugation for 15 min. The plasmid 
DNA containing supernatant was mixed with 600 µL isopropanol and precipitated DNA was 
sedimented at 4 °C for 15 min. The sediment was washed with 400 µL 70 % ethanol at 4 °C, 
dried at 50 °C, dissolved in 50 µL dH2O and stored at –20 °C (Sambrook and Russell, 2001). 
 GTE D(+)-glucose 50 mM 
  tris(hydrolxymethyl)aminomethane  
  (Tris)-HCl pH 8.0 25 mM 
  ethylenediaminetetraacetic acid  
  (EDTA) 10 mM 
 P1 Tris-HCl pH 8.0 50 mM 
  EDTA 10 mM 
  RNase A 100 µg/mL 
 NaOH/SDS NaOH 200 mM 
  sodium dodecyl sulfate (SDS) 1 % (w/v) 
 sodium acetate sodium acetate 3 M 
  adjusted to pH 4.8 with acetic acid  
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 potassium acetate potassium acetate 3 M 
  adjusted to pH 5.5 with acetic acid  
 TES Tris-HCl pH 8.0 50 mM 
  EDTA 10 mM 
  NaCl 150 mM 
 CPI phenol 50 % (v/v) 
  chloroform 49 % (v/v) 
  isoamyl alcohol 1 % (v/v) 
 RNase A RNase A 10 mg/mL 
  solved in 50 % glycerol 
 
2.4.5 Extraction of genomic DNA 
Genomic DNA was extracted using a modified protocol according to Lahiri et al., 1992. 
Bacterial cells were cultured in 5 mL of the respective medium and grown at 37 °C overnight. 
1.5 mL culture were centrifuged (11’000 x g, 5 min, RT), cells were suspended in 200 µL lysis 
buffer and 66 µL 5 M NaCl were added. After intensive mixing, 1 µL RNase A was added and 
the sample was incubated at 37 °C for 30 min. Cell debris was separated by centrifugation 
(11’000 x g, 10 min, 4 °C) and the supernatant was gently mixed with chloroform (1:1, v/v). 
After an additional centrifugation step (11’000 x g, 3 min, RT), the upper DNA containing 
aqueous phase was mixed with 100 % ethanol (1:2, v/v) for DNA precipitation. The DNA was 
sedimented (11’000 x g, 15 min, 4 °C) and washed twice with 200 µL 70 % ethanol 
(11’000 x g, 5 min, 4 °C). The sediment was dried at 70 °C, the genomic DNA was solved in 
50 µL dH20 and stored at 4 °C.  
 lysis buffer EDTA 1 mM 
  sodium acetate 20 mM 
  SDS 1 % (w/v) 
  Tris-acetate pH 7.8 40 mM 
 RNase A RNase A 10 mg/mL 
  solved in 50 % glycerol 
 
2.4.6 Determination of DNA concentration 
The absorbance of a DNA sample at 260 and 280 nm was determined spectrophoto-
metrically. An absorbance of 1 at 260 nm corresponds to a double-stranded DNA 
concentration of 50 ng/µL. Protein impurities show a maximum absorption at 280 nm. The 
quotient A260/A280 indicates the DNA sample purity. The DNA sample is supposed to be pure 
when A260/A280 = 1.8 – 2.0 (Sambrook and Russell, 2001).  
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2.4.7 DNA amplification by polymerase chain reaction (PCR) 
DNA fragments were amplified by PCR using the Phusion® High-Fidelity DNA Polymerase or 
the Taq DNA Polymerase. The polymerases, their corresponding buffers and the 
deoxynucleotide triphosphate (dNTP) mixture were obtained from New England Biolabs 
(Ipswich, MA, USA). Oligodeoxynucleotides were designed to bind specific target site 
sequences and provided restriction endonuclease recognition sites, if the fragment was 
amplified for cloning purposes (for primers used in this study, see Table 6).  
PCR reactions (total volume: 20 µL) were composed of a dNTP mixture, the respective 
primers containing the desired target sites for restriction endonucleases, the DNA 
polymerase and a polymerase-specific buffer. The template DNA was either provided as an 
aqueous solution or a bacterial colony was added to the mixture. Colonies of gram positive 
organisms or of P. putida were lysed before subjecting to PCR. For this, a cell colony was 
suspended in 20 µL lysis buffer and treated at 95 °C for 15 min. Subsequently, 180 µL dH2O 
were added and 1 µL of this mixture was used as PCR template. The compositions of 
reactions using the Phusion® High-Fidelity DNA Polymerase or the Taq DNA Polymerase are 
summarized below.  
During PCR, the template DNA was initially denatured (98 °C, 5 – 10 min) and subsequently, 
DNA amplification took place in 30 cycles consisting of denaturation (98 °C, 10 sec), primer 
annealing (55 – 75 °C, 15 – 30 sec) and elongation (72 °C, time period depending on the 
target DNA length and the processivity of the employed polymerase; Phusion®: 30 sec/kb; 
Taq: 60 sec/kb). After a final elongation step (72 °C, 10 min), PCR samples were stored at 
4 °C (Sambrook and Russell, 2001).  
 compounds Phusion® polymerase Taq polymerase 
 template DNA colony or 0.2 – 5 ng colony or 0.2 – 5 ng 
 buffer 4 µL GC (5x) or HF (5x) 2 µL ThermoPol® (10x) 
 dNTP mixture 0.2 mM 0.2 mM 
 forward primer 1 µM 1 µM 
 reverse primer 1 µM 1 µM 
 polymerase 20 U/mL 20 U/mL 
 dH2O add to 20 µL add to 20 µL 
 lysis buffer NaOH 50 mM 
  SDS 0.25 % (w/v) 
 
2.4.8 DNA fragment purification after PCR 
After PCR, amplified DNA fragments were purified using the QIAquick PCR Purification Kit 
(Qiagen, Hilden, Germany) according to the manufacturer’s instructions. 
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2.4.9 Restriction of DNA 
DNA fragments amplified by PCR and plasmid DNA were digested by restriction 
endonucleases (New England Biolabs, Ipswich, MA, USA) according to the manufacturer’s 
instructions. 
 
2.4.10 Agarose gel electrophoresis 
DNA fragments of different length obtained by PCR or restriction digest were separated by 
agarose gel electrophoresis. 
DNA samples were mixed with loading dye and loaded onto an agarose gel (1 – 2 % (w/v) 
agarose in TAE buffer). For DNA fragment size determination, a DNA standard was handled 
analogously (GeneRulerTM DNA Ladder Mix; Thermo Fisher Scientific, Waltham, MA, USA). 
Electrophoresis was performed using a voltage of 80 – 100 V and for DNA detection, the gel 
was incubated with ethidium bromide solution (10 µg/mL) for 20 min or with GelStar™ 
Nucleic Acid Gel Stain (Lonza, Basel, Switzerland) for at least 30 min. Then, the DNA was 
visualized using UV light or blue light, respectively (Sambrook and Russell, 2001).  
 loading dye (6x) bromophenol blue 350 µM 
  xylene cyanol FF 450 µM 
  glycerol 50 % (w/v) 
 TAE buffer Tris-acetate pH 8.0 40 mM 
  EDTA 1 mM 
 
2.4.11 Purification of digested PCR fragments and plasmids 
After restriction endonuclease treatment, DNA fragments and vectors were separated by 
agarose gel electrophoresis and the gel was stained with GelStarTM Nucleic Acid Gel Stain 
(section 2.4.10). Target DNA fragments were excised and purified employing the QIAquick 
Gel Extraction Kit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions. 
 
2.4.12 Ligation 
DNA fragments and vectors were ligated employing the T4 DNA Ligase (New England Biolabs, 
Ipswich, MA, USA) according to the manufacturer’s instructions in varying ratios in a final 
volume of 20 µL. Samples were incubated at RT for 30 min and the resulting plasmids were 
transformed into E. coli cells (section 2.4.3). 
 
 
Materials and methods -46-  
2.4.13 Sequencing 
DNA sequence determination was performed by GATC Biotech (Konstanz, Germany) 
according to Sanger’s method (Sanger et al., 1977). Sequence files were analyzed using the 
Lasergene® software package (DNASTAR, Madison, WI, USA). 
 
2.4.14 Site-directed mutagenesis 
Site-directed mutagenesis is a versatile method to exchange single or few base pairs in DNA 
sequences (Sambrook and Russell, 2001). In this work, the QuikChange® II Site-Directed 
Mutagenesis Kit (Stratagene, La Jolla, CA, USA) was employed according to the 
manufacturer’s instructions in a final volume of 25 µL. The sequence to be mutated was 
plasmid encoded and specific primers contained the designated nucleotide sequence 
mutations. During PCR, the primers annealed to the template DNA and mutated plasmids 
were synthesized. To eliminate unmodified template plasmids, the obtained PCR samples 
were incubated with the restriction endonuclease DpnI specifically digesting methylated 
DNA which had been synthesized within a bacterial cell. The mutated plasmids were 
amplified using E. coli DH10B.  
 
2.4.15 Plasmid construction 
The plasmids generated in this study were constructed by inserting amplified target 
sequences into well-established vectors. The respective plasmids are summarized in Table 5 
and employed oligodeoxynucleotides are listed in Table 6 and Table 7. Methods employed 
for the plasmid construction are given in sections 2.4.1 to 2.4.14. 
 
Plasmid construction for recombinant aaPGS activity analysis (full-length enzymes) 
Gene sequences of selected putative aaPGSs were cloned into the pBAD-His-A vector 
designed for recombinant protein expression in E. coli TOP10 (Invitrogen, Karlsruhe, 
Germany). The vector provides the PBAD promoter (of araBAD) inducible by L(+)-arabinose in 
a dose-dependent manner (Guzman et al., 1995).  
Orfs Bphy_4019 (B. phymatum STM 815), Bthur0008_13400 (B. thuringiensis ATCC 10792), 
Krad_4555 (K. radiotolerans SRS 30216) and Mbar_A2435 (Methanosarcina barkeri str. 
Fusaro ATCC 29787) were amplified from genomic DNA by PCR. Since the aaPGS encoding 
sequence of P. polymyxa ATCC 842 was not available, the orf was amplified using random 
primers designed on the basis of aaPGS homologs from P. polymyxa SC2 and E681 (not 
shown). Plasmids pBAD-His-A/Krad4555, pBAD-His-A/Bp4019 and pBAD-His-A/A2435 were 
generously provided by S. Hebecker (unpublished). Insert sequences were verified by 
sequencing using primers 1 – 9 (Table 7). For the P. polymyxa ATCC 842 aaPGS, internal 
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sequencing primers 10 and 11 (Table 7) were designed after successive sequence 
elucidation. The obtained P. polymyxa aaPGS encoding sequence is given the appendix 
(section 8.1).  
 orf primer no. fragment restriction resulting plasmid 
  (Table 6) (bp) sites 
 Bphy_4019 1, 2 2’595 XhoI/HindIII pBAD-His-A/Bp4019 
 Bthur0008_13400 3, 4 2’589 XhoI/KpnI pBAD-His-A/Bthur0008_13400 
 Krad_4555 5, 6 1’041 SacI/HindIII pBAD-His-A/Krad4555 
 Mbar_A2435 7, 8 2’646 XhoI/XhoI pBAD-His-A/A2435 
 Ppoly_aaPGS 9, 10 2’643 SacI/KpnI pBAD-His-A/Ppoly_aaPGS 
 
Plasmid construction for recombinant aaPGS activity analysis (C-terminal domains) 
Vectors pGEX-6P-1 (GE Healthcare, Freiburg, Germany) and pET22b(+) (Merck, Darmstadt, 
Germany) were employed for recombinant production of C-terminal aaPGS domains of 
B. licheniformis, B. anthracis and S. thermophilus. Both vectors allow for the recombinant 
expression of proteins in E. coli BL21 (λDE3) by providing either a Ptac promoter in 
combination with an N-terminal GST-tag sequence (pGEX-6P-1) or alternatively a T7 
promoter and a C-terminal His6-tag (pET22b(+)). Plasmids pGEX-6P-1/YfiXΔaa1-518, pGEX-
6P-1/StMprFΔaa1-503 and pET22b(+)/BAS1375 Δaa1-527 were generously provided by 
S. Jäger (Jäger, 2011).  
Gene sequences encoding C-terminal domains of B. licheniformis ATCC 14580 YfiX (amino 
acid residues 519 – 850; YfiXΔaa1-518) and S. thermophilus ATCC 19258 MprF (residues 
504 – 851; StMprFΔaa1-503) were amplified by PCR using genomic template DNA and cloned 
into pGEX-6P-1 yielding pGEX-6P-1/YfiXΔaa1-518 and pGEX-6P-1/StMprFΔaa1-503 (Jäger, 
2011). Since the sequenced strain S. thermophilus LMG 18311 had not been available, 
primers were designed based on the sequence of the aaPGS homologous orf STU1256 (from 
S. thermophilus LMG 18311). Sequence analysis revealed that StMprFΔaa1-503 (from 
S. thermophilus ATCC 19258) solely differs from STU1256 in three non-conserved amino acid 
positions (Jäger, 2011). The sequence encoding amino acid residues 528 – 861 of B. anthracis 
BAS1375 was amplified using a synthetic gene (GENEART, Regensburg, Germany; optimized 
according to the codon usage of E. coli) as template. The resulting PCR fragment was cloned 
into vector pET22b(+) yielding pET22b(+)/BAS1375Δaa1-527 (Jäger, 2011).  
 orf primer no. fragment restriction resulting plasmid 
  (Table 6) (bp) sites 
 BAS1375Δaa1-527 11, 12 1’005 NdeI/XhoI pET22b(+)/BAS1375Δaa1-527 
 StMprFΔaa1-503 13, 14 1’047 BamHI/XhoI pGEX-6P-1/StMprFΔaa1-503 
 YfiXΔaa1-518 15, 16 999 BamHI/XhoI pGEX-6P-1/YfiXΔaa1-518 
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Construction of the mini-CTX2-PTC vector employed for PAO1 complementation studies 
Vector mini-CTX2 was developed for introducing exogenous DNA into the attB phage 
attachment site of the P. aeruginosa PAO1 chromosome (Hoang et al., 2000). The vector 
provides a tet (tetracycline resistance) and an int (integrase) gene and it can be transferred 
from E. coli to P. aeruginosa by conjugation due to the enclosed oriT. The multiple cloning 
site is flanked by FLP recombinase target sites (FRT) allowing for the excision of vector 
sequences after the integration of exogenous DNA into the P. aeruginosa chromosome 
(Hoang et al., 1998; Hoang et al., 2000).  
The mini-CTX2 vector was modified to generate mini-CTX2-PTC. A synthetic DNA sequence 
(promoter-terminator nconstruct) consisting of the PPA0920 promoter encoded upstream of 
orf PA0920 (187 bp), a linker sequence providing SphI and BamHI restriction sites and the 
rrnB terminator sequence trrnB (158 bp; Invitrogen, Darmstadt, Germany) was synthesized by 
GENEART (Regensburg, Germany; see Table 7 for sequences) and integrated into the 
SacI/HindIII site of mini-CTX2. This modified vector was then further modified by the 
integration of genes employed for the respective complementation of P. aeruginosa deletion 
mutant strains. 
 
Plasmids for the complementation of P. aeruginosa PAO1 ΔPA0920 
Formerly characterized aaPGS encoding genes were inserted into the SphI/BamHI site of 
mini-CTX2-PTC. The resulting plasmids were employed to complement the P. aeruginosa 
deletion mutant strain PAO1 ΔPA0920 (Lorenzo, 2006). The obtained strains allowed for the 
analysis of the impact of different aaPGS encoding genes under the control of an identical 
promoter in the gram negative model organism P. aeruginosa.  
Orfs Sa113 (from S. aureus NCTC 8325), BSU08425 (from B. subtilis subsp. subtilis str. 168), 
aaPGS2 (gi:69249189, from E. faecium DO), PA0920 (from P. aeruginosa PAO1) and the 
sequence encoding the C-terminal A-PGS domain (PA0920aa543-881, from P. aeruginosa 
PAO1) were amplified using the respective genomic DNA as template. Since the mini-CTX2-
PTC contains two SphI restriction sites, the sequence encoding the PPA0920 promoter was 
excised from the mini-CTX2-PTC using SacI and SphI to yield the 187 bp promoter fragment. 
This promoter and the amplified aaPGS encoding genes were integrated into the SacI/BamHI 
restriction site of mini-CTX2-PTC. Insert sequences were verified using primers 21 – 50 (Table 
7). Plasmids were transferred into PAO1 ΔPA0920 by diparental mating. 
 orf primer no. fragment restriction resulting plasmid 
  (Table 6) (bp) sites 
 Sa113 17, 18 2’525 SphI/BamHI mini-CTX2-P-SamprF-T 
 BSU08425 19, 20 2’567 SphI/BamHI mini-CTX2-P-BsmprF-T 
 aaPGS2 21, 22 2‘600 SphI/BamHI mini-CTX2-P-EfmprF-T 
 PA0920 23, 24 2‘642 SphI/BamHI mini-CTX2-P-PA0920-T 
 PA0920aa543-881 24, 25 1’019 SphI/BamHI mini-CTX2-P-PA0920aa543-881-T 
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Construction of the replacement vector pEX18Ap/ΔPA0919 
The gene replacement vector pEX18Ap/ΔPA0919 was constructed to delete the complete orf 
PA0919 from the PAO1 chromosome resulting in strain PAO1 ΔPA0919 (Groenewold, 2011). 
The vector encodes genomic sequences flanking the target gene which are separated by a 
Gm resistance cassette. The vector allows for the homologous recombination with specific 
genomic sequences resulting in the replacement of orf PA0919 by the Gm resistance 
cassette.  
A 438 bp and a 673 bp fragment representing the genomic sequences directly upstream and 
downstream of orf PA0919 were amplified by PCR using primers 26 and 27 or 28 and 29, 
respectively (see Table 6). The Gm resistance cassette was excised out of vector pPS858 
employing BamHI and ligated together with the two PCR-fragments into the KpnI/HindIII site 
of pEX18Ap yielding pEX18Ap/ΔPA0919 (Groenewold, 2011). 
 
Plasmids for the functional complementation of P. aeruginosa PAO1 ΔPA0919 
Different constructs consisting of orf PA0919 in combination with the putative PPA0919 
promoter sequence or alternatively with the PPA0920 promoter sequence were inserted into 
vector mini-CTX2-PTC. These plasmids allow for the insertion of the respective construct into 
the chromosomal attB site of PAO1 ΔPA0919 for recovery of the deleted function. For 
control experiments, mini-CTX2-PTC derivatives containing solely the PPA0919 or the PPA0920 
promoter sequence were constructed.  
Orf PA0919 was amplified together with its 430 bp upstream region representing the 
putative PPA0919 promoter using genomic DNA of P. aeruginosa PAO1 as template and cloned 
into mini-CTX2-PTC. Orf PA0919 was amplified (without any promoter sequence) and 
inserted into mini-CTX2-PTC under the control of the PPA0920 promoter as described above 
(see ‘Plasmids for the complementation of P. aeruginosa PAO1 ΔPA0920’). For control 
experiments, the PPA0919 promoter was employed without orf PA0919 and mini-CTX2-PTC 
was used as a control for the PPA0920 promoter. Insert sequences were verified using primers 
50 and 51 (Table 7) and the employed cloning primers (Table 6). Plasmids were transferred 
into PAO1 ΔPA0919 by diparental mating. 
 construct primer no. fragment restriction resulting plasmid 
  (Table 6) (bp) sites 
 PPA0919-PA0919 30, 31 1’714 SacI/BamHI mini-CTX2-PPA0919-PA0919-T 
 PPA0920-PA0919 32, 31 1’477 SphI/BamHI mini-CTX2-PPA0920-PA0919-T 
 PPA0919 30, 27 430 SacI/BamHI mini-CTX2- PPA0919-T 
 PPA0920    mini-CTX2-PTC (see above) 
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Plasmids for the analysis of the PPA0919 promoter employing different PPA0919-lacZ fusions 
For the analysis of the putative promoter sequence located directly upstream of orf PA0919, 
several promoter fragments of different size were cloned upstream of a lacZ gene into 
vector mini-CTX-lacZ (Becher and Schweizer, 2000). This vector was employed for the 
specific integration of the generated promoter-lacZ reporter gene constructs into the attB 
site of the P. aeruginosa chromosome allowing for the analysis of the respective promoter 
activity. 
A 430 bp fragment covering the genomic sequence directly upstream of orf PA0919 was 
amplified by PCR. Truncated fragment versions of 206 bp (containing the proposed –35 and 
–10 promoter elements) and of 140 bp (devoid of any promoter elements) were also 
generated by PCR. The obtained fragments were cloned into the vector mini-CTX-lacZ. Insert 
sequences were verified using the respective primers employed for fragment amplification 
(Table 6). Plasmids were transferred into P. aeruginosa PAO1 by diparental mating. 
 construct primer no. fragment restriction resulting plasmid 
  (Table 6) (bp) sites 
 PPA0919-430 33, 27 430 KpnI/BamHI mini-CTX-PPA0919-430-lacZ 
 PPA0920-206 34, 27 206 KpnI/BamHI mini-CTX-PPA0919-206-lacZ 
 PPA0919-140 35, 27 140 KpnI/BamHI mini-CTX-PPA0919-140-lacZ 
 
Plasmids for the recombinant production of PA0919 in E. coli 
For recombinant protein production, orf A0919 was cloned (without its predicted native 
secretion signal sequence for periplasmic localization encoded by amino acids 1 – 34) into 
vector pET22b(+) (Merck, Darmstadt, Germany). This vector allows for the production of 
recombinant PA0919 protein fused to an N-terminal E. coli PelB secretion signal peptide for 
periplasmic localization and a C-terminal His6-tag. The provided T7 promoter was employed 
for the IPTG dependent protein expression in E. coli BL21 (λDE3) (Studier et al., 1990). In a 
second approach, the identical PA0919 fragment was cloned into pET22b(+)Strep. This 
vector had been constructed by inserting the annealed oligonucleotides 36 and 37 (Table 6) 
into the HindIII/XhoI site of pET22b(+). Vector pET22b(+)Strep was generously provided by 
T. Nicke (unpublished). The resulting construct codes for a fusion protein with a C-terminal 
Strep-tag II sequence (Schmidt and Skerra, 2007).  
The sequence encoding amino acid residues 35 to 427 of the PA0919 protein was amplified 
by colony-PCR using PAO1 as template (primers 38 and 39, Table 6) and cloned into the 
NcoI/HindIII sites of pET22b(+) and pET22b(+)Strep resulting in pET22b(+)PA0919 and 
pET22b(+)PA0919-Strep, respectively. Insert sequences were verified by sequencing (primers 
16 and 52, Table 7).  
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Plasmids for the mutagenesis of the PA0919 protein 
The PA0919 protein was mutated to study the function of specific amino acid residues. In 
three individual experiments, serine 240, serine 307 and histidine 401 were changed to 
alanine.  
Plasmid pET22b(+)PA0919-Strep was subjected to site-directed mutagenesis. The mutated 
plasmids pET22b(+)PA0919-S240A-Strep, pET22b(+)PA0919-S307A-Strep and pET22b(+) 
PA0919-H401A-Strep were obtained (see section 2.4.14) and verified by sequencing (primers 
16 and 52, Table 7).  
 construct primer no. (Table 6) mutation resulting plasmid 
 PA0919-S240A-Strep 40, 41 S240A pET22b(+)PA0919-S240A-Strep 
 PA0919-S307A-Strep 42, 43 S307A pET22b(+)PA0919-S307A-Strep
 PA0919-H401A-Strep 44, 45 H401A pET22b(+)PA0919-H401A-Strep 
 
Plasmids for the localization of the PA0919 protein in P. aeruginosa PAO1 ΔPA0919 
For the localization of PA0919 in P. aeruginosa, two different approaches were employed: 
First, the PA0919 encoding sequence was fused to a C-terminal Strep-tag II sequence for 
detection purposes and cloned into the E. coli – P. aeruginosa shuttle vector pUCP20T 
(Schweizer et al., 1996) controlled by the native PA0919 promoter PPA0919. This vector 
provides a lactose inducible promoter upstream of the multiple cloning site and introduced 
proteins can be expressed as translational LacZ fusion proteins. The empty vector and a 
construct lacking the PA0919 leader sequence were employed for control. Second, identical 
constructs (PA0919 fused to Strep-tag II controlled by the PPA0919 promoter in the presence 
or absence of the PA0919 signal sequence) were inserted into mini-CTX-PTC for 
chromosomal integration. 
Orf PA0919 was amplified together with its 430 bp upstream region encoding the PPA0919 
promoter by PCR using genomic DNA for template and cloned into vectors pUCP20T and 
mini-CTX2-PTC. The resulting pUCP20T/PPA0919-PA0919-Strep was employed as template for 
site-directed mutagenesis (compare section 2.4.14) using primers 48 and 49 (Table 6) to 
delete the PA0919 secretion signal (amino acids 1 – 34) yielding pUCP20T/PPA0919-PA0919-
Δaa1-35-Strep. The insert was amplified by PCR and cloned into mini-CTX2-PTC resulting in 
mini-CTX2-PPA0919-PA0919-Δaa1-35-Strep-T. For control, the empty vector pUCP20T was 
employed. All insert sequences were verified using the employed cloning primers and 
additionally primers 50 and 51 (for mini-CTX2-PTC derivatives) or 53 and 54 (for pUCP20T 
variants) listed in Table 7. Plasmids were transferred into P. aeruginosa ΔPA0919 by 
diparental mating. 
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 construct primer no. fragment restriction resulting plasmid 
  (Table 6) (bp) sites 
 PPA0919-PA0919- 46, 47 1’756 KpnI/BamHI pUCP20T/PPA0919-PA0919- 
 Strep Strep 
 PPA0919-PA0919- 48, 49 1’657 KpnI/BamHI pUCP20T/PPA0919-PA0919- 
 Δaa1-34-Strep Δaa1-34-Strep 
 PPA0919-PA0919- 30, 47 1’756 SacI/BamHI mini-CTX2-PPA0919-PA0919- 
 Strep-T Strep-T 
 PPA0919-PA0919 30, 47 1’657 SacI/BamHI mini-CTX2-PPA0919-PA0919- 
 Δaa1-34-Strep-T Δaa1-34-Strep-T 
 
2.4.16 Diparental mating 
A diparental mating was performed to transfer E. coli – P. aeruginosa shuttle vectors (mini-
CTX or pUCP20T derivatives) by conjugation from E. coli to P. aeruginosa strains.  
The E. coli donor strain ST18 (Thoma and Schobert, 2009) carrying the respective plasmid 
and the P. aeruginosa target strain were cultivated overnight. 1 mL ST18 culture was gently 
centrifuged (6’000 x g, 1 min, RT) and cells were suspended using 50 µL of the respective 
P. aeruginosa pre-culture. The suspension drop was dried on a LB agar plate and cultivated 
at 37 °C for 6 h. Then, the cells were collected in 1 mL LB medium and plated on LB agar 
plates supplemented with the required antibiotics to select P. aeruginosa strains containing 
the respective extrachromosomal plasmid or the chromosomal integrated plasmid 
sequences in the attB locus (Schweizer et al., 1996; Hoang et al., 2000; Becher and 
Schweizer, 2000). 
 
2.4.17 Construction of markerless P. aeruginosa mutant strains 
Mini-CTX vector derivatives were designed to integrate a target sequences into the attB 
locus of the P. aeruginosa chromosome (Hoang et al., 2000; Becher and Schweizer, 2000).  
First, the mini-CTX vector derivative was transferred into P. aeruginosa by diparental mating 
(section 2.4.16) and integrated into the attB phage attachment site of the P. aeruginosa 
chromosome promoted by the vector encoded CTX integrase. Second, vector sequences (e.g. 
the resistance cassette) encoded between the FRT sites were excised. For this, vector pFLP2 
encoding the FLP recombinase (Hoang et al., 1998) was introduced into the mini-CTX 
modified P. aeruginosa strains by diparental mating (section 2.4.16). The FLP recombinase 
promoted the deletion of mini-CTX vector sequences to generate markerless P. aeruginosa 
strains. Subsequently, the pFLP2 plasmid was removed by plating the generated strains on 
LB agar plates containing 5 % (w/v) D(+)-sucrose. The pFLP2 vector encoded levansucrase 
(sacB) generates the toxic levan from sucrose and cells devoid of vector pFLP2 were 
obtained. The chromosomal insertion of the target sequence was verified by PCR (primers 19 
and 20, Table 7) and the loss of mini-CTX vector sequences and of the pFLP2 plasmid was 
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revised by plating the strains on agar plates containing the respective antibiotics 
(mini-CTX: Tet; pFLP2: Cb). 
 
2.4.18 Construction of the P. aeruginosa PAO1 ΔPA0919 deletion mutant 
Orf PA0919 was deleted from the P. aeruginosa PAO1 chromosome by replacement with a 
Gm resistance cassette using the well-established protocol of Hoang et al., 1998. To yield a 
markerless deletion strain, the chromosomally integrated Gm cassette was excised 
afterwards (section 2.4.17; Groenewold, 2011; Hoang et al., 1998). 
The gene replacement vector pEX18Ap/ΔPA0919 was transferred into PAO1 by diparental 
mating (section 2.4.16). Orf PA0919 was replaced by the Gm resistance cassette by 
homologous recombination within the upstream and downstream region of orf PA0919 also 
encoded on the gene replacement vector. Target clones became resistant against Gm and 
were able to grow on D(+)-sucrose containing media (otherwise the presence of the vector 
encoded sacB gene would result in the toxic levan, see section 2.4.17). The employed Gm 
resistance cassette was flanked by FRT sites. After transferring vector pFLP2 into the 
obtained P. aeruginosa strain, the Gm resistance cassette was excised from the chromosome 
by the FLP recombinase (compare section 2.4.17 for details) yielding the markerless deletion 
mutant strain PAO1 ΔPA0919 (Groenewold, 2011). 
 
2.4.19 Construction of complemented P. aeruginosa deletion mutant strains 
The deletion mutant strains PAO1 ΔPA0920 and PAO1 ΔPA0920 were complemented with 
various constructs using mini-CTX2-PTC or pUCP20T derivatives. Mini-CTX-lacZ derivatives 
were transferred into the PAO1 wild-type strain for promoter activity analysis. For plasmids 
and constructions, see section 2.4.15. The plasmids were transferred into the respective 
P. aeruginosa strain by diparental mating (section 2.4.16) and the mini-CTX derivatives were 
chromosomally integrated into the attB locus. The mini-CTX vector sequences were excised 
by FLP recombinase (section 2.4.17) to yield markerless P. aeruginosa strains. Plasmids and 
resulting strains are summarized in section 2.1.3. The chromosomal insertion was verified by 
PCR using primers 19 and 20 (Table 7). 
 
Cross-complementation of PAO1 ΔPA0920 with different aaPGS encoding genes 
PAO1 ΔPA0920 was complemented using different mini-CTX2 derivatives (mini-CTX2-P-
SamprF-T, mini-CTX2-P-BsmprF-T, mini-CTX2-P-EfmprF-T, mini-CTX2-P-PA0920-T and mini-
CTX2-P-PA0920aa543-881-T) to generate PAO1 mutant strains with altered lipid 
compositions. For this, the mini-CTX2 variants were transferred into P. aeruginosa PAO1 
ΔPA0920 and complemented markerless PAO1 ΔPA0920 mutant strains were generated. The 
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resulting strains were the homologously complemented strains harboring orf PA0920 
(named ΔPacomp) or the truncated PA0920 variant (ΔPa-aa543-881comp), respectively, and the 
chimeric strains cross-complemented with aaPGS encoding genes from S. aureus (ΔSacomp), 
from B. subtilis (ΔBscomp) or from E. faecium (ΔEfcomp).  
 
Complementation of PAO1 ΔPA0919 with different constructs for functional analysis 
PAO1 ΔPA0919 was complemented using different mini-CTX2 derivatives (mini-CTX2-PPA0919-
PA0919-T, mini-CTX2-PPA0920-PA0919-T, mini-CTX2-PPA0919-T and mini-CTX2-PTC) to generate 
PAO1 mutant strains containing orf PA0919 controlled by the formerly characterized PPA0920 
promoter (Klein et al., 2009) or by the putative PPA0919 promoter. For control, both 
promoters were inserted into PAO1 ΔPA0919, respectively. The unmarked complemented 
PAO1 ΔPA0919 mutant strains PAO1 ΔPA0919/PPA0920-PA0919-T (abbreviated Δ19 P20-19), 
PAO1 ΔPA0919/PPA0919-PA0919-T (Δ19 P19-19), PAO1 ΔPA0919/PPA0920-T (Δ19 P20) and PAO1 
ΔPA0919/PPA0919-T (Δ19 P19) were obtained. 
 
Strains containing PPA0919-lacZ fusions for the analysis of the PA0919-specific promoter 
Plasmids mini-CTX-PPA0919-430-lacZ, mini-CTX-PPA0919-206-lacZ and mini-CTX-PPA0919-140-lacZ 
carrying PPA0919 promoter fragments of different length fused to the lacZ reporter gene were 
introduced into the PAO1 wild-type strain for the chromosomal introduction and analysis of 
the fusion constructs. After the excision of the mini-CTX vector sequences, strains PAO1 
PPA0919-430-lacZ, PAO1 PPA0919-206-lacZ and PAO1 PPA0919-140-lacZ were obtained.  
 
Complementation of PAO1 ΔPA0919 with different constructs for PA0919 localization 
PAO1 ΔPA0919 was complemented for PA0919 localization experiments using two mini-
CTX2-PTC derivatives (mini-CTX2-PPA0919-PA0919-Strep-T, mini-CTX2-PPA0919-PA0919-Δaa1-34-
T) and three pUCP20T variants (pUCP20T empty vector, pUCP20T/PPA0919-PA0919-Strep, 
pUCP20T/PPA0919-PA0919-Δaa1-34-T) to gain mutant strains containing orf PA0919 fused to a 
Strep-tag II under the control of its native PPA0919 promoter. Mutant strains devoid of the 
PA0919 secretion signal were unable to secrete the PA0919-Strep fusion protein. For 
control, the empty pUCP20T vector was employed. All plasmids were transferred into 
P. aeruginosa ΔPA0919 by diparental mating (section 2.4.16). Mini-CTX2-PTC derivatives 
were integrated into the chromosomal attB locus and vector sequences were removed by 
the FLP recombinase (sections 2.4.16 and 2.4.17). Finally, the unmarked complemented 
PAO1 ΔPA0919 mutant strains PAO1 ΔPA0919 pUCP20T (abbreviated Δ19 pUC), PAO1 
ΔPA0919 pUCP20T/PPA0919-PA0919-Strep (Δ19 pUC/19), PAO1 ΔPA0919 pUCP20T/PPA0919-
PA0919-Δaa1-34-Strep (Δ19 pUC/1935-427), PAO1 ΔPA0919/PPA0919-PA0919-Strep-T (Δ19 19) 
and PAO1 ΔPA0919/PPA0919-PA0919-Δaa1-34-Strep-T (Δ19 1935-427) were obtained. 
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2.5 Lipid analysis 
Bacterial polar lipids were extracted employing two different protocols based on the method 
of Bligh and Dyer, 1959. For most gram negative bacteria (except P. putida, but also for 
K. radiotolerans), a time-saving variant was used (Garbus et al., 1963), whereas a protocol 
with extended incubation times (Klein et al., 2009) was employed for gram positive bacilli 
and P. putida. The extracted lipids were separated by two-dimensional thin-layer chromato-
graphy (TLC) and visualized by different methods. Radioactively labeled lipids were analyzed 
either by scintillation counting or autoradiography. 
 
2.5.1 Lipid extraction from gram negative bacteria 
For lipid composition analysis, cells of gram negative bacteria (except P. putida) or of the 
gram positive K. radiotolerans were harvested by centrifugation (4’000 x g, 20 min, 4 °C) 
according to the respective culture turbidity (15 mL were sedimented for OD578 = 0.6). Cell 
sediments were suspended in dH2O in a final volume of 100 µL and mixed intensively with 
375 µL methanol/chloroform (2:1, v/v). After centrifugation (11’000 x g, 3 min, RT), 100 µL 
dH2O and 100 µL chloroform were added and samples were mixed intensively. Phase 
separation was promoted by centrifugation (11’000 x g, 3 min, RT), the lower chloroform 
phase was isolated and evaporated at 40 °C. Dried lipids were stored at –20 °C (Garbus et al., 
1963). 
 
2.5.2 Lipid extraction from gram positive bacteria  
After harvesting of 500 mL cell culture of gram positive bacteria (except K. radiotolerans) or 
of the gram negative P. putida, the cells were washed with 50 mL 50 mM 4-(2-hydoxyethyl)-
1-piperazineethanesulfonic acid-(HEPES)-NaOH pH 7.0. The resulting sediments were freeze-
dried and stored at –20 °C. For lipid extraction, 100 mg dried cells were suspended in 9.5 mL 
extraction solution and stirred at 4 °C for at least 16 h. After centrifugation (3’600 x g, 
10 min, 4 °C), the supernatant was intensively mixed with 2.5 mL 0.3 % (w/v) NaCl and 
2.5 mL chloroform. Phase separation was achieved by centrifugation (3’600 x g, 5 min, 4 °C) 
and the lower chloroform phase was isolated. The solvent was evaporated and dried lipids 
were stored at –20 °C (Klein et al., 2009). 
 extraction solution chloroform 2.5 mL 
  methanol 5.0 mL 
  0.3 % (w/v) NaCl 2.0 mL 
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2.5.3 Lipid separation by two-dimensional TLC 
Lipids extracted from gram negative bacteria were dissolved in 20 µL methanol/chloroform 
(1:1, v/v) and loaded onto a TLC plate (10 x 10 cm; Macherey-Nagel, Düren, Germany). Lipids 
from gram positive bacteria (and P. putida) were solved in 500 µL methanol/chloroform (2:1, 
v/v) and equal sample volumes were applied to TLC plates. 
Lipid separation was carried out at 25 °C. For the first dimension, chloroform/methanol/ 
water (65:25:4, v/v/v) were employed and, after drying, chloroform/methanol/acetic 
acid/water (80:12:15:4, v/v/v/v) were used for the second dimension (Tindall, 1990). TLC 
plates were sprayed with 5 % (w/v) molybdatophosphoric acid (solved in ethanol; Roth, 
Karlsruhe, Germany) for detecting reducing compounds (e.g. lipids), with ninhydrin (Merck, 
Darmstadt, Germany) for visualizing amino group containing compounds or with 1.3 % 
molybdenum blue (Sigma-Aldrich, St. Louis, MO, USA) for verifying phosphate containing 
molecules, respectively. TLC plates treated with molybdatophosphoric acid and ninhydrin 
were incubated at 120 °C until lipid spot development (Klein et al., 2009). 
Polar lipids were quantified using Gelscan 6.0 software (BioSciTec, Frankfurt, Germany) 
based on molybdatophosphoric acid stained TLC plates. Overall amounts of polar lipids and 
aaPG levels were determined and values were related to appropriate references. 
 
2.5.4 Autoradiography analysis 
Samples containing 14C-labeled compounds were analyzed either by X-ray film autoradio-
graphy analysis or by scintillation counting. 
 
Autoradiography analysis using an X-ray film 
For some experiments, radioactive samples containing 14C-labeled compounds were 
analyzed by TLC followed by molybdatophosphoric acid or ninhydrin staining (see section 
2.5.3). To detect specifically 14C-labeled substances, TLC plates were covered with an X-ray 
film (Fuji Super RX; BEMA, Pleißenberg, Germany). After incubating for several days, X-ray 
films were developed using the Optimax® X-ray film processor (Protec®, Oberstenfeld, 
Germany).  
 
Autoradiography analysis by scintillation counting 
For scintillation counting analysis, the target substance was dissolved in 30 – 50 µL 
chloroform/methanol (1:1, v/v), added to 4 mL scintillation cocktail (OptiPhase HighSafe 2; 
PerkinElmer, Boston, MA, USA) and analyzed using a Tri-Carb® 2900TR scintillation analyzer 
(PerkinElmer, Boston, MA, USA). 
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2.6 Amino acid substrate specificity analysis of aaPGS enzymes 
For the elucidation of the aminoacyl-tRNA substrate specificity of aaPGS enzymes, native 
strains harboring aaPGS homologs or E. coli strains overproducing aaPGS full-length enzymes 
or catalytic domains were employed. For in vivo activity analysis, cells were cultured under 
different conditions and polar lipids were extracted and analyzed by two-dimensional TLC 
(chapter 2.5). Additionally, aaPGS specificities were analyzed using an in vitro activity assay 
according to Hebecker et al., 2011. For this, E. coli cells overproducing the respective aaPGS 
enzyme were grown and lysed. Crude cellular extracts were mixed with 14C-labeled amino 
acids and an ATP regenerating system. During incubation, the 14C-labeled amino acids were 
coupled to their respective tRNAs by aminoacyl-tRNA synthetases present in the crude 
cellular extract. Subsequently, these activated amino acids were transferred to PG by the 
respective aaPGS homolog. Afterwards, lipids were analyzed by two-dimensional TLC 
combined with autoradiography (chapter 2.5). 
 
2.6.1 Specificity determination of aaPGS enzymes using native strains 
The native strains were cultivated in their respective medium under neutral and acidic 
conditions. Subsequently, polar lipids were analyzed for to detect the formation of 
aminoacylated PG. 
 
Media preparation 
For the determination of the bacterial membrane lipid composition under neutral and acidic 
conditions, the pH of the used media was adjusted (for media formulation, see chapter 2.2): 
In the case of AB medium and SMM, the respective pH was obtained by the addition of the 
corresponding buffer (AB medium: A10 solution; SMM: SMM basis). LB and R2A media were 
adjusted to the respective pH value by the addition of 0.1 – 0.3 M sterile HCl (Uhlig, 2011). 
After pH adjustment, LB and R2A media were buffered in a ratio of 1:10 (v/v) with the 
appropriate A10 solution (see section 2.2.3). Media with neutral conditions were 
supplemented with the respective A10 buffer. 
 
Specificity determination of aaPGS enzymes by analyzing the lipid composition of native 
strains 
Media (60 – 500 mL in baffled flasks) were inoculated to an OD578 of 0.05 or in a ratio of 
1:100 (v/v) employing an overnight pre-culture (S. thermophilus: 3 d; Jäger, 2011) and 
incubated as specified in Table 9. Growth was monitored by OD578 measurement and the pH 
value was controlled using indicator test stripes (Macherey-Nagel, Düren, Germany). Cells 
were harvested by centrifugation (3’000 – 4’500 x g, 20 min, 4 °C) at an OD578 of at least 0.5 
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and stored at –20 °C (Uhlig, 2011). Alternatively, cells were cultured for 7 h and then the pH 
was shifted to the originally intended value. Incubation was continued for an additional hour 
and comparable amounts of cells were harvested (15 mL for a culture with OD578 = 0.6) and 
stored at –20 °C. 
Subsequently, polar lipids of the native strains were extracted, separated by two-
dimensional TLC and visualized by molybdatophosphoric acid and ninhydrin staining 
(sections 2.5.1 to 2.5.3). 
 
Table 9: Bacterial strains and parameters for cultivation under different conditions  
Cultures were inoculated using an overnight pre-culture and the bacterial strains were cultivated 
in their respective medium employing the specified parameters (Uhlig, 2011; Jäger, 2011). 
Strain Medium Cultivation parameters 
P. aeruginosa PAO1 
P. aeruginosa PA14 
P. putida 
AB medium 
pH 7.5 and pH 5.3 
8 – 24 h 
37 °C and 180 – 200 rpm 
B. licheniformis 
B. thuringiensis 
P. polymyxa 
SMM 
pH 7 and pH 5 
8 – 24 h 
37 °C and 180 – 200 rpm 
K. radiotolerans LB medium 
pH 7 and pH 5 
3 h or 8 h with the pH shift 
37 °C and 180 – 200 rpm 
B. phymatum R2A medium 
pH 7 and pH 5 
8 h with the pH shift 
30 °C and 180 – 200 rpm 
S. thermophilus TSB medium 
pH 7 
3 d 
37 °C without agitation 
 
 
2.6.2 Specificity determination of recombinant aaPGS enzymes 
The specificity of several aaPGS enzymes was analyzed by recombinant overproduction in 
E. coli. The lipid composition of the respective E. coli strains was analyzed to identify 
aminoacylated PG variants. Alternatively, E. coli cells containing recombinant aaPGS 
enzymes were lysed and subjected to an in vitro activity assay according to Hebecker et al., 
2011. For this, crude cellular extracted were mixed with radioactively labeled amino acids. 
During the assay, the amino acids were activated by binding to the respective tRNA and 
transferred to PG by the employed aaPGS enzyme. Subsequently, polar lipids were extracted 
and analyzed. 
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Analysis of the polar lipid composition of E. coli cells harboring recombinant aaPGS 
enzymes 
Sequences encoding the C-terminal aaPGS domains from B. licheniformis (YfiXΔaa1-518), 
S. thermophilus (StMprFΔaa1-503) and B. anthracis (BAS1375 Δaa1-527) were cloned into 
the expression vectors pGEX-6P-1 and pET22b(+)providing IPTG inducible expression system 
(compare 2.4.15 and Jäger, 2011). The resulting plasmids (pGEX-6P-1/YfiXΔaa1-518, 
pGEX-6P-1/StMprFΔaa1-503 and pET22b(+)/BAS1375 Δaa1-527) were transferred into E. coli 
BL21 (λDE3) (Jäger, 2011).  
100 mL LB medium (in baffled flasks, supplemented with Ap) were inoculated (1:100, v/v) 
using an overnight pre-culture of the respective E. coli strain. Cells were grown to an OD578 
of 0.5 at 37 °C and 200 rpm and protein production was induced employing 50 µM IPTG 
(300 µM for BL21 (λDE3) pGEX-6P-1/StMprFΔaa1-503). The cultivation was continued for 4 h 
(BL21 (λDE3) pGEX-6P-1/YfiXΔaa1-518, 37 °C) or overnight (BL21 (λDE3) pET22b(+)/BAS1375 
Δaa1-527, 25 °C; BL21 (λDE3) pGEX-6P-1/StMprFΔaa1-503, 17 °C). Cells were harvested by 
centrifugation (4’500 x g, 15 min, 4 °C) and stored at –20 °C. Lipids were analyzed as 
presented in sections 2.5.1 and 2.5.3 (Jäger, 2011). 
 
Specificity analysis of recombinant aaPGS enzymes using the in vitro activity assay  
For the recombinant production of several aaPGS enzymes (B. phymatum Bphy_4019, 
B. thuringiensis Bthur0008_13400, K. radiotolerans Krad_4555, M. barkeri Mbar_A2435, 
P. polymyxa Ppoly_aaPGS), the respective orfs were cloned into the pBAD-His-A vector 
providing the PBAD promoter inducible by L(+)-arabinose (Guzman et al., 1995; for plasmid 
construction, see section 2.4.15). The obtained plasmids (pBAD-His-A/Bp4019, pBAD-His-A/ 
Bthur0008_13400, pBAD-His-A/Krad4555, pBAD-His-A/A2435, pBAD-His-A/Ppoly_aaPGS) 
were transferred into E. coli TOP10. For control experiments, the empty pBAD-His-A vector 
was employed analogously. 
E. coli TOP10 strains carrying a pBAD-His-A derivative were grown in 500 mL LB medium (in 
baffled flasks, supplemented with Ap). Cultures were inoculated from an overnight pre-
culture (1:100, v/v) and cultivated at 37 °C and 200 rpm to an OD578 of 0.5. Protein 
production was induced by the addition of 0.2 % (w/v) L(+)-arabinose (Bp4019, 
Bthur0008_13400, Ppoly_aaPGS) or 2 % (w/v) L(+)-arabinose (Krad4555, Mbar_A2435) and 
cultivation was continued for 3 h. Cells were harvested by centrifugation (3’000 x g, 20 min, 
4 °C), sediments were washed using 50 mM HEPES-NaOH pH 7.8 (4’000 x g, 20 min, 4 °C) and 
subjected to the in vitro analysis.  
After recombinant aaPGS production, the E. coli cells were suspended in 50 mM HEPES-
NaOH pH 7.8 according to their culture turbidity (10 mL buffer were used for an OD578 of 2). 
Crude cellular extracts were obtained by French® Press passage at 19’200 lb/in² and mixed 
with ATP, the ATP-regenerating system (creatine phosphate, creatine phosphokinase), 
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[U-14C]-L-lysine and/or [1-14C]-L-alanine (Moravec Biochemicals, Brea, CA, USA) in a final 
volume of 500 µL. Sample compositions are indicated below. Samples were incubated at 
37 °C and 1’000 rpm for 1 h and stored at –20 °C.  
Polar lipids were extracted and analyzed by two-dimensional TLC combined with molybdato-
phosphoric acid staining. 14C-labeled phospholipids were detected by autoradiography 
(chapter 2.5). 
 stock solutions volumes (500 µL) final concentration 
 100 mM ATP 10 µL 2 mM 
 500 mM creatine phosphate 18 µM 18 mM 
 6.7 U/µL creatine phosphokinase 2.6 µL 35 U/mL 
 2 mM [1-14C]-L-alanine (51 mCi/mmol) 10 µL 40 µM 
 0.35 mM [U-14C]-L-lysine (288 mCi/mmol) 10 µL 7 µM 
 crude cellular extract add to 500 µL 
 
 
2.7 Determination of P. aeruginosa resistance phenotypes 
Several P. aeruginosa strains were analyzed concerning their resistance against antimicrobial 
compounds. In an initial approach, the Phenotype MicroArrayTM system from Biolog 
(Hayward, CA, USA; Bochner, 2009) providing a wide variety of antimicrobials was employed. 
The initially obtained results were re-evaluated in an independent experimental setup and 
the observed phenotypes were quantified by determining the minimal inhibitory 
concentrations (MIC) of selected compounds. 
 
2.7.1 Phenotype MicroArrayTM from Biolog  
The PAO1 wild-type strain, the PAO1 ΔPA0920 deletion mutant and the respective 
complemented variants containing aaPGS encoding genes from different organisms (see 
2.4.19 for strain construction) were analyzed using the Phenotype MicroArrayTM system 
(Biolog, Hayward, CA, USA; Bochner, 2009). The employed microplates PM9 – PM20 provide 
sensitivity tests for a wide variety of antimicrobial compounds, pH conditions and salt stress 
conditions. The plates were inoculated and an applied tetrazolium dye was reduced to the 
purple formazan by electrons provided by the cells’ metabolism during incubation. The dye 
formation was measured by the OmniLog® system and data were analyzed using the 
accessory software (Biolog, Hayward, CA, USA). Media and dye were obtained from Biolog 
(Hayward, CA, USA). 
The cells were cultivated on LB agar plates overnight and suspended in several steps in IF-0 
medium to a final culture transmission of 85 %. 21 mL IF-10a medium (per microplate) 
supplemented with the tetrazolium dye (Redox Dye Mix A; 1:100, v/v) were inoculated with 
 -61- Materials and methods 
105 µL of the cell suspension according to the manufacturer’s instructions. The prepared cell 
suspension was transferred into microplates PM9 – PM20 (100 µL/well). The inoculated 
plates were incubated in the OmniLog® incubator at 37 °C for 48 h and dye formation was 
observed online. Conditions causing differing phenotypes for the wild-type and the mutant 
strains were chosen for further investigations. 
 
2.7.2 Re-evaluation of the Phenotype MicroArrayTM experiments 
The Phenotype MicroArrayTM experiments (see section 2.7.1) were re-evaluated in an 
independent experimental setup. Cells (PAO1 wild-type, ΔPA0920 and the respective 
complemented strains) were grown in the presence of selected compounds identified in the 
initial Phenotype MicroArrayTM experiments in AB medium pH 5.3 to guarantee elevated 
aaPG levels (Klein et al., 2009). Due to the fact that the tetrazolium dye system employed for 
the Phenotype MicroArrayTM experiments was not appropriate under acidic conditions 
(Johno et al., 2010), cell growth was monitored by culture turbidity determination. 
Bacterial cells were grown overnight in AB medium pH 7.3 and suspended to a transmission 
of 85 %. In analogy to the Phenotype MicroArrayTM experiments, 17.5 mL AB medium pH 5.3 
(per microplate) were inoculated with 100 µL of the cell suspension and 96-well microplates 
(Sarstedt, Nümbrecht, Germany) prepared with different inhibitory compounds in varying 
concentrations were inoculated. The plates were covered with a gas permeable membrane 
(Breathe-EasyTM sealing membrane; Diversified Biotech, Dedham, MA, USA) and incubated 
without shaking at 37 °C for 18 h. Growth was determined by measuring the culture turbidity 
in the absence of the membrane at 595 nm employing the Model 680 microplate reader 
(Bio-Rad, Munich, Germany). 
 
2.7.3 MIC determination 
MICs were determined using a modified microdilution method according to Andrews, 2001. 
Cells were grown to late exponential phase, diluted to a specific OD578 and 96-well plates 
prepared with gradually varying inhibitor concentrations were inoculated. After incubation, 
the culture turbidity was determined. With this experimental setup, MICs were determined 
by gradually narrowing the respective antimicrobial compound’s concentration. 
Strains were grown in AB medium pH 7.3 overnight. 25 mL AB medium pH 5.3 were 
inoculated to OD578 = 0.05 and cultivated at 37 °C and 200 rpm for 4 h to the late exponential 
growth phase. Cultures were diluted to OD578 = 0.2 using AB medium pH 5.3. 96-well plates 
(Sarstedt, Nümbrecht, Germany) were prepared as follows: each well contained 100 µL of 
the respective antimicrobial compound in varying concentrations (aqueous solution) mixed 
with 50 µL of AB medium (pH 5.3, threefold concentrated). For each antimicrobial 
concentration, identical wells were prepared in quadruplicate. The plates were inoculated 
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with 50 µL cell suspension, covered with a gas permeable membrane (Breathe-EasyTM sealing 
membrane; Diversified Biotech, Dedham, MA, USA) and incubated in a plate incubator 
(PHMP-4; Grant bio, Cambridgeshire, UK) at 37 °C and 350 rpm. After 18 h, the sealing 
membrane was removed and bacterial growth was monitored by measuring the OD595 with a 
microplate reader (Model 680; Bio-Rad, Munich, Germany). 
The lowest antimicrobial compound concentration that resulted in an OD595 < 0.05 
(OD595 < 0.1 for daptomycin employing the ΔPA0920 complemented strains) was defined as 
the MIC. For protamine sulfate, the lowest concentration resulting in a constant OD595 
minimum level was employed. Concentration intervals were successively adjusted to the 
final MICs of the respective compound. 
For determining the relevance of the obtained results, the experiments were reproduced 
independently for at least three times. Standard deviations were evaluated based on 
OD595-concentration plots resulting in values of approximately 5 % (10 % for protamine 
sulfate and daptomycin). Significance analysis was performed employing a paired Student’s t 
test (McDonald, 2009). 
 
 
2.8 Promoter activity analysis 
Promoter activities of the PPA0920 and the putative PPA0919 promoter were performed using 
promoter-lacZ reporter gene fusions chromosomally introduced into the PAO1 wild-type 
strain. Cells were grown under distinct conditions and the β-galactosidase activity was 
determined by the method of Miller, 1992. 
 
2.8.1 Promoter activity determination using the β-galactosidase activity assay 
Conventionally, promoter activities are determined by the β-galactosidase activity assay 
employing promoter-lacZ fusions. Cells are cultivated under specific conditions, harvested 
and disrupted. The liberated β-galactosidase cleaves the artificial substrate 2-nitrophenyl-
β-D-galactopyranoside (ONPG) into galactose and 2-nitrophenolate which can be 
determined photometrically and indicates the activity of the promoter of interest (Miller, 
1992). 
Frozen cell pellets were thawed and suspended in 800 µL Z-buffer. If necessary, 5 µL 
10 mg/mL lysozyme were added and samples were incubated at 30 °C for 30 min. 10 – 15 µL 
0.1 % SDS and 10 – 15 µL chloroform were added, samples were intensively mixed and 
incubated at 30 °C for 5 min. 200 µL 4 mg/mL ONPG (Sigma-Aldrich, St. Louis, MO) were 
added and incubation was continued at 30 °C until the sample became yellow. The reaction 
was stopped using 500 µL 1 M Na2CO3 and cell debris was sedimented for 10 min at 
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11’000 x g. The absorption of the supernatant was measured at 420 nm. The β-galactosidase 
activity was calculated in Miller Units (MU) as follows with t representing the incubation 
time, OD578 the culture turbidity and V the sample culture volume (Miller, 1992):  
 
                         [  ]    
     
  [   ]              [  ]
      
 
 Z-buffer Na2HPO4 60 mM 
  NaH2PO4 40 mM 
  KCl 10 mM 
  MgSO4 1 mM 
  β-mercaptoethanol 50 mM 
 
2.8.2 Analysis of the PPA0920 promoter in the presence of antimicrobial agents 
The promoter upstream of orf PA0920 (PPA0920) was analyzed before (Klein et al., 2009) and it 
was found activated under acidic growth conditions. In this work, the response of the PPA0920 
promoter to several antimicrobial agents was analyzed. Strain PAO1-PPA0920-lacZ containing a 
transcriptional PPA0920-lacZ gene fusion integrated into the attB locus of the PAO1 
chromosome (Klein et al., 2009) was grown under acidic and neutral conditions and treated 
with the respective antimicrobials. For control, strain PAO1 KS11 harboring the lacZ gene 
without a controlling promoter in the attB site of the PAO1 chromosome was employed 
(Schreiber et al., 2006). The promoter activity was determined by measuring the 
β-galactosidase activity (see section 2.8.1).  
The presence of antimicrobial agents might influence cell morphologies (Fonseca and Sousa, 
2007; Soboh et al., 1995). Therefore, the β-galactosidase activity calculation based on 
culture turbidity determination (OD578) might provide deviating results. For this, the 
obtained β-galactosidase activities were also related to the overall bacterial protein content 
determined by the Bradford method (Irie et al., 2010). All experiments were performed in 
triplicate. 
60 mL AB medium (pH 5.3 and pH 7.3, in baffled flasks) were inoculated to an OD578 of 0.05 
using an overnight culture (AB medium pH 7.3) and incubated at 37 °C and 200 rpm for 2 h 
to accustom the cells to the specific pH conditions. Subsequently, the antimicrobial 
compounds were added and the incubation was continued for additional 4 h. For control, 
strains were incubated without antimicrobials. 2 h and 4 h after compound application, 
samples for the determination of the β-galactosidase activity and the protein content were 
taken in duplicate (11’000 x g, 10 min, RT; pellets were stored at –20 °C) and the cell 
morphology was investigated. The employed subinhibitory concentrations allowed for an 
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appropriate growth of the PAO1 derivatives and were chosen as follows: 1/4 of the MIC of 
the wild-type strain was employed for ampicillin (75 µg/mL), oxacillin (3 mg/mL), cefsulodin 
(15.25 µg/mL), protamine sulfate (25 µg/mL), poly-L-lysine (4.5 µg/mL) and domiphen 
bromide (2.48 µg/mL). 1/6 of the MIC was used for polymyxin E (1.33 µg/mL), 1/8 of the MIC 
for daptomycin (1.5 mg/mL) and 1/12 of the MIC for benzethonium chloride (2.58 µg/mL). 
The β-galactosidase activity was determined as described above (section 2.8.1). 
For the determination of the total protein content, frozen cell pellets were thawed, 
suspended in 60 – 600 µL 50 mM NaOH and cells were lysed at 95 °C and 1400 rpm for 
5 min. Cell debris was sedimented (11’000 x g, 10 min, RT) and 30 µL of the supernatant 
were mixed with 1 mL Bradford reagent and incubated at RT for 10 min according to the 
manufacturer’s instructions (Sigma-Aldrich, St. Louis, MO). The absorption at 595 nm was 
measured and the β-galactosidase activity was calculated based on the overall protein 
content instead of the culture turbidity (see above). 
Promoter activities determined for the promoter-less KS11 strain representing the 
experimental background were subtracted from the respective PPA0920 promoter activity. To 
evaluate the effects of the antimicrobial agents under all employed conditions (pH, 
antimicrobial agent, growth phase) the promoter activity of strains treated with antibiotics 
was related to the activity in the absence of any compound resulting in an induction ratio. 
Standard deviations were calculated according to Taylor, 1997. 
To verify if the determined promoter activities resulted in alterations of the lipid 
composition, the lipid composition of the KS11 control strain was determined under specific 
conditions using the following antimicrobials: ampicillin and oxacillin (1/4 MIC; pH 7.3, 4 h; 
pH 5.3, 2 h), protamine sulfate (1/4 MIC; pH 7.3, 2 h; pH 5.3, 2 h) and polymyxin E (1/6 MIC; 
pH 7.3, 4 h; pH 5.3, 2 h). Lipids were extracted and analyzed as described in sections 2.5.1 
and 2.5.3. 
 
2.8.3 PPA0919 promoter analysis 
The putative PPA0919 promoter located upstream of orf PA0919 was analyzed employing 
several PAO1 strains containing chromosomally integrated transcriptional promoter-reporter 
gene fusion constructs with varying promoter fragment sizes (PAO1 PPA0919-430-lacZ, PAO1 
PPA0919-206-lacZ and PAO1 PPA0919-140-lacZ, compare section 2.4.19). Strain PAO1 KS11 
harboring the lacZ gene in the absence of any promoter sequence was used for control 
(Schreiber et al., 2006). All experiments were performed at least in triplicate. 
Strains were grown in 60 mL AB medium (pH 7.3 and pH 5.3) in baffled flasks at 37 °C and 
200 rpm. Cultures were inoculated out of an overnight culture (AB medium pH 7.3) to 
OD578 = 0.05 and incubated for 24 h. At distinct time points, samples were taken in duplicate 
and the culture turbidity was measured at 578 nm. The β-galactosidase activity was 
determined employing the conventional assay (section 2.8.1). 
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Promoter activities were calculated by subtracting values obtained for the promoter-less 
control strain KS11 from the respective PPA0919 values. Standard deviations were calculated 
according to Taylor, 1997. Significance was assessed using a paired Student’s t test 
(McDonald, 2009). 
 
 
2.9 PA0919 protein production and purification 
The PA0919 protein and its derivatives were recombinantly produced in E. coli cells. The 
protein was synthesized fused to an N-terminal PelB secretion signal sequence and to a 
C-terminal His6-tag or Strep-tag II. During the recombinant production, the PA0919 fusion 
protein was secreted into the E. coli periplasm (compare section 2.4.15). Cells were treated 
with polymyxin B to obtain the periplasmic fraction and the protein was isolated by affinity 
chromatography.  
 
2.9.1 Production of recombinant PA0919 protein 
The recombinant PA0919 protein was produced by transferring pET22b(+)PA0919 or 
pET22b(+)PA0919-Strep derivatives into E. coli BL21 (λDE3), protein expression was induced 
with IPTG and the protein derivatives were secreted into the E. coli periplasm (compare 
section 2.4.15). 
500 mL LB medium (in baffled flasks, supplemented with Ap) were inoculated employing an 
overnight culture in a ratio of 1:100 (v/v). Cultures were incubated at 37 °C and 200 rpm to 
an OD578 of 0.5 to 0.6. After shifting the incubation temperature to 17 °C, protein production 
was induced by 25 µM IPTG and cultivation was continued overnight. Cells were harvested 
by centrifugation (3’000 x g, 20 min, 4 °C) and suspended in harvesting buffer containing 
D(+)-sucrose for spheroblast stabilization (Quan et al., 2013). After sedimentation (4’000 x g, 
30 min, 4 °C), the obtained cell pellets were stored at –20 °C (Sambrook and Russell, 2001). 
 harvesting buffer HEPES-NaOH pH 8.0 50 mM 
  NaCl 150 mM 
  D(+)-sucrose 20 % (w/v) 
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2.9.2 Isolation of the periplasmic fraction 
Recombinant PA0919 protein variants were isolated from the E. coli periplasm by treating 
the cells with polymyxin B and by stabilizing the spheroblast with sucrose combining two 
methods described by Quan et al., 2013. 
Frozen E. coli pellets containing overexpressed PA0919 protein variants (see section 2.9.1) 
were thawed on ice for 1 h. Cells were suspended in isolation buffer (twofold pellet volume) 
and incubated with agitation at 4 °C for 1.5 h. Cell debris was removed by centrifugation 
(20’000 x g, 1.5 h, 4 °C) and the supernatant representing the isolated soluble periplasmic 
fraction was separated.  
 isolation buffer HEPES-NaOH pH 8.0 50 mM 
  NaCl 150 mM 
  D(+)-sucrose 20 % (w/v) 
  polymyxin B 2 mg/mL 
 
2.9.3 Purification of His6-tagged PA0919 protein 
The isolated periplasmic fraction containing recombinant His6-tagged PA0919 protein was 
employed to purify the target protein by chromatography using a Ni-nitrilotriacetic acid 
(NTA) agarose containing column. The protein was specifically bound to the resin and eluted 
by imidazole after an extensive washing step (Sambrook and Russell, 2001). Protein 
purification was performed at 4 °C. 
A Poly-Prep chromatography column (BioRad, Munich, Germany) containing 0.5 mL Protino® 
Ni-NTA agarose (Macherey-Nagel, Düren, Germany) was washed extensively with dH2O and 
equilibrated with 10 column volumes (CV) of washing buffer. The isolated periplasmic 
fraction (section 2.9.2) was mixed carefully with the appropriate amount of 4 M NaCl to 
increase the NaCl concentration to the optimized value of 300 mM and incubated at 4 °C for 
15 min. The periplasmic fraction was loaded onto the Ni-NTA agarose column. After 
extensive washing (10 CV washing buffer) and a pre-elution step (4 CV pre-elution buffer), 
the His6-tagged PA0919 protein was eluted with 5x 2 CV elution buffer and stored at 4 °C. 
The Ni-NTA agarose column was regenerated employing 2 CV column buffer followed by 
2 CV 6 M guanidine hydrochloride. After extensive washing with 10 CV dH2O, 2 CV 100 mM 
NiSO4 were loaded onto the column followed by additional washing with 5 CV dH2O. The 
regenerated column was either employed directly or washed with 20 % ethanol and stored 
at 4 °C (modified according to the manufacturer’s instructions and Sambrook and Russell, 
2001). 
 washing buffer HEPES-NaOH pH 8.0 50 mM 
  NaCl 300 mM 
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 pre-elution buffer HEPES-NaOH pH 8.0 50 mM 
  NaCl 300 mM 
  imidazole 15 mM 
  re-adjusted to pH 8.0 after imidazole application 
 elution buffer HEPES-NaOH pH 8.0 50 mM 
  NaCl 300 mM 
  imidazole 300 mM 
  re-adjusted to pH 8.0 after imidazole application 
 column buffer Tris-HCl pH 8.0 20 mM 
  NaCl 500 mM 
  EDTA pH 8.0 50 mM 
 
2.9.4 Purification of Strep-tagged PA0919 protein 
For the purification of Strep-tagged PA0919 variant proteins, the isolated periplasmic 
fraction (section 2.9.2) was mixed with avidin to mask biotinylated proteins. Samples were 
loaded onto a Strep-Tactin® resin containing column and the PA0919 variant proteins were 
isolated by desthiobiotin-dependent elution according to the manufacturer’s instructions. 
Protein purification was performed at 4 °C. 
Poly-Prep chromatography columns (BioRad, Munich, Germany) were prepared with 1 mL 
Strep-Tactin® Superflow® high capacity resin (IBA, Göttingen, Germany) and equilibrated 
with 2x 5 CV washing buffer. The isolated soluble periplasmic fraction (section 2.9.2) was 
mixed gently with 0.4 µM avidin (Calbiochem® by Merck, Darmstadt, Germany) and stored 
at 4 °C for 15 min. The periplasmic fraction was loaded onto the column and after two 
washing steps (2x 5 CV washing buffer), the protein was eluted with 5x 1 CV elution buffer. 
The obtained protein was stored at 4 °C. 
Columns containing the Strep-Tactin® Superflow® high capacity resin were regenerated 
according to the manufacturer’s instructions employing 3x 5 CV regeneration buffer (IBA, 
Göttingen, Germany) while the color of the column turned from white to yellow. The 
columns were washed with column washing buffer I until the yellow color was removed. 
5 CV column washing buffer II were used to restore pH conditions. Strep-Tactin® Superflow® 
high capacity columns were stored either in regeneration buffer or in column washing 
buffer II at 4 °C. 
 washing buffer HEPES-NaOH pH 8.0 50 mM 
  NaCl 100 mM 
 elution buffer HEPES-NaOH pH 8.0 50 mM 
  NaCl 100 mM 
  desthiobiotin 2.5 mM 
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 regeneration buffer Tris-HCl pH 8.0 100 mM 
  NaCl 150 mM 
  EDTA 1 mM 
  2-(4’-hydroxyl-benzeneazo)benzoic acid 
  (HABA) 1 mM 
 column washing buffer I Tris-HCl pH 10.5 100 mM 
  NaCl 150 mM 
  EDTA 1 mM 
 column washing buffer II Tris-HCl pH 8.0 100 mM 
  NaCl 150 mM 
  EDTA 1 mM 
 
2.9.5 Dialysis 
Strep-tagged PA0919 variant proteins were dialyzed to exchange the employed buffer 
system. Protein containing elution fractions were dialyzed against at least 250 volumes of 
dialysis buffer employing a dialysis membrane (dialysis tubing membrane visking, molecular 
weight cutoff of 14 kDa; Roth, Karlsruhe, Germany) at 4 °C for at least 2 h. After dialysis 
buffer exchange, the procedure was continued at 4 °C for at least 2 h. The obtained protein 
was stored at 4 °C. 
 dialysis buffer HEPES-NaOH pH 6.8 20 mM 
 
2.9.6 Protein concentration 
If necessary, protein samples were concentrated up to 3 mg/mL using an Amicon® Ultra-0.5 
device exhibiting a nominal molecular weight limit of 10’000 (Merck, Darmstadt, Germany) 
according to the manufacturer’s instructions. 
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2.10 Protein biochemical methods 
Protein biochemical techniques used to characterize the PA0919 protein and its derivatives 
in this study are summarized in the following sections. 
 
2.10.1 Protein concentration determination 
Protein concentrations in solution were determined according to the method of Bradford, 
1976. The dye Coomassie Brilliant Blue G250 forms a complex with proteins and its maximal 
absorption shifts from 465 to 595 nm.  
30 µL protein-containing sample were mixed with 1 mL Bradford reagent (Sigma-Aldrich, 
St. Louis, MO, USA), incubated for 10 – 15 min and the absorbance at 595 nm was 
determined according to the manufacturer’s instructions. Highly concentrated protein 
samples were diluted employing the respective protein buffer and bovine serum albumin 
(Roth, Karlsruhe, Germany) dissolved in the corresponding protein buffer was used for 
calibration. 
 
2.10.2 Discontinuous SDS polyacrylamide gel electrophoresis (SDS-PAGE) 
The discontinuous SDS-PAGE was employed to analyze protein samples under denaturing 
conditions. The proteins were denatured by SDS and β-mercaptoethanol treatment and 
separated according to their molecular weight (Laemmli, 1970; Sambrook and Russell, 2001).  
Cell sediments of 1 mL bacterial culture taken during cultivation to monitor protein 
expression were suspended in 50 µL dH2O and mixed with 50 µL SDS loading dye. 20 µL of 
samples containing soluble proteins were mixed with 20 µL SDS loading dye. All samples 
were incubated at 95 °C for 10 min for cell disruption and protein denaturation and loaded 
onto the SDS polyacrylamide gel. Samples from membrane fractions were treated at 40 °C 
for 30 min to prevent protein aggregation (Klein et al., 2009). The Unstained Protein 
Molecular Weight Marker was employed as a protein size standard and the PageRulerTM 
Prestained Protein Ladder was used for gels subjected to Western Blot analysis (Thermo 
Fisher Scientific, Waltham, MA, USA). Electrophoresis was performed at 45 mA per gel. For 
protein band visualizing, the gels were treated with staining and de-staining solutions 
(Laemmli, 1970; Sambrook and Russell, 2001). 
 running gel, 12 % (w/v) Rotiphorese® Gel 30 8 mL 
  1.5 M Tris-HCl pH 8.8, 0.4 % (w/v) SDS 5 mL 
  10 % (w/v) ammonium peroxodisulfate 200 µL 
  N,N,N’,N’-tetramethylethylenediamine 20 µL 
  dH2O 7 mL 
  sufficient for preparing 4 gels 
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 stacking gel, 6 % (w/v) Rotiphorese® Gel 30 2 mL 
  0.5 M Tris-HCl pH 6.8, 0.4 % (w/v) SDS 2.5 mL 
  10 % (w/v) ammonium peroxodisulfate 100 µL 
  N,N,N’,N’-tetramethylethylenediamine 10 µL 
  dH2O 5.5 mL 
  sufficient for preparing 4 gels 
 SDS loading dye Tris-HCl pH 6.8 100 mM 
  glycerol 40 % (w/v) 
  β-mercaptoethanol 2 % (v/v) 
  SDS 3.2 % (w/v) 
  bromophenol blue 0.2 % (w/v) 
 electrophoresis buffer Tris-HCl pH 8.8 50 mM 
  glycine 385 mM 
  SDS 0.1 % (w/v) 
 staining solution acetic acid 10 % (v/v) 
  ethanol 30 % (v/v) 
  Coomassie Brilliant Blue G250 0.25 % (w/v) 
 de-staining solution acetic acid 10 % (v/v) 
  ethanol 30 % (v/v) 
 
2.10.3 Western Blot 
The Western Blot procedure was employed to prepare protein samples for N-terminal 
sequence determination or to detect specific proteins. 
Protein samples were separated by SDS-PAGE and unstained gels were equilibrated in 
Towbin buffer for 15 min. The polyvinylidene difluoride (PVDF) membrane (0.45 µm pore 
size; Millipore, Merck, Darmstadt, Germany) was washed with methanol for 10 min and 
equilibrated in Towbin buffer for 15 min. The semi-dry TransBlot® SD system (BioRad, 
Munich, Germany) was assembled and the proteins were transferred to the membrane at 
10 V for 40 min according to the manufacturer’s instructions. Alternatively, the Trans-Blot® 
TurboTM system (BioRad, Munich, Germany) was employed at 25 V for 17 min. After 
de-assembly, the membrane was washed with dH2O. 
For protein sequence determination purposes, the blotted proteins were stained with 
Ponceau S solution and bands of interest were excised from the membrane. 
 Towbin buffer Tris-HCl pH 9.5 25 mM 
  glycine 192 mM 
  methanol 15 % (v/v) 
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 Ponceau S solution Ponceau S 0.4 % (w/v) 
  trichloricacetic acid 3 % (w/v) 
  sulfosalicylic acid  3 % (w/v) 
 
2.10.4 Amino acid sequence determination 
For the determination of the N-terminal amino acid sequence according to Edman, 1950, the 
isolated protein was removed from the membrane and the sequence was analyzed step-by-
step. During one reaction cycle, phenyl isothiocyanate binds to the N-terminal amino group 
of the protein under specific reaction conditions. By changing the conditions, the peptide 
bond linking the first to the second amino acid is cleaved into a phenyl thiohydandoin and 
the protein lacking its N-terminal amino acid. The protein is removed and the amino acid is 
released from the phenyl thiohydandoin by changing the reaction conditions and analyzed 
afterwards (Edman, 1950). This work was kindly performed by Beate Jaschok-Kentner at the 
Helmholtz Centre for Infection Research, Braunschweig, Germany. 
 
2.10.5 Immunochemical-like detection of Strep-tagged PA0919 protein 
The PA0919 protein fused to the Strep-tag II was detected on the Western Blot membrane 
using a Strep-Tactin® alkaline phosphatase conjugate in an immunochemical-like detection 
procedure according to the manufacturer’s instructions.  
The membrane was incubated with agitation in blocking buffer at RT for 1 h or alternatively 
at 4 °C overnight. After washing with PBST buffer (3x 20 mL, 5 min, RT), the membrane was 
incubated with agitation with 10 mL PBST buffer supplemented with 10 µL 2 mg/mL avidin 
(Calbiochem® by Merck, Darmstadt, Germany) at RT for 10 min to mask biotinylated 
proteins. 2.5 µL Strep-Tactin® AP conjugate (IBA, Göttingen, Germany) were added and 
incubation was continued for 1 h. After washing with PBST buffer (2x 20 mL, 1 min) and with 
PBS buffer (2x 20 mL, 1 min), the membrane was equilibrated using 15 mL substrate buffer 
for 10 min. The substrate buffer was exchanged and 49.5 µL of each 5-bromo-4-chloro-
3-indolyl phosphate (BCIP) and nitrotetrazolium blue (NBT) were added for dye formation by 
alkaline phosphatase. The membrane was incubated with gentle agitation until protein 
bands were visible and the reaction was arrested by transferring the membrane into dH2O. 
 PBS buffer KH2PO4 4 mM 
  Na2HPO4 16 mM 
  NaCl 115 mM 
  adjusted to pH 7.4 with phosphoric acid 
 PBST buffer Tween® 20 0.1 % (v/v) 
  solved in PBS buffer 
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 blocking buffer bovine serum albumine 3 % (w/v) 
  Tween® 20 0.5 % (v/v) 
  solved in PBS buffer 
 substrate buffer Tris-HCl pH 8.8 100 mM 
  NaCl 100 mM 
  MgCl2 5 mM 
 BCIP BCIP 50 mg/mL 
  solved in 100 % dimethylformamide 
 NBT NBT 100 mg/mL 
  solved in 70 % dimethylformamide 
 
2.10.6 Determination of the PA0919 native molecular mass 
The native molecular mass of the PA0919 protein was determined by analytical gel 
permeation chromatography. The purified, dialyzed and Strep-tagged PA0919 protein and 
several protein standards employed for calibration (carbonic anhydrase, Mr: 29’000; bovine 
serum albumin, Mr: 66’000; yeast alcohol dehydrogenase, Mr: 150’000; β-amylase, 
Mr: 200’000) were analyzed using a Superdex 200 5/150 GL chromatography column 
(GE Healthcare, Munich, Germany). Approximately 50 µg of protein were loaded onto the 
column and eluted using a flow rate of 0.45 mL/min. Protein elution was detected via the 
absorption at 280 nm. The native molecular mass of the PA0919 protein was calculated by 
comparing elution volumes of the sample and the standard proteins.  
 buffer Tris-HCl pH 7.5 20 mM 
  NaCl 200 mM 
  MgCl2 0.5 mM 
  glycerol 5 % (w/v) 
  dithiotreitol 2 mM 
 
2.10.7 Spectroscopic cofactor analysis 
The presence of chromogenic cofactors was analyzed by absorption and fluorescence 
spectra measurement (Schmid, 2001; Lakowicz, 2006).  
The purified, dialyzed and Strep-tagged PA0919 protein (approximately 3 mg/mL) was 
analyzed by UV-visible light spectroscopy (260 – 900 nm) employing a V-650 spectrometer 
(Jasco, Groß Umstadt, Germany) and by fluorescence spectroscopy (excitation: 250 – 
450 nm, emission: 250 – 800 nm) using a LS50B luminescence spectrometer (PerkinElmer, 
Boston, MA, USA). 
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2.10.8 Inductively coupled plasma – mass spectrometry (ICP-MS) 
For the determination of protein-associated metal ions, the purified, dialyzed and Strep-
tagged PA0919 protein (8 mg/mL, 180 µM) was analyzed by ICP-MS performed by Currenta 
(Leverkusen, Germany) concerning the metal ions Cu2+, Fe2+, Mg2+, Mn2+, Ni2+ and Zn2+(and 
others). The detection limit of 0.1 mg/kg was declared by the provider. 
 
2.10.9 Protein lipid overlay assay 
The binding of the PA0919 protein to selected membrane lipids was analyzed by performing 
a protein lipid overlay assay (Dowler et al., 2002). A hydrophobic membrane providing 
selected membrane lipids was incubated with Strep-tagged PA0919 wild-type protein. After 
extensive washing, bound PA0919 protein was detected via its Strep-tag II using a protocol 
differing slightly from the manufacturer’s instructions.  
For positive control, 10 µg purified, dialyzed and Strep-tagged PA0919 wild-type protein was 
spotted onto the employed Membrane Lipid StripTM P-6002 (Echelon Biosciences, Salt Lake 
City, UT, USA). The membrane was dried and incubated with 10 mL PBST buffer (PBS-Tween® 
tablets; Medicago, Uppsala, Sweden) supplemented with 3 % (w/v) bovine serum albumine 
at 4 °C overnight. The PA0919 protein (10 µg/mL) was added and incubation was continued 
to support protein-lipid binding at 4 °C overnight. The membrane was washed with PBS (5x, 
10 min) and incubated in 10 mL PBS supplemented with 2.5 µL Strep-Tactin® AP conjugate 
(IBA, Göttingen, Germany) for 1 h. After additional washing with PBS (4x, 10 min), the 
membrane was equilibrated in 10 mL AP buffer for 10 min. The AP buffer was exchanged 
and the detection reaction was started by the addition of 33 µL NBT and 66 µL BCIP (see 
section 2.10.5). After sufficient dye formation, the reaction was arrested by transferring the 
membrane into dH2O. 
 PBS buffer KH2PO4 4 mM 
  Na2HPO4 16 mM 
  NaCl 115 mM 
  adjusted to pH 7.4 
 AP buffer Tris-HCl pH 8.0 100 mM 
  NaCl 100 mM 
  MgCl2 5 mM 
 
2.10.10 Binding of 14C-labeled alanine 
For the investigation of the PA0919 alanine binding capacity, purified, dialyzed and Strep-
tagged protein variants were bound to Strep-Tactin® resin and incubated with 14C-labeled 
alanine. After extensive washing, the protein was eluted and the radioactivity of the 
obtained samples was determined by scintillation counting. 
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Portions of 0.1 mL Strep-Tactin® Superflow® high capacity resin (IBA, Göttingen, Germany) 
were equilibrated with column buffer and incubated with 0.1 mL of a solution containing 
50 µM PA0919 wild-type or PA0919 S307A mutant protein for 15 min. For control, a sample 
without protein was handled analogously. Resins were washed using 0.5 mL washing buffer, 
mixed with 0.1 mL 100 µM [1-14C]-L-alanine (Moravec Biochemicals, Brea, CA, USA) and 
incubated with gentle agitation for 1 h. After separating the radioactive solution, the resin 
was washed twice with 0.5 mL washing buffer to remove unbound 14C-labeled alanine. The 
resin was suspended in 0.2 mL elution buffer and the complete mixture was transferred into 
4 mL scintillation solution (OptiPhase HighSafe 2; PerkinElmer, Boston, MA, USA). Samples 
taken during the loading and washing procedure and the resin samples were analyzed by 
scintillation counting (TriCarb® 2900TR, PerkinElmer, Boston, MA, USA).  
 washing buffer HEPES-NaOH pH 8.0 50 mM 
  NaCl 100 mM 
 elution buffer HEPES-NaOH pH 8.0 50 mM 
  NaCl 100 mM 
  desthiobiotin 2.5 mM 
 
 
2.11 PA0919 in vitro activity analyses 
The PA0919 protein was analyzed in vitro employing various p-nitrophenol derivatives to 
elucidate its substrate specificity. The identified substrate analog was employed to 
determine the catalytically active amino acids of the PA0919 protein using highly specific 
inhibitory substances. Finally, the PA0919 in vitro activity was analyzed in the presence of 
the putative native substrate A-PG. 
 
2.11.1 Substrate specificity analysis 
For the determination of PA0919 substrate specificity, an in vitro activity assay was 
performed employing artificial chromogenic p-nitrophenol derivative substrates. When 
these substances are hydrolyzed, the product formation of p-nitrophenolate can be 
determined by measuring the absorption at 400 nm (Max et al., 2012). All experiments were 
performed in triplicate. 
The chromogenic substrates Ala-ONp, Gly-ONp, Ac-Gly-ONp, Boc-Ala-ONp, Ala-pNA 
(Bachem, Bubendorf, Switzerland), 4-nitrophenyl butyrate, 4-nitrophenyl acetate and 
4-nitrophenyl phosphate (Sigma-Aldrich, St. Louis, MO, USA) were commercially available. 
Instead, Lys-ONp was synthesized de novo by H. Kuhz and Dr. J. S. Dickschat (Institute for 
Organic Chemistry, Technische Universität Braunschweig, Braunschweig, Germany) by 
combining the methods of Ke et al., 2009, and Schnabel, 1964 (compare Figure 5).  
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The amino groups of the basic compound L-lysine (1) were protected by the addition of tert-
butyloxycarbonyl (Boc) groups. The resulting N,N’-di-(tert-butyloxycarbonyl)-L-lysine (2) was 
esterified with p-nitrophenol (3) under carboxylic acid activation by dicyclohexylcarbo-
diimide (DCC). The protecting Boc groups were removed by hydrobromic acid treatment 
yielding Lys-ONp dihydrobromide (5). 
For the in vitro activity assay, the chromogenic substrates were dissolved in dimethyl 
sulfoxide (DMSO) and dialysis buffer was employed for 4-nitrophenol phosphate. Purified, 
dialyzed and Strep-tagged PA0919 protein was diluted using dialysis buffer and mixed with 
the respective chromogenic p-nitrophenol derivative at RT in a final volume of 300 µL to 
start the in vitro activity assay. Immediately after mixing, the p-nitrophenolate formation 
was monitored by measuring the absorption at 400 nm (V-650 spectrometer; Jasco, Groß 
Umstadt, Germany) for at least 2 min. Analogous experiments were performed without the 
respective PA0919 protein to determine the spontaneous hydrolysis of the respective 
chromogenic substrate. Initial slopes of the obtained p-nitrophenolate formation curves 
were calculated and for protein activity determination, the rate of spontaneous hydrolysis 
was subtracted from the corresponding experiment in the presence of the PA0919 protein. 
All experiments were independently performed at least in triplicate. 
Figure 5: Synthesis of Lys-ONp (kindly provided by J. S. Dickschat) 
For the synthesis of Lys-ONp, L-lysine (1) was solved with KOH in a mixture of H2O and THF. Boc2O 
was added carefully and the mixture was stirred at 50 °C for 14 h. For product isolation, the 
mixture was acidified with HCl and extracted with EtOAc. Extracts were pooled, dried by MgSO4 
and concentrated in vacuo. After column chromatography (silica gel, hexane/EtOAc 2:1; v/v), the 
product N,N’-di-(tert-butyloxycarbonyl)-L-lysine (2) was obtained. The product was solved in 
CH2Cl2, p-nitrophenol (3) and DCC were added and the mixture was stirred at RT overnight. The 
precipitate was isolated and washed with CH2Cl2 and, after solvent removal, the p-nitrophenyl 
ester of N,N’-di-(tert-butyloxycarbonyl)-L-lysine (4) was obtained. After adding a mixture of HBr 
and acetic acid and stirring at RT for 2 h, the precipitated product L-lysine p-nitrophenylester 
dihydrobromide (5, Lys-ONp) was isolated, washed with EtOAc and dried.  
Figure and information were generously provided by Dr. J. S. Dickschat. 
THF: tetrahydrofuran, Boc2O: di-tert-butyl dicarbonate, DCC: dicyclohexylcarbodiimide. 
1 2
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3
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 dialysis buffer HEPES-NaOH pH 6.8 20 mM 
 sample composition HEPES-NaOH pH 6.8 20 mM 
  PA0919 derivative 3 – 12 µM 
  DMSO 2 % (v/v) 
  chromogenic p-nitrophenol derivative 50 µM 
 
2.11.2 PA0919 inactivation by inhibitory substances  
Purified, dialyzed and Strep-tagged PA0919 protein was incubated with the inhibiting 
compounds phenylmethylsulfonyl fluoride (PMSF), Nα-tosyl-L-lysine chloromethyl ketone 
(TLCK) and EDTA and the residual enzyme activity was analyzed using the well-established in 
vitro assay (see section 2.11.1).  
Stock solutions of PMSF (in DMSO), TLCK (in 50 mM sodium acetate pH 4.8) and EDTA (in 
dH2O, pH 8.0) were prepared. Purified, dialyzed and Strep-tagged PA0919 wild-type protein 
was pre-incubated with PMSF, TLCK and EDTA at 4 °C for 30 min, respectively. 60 µL of the 
prepared mixture were subjected to the in vitro activity assay using Ala-ONp as the substrate 
in a final volume of 300 µL. The assay was performed and monitored as described in section 
2.11.1. Control experiments were prepared without the inhibiting compound. Values 
obtained for samples without protein were treated analogously and employed to determine 
the spontaneous hydrolysis of the substrate Ala-ONp in the presence of the specific 
inhibitor. Values for the spontaneous hydrolysis were subtracted from the corresponding 
experiment in the presence of PA0919 protein (in analogy to section 2.11.1). All experiments 
were performed in duplicate and the whole study was repeated in triplicate independently.  
 compound stock solution pre-incubation final concentration 
 PMSF 150 mM 5 mM 1 mM 
 TLCK 9 mM, 150 mM 0.3 mM, 5 mM 60 µM, 1 mM 
 EDTA 150 mM 5 mM 1 mM 
 DMSO   2 % (v/v) 
 PA0919 protein  30 µM 6 µM 
 Ala-ONp 10 mM  50 µM 
 
2.11.3 PA0919 protein in vitro activity assay in the presence of 14C-labeled A-PG 
The activity of the PA0919 protein in the presence of the putative native substrate A-PG was 
investigated. Since A-PG was not commercially available, the radioactively labeled substrate 
was synthesized using the well-established A-PGS in vitro assay (compare Hebecker et al., 
2011). The 14C-labeled A-PG was extracted and solubilized for the subsequent PA0919 in 
vitro activity assay.  
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A-PGS in vitro assay for the synthesis of [1-14C]-A-PG 
The A-PGS in vitro assay was employed to synthesize sufficient amounts of A-PG for the 
analysis of the PA0919 activity according to Hebecker et al., 2011. The A-PGS enzyme of 
P. aeruginosa transfers an alanine moiety form its corresponding tRNAAla to the 3’ or 
2’ hydroxyl group of PG (Hebecker et al., 2011). During the employed assay, the tRNAAla can 
be re-used by its corresponding Ala-tRNAAla synthetase (PA0903). To provide sufficient ATP 
molecules, an ATP regenerating system (consisting of creatine phosphate and creatine 
phosphokinase) was added to the reaction mixture (Hebecker et al., 2011). The recombi-
nantly produced and purified catalytic A-PGS domain from P. aeruginosa (A-PGS543-881; all 
tags were removed after purification) used in this assay was generously provided by 
S. Hebecker. The application of [1-14C]-L-alanine allowed for the detection of synthesized 
[1-14C]-A-PG, but also for product detection after the PA0919 in vitro assay (see below). 
E. coli Rosetta (λDE3) pLysS pET28b(+)PA0903 was grown in 500 mL cultures (LB medium 
supplemented with Kan and Cm) at 37 °C and 180 rpm. At OD578 = 0.5, the cultures were 
shifted to 30 °C and 180 rpm for 10 min. Protein production was induced with 200 µM IPTG 
and cultivation was continued at 30 °C and 180 rpm for 4 h. The cultures were harvested 
(3’000 x g, 20 min, 4 °C), washed with 50 mM HEPES-NaOH pH 7.8 (4’000 x g, 20 min, 4 °C) 
and suspended according to the culture turbidity (10 mL buffer were used for an OD578 of 2) 
using the same buffer. Crude cellular extracts were obtained by French® Press passage at 
19’200 lb/in². 
The assay was performed in reaction volumes of 1 mL containing purified A-PGS543-881, ATP 
and an ATP regenerating system (creatine phosphokinase, creatine phosphate) in 50 mM 
HEPES-NaOH pH 7.8 and [1-14C]-L-alanine (Moravec Biochemicals, Brea, CA, USA) in a final 
volume of 300 µL. The reaction was started by the addition of 700 µL crude cellular extract 
and mixtures were incubated at 37 °C and 1’000 rpm for 1 h. Samples were taken at distinct 
time points to monitor A-PG synthesis by scintillation counting after lipid extraction (see 
chapter 2.5). The reaction was stopped by adding 10 µL 10 mg/mL RNase A (Invitrogen by 
Life Technologies, Darmstadt, Germany) and mixtures were incubated at 37 °C for 15 min. 
Samples were stored at –20 °C in 200 µL portions. 
 stock solutions volumes (1000 µL) final concentration 
 100 mM ATP 10 µL 2 mM 
 500 mM creatine phosphate 18 µM 18 mM 
 6.7 U/µL creatine phosphokinase 2.6 µL 35 U/mL 
 2 mM [1-14C]-L-alanine (51 mCi/mmol) 10 µL 20 µM 
 purified A-PGS543-881  10 µM 
 50 mM HEPES-NaOH pH 7.8 add to 300 µL 
 crude cellular extract 700 µL 
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Preparation of [1-14C]-A-PG for the PA0919 in vitro activity assay 
The synthesized [1-14C]-A-PG was isolated from the reaction mixture to prevent 
contamination of the PA0919 in vitro activity assay with 14C-labeled alanine and the isolated 
lipids were solubilized by TritonTM X-100 treatment.  
The polar lipids were extracted from the 200 µL portions as described in section 2.5.1. After 
chloroform evaporation, isolated lipids were solved in 190 µL dialysis buffer (section 2.9.5) 
supplemented with 3.2 mg/mL TritonTM X-100 (Sigma-Aldrich, St. Louis, MO, USA) and 
incubated under vigorous shaking at 37 °C for 15 min. Unsolved lipids were removed by 
centrifugation (11’000 x g, 10 min, RT) and solubilized lipids were subjected to the PA0919 
in vitro activity assay.  
 
PA0919 in vitro activity assay employing [1-14C]-A-PG 
Strep-tagged PA0919 variant proteins were mixed with solubilized lipids containing [1-14C]-
A-PG. After incubation, samples were subjected to TLC analysis for product detection. All 
experiments were reproduced at least three times independently. 
80 µL of 80 µM purified, dialyzed and Strep-tagged PA0919 variant protein was mixed with 
80 µL solubilized lipid mixture and incubated at 37 °C and 1’000 rpm for 30 min. For control, 
a sample without protein was handled analogously. The reactions were stopped by heat at 
60 °C for 5 min.  
For product formation analysis, 12 µL of the individual samples were loaded onto a TLC plate 
(Macherey-Nagel, Düren, Germany). 1 µL 10 mM L-alanine (Sigma-Aldrich, St. Louis, MO, 
USA) was used as a reference. Lipids were separated from amino acids at 25 °C on TLC plates 
using a solvent mixture of n-butanol, acetic acid and water (5:3:2, v/v/v; Qiu et al., 2010). 
Amino group carrying molecules were detected by ninhydrin (Merck, Darmstadt, Germany) 
and incubation at 100 °C (Klein et al., 2009). Plates were subjected to autoradiography 
analysis (section 2.5.4) to specifically detect 14C-labeled spots.  
 
 
2.12 Localization of PA0919 in P. aeruginosa 
The PA0919 protein was localized in P. aeruginosa using strain Δ19 pUC/19 (compare section 
2.4.19) carrying a PA0919-Strep fusion protein. The strain was cultivated under acidic growth 
conditions and cells were fractionated by different methods into periplasm, cytoplasm, outer 
and inner membrane fractions. The PA0919 protein was detected within these fractions 
after SDS-PAGE and Western Blot via its C-terminal Strep-tag II. 
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2.12.1 Cultivation of P. aeruginosa strains for PA0919 protein localization 
P. aeruginosa Δ19 pUC/19 was cultivated under acidic conditions and harvested before 
subjecting the cells to fractionation procedures. 
500 mL AB medium pH 5.3 (in baffled flasks, supplemented with Cb) were inoculated to an 
OD578 of 0.05 using an overnight P. aeruginosa Δ19 pUC/19 culture and incubated at 37 °C 
and 200 rpm for 6 h. Cells of 1 L culture were harvested by centrifugation (3’000 x g, 15 min, 
4 °C) and washed with 50 mL buffer (4’000 x g, 20 min, 4 °C). The harvesting buffer 
containing D(+)-sucrose for spheroblast stabilization (Quan et al., 2013) was employed for 
the isolation of the periplasmic (section 2.9.1) and the cytoplasmic fraction, whereas the Tris 
buffer was used for cells subjected to the total membrane isolation procedure. Cells 
designated for periplasm/cytoplasm isolation were directly employed, whereas sediments 
for membrane preparation were stored at –20 °C. 
 harvesting buffer HEPES-NaOH pH 8.0 50 mM 
  NaCl 150 mM 
  D(+)-sucrose 20 % (w/v) 
 Tris buffer Tris-HCl pH 8.0 50 mM 
 
2.12.2 Isolation of the periplasmic and cytoplasmic fraction 
For the localization of the PA0919 protein, periplasmic and cytoplasmic fractions were 
isolated from P. aeruginosa Δ19 pUC/19 cells. First, the periplasmic fraction was isolated by 
polymyxin B treatment in analogy to section 2.9.2 and the obtained spheroblasts were 
employed for the cytoplasm isolation (Jensch and Fricke, 1997). 
After harvesting (section 2.12.1), the cell sediments of 1 L culture were suspended carefully 
in isolation buffer (compare section 2.9.2; using 2 buffer volumes for 1 sediment volume) 
and incubated with gentle agitation at 4 °C for 3 h. The spheroblasts were separated by 
centrifugation (10’000 – 20’000 x g, 15 min, 4 °C) and the periplasmic fraction was obtained 
as the supernatant. The spheroblast sediment was stored at –20 °C.  
The frozen spheroblasts were thawed and suspended in cytoplasm buffer using 4 buffer 
volumes for 1 pellet volume. 250 mg glass beads were added to 750 µL cell suspension and 
cells were disrupted by FastPrep® treatment (3x at 5.5 m/s and 45 sec; MP Biomedicals, 
Eschwege, Germany). The cytoplasmic fraction was obtained as the supernatant after cell 
debris removal (20’000 x g, 1 h, 4 °C).  
 isolation buffer HEPES-NaOH pH 8.0 50 mM 
  NaCl 150 mM 
  D(+)-sucrose 20 % (w/v) 
  polymyxin B 2 mg/mL 
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 cytoplasm buffer HEPES-NaOH pH 8.0 50 mM 
  NaCl 100 mM 
 
2.12.3 Isolation of total membrane protein fractions 
Total membrane fractions were obtained by lysing the cells and removing cell debris. The 
membrane fraction sediment was obtained after high-speed centrifugation according to 
Strugatsky et al., 2013. 
After cell harvesting (section 2.12.1), 50 mM Tris-HCl pH 8.0 was added to the thawed cell 
sediment of 1 L culture to a final volume of 15 mL. Cells were lysed by French® Press passage 
at 19’200 lb/in² and cell debris was removed by low-speed centrifugation (2’000 x g, 25 min, 
4 °C). The supernatant was subjected to a high-speed centrifugation (110’000 x g, 65 min, 
4 °C) and the sedimented membrane fraction was carefully washed (3x 500 µL). Membrane 
proteins were solubilized with gentle agitation using 5 mL solubilization buffer at 4 °C for 2 h 
and subjected to a second high-speed centrifugation (110’000 x g, 65 min, 4 °C) to sediment 
lipids. Solubilized membrane proteins were obtained in the supernatant.  
 washing buffer Tris-HCl pH 8.0 50 mM 
  MgCl2 20 mM 
 solubilization buffer Tris-HCl pH 8.0 50 mM 
  MgCl2 20 mM 
  TritonTM X-100 2 % (v/v) 
 
2.12.4 Separation of membranes by isopycnic sucrose gradient centrifugation 
After cell lysis and removal of cell debris, the inner and the outer membrane of 
P. aeruginosa Δ19 pUC/19 were obtained by centrifugation employing an isopycnic sucrose 
gradient according to Magnowska, 2010.  
 
After thawing, the sediment of 3 L cell culture was suspended in cell disruption buffer in a 
final volume of 15 mL. Cells were disrupted by French® Press passage at 19’200 lb/in² and 
cell debris was removed by low-speed centrifugation (20’000 x g, 25 min, 4 °C). 4 – 4.5 mL of 
the supernatant was loaded on top of the isopycnic sucrose gradient (3 mL of 2.0 M, 1.5 M 
and 0.5 M D(+)-sucrose solutions) and high-speed centrifugation was performed 
(100’000 x g, 65 min, 4 °C) using the swing-out-rotor SW 40 Ti (Beckman Coulter, Brea, CA, 
USA). The visible membrane fractions (upper: inner membrane; lower: outer membrane) 
were carefully isolated from the gradient.  
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 cell disruption buffer potassium acetate 100 mM 
  magnesium acetate 5 mM 
  HEPES-NaOH pH 8.0 50 mM 
  β-mercaptoethanol 0.05 % (v/v) 
  cOmplete protease inhibitor cocktail  
   1 tablet/50 mL 
 
2.12.5 Isolation of the outer membrane by sarcosyl treatment 
After cell disruption and cell debris removal, the total membrane fraction was sedimented 
and the outer membrane fraction was separated from the inner one by sarcosyl treatment 
combining different methods (Eitel and Dersch, 2002; Bölin et al., 1982; Filip et al., 1973). 
Frozen P. aeruginosa Δ19 pUC/19 cells sediments of 2 L cell culture were thawed and mixed 
with TEM buffer in a final volume of 20 mL. Cells were disrupted by twofold French® Press 
passage at 19’200 lb/in² and cell debris was removed by low-speed centrifugation (2’800 x g, 
10 min, 4 °C). The total membrane fraction was isolated by high-speed centrifugation 
(110’000 x g, 65 min, 4 °C) and suspended with gentle agitation using 20 mL sarcosyl solution 
at 4 °C overnight. The suspension was additionally centrifuged (110’000 x g, 65 min, 4 °C). 
The supernatant containing the inner membrane fraction was removed and concentrated for 
protein analysis (compare section 2.9.6). The sedimented outer membrane fraction was 
resolved (20 mL sarcosyl solution, gentle agitation, 4 °C for 2 h) and subjected to high-speed 
centrifugation for improving the purity. The obtained outer membrane sediment was 
solubilized with gentle agitation in 1 mL sample buffer I at 4 °C for 1 h and 333 µL sample 
buffer II were added subsequently.  
 TEM buffer Tris-HCl pH 8.0 10 mM 
  EDTA pH 8.0 5 mM 
  β-mercaptoethanol 1 mM 
  DNase I 6 µg/mL 
  cOmplete protease inhibitor cocktail  
   1 tablet/50 mL 
 sarcosyl solution sodium N-laurylsarcosinate 0.5 % (w/v) 
  β-mercaptoethanol 1 mM 
 sample buffer I Tris-HCl pH 8.0 10 mM 
  lysozyme 2 mg/mL 
 sample buffer II Tris-HCl pH 6.8 62.5 mM 
  SDS 1 % (w/v) 
  glycerol 10 % (w/v) 
  β-mercaptoethanol 0.5 % (v/v) 
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2.12.6 Sample preparation for localization studies 
Samples of the cellular fractions obtained by different isolation methods (sections 2.12.2 to 
2.12.5) were mixed with SDS sample buffer (1:1 or 1:2, v/v) and subjected to SDS-PAGE as 
described in section 2.10.2. Proteins were transferred to a membrane by performing a 
Western Blot (section 2.10.3) and the Strep-tagged PA0919 protein was detected via the 
employed Strep-tag-II (section 2.10.5) in the respective cellular fractions. 
 
 
2.13 Bioinformatic tools 
Several bioinformatic tools were used for the generation of amino acid sequence 
alignments, for phylogenetic tree construction, for operon and promoter analysis and for 
protein topology prediction.  
 
2.13.1 Sequence alignment 
The basic local alignment search tool (BLAST) was employed for the identification of 
homologous sequences using amino acid sequences of PA0920 and PA0919 for query 
(Altschul et al., 1990). C-terminal domains of aaPGS enzymes were defined based on a 
sequence alignment with the C-terminal domain of the A-PGS of P. aeruginosa (Hebecker et 
al., 2011) using ClustalW2 (Larkin et al., 2007). Identified homologous sequences were 
aligned by ClustalW2 and sequence logos were created with WebLogo (Crooks et al., 2004). 
The Lasergene® software package (DNASTAR, Madison, WI, USA) was employed for 
sequence identity analysis and vector design for cloning purposes. 
 
2.13.2 Phylogenetic tree construction 
The interactive Tree Of Life (iTOL) software provided by the European Molecular 
Biotechnology Laboratory (EMBL; Heidelberg, Germany; www.itol.embl.de) was employed 
for the construction of a phylogenetic tree (Letunic and Bork, 2007). Therefore, 
representative members were selected and the presence of aaPGS homologs was 
individually verified by using the C-terminal domain of P. aeruginosa A-PGS for query in 
BLAST analysis (Altschul et al., 1990). AaPGS absence was defined by an E-value > e-40 and for 
Mycobacteria (containing fusion proteins of aaPGS and tRNA synthetase; Maloney et al., 
2009), an E-value > e-20 was used. 
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2.13.3 Operon prediction and cluster analysis 
Orfs PA0920 and PA0919 were employed as query for the DOOR database (Mao et al., 2009) 
and cluster analysis was performed using the microbial genome database MBGD for 
comparative analysis (Uchiyama et al., 2010) to identify orthologous PA0920/PA0919 
groups. Both databases were used according to the provider’s instructions, respectively. 
 
2.13.4 Prediction of promoter elements and ribosome binding site 
The 430 bp sequence located upstream of orf PA0919 on the PAO1 chromosome was 
analyzed employing the online tool BPROM (SoftBerry, Mount Kisco, NY, USA; 
www.softberry.com) according to the provider’s instructions. This tool was developed to 
identify putative promoter elements recognized by sigma factor σ70. 
The ribosome binding site (RBS, also termed Shine-Dalgarno sequence) is located within 
20 bp upstream of the translation start of the gene. This sequence traditionally consists of 
adenines and guanines in slightly varying order and is recognized by the anti-Shine-Dalgarno 
sequence provided by the ribosomal 16 S rRNA during the translation initiation process (Ma 
et al., 2002). The RBS upstream of orf PA0919 was identified due to its similarity to the E. coli 
RBS consensus sequence (Schneider and Stephens, 1990) and by comparison to the 
P. aeruginosa anti-Shine-Dalgarno sequence (Ma et al., 2002). 
 
2.13.5 Secretion signal and transmembrane helices prediction 
The PA0919 amino acid sequence was analyzed using the online tool SignalP 4.1 (Petersen et 
al., 2011) allowing for the identification of N-terminal secretion signal sequences and 
developed especially for discriminating signal sequences from membrane helices. The online 
tool TMHMM (Krogh et al., 2001) was employed to predict transmembrane helices within 
the PA0919 protein. 
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3 Results 
The aminoacyl-tRNA substrate specificity of nine as yet uncharacterized aaPGS enzymes was 
investigated. The determinants for the aaPGS substrate specificity were analyzed and the 
phylogenetic distribution of bacteria containing aaPGS enzymes was investigated to identify 
evolutionary correlations. 
Furthermore, the functional roles of different aaPG variants were analyzed by introducing 
different aaPGS enzymes into the gram negative model organism P. aeruginosa. The lipid 
composition and the susceptibility to antimicrobial compounds of the obtained strains were 
analyzed. Additionally, the response of the A-PGS specific promoter to antimicrobial 
compounds was investigated under neutral and acidic conditions in P. aeruginosa. 
Orf PA0919 which is clustered together with the A-PGS encoding orf PA0920 is analyzed in 
vivo in the model organism P. aeruginosa and the PA0919 specific promoter was identified. 
Furthermore, the PA0919 protein was recombinantly produced and characterized in vitro. 
Finally, the PA0919 protein was localized in the native host P. aeruginosa. 
 
 
3.1 Substrate specificity of aaPGS enzymes 
For several bacterial pathogens, the synthesis of aminoacylated PG was found to result in 
the resistance against several antimicrobial compounds and in some cases also in reduced 
virulence (Klein et al., 2009; Maloney et al., 2009; Peschel et al., 2001; Thedieck et al., 2006; 
Samant et al., 2009). Therefore, the development of an aaPGS specific inhibitor had been 
proposed as promising strategy to overcome infections of aaPGS harboring bacteria (Roy, 
2009). For this, aaPGS enzymes had to be classified according to their aminoacyl-tRNA 
substrate specificity. To date, eight L-PG and two A-PG specific enzymes had been elucidated 
(compare Table 10).  
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Table 10: Overview of annotated aaPGS enzymes from the literature 
Strain Enzyme/orf Specificity Reference 
Agrobacterium tumefaciens LpiA L-PG Roy and Ibba, 2009 
Bacillus anthracis BAS1375 L-PG Samant et al., 2009 
Bacillus subtilis MprF L-PG, A-PG Roy and Ibba, 2009 
Roy and Ibba, 2008a 
Sohlenkamp et al., 2007 
Caulobacter crescentus CC_2047 L-PG Contreras et al., 1978 
Jones and Smith, 1979 
Clostridium perfringens CPR_1564 A-PG Roy and Ibba, 2009 
Roy and Ibba, 2008b 
CPR_1258 L-PG Roy and Ibba, 2008b 
Enterococcus faecalis EF_1027 L-PG, A-PG, R-PG Bao et al., 2012 
Enterococcus faecium ZP_000604896 L-PG, A-PG, R-PG Roy and Ibba, 2009 
Listeria monocytogenes Lmo1695 L-PG, L-DPG Thedieck et al., 2006 
Mycobacterium smegmatis LysX L-PG Maloney et al., 2011 
Mycobacterium tuberculosis LysX L-PG Maloney et al., 2009 
Pseudomonas aeruginosa PAO1 A-PGS (PA0920) A-PG Hebecker et al., 2011 
Klein et al., 2009 
Rhizobium tropici LpiA L-PG Sohlenkamp et al., 2007 
Staphylococcus aureus MprF L-PG Ernst et al., 2009 
Staubitz et al., 2004 
Peschel et al., 2001 
 
Since the number of as yet characterized A-PG specific enzymes was limited (compare Table 
10), the bioinformatic annotation of L-PGS and A-PGS enzymes was not possible. Further-
more, the observed broadened specificity for the employed aminoacyl-tRNA substrate of 
three aaPGS enzymes (Table 10) indicates a high diversity for this class of enzymes. In the 
present study, the mechanism responsible for the development of different aminoacyl-tRNA 
substrate specificities of aaPGS enzymes was investigated. Therefore, the specificity of nine 
as yet uncharacterized aaPGS homologs was elucidated to identify additional A-PGS 
enzymes. For this, selected aaPGS harboring bacteria and E. coli strains producing 
recombinant aaPGS enzymes were analyzed concerning their lipid composition using well-
established techniques (chapter 2.6). The initial results were verified using in vitro activity 
assays in the presence of radioactively labeled amino acids (section 2.6.2). Finally, the 
determinants for the aaPGS substrate specificity were investigated based on an amino acid 
sequence analysis. The phylogenetic distribution of bacteria containing aaPGS enzymes was 
analyzed to identify evolutionary correlations. 
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3.1.1 Substrate specificity determination of selected aaPGS enzymes 
Recombinant aaPGS enzymes or C-terminal catalytic aaPGS domains were overproduced and 
the E. coli lipid composition was analyzed (section 2.6.2). Since the E. coli host does not 
provide an aaPGS homolog, the overproduction of recombinant aaPGS enzymes resulted in 
the formation of an additional phospholipid. This can be observed after lipid extraction by 
two-dimensional TLC combined with molybdatophosphoric acid or ninhydrin staining 
(Staubitz et al., 2004; Klein et al., 2009).  
Furthermore, the substrate specificity of the aaPGS enzymes was verified using an in vitro 
activity assay: For this, aaPGS overproducing E. coli cells were lysed and incubated in the 
presence of radioactively labeled amino acids. During incubation, 14C-labeled amino acids 
were transferred to their respective tRNA by aminoacyl-tRNA synthetases. The activated 
amino acids were coupled to PG by the respective aaPGS enzyme. PG, tRNAs and aminoacyl-
tRNA synthetases were provided by the crude cellular extracts. Subsequently, the 
synthesized radioactively labeled aaPG was identified after lipid extraction by two-
dimensional TLC in combination with autoradiography (section 2.6.2).  
Additionally, the lipid composition of aaPGS harboring native strains was analyzed under 
neutral and acidic growth conditions and their aaPG amount was quantified (sections 2.6.1 
and 2.5.3). 
The results of all analyses are summarized and presented in Figure 6 (page 91). 
 
L-PG formation was observed for the aaPGS enzymes of B. anthracis, B. licheniformis, 
B. thuringiensis and S. thermophilus 
The human pathogen B. anthracis causes the serious anthrax disease (Koehler, 2009). To 
elucidate the substrate specificity of the aaPGS of B. anthracis, the C-terminal catalytic 
enzyme domain (BAS1375Δaa1-527) was overproduced in E. coli and the specific formation 
of L-PG was observed (Figure 6, A), when compared to the E. coli lipid composition in the 
absence of any aaPGS enzyme (Figure 6, A: negative control). The observed synthesis of L-PG 
by the B. anthracis C-terminal domain corresponds to a previous study reporting an overall 
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amount of 10 % L-PG for the native B. anthracis in the presence of the aaPGS homologous 
orf BAS1375 (Samant et al., 2009).  
B. licheniformis is used for the industrial production of several exoenzymes like amylases and 
proteases and also for the synthesis of the polypeptide antibiotic bacitracin (Veith et al., 
2004). The formation of L-PG was observed for the E. coli strain producing the recombinant 
C-terminal aaPGS domain of B. licheniformis (YfiXΔaa1-518; Figure 6). The analysis of lipid 
composition of the native B. licheniformis strain identified an amount of 3 % L-PG under all 
conditions when compared to the overall polar lipid content (Figure 6, B).  
B. thuringiensis is employed in agriculture due to its production of insecticidal proteins 
(Ibrahim et al., 2010). The overproduction of the full-length aaPGS enzyme of B. thuringiensis 
(Bthu_13400) in E. coli resulted in the formation of L-PG (Figure 6, A). The observed L-PG 
specificity was verified by the in vitro activity assay in the presence of radioactively labeled 
amino acids (compare Figure 6, A). Furthermore, 10 % L-PG (compared to the overall polar 
lipid content) were determined for the native B. thuringiensis strain under all employed 
conditions (Figure 6, B).  
S. thermophilus is able to ferment lactose to lactic acid and is therefore employed in dairy 
industry (Delorme, 2008). The C-terminal aaPGS domain of S. thermophilus (StMprf 
Δaa1-503) was recombinantly overproduced in E. coli. However, the overproduction did not 
result in the observation of an additional phospholipid in E. coli (Jäger, 2011). It seems 
reasonable that the recombinant C-terminal domain lacks any catalytic activity as it was 
observed previously for the C-terminal domain of the S. aureus L-PGS (Ernst et al., 2009). 
However, for the native S. thermophilus strain, an amount of 10 % L-PG compared to the 
overall polar lipid content was observed (Figure 6, B; Jäger, 2011). Due to the fact that a 
single aaPGS homologous orf was identified by BLAST analysis in S. thermophilus LMG 18311, 
it was concluded that orf STU1256 encodes for an L-PGS enzyme (Jäger, 2011).  
Under acidic conditions, highly increased aaPG amounts were observed in several bacteria 
(e.g. Houtsmuller and van Deenen, 1965; Klein et al., 2009; Sohlenkamp et al., 2007). 
However, the amount of L-PG was found identical for B. thuringiensis and B. licheniformis 
under acidic (pH 5) and neutral conditions (pH 7) (not shown). Therefore, it was concluded 
that the adaptation of these strains to acidic growth condition is not facilitated by elevated 
aaPG levels which might indicate that the synthesis of L-PG is not a general cellular 
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mechanism for the adaptation to acidic conditions. Since S. aureus does not contain any PE 
(Peschel et al., 2001), it seems reasonable that L-PG can substitute the function of this 
phospholipid to some extend.  
The observed amounts of 3 to 10 % L-PG for the investigated bacteria (compare Figure 6, B) 
clearly indicate that L-PG is a standard membrane component under the employed growth 
conditions. Interestingly, a high amount of 10 % L-PG was observed for S. thermophilus 
which produces high concentrations of lactate from lactose (Delorme, 2008). In P. aerugi-
nosa, the synthesis of A-PG resulted in an increased resistance against sodium lactate (Klein 
et al., 2009). It was concluded that L-PG synthesis is not generally related to the anti-
microbial resistance or pathogenicity of specific organisms. Instead, it might be a mechanism 
for the adaptation of bacterial membranes to various environmental requirements.  
 
High levels of A-PG are synthesized in Pseudomonads under acidic growth conditions 
A-PG synthesis had been described for P. aeruginosa PAO1 under acidic conditions (Klein et 
al., 2009). Here, the non-pathogenic P. putida often used in biotechnological processes 
(Nelson et al., 2002) and the highly virulent pathogen P. aeruginosa PA14 strain (Lee et al., 
2006) were analyzed concerning their lipid composition (section 2.6.1). For both strains, a 
minor A-PG amount of 0.5 % was observed under neutral conditions (pH 7.3; not shown), 
whereas A-PG levels of 5 % (P. putida) and 4 % (P. aeruginosa PA14) compared to the overall 
polar lipid content were detected under acidic growth conditions (pH 5.3; compare Figure 6, 
B). The lipid composition analysis did not reveal the synthesis of L-PG. Since BLAST analysis 
identified only a single aaPGS homologous gene in both organisms and since both enzymes 
share a high sequence identity with the A-PGS of P. aeruginosa PAO1 (at least 79 % for the 
full-length enzymes), it was concluded that orf PP_1202 from P. putida and orf PA14_52350 
from P. aeruginosa PA14 encode A-PG specific enzymes. Due to the newly and previously 
observed A-PG synthesis in Pseudomonads under acidic conditions, one might speculate that 
the formation of A-PG represents a general mechanism to adapt membranes of 
Pseudomonads to acidic growth conditions. 
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A-PG formation was observed for the aaPGS enzymes of B. phymatum, K. radiotolerans 
and P. polymyxa 
For the gram negative β-proteobacterium B. phymatum which is able to fix nitrogen (Elliott 
et al., 2007), an amount of 0.5 % A-PG compared to the polar lipid content was determined 
for the native strain (see Figure 6, B). This result was confirmed by the in vitro analysis of the 
recombinantly overproduced aaPGS homolog, for which solely the synthesis of A-PG was 
observed (see Figure 6, A).  
The gram positive bacterium K. radiotolerans had been found to tolerate high levels of 
γ-radiation (Bagwell et al., 2008). For the native K. radiotolerans strain, an amount of 0.5 % 
A-PG compared to the overall polar lipid content was detected (Figure 6, B) and for the 
respective recombinant enzyme, the formation of A-PG was observed using the in vitro assay 
(Figure 6, A).  
For the gram positive diazotrophic bacterium P. polymyxa, the synthesis of antimicrobial 
polymyxins and fusaricidins had been observed (Raza et al., 2008). The analysis of the 
phospholipid composition of the native P. polymyxa strain revealed an amount of 4 % A-PG 
(compared to the overall polar lipid content; Figure 6, B). For the recombinant aaPGS 
enzyme of P. polymyxa, solely the formation of A-PG was observed using the in vitro assay in 
the presence of radioactively labeled alanine and lysine (Figure 6, A). Since a level of 4 % 
A-PG was observed under all employed conditions, one might propose that the formation of 
A-PG is important for the resistance of P. polymyxa against cationic antimicrobial polymyxins 
produced by this bacterium.  
For these three bacteria, the formation of A-PG was detected under acidic and neutral 
growth conditions (pH 5 and pH 7). It is concluded that these organisms employ a different 
adaption strategy compared to the Pseudomonads described above. Although B. phymatum 
is phylogenetically related to Pseudomonads, the observed A-PG content was not found 
increased under acidic growth conditions. This indicates that an increased A-PG formation is 
not a general principle to adapt bacterial membranes to acidic stress conditions. 
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A-PG synthesis was also observed for the aaPGS enzyme from the archaeon M. barkeri 
The archaeon M. barkeri is highly oxygen-sensitive and synthesizes methane using different 
pathways (Maeder et al., 2006). Archaeal phospholipids differ in their structure from 
bacterial phospholipids (compare 1.3.2). Archaeal phospholipids contain diether phospho-
lipid molecules and their hydrophobic isoprene residues are bound to a glycerol-1-posphate 
backbone. Interestingly, the polar lipid head groups were found identical in archaea and 
bacteria (compare section 1.3.2; Koga, 2011). AaPGS homologous enzymes were identified in 
the archaeal kingdom solely in the Methanosarcinacae (Roy and Ibba, 2008b).  
Since M. barkeri is highly sensitive to oxygen, the substrate specificity of the respective 
aaPGS homolog was analyzed by recombinant production in E. coli. The analysis of the lipid 
composition of the E. coli strain overproducing the aaPGS enzyme of M. barkeri revealed the 
formation of A-PG, which was confirmed by the in vitro activity assay in the presence of 
radioactively labeled amino acids (Figure 6, A). 
 
Figure 6: Substrate specificity determination of aaPGS enzymes (see next page) 
A. The recombinant C-terminal aaPGS domains of B. anthracis (BAS1375Δaa1-527) and 
B. licheniformis (YfiXΔ1-518) were overproduced in E. coli BL21 (λDE3). After cultivation, the 
polar lipids were extracted and analyzed by two-dimensional TLC combined with molybdato-
phosphoric acid staining (section 2.6.2) (Jäger, 2011). 
The recombinant full-length enzymes of B. thuringiensis (Bthur_134000), B. phymatum 
(Bphy_4019), K. radiotolerans (Krad_4555), P. polymyxa (Ppoly_aaPGS) and M. barkeri 
(Mbar_A2435) were overproduced in E. coli TOP10. After cell lysis, crude cellular extracts 
were subjected to the in vitro activity assay in the presence of 14C-labeled L-alanine and/or 
L-lysine. Subsequently, polar lipids were extracted, separated and analyzed by two-
dimensional TLC and molybdatophosphoric acid staining. 14C-labeled phospholipids were 
visualized by autoradiography which revealed the formation of 2’ and 3’ A-PG as partially 
overlapping lipid spots (2’ A-PG: lower spot, 3’ A-PG: upper spot; Hebecker et al., 2011). 
For experimental details, see section 2.6.2. 
B. Native strains harboring aaPGS enzymes were cultivated, polar lipids were extracted, analyzed 
by two-dimensional TLC and lipids were visualized by molybdatophos-phoric acid and 
ninhydrin staining (section 2.6.1). 
Presented TLC plates were stained with molybdatophosphoric acid. L-PG position is indicated by a 
rectangle and A-PG position is given by a circle. Identical sections of the TLC plate after 
autoradiography analysis (dotted frames) or after ninhydrin staining (dashed frames) are 
presented in the upper left of the respective TLC plate. TLC plates and X-ray films of Bphy_4019, 
Krad_4555 and Mbar_A2435 were generously provided by S. Hebecker. Results for 
S. thermophilus strain the C-terminal aaPGS domain of B. licheniformis were taken from Jäger, 
2011. 
Phospholipids were named according to Kämpfer et al., 2006, Thedieck et al., 2006 and Klein et 
al., 2009: A-PG: alanyl-phosphatidylglycerol, DGDG: diglucosyl diacylglycerol, DPG: diphos-
phatidylglycerol, L-PG: lysyl-phosphatidylglycerol, PE: phosphatidylethanolamine, PG: phospha-
tidylglycerol. 
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It is worth noting that the M. barkeri aaPGS enzyme is able to modify the PG substrate of 
E. coli which differs in structure from the corresponding archaeal phospholipid archaetidyl-
glycerol (isoprenoid ether of sn-glycerol-1-phosphate, compare section 1.3.2; Koga, 2011). 
This is in good agreement with a study elucidating the determinants of the PG substrate for 
recognition by the P. aeruginosa A-PGS using various substrate derivatives (Hebecker et al., 
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2011): It had been reported that the hydrophilic rather than the hydrophobic part of PG is of 
importance for substrate recognition. Importantly, an ‘archaeal-like’ substrate derivative 
(1,2-diphytanoyl-sn-glycero-3-phospho-(1´rac-glycerol)) with two isoprenoid-like fatty acid 
ester side chains was also utilized by the P. aeruginosa A-PGS (Hebecker et al., 2011). 
Therefore, it might be concluded that the aaPGS enzyme of M. barkeri is able to synthesize 
A-PG in the native strain. For several Methanosarcina genes, the lateral transfer of these 
genes from bacteria had been described (Deppenmeier et al., 2002; Maeder et al., 2006). 
Because BLAST analyses of archaeal genomes detected aaPGS homologs only in 
Methanosarcinaceae and indicated a high sequence identity to the P. aeruginosa A-PGS, a 
comparable transfer of the M. barkeri A-PGS encoding gene donated by a bacterium seems 
reasonable. 
The specificities of the investigated aaPGS enzymes determined in this study are summarized 
in Table 11. 
 
Table 11: Identified substrate specificities of aaPGS enzymes 
*BAS1375 full-length L-PGS activity had been elucidated previously by Samant et al., 2009, and 
the lipid content had been determined based on TLC plates presented in the same publication. 
n.d.: not determined, - : no increase of cellular aaPG concentration, + : aaPG concentration 
increased, † : aaPG content [%] at pH 7.3 / pH 5.3. 
Strain Enzyme/orf Specificity 
AaPG amount of overall 
lipid content [%] 
Acidic 
induction 
Bacillus anthracis str. Sterne BAS1375 L-PG* 10* n.d. 
Bacillus licheniformis  
ATCC 14580 
YfiX L-PG 3 - 
Bacillus thuringiensis  
ATCC 10792 
Bthur0008_13400 L-PG 10 - 
Streptococcus thermophilus 
ATCC 19258 
STU1256 L-PG 10 n.d. 
Pseudomonas aeruginosa 
UCBPP-PA14 
PA14_52350 A-PG 0.5 / 4† + 
Pseudomonas putida KT2440 PP_1202 A-PG 0.5 / 5† + 
Burkholderia phymatum  
STM 815 
Bphy_4019 A-PG 0.5 - 
Kineococcus radiotolerans  
SRS 30216 
Krad_4555 A-PG 0.5 - 
Paenibacillus polymyxa  
ATCC 842 
aaPGS A-PG 4 - 
Methanosarcina barkeri  
ATCC 29787 
Mbar_A2435 A-PG n.d. n.d. 
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3.1.2 Determinants for aaPGS substrate specificity 
An overall amount of 23 aaPGS enzymes has been characterized yet (see Table 10 and Table 
11). This amount allows for an amino acid-based sequence analysis to identify the 
determinants for the aaPGS substrate specificity.  
Former analyses revealed that the N-terminal domains of aaPGS enzymes, which anchor the 
aaPGS enzyme to the cell membrane and translocate aaPG molecules to the outer 
membrane leaflet, are highly variable and show very low sequence identity values (Peschel 
et al., 2001; Hebecker et al., 2011; Ernst et al., 2009; Slavetinsky et al., 2012). In contrast, the 
C-terminal aaPGS domains are more conserved and share a considerable sequence identity 
value (at least 16 %; compare appendix, Figure 33). Several previous experiments located the 
catalytic active site to the C-terminal aaPGS domain and it was found responsible for 
substrate recognition and amino acid transfer to PG (Hebecker et al., 2011; Ernst et al., 
2009; Roy and Ibba, 2009). Consequently, C-terminal catalytic domains of aaPGS enzymes 
with elucidated aminoacyl-tRNA substrate specificity (summarized in Table 10 and Table 11) 
were defined by comparison of their respective sequence to the amino acid sequence of the 
C-terminal domain of the P. aeruginosa A-PGS according to Hebecker et al., 2011. The 
sequence identity values for the C-terminal aaPGS sequences were calculated using the 
Lasergene® software package (DNASTAR, Madison, WI, USA) and are given in the appendix, 
Figure 33. The sequence identity analysis demonstrated that the employed L-PGS enzyme 
sequences indicated a sequence identity value of at least 16 % (Figure 33, light gray), 
whereas a value of 31 % was obtained for the A-PGS enzymes (dark gray). Interestingly, the 
minimal sequence identity of 17 % was calculated for the cross-comparison of L-PGS and 
A-PGS sequences (black). This result might indicate that the substrate specificity of A-PG and 
L-PG synthesizing enzymes is not determined by characteristic sequence motifs. 
This assumption was verified by employing the defined C-terminal aaPGS enzyme domains 
to generate several sequence alignments using ClustalW2 (Larkin et al., 2007). These 
alignments were grouped according to the aaPGS specificity (Figure 7). Based on the 
sequence alignments of A-PGSs, of L-PGSs and of all aaPGS enzymes, sequence logos 
indicating the amino acid conservation were generated by WebLogo (Crooks et al., 2004) 
and arranged together with the formerly aligned aaPGS sequences in Figure 7. 
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The analysis of the sequence logos did not result in the identification of an amino acid 
position that is characteristic for L-PGS enzymes or alternatively for A-PGS enzymes 
(compare Figure 7). Instead, an almost identical distribution of conserved positions was 
observed for both sequence logos, as verified by the logo for the overall aaPGS sequences. In 
consequence, C-terminal sequences of B. subtilis, E. faecium and E. faecalis exhibiting 
broadened aminoacyl-tRNA substrate specificities (Roy and Ibba, 2009; Bao et al., 2012) can 
be related to both the A-PGS and the L-PGS enzyme group. Interestingly, the C-terminal 
Bacillus aaPGS sequences share an identity of at least 63 % (see appendix, Figure 33), 
although the aaPGS homologs of B. anthracis (Samant et al., 2009), B. licheniformis and 
B. thuringiensis are specific for lysine, whereas the B. subtilis enzyme makes use of both 
alanine and lysine in vitro (Roy and Ibba, 2009). 
In a previous study, 15 amino acid residues with relevance for PG modification had been 
identified within the C-terminal A-PGS domain of P. aeruginosa (Hebecker et al., 2011; see 
Figure 7). These key residues and also their neighboring amino acid residues were found 
conserved within the sequence logos of A-PGS and also of L-PGS enzyme sequences. One 
might conclude that these residues are important for the general transesterification process 
but do not directly determine the aminoacyl-tRNA substrate specificity.  
Taken together, these results indicate that the specificity of aaPGS enzymes for Ala-tRNAAla 
or Lys-tRNALys cannot be predicted based on the C-terminal aaPGS amino acid sequence, 
since no determinants for the respective specificity were identified. Instead, a diverse 
evolutionary origin for the individual specificity is proposed.  
Figure 7: Sequence alignments and logos for aaPGS C-terminal catalytic domains (see next page) 
The C-terminal domains of aaPGS enzymes were defined based on a sequence alignment with the 
C-terminal A-PGS domain of P. aeruginosa (Hebecker et al., 2011). Defined C-terminal sequences 
were aligned by ClustalW2 (Larkin et al., 2007) generating sequence alignments grouped 
according to the aaPGS aminoacyl-tRNA substrate specificity (A-PGS group (above), L-PGS group 
(below), aaPGSs with relaxed specificity (middle)). Sequence logos were calculated by WebLogo 
(Crooks et al., 2004) employing the overall aaPGS sequences, the A-PGS group and the L-PGS 
group, respectively. All amino acid residues from P. aeruginosa A-PGS (A_PAO1) analyzed in a 
previous study (Hebecker et al., 2011) are indicated within the sequence (key residues for 
enzymatic catalysis are highlighted yellow). 
PAO1: P. aeruginosa PAO1, Bph: B. phymatum, Cpe: C. perfringens, Kra: K. radiotolerans, Mba: 
M. barkeri, PA14: P. aeruginosa PA14, Ppoly: P. polymyxa, Pput: P. putida, Bsu: B. subtilis, Efm: 
E. faecium, Efs: E. faecalis, Atu: A. tumefaciens, Ban: B. anthracis, Bli: B. licheniformis, Bthu: 
B. thuringiensis, Ccre: C. crescentus, Lmo: L. monocytogenes, Rtr: R. tropici, Sa: S. aureus, Sth: 
S. thermophilus, Msm: M. smegmatis, Mtb: M. tuberculosis.  
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A_PAO1     543----RAAPPAIREPNAEELQRAARIIRHSD--QPDGGLALTGDKALLFHESD---DAFLMYARRGRSMIALYDPIGPAMQRAELIWQFRDLCDLHHA 630
A_Bph 531----RPAAGRFVKPAQQDLADAARIFRAQE--RSDAGLALMGDKSFLFSESR---QAFLMYAKYGRTWAALHDPVGPRAEWADLIRKFVALAHAHGG 618
A_Cpe 228----MPKIEDDERYMDADLEKVSKFFKEIDYGTIFSHLVYLKDKKVFWANEG---ESLIMYSKYKDKIIVLGDPIATKENLYSCIEEFQAFTNLYGY 317
A_Kra 8----ASAALGPQVACEQVMARVSAVVARSR--RCTAHLAFTGDKRFHFSPSG---AAFLMYQVEGRSWVVMGDPVGDPADFPELVRSFVGEIDRHGG 95
A_Mba 521----SPFSRDIHMPGAEEMELAKRIINQSE--ETAGNLVFTGDKYLLFDDEK---KAFLMYGVSGKTWVAMGDIVGTSNQAKELIWDFYEMSKLHQG 608
A_PA14     543----RAAPPAIREPDAEELQRAARIIRHSD--QPDGGLALTGDKALLFHEGD---DAFLMYARRGRSMIALYDPIGPAMQRAELIWQFRDLCDLHHA 630
A_Ppoly 546----RPQRSISNLPDAQELVKLKEFLERQG-GNLVSHMLFLGDKYLYWTKDE---QVVLPYARSRDKLIVLGDPLGPKERVSEAIQEFQRFADRYAL 634
A_Pput 542----RTAPPVIHLPDEEELQRANRILQASD--QPDGGLALTGDKALLFHPRG---NAFLMYARRGRSLVALYDPIGPAQERAEMIWQFRDLCDLHHA 629
AL_Bsu 520----VYHKRTKPIGEKADPERLAAFLNEKG-GNALSHLGFLGDKRFYFSSDG---NALLLFGKIARRLVVLGDPSGQRESFPLVLEEFLNEAHQKGF 608
ALR_Efm 510---HFLQGEKKQIGEAFNEEKALKILTTYG-GNSDSQLIFLKDKRMFAYEKDGEPTVLLQFACFNNKCIVMGDPSGKKEDFPEAIEAFIEETDRLCY 602
ALR_Efs 506---RYLQGKKHQVGEFPEDSILHNILTTYG-GNIDSELVFLHDKQVFLYPKE-EPTVFLQFNTINNKCVVMGNPSGNKEDFPAAIDAFLKETDRFGY 597
L_Atu 528----RPVTFKPDSIQPEDVERATDIVMRQD--SADANLVRMGDKHVMFSESG---NAFIMYGIQGRSWIAFADPVGDEEDFPDLVWQFVEAARGAGA 615
L_Ban 528-----NRYRNEFPGQPANDKRLQNFLDEHG-GNVLSHLGFLGDKQFFFSSDG---KALLLFSITGKRLVVLGDPIGDPSSYRTVLQEFLAEADRFGY 615
L_Bli 519------NRKTKEIGEEPDPEKLEAFLEEKG-GNALSHLGFLGDKRFFYSSDG---NALIQFAKVGQRLVVLGDPSGREDSFPLVIKEFLHAADQKGY 605
L_Bthu 526-----NRYRNEFPGQPANDKRLQNFLDEHG-GNVLSHLGFLGDKQFFFSSDG---KALILFSITGKRLIVLGDPIGDPSSYRTVLQEFLAEADRFGY 613
L_Ccre 187----TAATPPVVDDTDPEFDRVRAILAKAEGAEPSANLALLGDKRFLFSASG---ETFLMFGVRGRSWIALGPPVGKREERMELFWRFRELADAHAA 276
L_Cpe 503----NIRRKIPVKTFDQCSEYIEKIIEEYK-GDSLTHLVFLKDKYIYLNEDK---DLFIQYEVYGDKLFVLGNPVGNNENLFREIEKFCEYADNYGY 591
L_Lmo 510----YLSTTKEKLGSPFEAVKVREHLAKWG-GNEVSHTMFLRDKLLFWAAEG---EVLFSYRIIADKMVIMGEPTGNMDKMEAAIEEVMMNADRFGY 598
L_Rtr 530----RPATKRPEPVSDDAVARAVEIVRKQG--VADANLVRMGDKSIMFSEKG---DAFIMYGKQGRSWIALFDPVGPAQALPDLIWRFVETARAAGC 617
L_Sa 510-----FDYQFSKVRISSKIEDCEEIINQYG-GNYLSHLIYSGDKQFFTNENK---TAFLMYRYKASSLVVLGDPLGDENAFDELLEAFYNYAEYLGY 597
L_Sth 504---RVLAPRKH-FGQSMDNERFTALLEKYG-GASESALAYLHDKRLFWYRVDGQDQVVFQFAQISNKCVVMGNPIGNEKYYRPAWEAFLKNLSDWNL 595
L_Msm 217-------QRASNALTGEDESAIRGLLELYGKNDSLGYFATRRDKSVVFAPNG---RAAITYRVEVGVCLASGDPVGDPKSWPQAIAAWLQLCQAYGW 303
L_Mtb 293-------QRADNALTGEDESAIRGLLDLYGKDDSLGYFATRRDKSVVFASSG---RACITYRVEVGVCLASGDPVGDHRAWPQAVDAWLRLCQTYGW 379
aaPGS
A-PGS 
L-PGS 
A_PAO1     RPVFYQVRAENLPFYMDIGLTALKLGEEARVDLLRFDLENKGKEMKDLRYTWNRGQRDGLALEFH-EPGQAP--LDELKAISDAWLGGKQVREKGFSLGR 727
A_Bph RAAFYQVRANALPLYLDAGLTLMKLGEEAHVVLDEFDLKG--PHRAHLRYALKRCERDGFSVEVI-EPARVPESIATLRTISDGWLDSRDAREKSFSVAA 715
A_Cpe DVVFYEIEEKNFSTYHDAGYYFFKLGEEARIDLEEFNLIG--SKKSAFRNTLRRVEREGYNFSII-EPPFNNEVVSQLKEISDKWLGDR--KEKGFSLGW 412
A_Kra RPVFYNVLPDHADLYRACGLTLAKLGEEAVVPLEGFTLAG--KSKVNLRNCRNKSQRLGLSVDFV-APEDVAPLLPALREVSDAWLTHRNGKEKRFSLGA 192
A_Mba RAAFYEVSEKYIPVYLDLGLTLIKIGEEAKVSLEAFTLEG--STGKDFRYTVRNVEKKGYWFEIV-SKEEVQSLMPELKKISDAWLKLKAGKEKRFSIGY 705
A_PA14     RPVFYQVRAENLPFYMDIGLTALKLGEEARVDLLRFDLENKGKEMKDLRYTWNRGQRDGLALEFH-EPGQAP--LDELKAISDAWLGGKQVREKGFSLGR 727
A_Ppoly TAVFYQASPEYLSIYHENGYRFFKLGEEALVPLESCTLTG--KSNQALRSAKNRLGREGYSFEMI-QPPLEASLIEEMRHISDIWLDGR--KEKGYSLGW 729
A_Pput RPVFYQVRAENLPFYMDIGLTALKLGEEARVDLRRFDLEAKGKEMKDLRYTWNRGGRDGLSLEIH-EPGHAP--LAELKEISDAWLGGKNVREKGFSLGR 726
AL_Bsu SVLFYQIEREDMALYHDFGYNFFKLGEEAYVDLNTFTLTG--KKKAGLRAINNRFEREEYTFHVD-HPPFSDAFLEELKQISDEWLGSK--KEKGFSLGF 703
ALR_Efm LPVFYETSEEIVMILHEFGYDFIKMGEEAYVDLNSFTTSG--KKMKGTRAVLNRIEREGFTFDVL-QPPFSTEQMSTFKNISDNWLGSR--KEKGFSLGF 697
ALR_Efs VPVFYETNEDSVMLLHEFGYEFIKMGEEALVNLETFTMSG--KKFKGTRAVFNKITKAGYSFDVL-QPPFSTEQMHELKAISDSWLDNR--KEKGFSLGF 692
L_Atu RAAFYQISPFLLSHCADAGLRAFKLGELALVDLTAFELKG--GKLATLRQSLSRGARDGLTFEVV-EQSQVPDIMDELQQVSDGWLAHHNTREKRFSLGA 712
L_Ban ICVFYQIESKWMSLYHDFGYNFFKLGEEAVVDLNTFTITG--KKRAGMRATFNRFEREGYTFSIH-QPPFSNELFEELRKVSDAWLGGK--KEKSFSLGY 710
L_Bli LVIFYQIEREDMALYHDFGYRFFKLGEEAIVDLDTFTISG--KKRAGLRAIYNRFEREGYTFHVE-QPPFSREFLNELRQVSDEWLGRK--KEKGFSLGF 700
L_Bthu ICVFYQIESKWMSLYHDFGYNFFKLGEEAVVDLNTFTITG--KKRAGMRATFNRFEREGYTFSIH-EPPFSDELYEELRKVSDAWLGGK--KEKGFSLGY 708
L_Ccre RAGFYGLGPDDLPDTVDLGLAIQKTGESAAVPLEAFSLVGRRREV--LRRNWRKAGEGGAAFEVL-PVGAAPTMMDELKSISDSWLSHHAGGEKSFSMGG 373
L_Cpe TPVFYQVNEEMISYLHSNGYDFMKIGEEAKVDVKEFKVVG--NKMKSLKTSRSKVTKEGYTFHMV-EPPFSREFLDYLKEISDEWLDGR--KEKGFSVGF 686
L_Lmo RPVFYEVRGTMIPYLHDHGFDFIKLGEEGFVDVQNFTMSG--KKKKGERALMNKLEREGYTFEII-EPPFNHDTWTTLRAVSDEWLDGR--EEKGFSLGF 693
L_Rtr RVVFYQISPALLSYCADAGLRAFKLGELAVVNLANFELKG--GKWANLRQTASRAVRDGLEFAVI-EPQDIPDVLDQLAHVSDTWLADHNAKEKSFSLGA 714
L_Sa DVIFYQVTDQHMPLYHNFGNQFFKLGEEAIIDLTQFSTSG--KKRRGFRATLNKFDELNISFEII-EPPFSTEFINELQHVSDLWLDNR--QEMHFSVGE 692
L_Sth QALFYEADERVTLMLHDYGFDFMKFGENAMVDLTTYSIDG--KHGKKFRKPTNRVEKAGFQFKLL-NPPFSETQMQEMKAVSDIWLNGR--KEKGFSLGF 690
L_Msm APGVMGASLAGAEAYRAAGLNALQLGDEAILHPDRFRLSG--PDMRAVRQAVTRARRAGTSVRIRRHRELSPEEMAAVIRRADAWRDTETERGFSMALGR 401
L_Mtb APGVMGASSQGAQTYREAGLTALELGDEAILRPADFKLSG--PEMRGVRQAVTRARRAGLTVRIRRHRDIAEDEMAQTITRADSWRDTETERGFSMALGR 477
aaPGS
A-PGS 
L-PGS 
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A_PAO1     FTPAYLNFFRIAIVR--HQGKPVAFANLLETDSR-ELASLDLMRVH-PDAPKLTMEFLMLGLILHYKAQGHARFSLGMVPLAGLQPRRGAPLT---QRLG 820
A_Bph FTEDYLAAQSVMLVR--QKGEPVAFVTFMTTDLN-TEATVGVMRHV-PQASPYAMEYLFTQLALHLKQADFRSLSLGIAPFSGMSPTPLASRW---HRLA 808
A_Cpe FSEDYIQRSPIAILKNEEENKIMGFVTIMDANDGGETVAIDLMRID-KDAPNASMDYLMLNLFLTFKEKGYKYFSLGEAPLSNVGFNTHSHLQ---EKLA 508
A_Kra FDEDYVSRFPLVVVR--QEGRIIAFATLWVGGDG-HEVQVDLMRRL-PDGPRTVMTYLFVECILWAGENGFTSFNLGMAPLSGLRTGTGPSLW---NRLG 285
A_Mba FNEKYLSNFPIALVR--NESEIVAFANIWTGADN-EEISVDLMRHS-PDAPDRTMEYLFVKLMLWGKEKGYRRFSLGMAPLSGLETRQFAPMW---HKIG 798
A_PA14 FTPAYLNFFRIAIVR--HQGKPVAFANLLETDSR-ELASLDLMRVH-PEAPKLTMEFLMLGLILHYKAQGHARFSLGMVPLAGLQPRRGAPLT---QRLG 820
A_Ppoly FKESYLQLAPIALLK-DSEGKVIAFATMAPAYDHGQTVSIDLMRHL-PDTPNGTMDYLFTRVIEWAKESGYTTFNLGMAPLSQVGQSEKALRE---EKLA 824
A_Pput FSPDYLQHFRIALIR--FQGRPVAFANLLETHGN-ELASLDLMRAH-PEAPKLTMEFMMIGLILHYKSHDYGRFSLGMVPLSGLQPRRGAPLT---QRLG 819
AL_Bsu FDPSYLQKAPIAYMK-NAEGEIVAFANVMPMYQE-GEISVDLMRYR-GDAPNGIMDALFIRMFLWAKEEGCTSFNMGMAPLANVGTAFTSFWS---ERFA 797
ALR_Efm FSEDYLQRAPIAVVK-NTQEEIVAFATIMPTYTNNKVGTIDLMRYDSKKAPSGSMDFLFLHLFAYMKEEHIQWFNLGMAPLSNVGTSRKSFLQ---ERIA 793
ALR_Efs FDEAYLQRNPIAVVR-NAEGEMVSFANIIPSYTN-EVGTIDLMRHHKEKAPSGSMDFLFIHLFEYMKTENIHYFNLGMAPLANVGQSRKSFIQ---ERIA 787
L_Atu FEPDYILSQPVAVLR--KDGKITAFANLMVTETK-KEATIDLMRFS-ADAPRGSMDFLFVSIMQHLREAGYESFNLGMAPMSGMSKRDAAPVW---DRIG 805
L_Ban FDHEYISRAPIATLS-DADGKIIAFTTFMPVYQD-GSLSVDLMRYY-PDAPSGIMDAIFIHLFQWAKENEYHSFNIGMAPLSNVGLSTQSFWS---ERVA 804
L_Bli FQEDYLQKAPIAVLK-SEEGEIVAFMNIMPMYRE-GEISIDLMRYS-KKAPKGIMDALFIYLFQWGKEQGYTAFNMGMAPLSNVGTTFQSFWT---ERLA 794
L_Bthu FDREYISRAPIATLS-DADGKIIAFTTFMPVYQN-GSLSVDLMRYY-PDAPSGIMDAIFIHLFQWAKENEYHSFNIGMAPLSNVGLSTQSFWS---ERVA 802
L_Ccre FDPRYVAEFPVAVVR--SEGKIVAFATLWTTAAK-TAFSMDLMRYS-DEAPKNVMDYLFVELLQWGKDEGYSAFEFGVAPLAGLQDRPLAPIM---SRVG 466
L_Cpe FDEDYLNKAPIAILR-DREGEIKAFANIMYMYDD-ESFSVDLMRFS-KNTPRGVMDFMFINLIEYGKEKGYEIFNMGMAPLANVGLSKYAFWN---EKLA 780
L_Lmo FDTYYLEQAPIAIAK-NGEGTIVGFASMMPSYTD-EMTSIDLMRYS-KEAPSGIMDFLFINLFEKAKEDGFQTFNAGMAPLANVGESKYAFLG---ERLA 787
L_Rtr FDPDYVCSQPVGVLK--KDGKIVAFANILMTETK-EEGSVDLMRFS-PDAPKVSMDFLFVQILEYLKGEGFQRFNLGMAPLSGMSRRESAPVW---DRVG 807
L_Sa FNEEYLSKAPIGVMR-NEENEVIAFCSLMPTYFN-DAISVDLIRWL-PELDLPLMDGLYLHMLLWSKEQGYTKFNMGMATLSNVGQLHYSYLR---ERLA 786
L_Sth FDEAYLQQAPIAIVE-SKEGEIVAFANIMPTQNK-RVATIDLMRYDFKKAPEGIMDYLFVKLFQYFKAEGKQYFDMGMAPLANVGTEEDSFIE---EKVA 785
L_Msm LGDP-ADDDCLLVEAVQ-GDEVVAMLSLVPWGSN--GVSLDVMRRS-PRSPNGTIELMVSELCMQAEDIGISRISLNFAMFRSAFEQGAQLGAGPVARLW 496
L_Mtb LGDP-ADSDCLLVEAIDPHNQVLAMLSLVPWGTT--GVSLDLMRRS-PQSPNGTIELMVSELALHAESLGITRISLNFAVFRAAFEQGAQLGAGPVARLW 573
aaPGS
A-PGS 
L-PGS 
A_PAO1     ALVFRRGEQFYNFQGLRRFKDKFQPDWEPRYLAVPAG-----LDPLVALADTAALIAGGLTGLVK---------R---------------------- 881
A_Bph NIVWRFGGRFYNFRGLRAFKSKFQPHWEPRYLAASGS-----VGVFFTLADLSLLAGGRRS------------------------------------ 864
A_Cpe RLVYNSGNIFYSFDGLRRYKSKFSPIWQPRYLAYPKF-----MSLPEVFINLCLLIANSKERVEKK------------------------------- 569
A_Kra HLLWTHGEQFYNFQGLRTFKQGFSPEWRTCYVAAPGE-----LALPNAMVDVATLVGGGIRGVVHS------------------------------- 346
A_Mba SLIFTHGEHFYNYKGLRDFKEKFNPIWSPKYITLPNG-----FKQGFVLKDIAALISGGVKGIFSKENKRPASRRGNQLPEKPSEELT--------- 881
A_PA14 ALVFRRGEQFYNFQGLRRFKDKFQPDWEPRYLAVPAG-----LDPLVALADTAALIAGGLTGLVK---------R---------------------- 881
A_Ppoly RLVFQYGGHFYGFQGLRRFKDKFKPQWEPRYLAYPAS-----VFLPILTLELVYLVSKRSD------------------------------------ 880
A_Pput SLVFRRGEQLYNFQGLRRFKDKFQPDWEPRYMAVPAG-----LDPLVALADTAALIAGGLTGLVK---------R---------------------- 880
AL_Bsu AVIFNNVRYMYSFSGLRAFKEKYKPEWRGKYLAYRKN-----RSLSVTMFLVTRLIGKSKKDSV--------------------------------- 856
ALR_Efm YLVYEFGSHFYSFHGLREYKSKYATNWVSRYTLYSRD-----SWIAYVMIALLIID--NAPVEQTQGRISGLKKWIRRKY----------------- 866
ALR_Efs ALIYEFGSEIYSFQGLREYKEKFASKWQPRYTLYSKS-----SWIVYVMIALLIVD--QKNID---------------------------------- 843
L_Atu STLFEHGERFYNFKGLRAFKAKFHPKWEPRYLAVQNG-----ADAALALMDATVLISGGVRGVIGK------------------------------- 866
L_Ban AAIFNNVRYTYSFSGLRHFKEKYKPAWSGKYLAFRKN-----HSLPITMLSVTKLIGKRK---NS-------------------------------- 861
L_Bli AVIFNNVSYMYSFSGLRSFKEKYKPVWRGKYLAYRKN-----RSLPVTMILVTRLIGRRTK------------------------------------ 850
L_Bthu AAIFNNVRYTYSFSGLRHFKEKYKPAWSGKYLAFRKN-----HSLPITMLSVTKLIGKKKKQLNS-------------------------------- 862
L_Ccre RLLYERGEEIYNFQGVRRYKDKYDPVWQPRYIAAPQK-----WAIPFLLADIGLLSSGGVSGLAK---------RPKKLPEKAAT------------ 537
L_Cpe LQFYENGQALYSFKGLRRFKEKFSHNWEYKYIAYRRN-----TSILITVIQAAIVCSRNRNVDESIVVRN--LKSLIK------------------- 851
L_Lmo GLVYRYSQGFYGFKGLRNFKSKYVTEWEQKFVAFRKR-----SSIAFTMLQLMILVGKKRPLANSQVVLDFPLEEETKKPDSE-------------- 865
L_Rtr GTVFEHGERFYNFKGLRAFKSKFHPEWQPRYLAVSGG-----VSPMIALMDATFLIGGGLKGVVRK------------------------------- 868
L_Sa GRVFEHFNGLYRFQGLRRYKSKYNPNWEPRFLVYRKD-----NSLWESLSKVMRVIRHK-------------------------------------- 840
L_Sth NLVYVFAQRFYSFSGLQRYKEKFSPIWSPKYIVYPKR-----TWLLFDMIAIFRID--NRKIEDKMKKRRLWK------------------------ 851
L_Msm RALLVFFSKWWQLESLYRSNMKYQPEWVPRYACYEDARLVPRVGVASVIAEGFLVLPFSRRNKQHTGEHIAAPDTLVQSGRLHRDGSAPDVTGLQGE 593
L_Mtb RGLLVFFSRWWQLETLYRSNMKYQPEWVPRYACYEDARVIPRVGVASVIAEGFLVLPFSRRNRVHTGHHPAVPERLAATGLLHHDGSAPDVSGLRQV 670
aaPGS
A-PGS 
L-PGS 
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3.1.3 Phylogenetic distribution of aaPGS enzymes 
The formerly described results might indicate a diverse evolutionary origin for aaPGS 
enzyme sequences with different specificities. A-PGSs might exhibit a smaller amino acid 
binding pocket than L-PGSs. Due to the lack of a characteristic amino acid conservation 
pattern distinguishing both enzyme variants from each other, minor amino acid substitutions 
in spatial positions might result in the tuning of the respective amino acid binding pocket 
and in the evolution of the respective aminoacyl-tRNA specificity. Thus, the aaPGS homologs 
of B. subtilis, E. faecium and E. faecalis showing a broadened amino acid substrate specificity 
(Roy and Ibba, 2009; Bao et al., 2012) might represent evolutionary intermediate states. 
Different aaPG variants might enable the respective organism to fine-tune its membrane 
composition and lipid homeostasis. As mentioned before, C-terminal Bacillus aaPGS enzyme 
domains share a high sequence identity (see appendix, Figure 33), which might indicate that 
the broadening of B. subtilis MprF substrate specificity has occurred recently and therefore 
cannot be observed in related species. 
To investigate the diverse evolution of aaPGS sequences, a phylogenetic tree consisting of 
representative prokaryotes was generated using the iTOL program (section 2.13.2; Letunic 
and Bork, 2007) and is presented in Figure 8. Within this tree, organisms carrying an aaPGS 
homolog identified by BLAST analysis (Altschul et al., 1990; highlighted gray) and aaPGS 
enzymes with characterized substrate specificity are indicated (A-PGS: yellow; L-PGS: blue; 
broadened substrate specificity: orange). From this representation it becomes clear that 
A-PGS and L-PGS enzymes are detected within the Bacilli and the Actinobacteria and that 
enzymes with broadened specificity are only found in the Bacilli group. However, for none of 
the specificity groups, a phylogenetic clustering was observed and – vice versa – organisms 
of the same phylogenetic branch do not share the same aaPGS dependent lipid homeostasis.  
 
Figure 8: Phylogenetic distribution of aaPGS enzymes in prokaryotes (see next page) 
The pylogenetic tree of representative prokaryotes was generated using iTOL (Letunic and Bork, 
2007). Organisms with aaPGS homologs identified by BLAST analysis are indicated (dark gray). 
Microbes with characterized A-PGS (yellow) and L-PGS enzymes (blue) are highlighted. B. subtilis, 
E. faecalis and E. faecium enzymes (orange) exhibit a broadened substrate specificity. 
* C. perfringens possesses both an A-PGS and an L-PGS. # The corresponding activity has been 
newly elucidated (compare Table 11). ‡ Data are taken from the literature (compare Table 10). 
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3.2 Impact of different aaPGs on P. aeruginosa resistance phenotypes 
The aminoacylation of PG with alanine and lysine was related to the resistance against 
several antimicrobial compounds for different bacteria (e.g. Peschel et al., 2001; Klein et al., 
2009). It is not clear, if the observed resistance phenotypes resulted from a comparable 
mechanism of A-PG and L-PG or if the aaPG variants have different effects in different 
bacteria. For this, the well-established gram negative model organism P. aeruginosa PAO1 
was chromosomally modified to synthesize different aaPG variants in the same genetic 
background. The constructed strains were employed to study the impact of specifically 
altered aaPG contents in the bacterial membrane on the resistance against a set of 
antimicrobial compounds. 
 
3.2.1 Construction of P. aeruginosa mutant strains with altered aaPG content 
To elucidate the role of the respective aaPG in P. aeruginosa, the PAO1 wild-type and the 
A-PGS deficient PAO1 ΔPA0920 deletion mutant strain (Lorenzo, 2006) were employed. 
Additionally, mutant strains synthesizing aaPG variants were constructed based on the PAO1 
ΔPA0920 deletion mutant strain. All constructs consisted of the native PA0920 promoter 
PPA0920, an aaPGS encoding gene and the trrnB terminator and were chromosomally integrated 
into the specific chromosomal attB locus for ΔPA0920 complementation (see Figure 9). The 
resulting strains were devoid of any resistance marker genes (see section 2.4.19). This 
mutant design guaranteed for a consistent transcriptional response in all complemented 
strains. 
Orf PA0920 encoding the P. aeruginosa A-PGS was introduced into the attB locus which 
results in the homologous complementation variant of the ΔPA0920 deletion mutant strain 
(ΔPacomp). The truncated version of orf PA0920 (PA0920aa543-881) encoding the C-terminal 
catalytic A-PGS domain (Hebecker et al., 2011) was also employed yielding strain ΔPa-aa543-
881comp. For the synthesis of L-PG in P. aeruginosa, strain ΔPA0920 was cross-complemented 
using the S. aureus mprF gene (Sa113; Peschel et al., 2001) and for the simultaneous 
production of L-PG and A-PG, the B. subtilis mprF gene (BSU08425; Roy and Ibba, 2009) was 
employed resulting in strains ΔSacomp and ΔBscomp. For the E. faecium aaPGS2, the 
modification of PG with alanine, lysine and arginine was observed in vitro (Roy and Ibba, 
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2009). The respective gene was also selected for the cross-complementation of the ΔPA0920 
deletion mutant to yield strain ΔEfcomp (for details, see section 2.4.19). 
 
 
 
3.2.2 Lipid composition and growth behavior of complemented P. aeruginosa 
PAO1 ΔPA0920 mutant strains 
The induction of the A-PGS promoter PPA0920 under acidic growth conditions (pH 5.3) resulted 
in the formation of 6 % A-PG compared to the overall polar lipid content for the PAO1 wild-
type (Klein et al., 2009). To investigate if the various complemented mutants of PAO1 
ΔPA0920 synthesize the expected PG variants in P. aeruginosa, strains were grown under 
acidic conditions (pH 5.3; section 2.3.5) and their lipids were separated by two-dimensional 
TLC and visualized using molybdatophosphoric acid (sections 2.5.1 and 2.5.3). The resulting 
TLC plates are presented in Figure 10. For all complemented mutant strains, no variations in 
the amounts of the P. aeruginosa standard phospholipids PG, PE and DPG were observed 
(compare Figure 10). The A-PG content of the PAO1 wild-type was defined as 100 % and the 
aaPG amounts of the complemented strains were related to this value. 
 
Figure 9: Complementation variants of the PAO1 ΔPA0920 deletion mutant strain 
The P. aeruginosa PAO1 ΔPA0920 deletion mutant strain was chromosomally complemented with 
orf PA0920 (strain ΔPacomp) or with a truncated PA0920 variant (PA0920aa543-881, yielding strain 
ΔPa-aa543-881comp) at the attB locus. Analogously, ΔPA0920 was cross-complemented employing 
the aaPGS enconding genes from S. aureus (ΔSacomp), B. subtilis (ΔBscomp) and E. faecium (ΔEfcomp). 
For details, see section 2.4.19. 
The specificity of the respective aaPGS enzyme is indicated. A-PG: alanyl-phosphatidylglycerol, 
L-PG: lysyl-phosphatidylglycerol, R-PG: arginyl-phosphatidylglycerol, PPA0920: native promoter of 
orf PA0920, trrnB: rrnB terminator sequence, attB: attachment site B locus. 
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Results -102-  
 
 
For the homologous complemented ΔPacomp strain, an increased amount of 200 % A-PG 
compared to the wild-type strain was determined. This elevated A-PG level might be a 
consequence of the integration of the respective construct into the attB locus site which 
provided an artificial chromosomal context compared to the wild-type strain (compare 
section 3.2.1). Due to the elevated A-PG content of the ΔPacomp mutant, this strain allowed 
for the determination of resistance phenotypes under artificially raised A-PG amounts in 
P. aeruginosa. 
No A-PG was detected in the polar lipids of strain ΔPa-aa543-881comp containing the 
C-terminal soluble A-PGS domain catalyzing the alanylation of PG in vitro (Hebecker et al., 
2011). This observation might be a result of the deletion of the transmembrane domain 
anchoring the catalytic A-PGS domain to the cytoplasmic membrane. The ΔPa-aa543-881comp 
strain was excluded from further investigation because of its ΔPA0920 deletion mutant 
phenotype.  
 
Figure 10: Lipid composition of P. aeruginosa PAO1 ΔPA0920 complementation variants 
P. aeruginosa mutant strains were cultured in AB medium pH 5.3 at 37 °C for 24 h (section 2.3.5). 
After harvesting, polar lipids were extracted, analyzed by two-dimensional TLC and stained with 
molybdatophosphoric acid (sections 2.5.1 and 2.5.3). A-PG and L-PG positions are indicated by a 
circle or a rectangle, respectively. Relative aaPG amounts were quantified and related to the wild-
type strain A-PG level defined as 100 % (section 2.5.3).  
A-PG: alanyl-phosphatidylglycerol, DPG: diphosphatidylglycerol, L-PG: lysyl-phosphatidylglycerol, 
PE: phosphatidylethanolamine, PG: phosphatidylglycerol. 
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Strain ΔSacomp was cross-complemented with the gene encoding the well-characterized 
L-PGS (MprF) from S. aureus (Peschel et al., 2001; Staubitz et al., 2004). As expected from 
previous studies, L-PG was detected for strain ΔSacomp and the amount was quantified to 
120 % compared to the PAO1 wild-type. The artificial synthesis of the positively charged 
L-PG instead of the zwitterionic A-PG in almost comparable amounts in P. aeruginosa 
provided a versatile tool to elucidate the validity of the ‘charge repulsion’ model originally 
proposed for the gram positive S. aureus (see section 1.4.3; Peschel et al., 2001) in the 
context of the gram negative model organism P. aeruginosa. 
For strain ΔBscomp harboring the B. subtilis mprF gene, the formation of A-PG and L-PG was 
observed. In former studies, the synthesis of both aaPG variants had been reported with the 
dominant formation of L-PG and minor amounts of A-PG (Roy and Ibba, 2009). Therefore, 
the observed lipid levels of 120 % L-PG and 10 % A-PG were in good agreement with the 
previous in vitro characterization. Because of the concomitant synthesis of both L-PG and 
A-PG, strain ΔBscomp was an appropriate tool to analyze resistance phenotypes in the 
presence of two aaPGs in P. aeruginosa. 
20 % L-PG was detected for the ΔEfcomp strain cross-complemented with the aaPGS2 from 
E. faecium. The aaPGS2 had been characterized to synthesize predominantly L-PG together 
with minor amounts of R-PG and A-PG before (Roy and Ibba, 2009). Due to the low L-PG 
amount detected in ΔEfcomp, it seems reasonable that the levels of A-PG and R-PG were 
below the detection limit of the employed method. Therefore, strain ΔEfcomp was not 
subjected to further investigations. 
Importantly, for the chimeric mutant strains ΔSacomp, ΔBscomp and ΔEfcomp, the observed aaPG 
formation resulted from the utilization of the specific P. aeruginosa aminoacyl-tRNAs as 
amino acid substrate donors. These results were in good agreement with a previous study 
elucidating that the individual tRNA sequence is of minor importance for the aminoacyl-
tRNA recognition. Instead, the amino acid moiety of the aminoacyl-tRNA substrate was 
identified as the major determinant (Hebecker et al., 2011).  
To further characterize the complemented PAO1 ΔPA0920 variants, their growth behavior 
was analyzed under neutral and acidic growth conditions (pH 7.3 and pH 5.3). The resulting 
growth curves are presented in Figure 11. 
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The growth of the ΔPA0920 deletion mutant strain was identical to the behavior of the PAO1 
wild-type strain under acidic and neutral growth conditions. This was also observed for the 
constructed complemented strains (Figure 11). 
 
3.2.3 AaPGS dependent resistance phenotypes of P. aeruginosa 
In several bacterial pathogens, the aminoacylation of PG had been related to a reduced 
susceptibility to antimicrobial agents (e.g. S. aureus, M. tuberculosis, P. aeruginosa; Peschel 
et al., 2001; Maloney et al., 2009; Klein et al., 2009). To analyze the impact of different 
aaPGs, P. aeruginosa strains producing elevated A-PG amounts, L-PG or A-PG and L-PG 
simultaneously (compare sections 3.2.1 and 3.2.2) were analyzed concerning their resistance 
phenotypes in the presence of antimicrobial compounds.  
In an initial approach, the PAO1 wild-type, the PAO1 ΔPA0920 deletion mutant and the 
complemented strains were cultivated under 1152 different conditions employing the 
Phenotype MicroArrayTM system (Biolog, Hayward, CA, USA) at neutral pH conditions 
(section 2.7.1). This system allows for a high-throughput investigation of a wide variety of 
antimicrobial substances (Bochner, 2009). The strains were cultivated in 96-well plates 
Figure 11: Growth curves of P. aeruginosa PAO1 ΔPA0920 complementation variants 
P. aeruginosa mutant strains were cultured in AB medium pH 7.3 and pH 5.3 at 37 °C and 200 rpm 
(section 2.3.5). Culture turbidity was measured at 578 nm.  
Rhombus: PAO1 wild-type, square: PAO1 ΔPA0920, triangle: ΔPacomp, dot: ΔSacomp, plus: ΔBscomp. 
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providing the substances to be analyzed. During incubation, an applied tetrazolium dye was 
reduced by electrons provided by the respiratory chain of the bacteria. The resulting purple 
formazan was detected to determine the survival of the bacteria under the specifically 
employed conditions (section 2.7.1). This initial analysis revealed a set of around 
30 conditions with different phenotypes for the applied mutant strains compared to the 
wild-type strain (data not shown). Compounds resulting in diverse phenotypes for the wild-
type and the mutant strains were subjected to further analyses. 
The initial results were verified in a second independent experimental setup (see section 
2.7.2). The employed P. aeruginosa strains were diluted in AB medium pH 5.3 according the 
Phenotype MicroArrayTM protocol and 96-well plates were individually prepared with 
inhibitory compounds in varying concentrations. The plates were inoculated with the 
prepared cell suspensions, covered with a gas permeable membrane and incubated without 
shaking at 37 °C for 18 h. Cell growth was monitored by measuring the culture turbidity in 
the absence of the membrane. The employed acidic conditions ensured maximal cellular 
aaPG content due to the employed PPA0920 promoter (Klein et al., 2009). For the present 
study, antimicrobial compounds were selected based on the initial Phenotype MicroArrayTM 
experiments. Compounds further reported to result in resistance phenotypes mediated by 
aaPGS enzymes (daptomycin, oxacillin, methicillin, polymyxins, nisin), to have a direct 
influence on the integrity of bacterial membranes (poly-L-lysine) or to be of special clinical 
interest (vancomycin) were also employed (Hachmann et al., 2009; Komatsuzawa et al., 
2001; Nishi et al., 2004; Hartmann and Galla, 1978; Rossetti et al., 2004; Mogi and Kita, 
2009; Bao et al., 2012). 
Growth differences observed for the respective strains resulted in the utilization of the 
antimicrobials ampicillin, oxacillin, cefsulodin, daptomycin, protamine sulfate, poly-L-lysine, 
polymyxin E, benzethonium chloride, domiphen bromide and vancomycin for further 
investigations (for chemical structures of antimicrobial compounds, see appendix, Figure 34). 
Resistance phenotypes mediated by aaPG synthesis in the presence of daptomycin and 
several β-lactam antibiotics had been described before for S. aureus and B. subtilis 
(Hachmann et al., 2009; Komatsuzawa et al., 2001; Nishi et al., 2004; Jones et al., 2008) and 
a reduced susceptibility of P. aeruginosa synthesizing A-PG was observed for protamine 
sulfate and cefsulodin (Klein et al., 2009). 
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To quantify the observed growth differences of the employed P. aeruginosa mutant strains 
in the presence of the selected antimicrobial compounds, a modified microdilution method 
for MIC determination was employed (see section 2.7.3). Cells were grown under acidic 
conditions to induce aaPG synthesis (compare 3.2.2; Klein et al., 2009) and mixed with 
antimicrobial compounds in gradually varying concentrations in 96-well plates. After 
incubation, the culture turbidity of each well was measured and the lowest concentration 
with an OD595 < 0.05 was defined as the MIC (OD595 < 0.1 for daptomycin; the lowest 
concentration resulting in a constant OD595 minimum level was employed for protamine 
sulfate). Each value employed for MIC determination was averaged from four parallel 
growth experiments in different wells. MIC determination experiments were reproduced 
independently at least in triplicate. This system allows for the efficient determination of 
resistance phenotypes in the presence of gradually varying concentrations. The MICs 
obtained for the complemented ΔPA0920 mutant strains are summarized in Table 12. 
 
Table 12: MICs (µg/mL) of P. aeruginosa strains with different aaPG contents 
For MIC determination, strains were treated with gradually varying concentrations of the 
antimicrobials in AB medium pH 5.3 (section 2.7.3). The relative standard deviation was 
approximately 5 % (10 % for protamine sulfate and daptomycin). P values were calculated by 
significance analysis and are indicated: P ≤ 0.1 (*), P ≤ 0.05 (**) and P ≤ 0.01 (***). Lipid amounts 
are indicated as determined in section 3.2.2. All concentrations are given in µg/mL. Experiments 
were performed at least in triplicate. 
aaPG: aminoacyl-phosphatidylglycerol, A-PG: alanyl-phosphatidylglycerol, L-PG: lysyl-
phosphatidylglycerol. 
 wild-type ΔPA0920 ΔPacomp ΔSacomp ΔBscomp 
 100 % A-PG 0 % aaPG 200 % A-PG 120 % L-PG 
120 % L-PG 
10 % A-PG 
ampicillin 300 ± 15 60*** ± 3 300 ± 15 90*** ± 5 60*** ± 3 
oxacillin 12‘000 ± 600 10‘000 ± 500 12‘000 ± 600 5‘000*** ± 250 5‘000*** ± 250 
cefsulodin 61 ± 3 28*** ± 2 44** ± 2 44** ± 2 28*** ± 2 
daptomycin 12‘000 ± 1200 6‘000** ± 600 9‘000* ± 900 3‘000** ± 300 6‘000** ± 600 
protamine sulfate 100 ± 10 40* ± 4 40* ± 4 40* ± 4 40* ± 4 
poly-L-lysine 18 ± 1 9*** ± 0.5 9*** ± 0.5 6*** ± 0.5 9*** ± 0.5 
polymyxin E 8 ± 0.5 5** ± 0.3 4** ± 0.3 5** ± 0.3 5** ± 0.3 
benzethonium chloride 31 ± 1.6 25*** ±1.3 16*** ± 0.8 16*** ± 0.8 25** ± 1.3 
domiphen bromide 9.9 ± 0.5 8.7 ± 0.4 8.7 ± 0.4 8.7 ± 0.4 8.7 ± 0.4 
vancomycin 17‘800 ± 900 15‘600 ± 800 15‘600 ± 800 17‘800 ± 900 15‘600 ± 800 
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Of note, the MICs determined for oxacillin, daptomycin and vancomycin are at least three 
orders of magnitude higher than employed for clinical application (Enoch et al., 2007; 
Wright, 1999; Truong et al., 2012). The observed changes of MIC due to the presence or 
absence of aaPGS encoding genes are comparable to alterations reported for multiresistant 
P. aeruginosa clinical isolates (Strateva and Yordanov, 2009; Riou et al., 2010). 
 
Phenotypes in the presence of β-lactam antibiotics 
P. aeruginosa strains possess a high intrinsic resistance against β-lactam antibiotics due to 
their low outer membrane permeability and their chromosomally encoded detoxification 
systems like antibiotic inactivating enzymes and multidrug efflux pumps (section 1.2.1; 
Hancock and Speert, 2000). In a former study, the susceptibility of P. aeruginosa to the 
cephalosporin cefsulodin had been related additionally to the presence of A-PG in cellular 
membranes (Klein et al., 2009). In this work, the presence of modified A-PG levels (strains 
ΔPA0920 and ΔPacomp), of L-PG (ΔSacomp) or of L-PG and A-PG concomitantly (ΔBscomp) 
resulted in MIC reductions when compared to the PAO1 wild-type (see Table 12). 
 
Ampicillin 
The deletion of orf PA0920 from the PAO1 genome resulted in a MIC reduction from 
300 µg/mL to 60 µg/mL in the presence of ampicillin. For the homologously complemented 
ΔPacomp strain, a MIC of 300 µg/mL was observed representing the wild-type phenotype. This 
result indicated that the elevated A-PG level of ΔPacomp had no influence on the susceptibility 
to ampicillin. A MIC of 90 µg/mL was observed for the ΔSacomp strain. Obviously, the 
synthesis of 120 % L-PG resulted in an only partially restored phenotype. However, for the 
ΔBscomp strain, exhibiting 10 % A-PG and 120 % L-PG, a MIC of 60 µg/mL was determined 
representing the deletion mutant strain resistance phenotype. Thus, the ampicillin 
resistance in P. aeruginosa depends on the incorporation of sufficient amounts of A-PG into 
the cellular membranes.  
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Oxacillin 
For the PAO1 wild-type, a MIC of 12 mg/mL oxacillin was observed, whereas a reduced value 
of 10 mg/mL was determined for the deletion mutant strain indicating the influence of A-PG 
on the susceptibility of P. aeruginosa to the employed β-lactam. A MIC of 12 mg/mL was also 
detected for strain ΔPacomp. Apparently, the synthesis of 200 % A-PG restored the wild-type 
phenotype as it was also observed for ampicillin. However, the MICs of strains ΔSacomp and 
ΔBscomp were determined to 5 mg/mL meaning that these strains were more susceptible to 
oxacillin than the ΔPA0920 deletion mutant strain devoid of any aaPG. Obviously, the 
artificially altered membrane lipid composition with 120 % L-PG (ΔSacomp) or with 120 % L-PG 
and 10 % A-PG (ΔBscomp) has deleterious effects on the oxacillin resistance of P. aeruginosa.  
By comparing the chemical structures of ampicillin and oxacillin (see appendix, Figure 34), it 
becomes clear that minor structural alterations discriminating these compounds have 
important consequences for the resistance of P. aeruginosa represented by a 40-fold 
increased MIC for oxacillin (12 mg/mL) compared to ampicillin (300 µg/mL). Studies of the 
E. coli outer membrane protein OmpF indicated a selective transport for zwitterionic 
β-lactam antibiotics (ampicillin). Instead, mono- or dianionic β-lactams (oxacillin) were 
transported with significantly lower rates (Yoshimura and Nikaido, 1985; Nestorovich et al., 
2002; Vidal et al., 2005). A comparable selective uptake mechanism might also be present in 
P. aeruginosa judging from the highly increased resistance to oxacillin compared to 
ampicillin. However, three decades ago, it was shown that phospholipid bilayers are 
permeable for β-lactams with varying rates depending presumably on the β-lactam charge 
characteristic (Yamaguchi et al., 1982). According to the differing MICs obtained for the 
cross-complemented strains in the presence of ampicillin and oxacillin compared to the wild-
type and the ΔPA0920 deletion mutant strain in this study, other membrane parameters like 
fluidity or polarity might also be involved in the observed susceptibility phenotypes. 
 
Cefsulodin 
The MIC for the ΔPA0920 deletion mutant (28 µg/mL) was found reduced compared to the 
wild-type strain (61 µg/mL) in the presence of the cephalosporin cefsulodin. Interestingly, in 
contrast to the results for ampicillin and oxacillin, a reduced MIC of 44 µg/mL was observed 
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for strain ΔPacomp, restoring the wild-type phenotype only partially. It seems reasonable that 
the P. aeruginosa cefsulodin resistance depends on a specific A-PG level. For the cross-
complemented strains, MICs of 44 µg/mL (ΔSacomp) and 28 µg/mL (ΔBscomp) were obtained 
confirming the hypothesis of an accurate lipid homeostasis. Interestingly, the relative 
amount of 120 % L-PG (ΔSacomp) resulted in the same partially restored phenotype as it was 
observed for 200 % A-PG (ΔPacomp). 
 
Phenotypes in the presence of daptomycin 
Daptomycin is a new lipopeptide antibiotic employed for the treatment of serious infections 
with gram positive bacteria being resistant to several antimicrobial compounds (Enoch et al., 
2007). The specific mechanism of action was proposed: The lipopeptide interacts with PG 
molecules of the membrane in a Ca2+-dependent manner and pores are formed within the 
membrane by aggregating oligomers. Consequently, the membrane becomes depolarized, 
the membrane potential collapses and subsequently, the cells die (Muraih et al., 2011; 
Pogliano et al., 2012).  
As became clear from the present study (compare Table 12), P. aeruginosa is highly resistant 
to daptomycin presumably due to the low outer membrane permeability (Hancock and 
Speert, 2000). MICs of 12 mg/mL and 6 mg/mL were obtained for the wild-type strain and 
the ΔPA0920 deletion mutant, respectively. A MIC of 9 mg/mL observed for strain ΔPacomp 
indicated a partially restored wild-type phenotype due to the elevated A-PG level of 200 % 
present in this strain. In contrast, MICs of 3 mg/mL and 6 mg/mL were determined for 
strains ΔSacomp and ΔBscomp, respectively. The synthesis of 120 % L-PG in strain ΔSacomp 
increased the susceptibility of the cells to daptomycin, whereas the presence of 10 % A-PG 
and 120 % L-PG resulted in a deletion mutant phenotype for strain ΔBscomp. From this it 
might be concluded that the incorporation of A-PG into P. aeruginosa membranes is 
important for daptomycin resistance, whereas the formation of L-PG increases the 
susceptibility to this lipopeptide antibiotic. In several previous studies, daptomycin 
resistance phenotypes had been related to L-PG formation in S. aureus and B. subtilis 
(Friedman et al., 2006; Hachmann et al., 2009; Julian et al., 2007; Mishra et al., 2009; Rubio 
et al., 2011). In a recently published study, the daptomycin resistance of S. aureus strains 
synthesizing different aaPG variants had been compared. Interestingly, the phenotypes of 
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strains incorporating A-PG or L-PG into the cytoplasmic membrane did not differ from each 
other (Slavetinsky et al., 2012). The diverging results obtained for the gram positive model 
organism S. aureus by Slavetinsky et al., 2012, and for the gram negative model organism 
P. aeruginosa in this study might indicate that different mechanisms are responsible for 
daptomycin resistance. Interestingly, other studies indicated that daptomycin resistance in 
Enterococci and B. subtilis depends on the level of PG rather than on the L-PG content 
(Mishra et al., 2012a; Hachmann et al., 2011) but might also be influenced by membrane 
fluidity (Mishra et al., 2012b). Since the PG content of the employed P. aeruginosa strains 
was identical, the ‘PG reduction’ hypothesis does not explain the observed phenotypes. 
 
Phenotypes in the presence of CAMPs 
Cationic antimicrobial compounds are widely used by various organisms for the defense of 
competing species. Most CAMPs consist of two domains: a cationic part interacting with 
negatively charged bacterial membrane surfaces and a hydrophobic part putatively 
mediating the integration and pore formation into the membranes (Zasloff, 2002; Peschel 
and Sahl, 2006). To escape CAMPs produced by competing organisms, several resistance 
mechanisms have evolved in bacteria like the alteration of the membrane surface charge, 
e.g. by the formation of L-PG (Koprivnjak and Peschel, 2011; Peschel and Sahl, 2006). The 
‘charge repulsion’ model postulated by Peschel et al., 2001, was developed based on 
increased susceptibilities to CAMPs for L-PG deficient S. aureus strains. In the present study, 
the CAMPs protamine sulfate, poly-L-lysine and polymyxin E were employed to analyze the 
impact of different aaPGs in P. aeruginosa. For several organisms, an interaction of these 
CAMPs with membrane components was described as the antimicrobial action mechanism 
(Aspedon and Groisman, 1996; Conte et al., 2007; Epand et al., 2010; Johansen et al., 1997; 
Koo et al., 2001; Lim et al., 2010; Zhang et al., 2000). For complemented S. aureus strains 
analyzed by CAMP treatment, restored wild-type MICs had been observed (Peschel et al., 
2001).  
For the ΔPA0920 deletion mutant strain, an increased susceptibility to protamine sulfate 
indicated by a MIC of 40 µg/mL compared to the wild-type strain (100 µg/mL) was observed 
(see Table 12). Likewise, for all complemented strain variants, a MIC of 40 µg/mL was 
obtained in the presence of protamine sulfate. The results for poly-L-lysine exhibited an 
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identical tendency: A MIC of 18 µg/mL was detected for the wild-type strain, which was 
reduced to 9 µg/mL for strains ΔPA0920, ΔPacomp and ΔBscomp. For ΔSacomp, a MIC of 6 µg/mL 
indicated an increased susceptibility to poly-L-lysine in the absence of A-PG. The treatment 
of the various P. aeruginosa strains with polymyxin E resulted in reduced MICs of 5 µg/mL 
for the ΔPA0920 deletion mutant and for the ΔSacomp and ΔBscomp strains compared to a MIC 
of 8 µg/mL determined for the wild-type. The susceptibility of the homologously 
complemented strain ΔPacomp to polymyxin E was slightly increased (4 µg/mL) compared to 
the other mutant strains.  
In summary, the wild-type resistance phenotype for CAMP molecules was not restored by 
any of the complemented strains possessing elevated A-PG levels (ΔPacomp), L-PG (ΔSacomp) or 
L-PG together with A-PG (ΔBscomp). In conclusion, it is proposed that the membrane lipid 
homeostasis is of high importance for CAMP resistance in the employed gram negative 
model organism P. aeruginosa. Neither the ‘charge repulsion’ mechanism, as it was pro-
posed for the resistance of L-PG synthesizing S. aureus strains against CAMPs (Peschel et al., 
2001), nor the ‘PG reduction’ hypothesis, as it was proposed based on studies analyzing the 
resistance of Enterococci and B. subtilis to daptomycin (Mishra et al., 2012a; Hachmann et 
al., 2011), do explain the results for the P. aeruginosa mutant strains observed in this study. 
 
Phenotypes in the presence of cationic surfactants 
Cationic surfactants possess an antimicrobial activity against a wide variety of bacteria and 
are therefore used as disinfectant components and for liquid drug conservation (Hegstad et 
al., 2010). Because P. aeruginosa possesses a high intrinsic resistance (Hancock and Speert, 
2000), disinfectants must be selected with caution. Remarkably, P. aeruginosa strains can 
grow in the presence of disinfectants and have been isolated out of disinfectants previously 
(Bullard et al., 2011; Lanini et al., 2011). In this study, the quaternary ammonium 
compounds benzethonium chloride and domiphen bromide were employed to treat 
P. aeruginosa strains with artificially altered membrane compositions (see Table 12). These 
compounds are proposed to interact with bacterial membranes in a detergent-like mode of 
action because of their amphiphilic structure (Gilbert and Moore, 2005). 
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The MIC of the ΔPA0920 deletion mutant strain was reduced to 25 µg/mL in the presence of 
benzethonium chloride compared to 31 µg/mL observed for the wild-type strain. 
Interestingly, for strain ΔPacomp synthesizing elevated A-PG levels and for the L-PG producing 
ΔSacomp strain, an increased susceptibility of 16 µg/mL was detected. A deletion mutant-like 
phenotype (25 µg/mL) was observed for the ΔBscomp strain incorporating both L-PG and A-PG 
into its membrane. Domiphen bromide treatment resulted in MICs of 9.9 µg/mL for the wild-
type strain and of 8.7 µg/mL for all mutant strains. 
Due to these results obtained for all complemented strains which provide an altered 
membrane composition resulting in a more positively charged membrane surface, the 
resistance of P. aeruginosa to the quaternary ammonium surfactants cannot be related 
directly to the membrane surface charge. Thus, the formerly postulated ‘charge repulsion’ 
mechanism (Peschel et al., 2001) is inapplicable for the P. aeruginosa model organism used 
in this study. Instead, the characteristics of the present lipids and a fine-tuning of membrane 
lipid homeostasis are proposed to be of high importance.  
 
Phenotypes in the presence of vancomycin 
The glycopeptide antibiotic vancomycin has been used to treat infections caused by gram 
positive bacteria since more than 20 years. It binds to peptidoglycan precursors and 
prevents the transpeptidation reaction cross-linking specific amino acid residues (Courvalin, 
2006). 
In this study, P. aeruginosa strains with artificial aaPG levels were incubated with 
vancomycin (see Table 12). The vancomycin treatment of the wild-type strain resulted in a 
MIC of 17.8 mg/mL, whereas the value was slightly reduced to 15.6 mg/mL for the ΔPA0920 
deletion mutant and the complemented mutant strains ΔPacomp (200 % A-PG) and ΔBscomp 
(120 % L-PG, 10 % A-PG). Importantly, for the ΔSacomp strain (120 % L-PG), a wild-type-like 
MIC of 17.8 mg/mL was observed. These observations are consistent with previous results 
obtained by vancomycin treatment of gram positive S. aureus strains. These results indicated 
that the resistance of both pathogens to vancomycin does not depend directly on the 
synthesis of aaPG (Komatsuzawa et al., 2001; Julian et al., 2007). 
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3.3 Cellular response of P. aeruginosa in the presence of selected 
antimicrobial agents  
The bacterial membrane lipid composition can be adapted to various environmental 
conditions (Hazel and Williams, 1990). Former studies reported the alteration of 
transcriptional and translational profiles of a wide variety of genes and proteins in response 
to several antimicrobials. The altered profiles resulted in the adaptation of the cells to the 
respective stress condition (Brazas and Hancock, 2005; Wenzel and Bandow, 2011; Davies et 
al., 2006). In this work, the influence of selected antimicrobial agents on the transcriptional 
regulation of the A-PG synthesizing A-PGS of P. aeruginosa was investigated. For this, the 
formerly constructed PAO1-PPA0920-lacZ strain was employed harboring the PPA0920 promoter 
upstream of the lacZ reporter gene within the attB integration site of the PAO1 chromosome 
(Klein et al., 2009). In a previous study, the PPA0920 promoter was identified to be activated 
under acidic growth conditions (Klein et al., 2009). Hence, PPA0920 promoter activity was 
analyzed under neutral and acidic growth conditions (pH 7.3 and pH 5.3) in the presence of 
selected antimicrobials in subinhibitory concentrations (0.08- to 0.25-fold MIC of the PAO1 
wild-type) to allow for appropriate growth (compare section 2.8.2). During incubation, 
samples were taken and the β-galactosidase activity was determined. The obtained values 
were related to the culture turbidity and the overall bacterial protein content to eliminate 
deviations in the promoter activity determination due to cell morphology alterations 
induced by the antimicrobial agents (for details, see section 2.8.2). Notably, the 
β-galactosidase activities calculated on the basis of the overall protein content were 
consistent with the values conventionally calculated on the basis of the culture turbidity 
(data not shown).  
In all cases, a significant promoter activity induction was obtained under acidic growth 
conditions compared to neutral conditions. Exemplary results for daptomycin and poly-
myxin E are displayed in Figure 12.  
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For the experiment in the absence of antimicrobials, an induction of the promoter activity 
under acidic growth conditions (pH 5.3) from 253 to 681 MU (2 h) and from 300 to 768 MU 
(4 h) was observed compared to the values obtained at pH 7.3. Daptomycin treatment 
resulted in comparable values under all observed conditions (2 h: 218 MU (pH 7.3), 625 MU 
(pH 5.3); 4 h: 325 MU (pH 7.3), 720 MU (pH 5.3)) indicating that the transcript level of the 
A-PGS was not altered in the presence of this lipopeptide antibiotic. Interestingly, the 
application of polymyxin E resulted in increased β-galactosidase activities under both pH 
conditions after 2 h (pH 7.3: 609 MU; pH 5.3: 1571 MU) representing induction ratios of 2.4 
(pH 7.3) and 2.3 (pH 5.3). After 4 h of polymyxin E treatment, the induction ratios were 
reduced but were still present as indicated by values of 425 MU (pH 7.3: ratio 1.4) and 
1132 MU (pH 5.3: ratio 1.5). 
In general, the β-galactosidase activity was increased under acidic conditions in comparable 
ranges in the presence of all employed antimicrobials, respectively, indicating the dominant 
influence of the acidic pH on the PPA0920 promoter activity. Interestingly, the overall extent of 
Figure 12: PPA0920 promoter activity in the presence of daptomycin and polymyxin E 
The PPA0920 promoter activity was analyzed employing strain PAO1-PPA0920-lacZ harboring the 
transcriptional PPA0920-lacZ promoter-reporter gene fusion. The cells were cultivated in AB medium 
(pH 5.3 and pH 7.3) in the presence of daptomycin and polymyxin E in subinhibitory 
concentrations. The β-galactosidase activity was determined 2 h and 4 h after antimicrobial 
application (section 2.8.2).  
White: untreated cultures, light gray: cultures treated with 1.5 mg/mL daptomycin, dark gray: 
cultures treated with 1.33 µg/mL polymyxin E. 
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the promoter activity was additionally modulated by some of the applied antimicrobials as 
exemplified for polymyxin E above (Figure 12) and it depends on the growth phase of the 
bacteria. In order to quantify the promoter activity modulation caused by the individual 
compound, induction ratios were calculated relating promoter activities in the presence of 
the respective compound to values obtained without any antimicrobial compound. The 
results are presented in Table 13.  
 
Table 13: PPA0920 promoter induction by several antimicrobial compounds 
The PPA0920 promoter induction was analyzed employing the PAO1-PPA0920-lacZ strain harboring a 
transcriptional PPA0920-lacZ promoter-reporter gene fusion inserted into the attB locus of the PAO1 
chromosome. Cells were cultured in AB medium (pH 5.3 and pH 7.3) for 2 h. The respective 
antimicrobials were added in subinhibitory concentrations and the β-galactosidase activity was 
determined 2 h and 4 h after compound application. The promoter activity modulation by the 
individual compound was calculated as the induction ratio representing the promoter activity in 
the presence of the respective antimicrobial agent related to the control experiment in the 
absence of any antimicrobial compound. A ratio > 1 represents an increased induction of the 
PPA0920 promoter caused by the individual compound. Modulation maxima and minima are 
indicated by bold letters. Experiments were performed at least threefold.  
 pH 5.3 pH 7.3 
 2 h 4 h 2 h 4 h 
ampicillin 1.2 ± 0.1 0.8 ± 0.2 1.2 ± 0.1 1.9 ± 0.2 
oxacillin 1.2 ± 0.3 0.9 ± 0.3 1.0 ± 0.3 1.6 ± 0.3 
cefsulodin 1.1 ± 0.2 0.8 ± 0.1 0.9 ± 0.1 0.9 ± 0.1 
daptomycin 0.9 ± 0.0 0.9 ± 0.1 0.9 ± 0.3 1.1 ± 0.2 
protamine sulfate 1.6 ± 0.4 1.2 ± 0.3 1.9 ± 0.6 1.5 ± 0.2 
poly-L-lysine 0.6 ± 0.1 0.7 ± 0.1 1.1 ± 0.2 1.1 ± 0.1 
polymyxin E 2.3 ± 0.5 1.5 ± 0.2 2.4 ± 0.4 1.4 ± 0.2 
benzethonium chloride 0.8 ± 0.1 0.7 ± 0.0 1.2 ± 0.1 1.0 ± 0.1 
domiphen bromide 1.0 ± 0.4 0.8 ± 0.2 1.0 ± 0.1 0.9 ± 0.1 
 
The treatment of the PAO1-PPA0920-lacZ strain with the β-lactam antibiotics ampicillin and 
oxacillin resulted in increased PPA0920 promoter activities (induction ratios of 1.9 and 1.6) 
under neutral conditions after 4 h, whereas the activity was almost unaffected under all 
other conditions. In contrast, in the presence of the cephalosporin cefsulodin and the 
lipopeptide daptomycin, no promoter activity alteration was observed under all employed 
conditions (see above, Figure 12). 
For the employed CAMP molecules, a modulated promoter activity was observed for each 
compound: Whereas an increased promoter activity was obtained under all employed 
conditions after the application of protamine sulfate (ratios of 1.2 to 1.9) and polymyxin E 
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(ratios of 1.4 to 2.4; see also Figure 12), a reduced promoter induction was determined 
when poly-L-lysine was applied under acidic conditions (ratios of 0.6 and 0.7). Poly-L-lysine 
treatment had almost no effect on the promoter induction under neutral conditions.  
The utilization of the cationic surfactant benzethonium chloride resulted in a clearly reduced 
promoter induction under acidic growth conditions after for 4 h (ratio of 0.7), whereas no 
modulation of the promoter activity was observed under the all other conditions. The 
presence of domiphen bromide did not affect the PPA0920 promoter activity.  
The obtained results indicate that the A-PGS expression is modulated in response to some 
but not all antimicrobial agents for which a resistance phenotype according to the synthesis 
of A-PG was observed (compare section 3.2.3). Interestingly, even for the functionally 
related CAMP molecules protamine sulfate, polymyxin E and poly-L-lysine, the transcription 
of the A-PGS was differently modulated (Table 13). These results indicate a diverse function 
of A-PG in the presence of various environmental stresses reflected by the individual 
regulation of the PPA0920 promoter in response to several antimicrobials, acidic or neutral 
growth conditions and in distinct growth phases. 
Consequently, it was analyzed if the observed promoter activity modulations resulted in 
altered lipid compositions. For this, the membrane lipids of the control strain P. aeruginosa 
KS11 (Schreiber et al., 2006) were extracted and separated by two-dimensional TLC after 2 h 
and 4 h treatment with the respective compound (compare section 2.8.2). However, only 
after oxacillin application, a slight increase of the A-PG content was observed at pH 7.3 (data 
not shown). Hence, it was concluded that the cellular A-PGS amount and consequently, the 
A-PG content are fine-tuned by the applied antimicrobials as indicated by the observed 
transcriptional modulation. In conclusion, the acidic pH condition was identified as the 
dominant effector increasing the PPA0920 promoter activity and the A-PG amount. 
Additionally, the PPA0920 activity can be modulated by specific antimicrobial compounds. 
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3.4 PA0920 is clustered together with PA0919 in gram negative bacteria 
The A-PGS (orf PA0920) is encoded together with orf PA0919 on the P. aeruginosa PAO1 
chromosome. Both orfs are separated by one single base pair. Therefore, they are predicted 
to form an operon according to the DOOR database (Mao et al., 2009; data not shown). The 
MBGD database (Uchiyama et al., 2010) was also employed to analyze the clustering of 
PA0920 and PA0919 homologous orfs in other aaPG synthesizing bacteria. PA0919 homo-
logous genes were detected downstream of aaPGS encoding genes e.g. in A. tumefaciens 
(AcvB, 61 % sequence identity compared to PA0919), R. tropici (AtvA, 38 %), Ralstonia 
pickettii (Rpic_3994, 60 %) and B. phymatum (Bphy_4018, 36 %). In some organisms, at least 
two copies of PA0919 homologs were detected with at least one orf located distantly in the 
genome (e.g. in Xanthomonas axonopodis, Pedobacter heparinus, Xylella fastidiosa or 
Sinorhizobium meliloti). In contrast, the PA0919 homologous gene virJ is encoded on 
octopine-type Ti-plasmids of A. tumefaciens (VirJ encoded on the pTiA6 plasmid, 33 %) 
clustered together with virulence genes for plant infection (Pan et al., 1995; Kalogeraki and 
Winans, 1995). Only in Cellvibrio japonicus, a potential PA0919 homolog (CJA_1309, 31 %) 
was detected in the absence of any aaPGS encoding gene. 
Interestingly, the MBGD analysis did not identify any PA0919 homologous genes in gram 
positive bacteria. This result is in good agreement with a former study locating PA0919 to 
the periplasm of P. aeruginosa employing a translational PA0919-PhoA fusion construct 
(Lewenza et al., 2005). Although PA0919 has not been analyzed biochemically yet, the 
predicted operon structure of PA0920 and PA0919 might indicate a function of the PA0919 
protein in A-PG homeostasis. 
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3.5 PA0919 deletion results in various phenotypes 
The first hints towards the function of PA0919 were obtained by analyzing mutant strains 
with transposon insertion sites within orf PA0919. These results were verified by generating 
a ΔPA0919 deletion mutant and several complemented strain variants and analyzing their 
growth behavior, lipid composition and antibiotic resistance phenotypes. 
 
3.5.1 PA0919 transposon mutant strains provided increased A-PG levels 
To get initial evidence towards the function of PA0919, two mutant strains with different 
transposon insertion sites within orf PA0919 were characterized (MPAO1 17368 and 53595, 
see Table 4 for details; strains were generously provided by Prof. Dr. S. Häußler from the 
Helmholtz Centre for Infection Research, Braunschweig, Germany; Jacobs et al., 2002). The 
mutant strains and their corresponding wild-type strain MPAO1 were grown under neutral 
and acidic conditions (pH 7.3 and pH 5.3) to late stationary phase. Subsequently, polar lipids 
were extracted and analyzed by two-dimensional TLC (sections 2.3.5, 2.5.1 and 2.5.3). 
Growth behavior and lipid patterns of both mutant strains were not affected under neutral 
conditions compared to the wild-type strain (data not shown). In contrast, bacterial growth 
of both mutant strains was reduced in acidified medium and A-PG levels were highly 
increased compared to the MPAO1 wild-type (data not shown).  
 
3.5.2 Construction of the ΔPA0919 deletion mutant and complemented 
variants 
To substantiate the results of the transposon mutant analysis, orf PA0919 was deleted from 
the PAO1 wild-type strain by homologous recombination (section 2.4.18) employing the 
method of Hoang et al., 1998, yielding the markerless deletion mutant strain PAO1 ΔPA0919 
(Groenewold, 2011). For detailed phenotype analyses, this strain was specifically 
complemented with different constructs as presented in Figure 13.  
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First, a fragment covering orf PA0919 together with its 430 bp upstream region (carrying the 
putative PPA0919 promoter region) was inserted at the attB locus of the PAO1 ΔPA0919 
chromosome resulting in strain Δ19 P19-19. Interestingly, the putative PPA0919 promoter 
region is located within orf PA0920 (A-PGS) encoded upstream of orf PA0919. Second, orf 
PA0919 was cloned under the control of the PPA0920 promoter which had been shown to be 
induced under acidic conditions (see chapter 3.3 and Klein et al., 2009) yielding strain 
Δ19 P20-19. For control, the deletion mutant strain was complemented solely with each of 
the promoters, resulting in strains Δ19 P19 and Δ19 P20. For strain construction details, see 
section 2.4.19. 
 
3.5.3 PA0919 deficient strains exhibit a stationary growth phenotype and an 
increased A-PG content  
For initial analysis, the PAO1 wild-type, the ΔPA0919 deletion mutant and the different 
ΔPA0919 complemented strains were grown under acidic and neutral conditions (pH 5.3 and 
pH 7.3) to the late stationary growth phase. Growth was monitored by measuring the 
culture turbidity. An identical growth behavior was observed for all strains under neutral 
conditions (see appendix, Figure 35), whereas growth was reduced for mutant strains devoid 
Figure 13: Complementation variants of PAO1 ΔPA0919 for functional analysis of PA0919 
Strain PAO1 ΔPA0919 was chromosomally complemented with the orf PA0919 controlled by its 
own putative promoter (strain Δ19 P19-19) or under the control of the PPA0920 promoter 
(Δ19 P20-19), respectively. For control, both promoters were solely inserted into the ΔPA0919 
chromosome (Δ19 P19 and Δ19 P20). Construction details are presented in section 2.4.19. 
attB: attachment site B locus, PPA0919: putative native promoter of orf PA0919, PPA0920: native 
promoter of orf PA0920, trrnB: rrnB terminator sequence. 
trrnBconstructs
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of orf PA0919 compared to PA0919 harboring strains. Growth curves obtained under acidic 
growth conditions are presented in Figure 14.  
 
 
Cultivation of strains devoid of orf PA0919 (ΔPA0919, Δ19 P20 and Δ19 P19) under acidic 
conditions resulted in a stationary growth phase phenotype when compared to strains 
possessing a copy of orf PA0919 (PAO1 wild-type, Δ19 P20-19 and Δ19 P19-19). The observed 
phenotype was in good agreement with the results initially obtained by the transposon 
mutant strain investigation (section 3.5.1). Interestingly, reduced generation times obtained 
under acidic growth conditions had been reported before for R. tropici and A. tumefaciens 
mutant strains lacking the respective PA0919 homolog AtvA or AcvB, whereas the 
generation times had not been found affected significantly under neutral conditions 
(Vinuesa et al., 2003). It was concluded that PA0919 is important for the growth of 
P. aeruginosa under acidic growth conditions. 
The analysis of P. aeruginosa transposon mutant strains devoid of a functional PA0919 
protein indicated an increased A-PG level under acidic conditions (section 3.5.1). Therefore, 
the employed PAO1 wild-type and the corresponding ΔPA0919 mutant strain variants were 
cultivated to late stationary phase under acidic conditions (compare section 2.3.5), when the 
Figure 14:  Stationary growth phenotype observed for P. aeruginosa strains devoid of orf 
PA0919 
Different P. aeruginosa mutant strains were cultured in AB medium pH 5.3 at 37 °C and 200 rpm 
(section 2.3.5). Culture turbidity was measured at 578 nm.  
Rhombus: PAO1 wild-type, square: PAO1 ΔPA0919, triangle: Δ19 P20, cross: Δ19 P20-19, star: 
Δ19 P19, dot: Δ19 P19-19. 
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PPA0920 promoter was activated (Klein et al., 2009). Polar lipids were extracted, analyzed by 
two-dimensional TLC and visualized by molybdatophosphoric acid staining (sections 2.5.1 
and 2.5.3). The resulting TLC plates are displayed in Figure 15. 
 
 
For the PAO1 wild-type strain, the formerly reported amount of 6 % of the overall lipid 
content was observed under acidic growth conditions (Klein et al., 2009). This A-PG level was 
defined as 100 % and the values obtained for the various mutant strains were related to this. 
For the ΔPA0919 deletion mutant strain, a significantly increased A-PG level of 200 % was 
observed indicating the relevance of orf PA0919 for A-PG lipid homeostasis in P. aeruginosa. 
For both complemented strains containing orf PA0919 (Δ19 P20-19 and Δ19 P19-19), the A-PG 
amount was approximately 110 %. This value is comparable to the wild-type situation. In 
contrast, the control strains solely harboring the promoters (Δ19 P20 and Δ19 P19), the 
elevated A-PG level characteristic for the deletion mutant strain was observed (200 % A-PG). 
The cellular content of the P. aeruginosa standard phospholipids PE, PG and DPG was 
identical in all mutant strains (not shown). Under neutral growth conditions, no significant 
A-PG amounts were detected (see appendix, Figure 35) which might be attributed to 
absence of the A-PGS whose expression is not induced under neutral conditions (Klein et al., 
2009). 
Figure 15: Lipid composition of P. aeruginosa PAO1 ΔPA0919 complemented strains 
Various P. aeruginosa mutant strains were cultured in AB medium pH 5.3 for 24 h (section 2.3.5). 
After harvesting, polar lipids were extracted, analyzed by two-dimensional TLC and stained with 
molybdatophosphoric acid (sections 2.5.1 and 2.5.3). Relative A-PG amounts were quantified 
(section 2.5.3) and related to the wild-type strain A-PG level defined as 100 %. The position of 
A-PG position is indicated by an arrow. 
A-PG: alanyl-phosphatidylglycerol, PE: phosphatidylethanolamine. 
PAO1 Δ19 P19-19Δ19 P20-19
100 % 110 % 110 %
PE
ΔPA0919 Δ19 P20 Δ19 P19
200 % 200 % 200 %
A-PG
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In summary, the growth experiments and the lipid analyses clearly indicate the relevance of 
PA0919 for A-PG lipid homeostasis in P. aeruginosa. Besides, these results indicate the 
presence of a specific PPA0919 promoter upstream of orf PA0919. 
 
3.5.4 Resistance phenotypes of ΔPA0919 derivative strains 
Previously, alterations of the A-PG content were related to an increased susceptibility of 
P. aeruginosa to several antimicrobial agents (section 3.2.3). To elucidate the influence of 
PA0919 on the antimicrobial susceptibility of P. aeruginosa, the ΔPA0919 deletion mutant 
and the respective complemented variants were treated with selected compounds.  
The strains were subjected to the modified microdilution method for MIC determination 
established in this study (section 2.7.3). The cells were cultured under acidic conditions and 
treated with antimicrobials at varying concentrations. The culture turbidity was determined 
and the MIC value was defined as the lowest antimicrobial concentration with OD595 < 0.5. 
The results are summarized in Table 14. 
 
Table 14: MICs (µg/mL) of P. aeruginosa ΔPA0919 related strains 
The various strains were treated with gradually varying concentrations of the respective 
antimicrobial in AB medium pH 5.3 (section 2.7.3). The relative standard deviation was 
approximately 5 % (10 % for daptomycin). A-PG amounts are determined in section 3.5.3. P values 
were calculated by significance analysis and are indicated: P ≤ 0.1 (*), P ≤ 0.05 (**) and P ≤ 0.01 
(***). For experimental details, see section 2.7.3. 
All concentrations are given in µg/mL. Experiments were performed at least in triplicate. 
A-PG: alanyl-phosphatidylglycerol. 
 wild-type ΔPA0919 Δ19 P20 Δ19 P20-19 Δ19 P19 Δ19 P19-19 
 100 % A-PG 200 % A-PG 200 % A-PG 110 % A-PG 200 % A-PG 110 % A-PG 
ampicillin 360 ± 18 180** ± 9 150** ± 8 360 ± 18 150*** ± 8 360 ± 18 
cefsulodin 61 ± 3 55 ± 3 33** ± 2 44* ± 2 39*** ± 2 44* ± 2 
daptomycin > 15’000 
9’000* 
± 900 
9’000* 
± 900 
> 15’000 
9’000** 
± 900 
> 15’000 
poly-L-lysine 8 ± 0.4 6* ± 0.3 6* ± 0.3 8 ± 0.4 6* ± 0.3 8 ± 0.4 
polymyxin E 4 ± 0.2 2* ± 0.1 2* ± 0.1 4 ± 0.2 2* ± 0.1 4 ± 0.2 
polymyxin B 2.4 ± 0.1 1.7* ± 0.1 1.7* ± 0.1 2.4 ± 0.1 1.7* ± 0.1 2.4 ± 0.1 
benzethonium chloride 22 ± 1.1 11*** ± 0.6 11*** ± 0.6 18** ± 0.9 11*** ± 0.6 18** ± 0.9 
domiphen bromide 6.8 ± 0.3 5.0*** ± 0.3 5.0* ± 0.3 6.2 ± 0.3 5.0** ± 0.3 6.2 ± 0.3 
vancomycin 
23’800 
± 1200 
20’800*** 
± 1000 
20’800*** 
± 1000 
23’800 
± 1200 
20’800*** 
± 1000 
23’800 
± 1200 
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The MICs observed for the PAO1 wild-type strain were in a comparable range as the 
previously obtained results (compare Table 12).  
The ΔPA0919 deletion mutant containing an A-PG level of 200 % was found more susceptible 
to all employed antimicrobial compounds as indicated by MIC reduction when compared to 
the wild-type strain. The presence of the β-lactams ampicillin and cefsulodin resulted in 
MICs of 180 µg/mL and 55 µg/mL compared to 360 µg/mL and 61 µg/mL for the wild-type 
strain, respectively. For the lipopeptide daptomycin, a MIC of 9 mg/mL was determined 
(compared to > 15 mg/mL for the wild-type). Treatment of the ΔPA0919 deletion mutant 
with the CAMPs poly-L-lysine, polymyxin E and polymyxin B resulted in reduced MICs of 
6 µg/mL (wild-type: 8 µg/mL), 2 µg/mL (wild-type: 4 µg/mL) and 1.7 µg/mL (wild-type: 
2.4 µg/mL). In the presence of the cationic surfactants benzethonium chloride and 
domiphen bromide, reduced values of 11 µg/mL (wild-type: 22 µg/mL) and 5.0 µg/mL (wild-
type: 6.8 µg/mL) were determined. The presence of vancomycin resulted in a slightly 
increased susceptibility of ΔPA0919 as represented by a MIC of 20.8 mg/mL compared to 
23.8 mg/mL observed for the wild-type strain.  
For the ΔPA0919 derivative strains complemented with orf PA0919 under the control of the 
well-known PPA0920 promoter (Δ19 P20-19) or of the putative PPA0919 promoter (Δ19 P19-19), 
MICs comparable to the wild-type strain values were obtained for most antimicrobials 
(ampicillin, daptomycin, poly-L-lysine, polymyxin E, polymyxin B, domiphen bromide and 
vancomycin). For the control strains containing solely the respective promoter (Δ19 P20 and 
Δ19 P19), MIC values identical to the deletion mutant strain were observed for these 
compounds.  
In the presence of benzethonium chloride, the wild-type phenotype was only partially 
restored by PA0919 (strains Δ19 P20-19 and Δ19 P19-19) and the control strains exhibited 
resistance phenotypes identical to the deletion mutant strain. After cefsulodin treatment, a 
different situation was observed: MICs for the control strains devoid of PA0919 (Δ19 P20 and 
Δ19 P19) were reduced in comparison to the deletion mutant strain (33 µg/mL and 39 µg/mL 
versus 55 µg/mL, compare Table 14). The presence of PA0919 resulted in a reduced 
susceptibility indicated by increased MICs (44 µg/mL for both strains), when compared to 
the respective control strain. Nevertheless, this value was not as high as the MIC for the 
ΔPA0919 deletion mutant strain (55 µg/mL) and was significantly reduced when compared 
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to the wild-type strain result (61 µg/mL). The deviating results for strains Δ19 P20-19 and 
Δ19 P19-19 in the presence of benzethonium chloride and cefsulodin (compared to the other 
compounds) might be ascribed to the slightly increased amount of 110 % A-PG in these 
strains. 
From these results it becomes clear that the reduction of the A-PG amount depending on 
the presence of PA0919 is of relevance for the fine-tuning of the cellular membrane lipid 
composition and for the resistance of P. aeruginosa against several antimicrobial agents. 
Furthermore, the complementation variant experiments supported the idea of the presence 
of a PA0919 specific promoter.  
 
 
3.6 Analysis of the PPA0919 promoter 
Orfs PA0920 and PA0919 are separated by one single base pair and were predicted to form 
an operon. In contrast, the abovementioned experiments employing the ΔPA0919 
complemented strain Δ19 P19-19 indicated that PA0919 might be controlled by a specific 
PPA0919 promoter (compare chapter 3.5). Here, the putative promoter sequence was analyzed 
in detail. 
 
3.6.1 Predicted promoter elements are located upstream of orf PA0919 
The formerly employed 430 bp promoter fragment located directly upstream of orf PA0919 
on the PAO1 chromosome was analyzed to identify potential promoter elements and the 
RBS controlling PA0919 expression (section 2.13.4). The theoretically determined elements 
are summarized in Figure 16. 
A –35 promoter region (TTCCGG) and a –10 element also designated as Pribnov box 
(TTCTACAAT) were identified by the BPROM software (SoftBerry, Mount Kisco, NY, USA) in 
an appropriate distance upstream of the PA0919 translation start site in the PAO1 
chromosome. A potential RBS also termed Shine-Dalgarno sequence was identified 
(TGGTGAAA) due to its similarity with the E. coli consensus sequence motif (Schneider and 
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Stephens, 1990) and according to the ribosomal anti-Shine-Dalgarno sequence (section 
2.13.4; Ma et al., 2002). 
 
 
 
3.6.2 PPA0919 analysis by transcriptional promoter-reporter gene fusions 
For the detailed investigation of the proposed PPA0919 promoter, a set of PPA0919 promoter-
reporter gene (lacZ) fusions were introduced into the PAO1 wild-type strain chromosome. 
Specific promoter fragments were designed according to the bioinformatically determined 
promoter elements (compare section 3.6.1). The employed constructs are displayed in 
Figure 17.  
 
...........TTCCGG....TTCTACAAT....TGGTGAAA....TGA ATG...
PA0919PA0920
T
-178 -161 -15 +1
RBS-10 region-35 regionPAO1 chromosome
Figure 16: Localization of the hypothetical PPA0919 promoter 
Orfs PA0920 and PA0919 are separated by one single base in the PAO1 chromosome. –35 and –10 
region promoter elements identified by the BPROM software (SoftBerry, Mount Kisco, NY, USA) 
are indicated. The RBS was identified by comparison to the E. coli RBS consensus sequence motif 
and to the P. aeruginosa anti-Shine-Dalgarno sequence (section 2.13.4). Positions are indicated 
related to the PA0919 translation start site.  
RBS: ribosome binding site (Shine-Dalgarno sequence).  
-430
lacZ
-206
lacZ
-140
lacZ
TGA ATG...
PA0919PA0920
T
+1
RBS-10-35
PAO1 chromosome
Figure 17: Construction of PPA0919 promoter fragment-reporter gene fusions 
Promoter fragments of 430 bp, 206 bp and 140 bp covering the genomic region upstream of orf 
PA0919 were fused to the reporter gene lacZ and introduced into the PAO1 wild-type 
chromosome. Bioinformatically identified –35 and –10 promoter regions, the detected RBS and 
the genomic organization of orfs PA0920 and PA0919 are indicated. Positions are indicated 
related to the PA0919 translation start site. 
RBS: ribosome binding site (Shine-Dalgarno sequence).  
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Three different constructs were generated: First, the formerly employed PPA0919 fragment 
covering 430 bp upstream of orf PA0919 on the PAO1 chromosome was employed. Second, 
a 206 bp promoter fragment representing the minimal promoter containing predicted –35 
and –10 regions was constructed. Third, a 140 bp fragment without any determined 
promoter elements was employed for control (compare section 2.4.19). The obtained strains 
(PAO1 PPA0919-430-lacZ, PAO1 PPA0919-206-lacZ and PAO1 PPA0919-140-lacZ) were grown under 
neutral and acidic conditions (pH 7.3 and pH 5.3; see section 2.8.3). The promoter-less strain 
KS11 (Schreiber et al., 2006) was used for background activity determination. Samples were 
subjected to the β-galactosidase activity assay to quantify the induction of the respective 
promoter fragment under the employed conditions (section 2.8.1). The calculated promoter 
activities are displayed in Figure 18.  
Under neutral pH conditions, an almost constant promoter activity of approximately 80 MU 
was obtained for the 430 bp PPA0919 promoter fragment. In contrast, the analysis of the same 
promoter fragment indicated an induction from 80 MU (early logarithmic phase) to 170 MU 
(stationary phase) under acidic conditions. The activity determination of the minimal PPA0919 
promoter (206 bp fragment) resulted in an almost constant level of 55 MU under acidic 
growth conditions and results ranging from 25 to 60 MU were obtained under neutral 
conditions. The 140 bp fragment not containing any promoter elements resulted in 
promoter activities between 0 and 20 MU. These values represent the background activity of 
the 140 bp sequence. From these results it becomes clear that the specific PPA0919 promoter 
is located upstream of orf PA0919. Due to the fact that the minimal promoter fragment of 
206 bp showed an almost constant activity under acidic conditions, whereas the activity of 
the 430 bp promoter fragment was significantly induced (P < 0.001), the presence of at least 
one additional promoter element is proposed. This element, which is presumably a 
transcription factor binding site, is located in the position between 430 bp and 206 bp 
upstream of the PA0919 transcription start site and might be responsible for the 
upregulation of the transcription under acidic conditions in the stationary phase. Instead, 
the presence of a repressor binding site is improbable since the transcription of orf PA0920 
would be affected by a bound repressor molecule. However, one might expect that the 
PPA0919 promoter activity is additionally modulated by other stimuli not analyzed in this 
study. 
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3.7 Characterization of the PA0919 protein 
Initially, the PA0919 protein was theoretically analyzed concerning potential active site 
amino acid residues. Furthermore, the PA0919 protein and mutated variants were 
recombinantly produced and purified from the periplasm of the E. coli host. The PA0919 
protein substrate specificity and the enzyme activity were analyzed in vitro. Specific 
inhibitory compounds were employed to identify potential active site amino acid residues 
and the activity of the PA0919 protein for the hydrolysis of the potential native substrate 
was investigated.  
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Figure 18: Analysis of the PPA0919 promoter 
PAO1 derivative strains harboring PPA0919 promoter fragments of different length fused to the 
reporter gene lacZ were incubated in AB medium pH 7.3 or pH 5.3 for 24 h. The promoter activity 
was determined by measuring the β-galactosidase activity (sections 2.8.1 and 2.8.3). Values of the 
promoter-less reference strain KS11 representing the background activity were subtracted. 
Results and standard deviations of at least three independent experiments are indicated. 
Dark gray: PPA0919-430-lacZ, middle gray: PPA0919-206-lacZ, light gray: PPA0919-140-lacZ. 
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3.7.1 Identification of potential active site amino acid residues 
Earlier studies of the PA0919 homolog AtvA of R. tropici had revealed that this protein 
contains a conserved amino acid sequence pattern named LIPASE_SER motif (accession 
number: PS00120, PROSITE; Sigrist et al., 2013) originally identified in lipases (Vinuesa et al., 
2003). Within this motif, a serine residue is highly conserved and an exchange to alanine in 
AtvA of R. tropici had resulted a phenotype characteristic for the ΔatvA deletion mutant 
strain (Vinuesa et al., 2003). Based on these results and due to the presence of further 
amino acid residues characteristic for catalytic diads/triads it had been proposed that AtvA 
and its homologs might represent a new class of lipolytic enzymes, although neither the 
substrate nor the products of this reaction had been identified (Vinuesa et al., 2003). 
In this work, the sequence alignment analysis of several PA0919 homologs indicated the 
presence of the abovementioned LIPASE_SER motif, a second conserved serine and 
additionally, a conserved histidine residue. Excerpts of the sequence alignment are given in 
Figure 19 (for the entire alignment, see appendix, Figure 36). 
These theoretical investigations suggested a catalytic function of the PA0919 protein. Since 
the reduction of the A-PG level had been related to the presence of PA0919 (section 3.5.3) 
and since the LIPASE-SER motif was identified in the PA0919 protein, it is reasonable that the 
PA0919 protein might hydrolyze A-PG. Taken into account that PA0919 but also PA0920 
expression is induced under acidic growth conditions (compare chapter 3.6 and Klein et al., 
2009), PA0919 might fine-tune the cellular A-PG level in P. aeruginosa under acidic stress 
conditions. 
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3.7.2 Heterologous production of recombinant PA0919 protein variants 
PA0919 was proposed to be located in the periplasm of P. aeruginosa by bioinformatic 
analysis and by a PA0919-PhoA fusion protein screening in a former study (Lewenza et al., 
2005). The secretion signal for periplasmic localization was predicted to consist of amino 
acids 1 – 34 of the entire PA0919 amino acid sequence by several bioinformatic programs 
(Lewenza et al., 2005). Therefore, PA0919 was cloned without its native secretion signal 
(amino acids 35 to 427) into the pET22b(+) vector. It was N-terminally fused to the E. coli 
PelB secretion signal encoding sequence and C-terminally linked to a His6-tag (compare 
section 2.4.15). In a second approach, a Strep-tag II (Schmidt and Skerra, 2007) was 
employed instead of the His6-tag. The fusion protein was overproduced in E. coli BL21 (λDE3) 
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Figure 19: Excerpts of a sequence alignment of PA0919 homologous proteins 
Selected PA0919 homologous proteins identified by BLAST analysis were aligned by ClustalW2 
(section 2.13.1). Partial alignments are given with the respective amino acid position within the 
specific protein. The LIPASE_SER motif (Vinuesa et al., 2003) is indicated above the corresponding 
alignment part. Conserved serines and a conserved histidine are indicated in bold letters and 
amino acid positions are numbered according to PA0919. Conservation degrees are indicated in 
increasing order by a period (.), a colon (:) or an asterisk (*). 
Gene names/locus tags: PA0919: P. aeruginosa PAO1, PP_1202: P. putida KT2440, Atu_AcvB: 
A. tumefaciens C58, Atu_VirJ: A. tumefaciens octopine-type Ti-plasmid pTiA6, Rtr_AtvA: R. tropici 
CIAT 899, Bphy_4018: B. phymatum STM815, Rpic_3994: R. pickettii 12J, XAC1368 and XAC2411: 
X. axonopodis 306, Phep_2436, Phep_2437 and Phep_2737: P. heparinus DSM2366, XF0754 and 
XF2679: X. fastidiosa 9a5c, CJA_1309: C. japonicus Ueda107. 
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cells (section 2.9.1). Samples of Strep-tagged PA0919 protein overproducing E. coli cells were 
subjected to SDS-PAGE analysis and the resulting gel is presented in Figure 20. 
 
 
The production of Strep-tagged PA0919 was not detectable 2 h after the induction of the 
protein production (compare lanes 1 and 2). After 16 h of incubation, high amounts of 
protein were observed (lane 3). A prolonged cultivation up to 18 h or 20 h did not result in 
increased protein amounts (lanes 4 and 5). 
After recombinant protein production, the periplasmic fraction was isolated from the E. coli 
cells by an optimized polymyxin B treatment protocol (section 2.9.2). The His6-tagged 
PA0919 protein was purified employing a Ni-NTA agarose chromatography column (section 
2.9.3) and for the Strep-tagged variant, a Strep-Tactin® resin was used (section 2.9.4). Due to 
the fact that the isolated His6-tagged PA0919 variant protein was contaminated by 
co-purified proteins (data not shown), the Strep-tagged PA0919 protein was employed for all 
investigations.  
 
Figure 20: Heterologous production of recombinant PA0919 protein 
E. coli BL21 (λDE3) containing pET22b(+)PA0919-Strep was incubated at 37 °C and 200 rpm to an 
OD578 of 0.5 to 0.6. Cultures were shifted to 17 °C, protein expression was induced by 25 µM IPTG 
and incubation was continued overnight. Samples were subjected to SDS-PAGE analysis according 
to their OD578. The gel was stained with Coomassie Brilliant Blue (sections 2.9.1 and 2.10.2). The 
calculated molecular weight of the PA0919 protein (44.6 kDa) is indicated by an arrow (fused to 
the Strep-tag II, PelB leader sequence removed). 
M: Unstained Protein Molecular Weight Marker, relative molecular masses (*1000) are indicated; 
1: cells prior to induction; cells after induction: 2 (2 h), 3 (16 h), 4 (18 h) and 5 (20 h).  
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For detailed enzyme activity studies, the PA0919-Strep protein was mutated (section 2.4.15) 
by exchanging three conserved amino acids using site-directed mutagenesis (compare 
section 3.7.1): The amino acid residue serine 307 (located within the LIPASE_SER motif and 
predicted to represent the catalytically active amino acid) and the highly conserved amino 
acid residues serine 240 and histidine 401 were replaced by alanine resulting in the mutant 
proteins S307A, S240A and H401A. The respective plasmids were transferred into E. coli 
BL21 (λDE3) and the Strep-tagged protein variants were produced and isolated from the 
E. coli periplasm by polymyxin B treatment. For protein purification, the soluble periplasmic 
fractions were loaded onto Strep-Tactin® affinity chromatography columns and extensively 
washed. The protein variants were eluted by desthiobiotin and dialyzed for buffer exchange 
(chapter 2.9). The SDS-PAGE of a representative Strep-tagged PA0919 wild-type protein puri-
fication and the samples of the corresponding mutant proteins are presented in Figure 21. 
 
Figure 21: Purification of Strep-tagged PA0919 protein 
E. coli BL21 (λDE3) containing pET22b(+)PA0919-Strep was incubated at 37 °C and 200 rpm to an 
OD578 of 0.5 to 0.6. Cultures were shifted to 17 °C, protein expression was induced by 25 µM IPTG 
and incubation was continued overnight (section 2.9.1). The periplasmic fraction was isolated 
(section 2.9.2), Strep-tagged PA0919 protein was purified using a Strep-Tactin® chromatography 
column (section 2.9.4) and subsequently dialyzed (section 2.9.5). Protein variants S240A, S307A 
and H401A were purified analogously. Samples were subjected to SDS-PAGE analysis (lanes 1 – 4: 
2 µL; lanes 5 – 9: 10 µL). The gel was stained with Coomassie Brilliant Blue (section 2.10.2). The 
calculated molecular weight of the PA0919 wild-type protein (44.6 kDa) is indicated by an arrow 
(fused to the Strep-tag II, PelB leader sequence removed). 
M: Unstained Protein Molecular Weight Marker, relative molecular masses (*1000) are indicated; 
Strep-tagged PA0919 wild-type protein: 1: periplasmic fraction, 2: column flow-through, 
3: washing step 1, 4: washing step 2, 5: elution fraction, 6: dialyzed protein.  
Variant proteins after dialysis: 7: S240A, 8: S307A, 9: H401A. 
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The periplasmic fraction of PA0919 wild-type protein expressing cells was obtained after 
polymyxin B treatment (lane 1) and loaded onto the Strep-Tactin® column. Considerable 
amounts of Strep-tagged PA0919 protein were bound to the resin as indicated by a 
reduction of the respective band in the flow-through fraction (lane 2). Contaminating 
proteins were removed by two washing steps (lanes 3 and 4) and the pure protein was 
eluted (lane 5). Approximately 3 mg were obtained from 1 L E. coli culture. To change the 
employed buffer system, a dialysis was performed (lane 6). Strep-tagged PA0919 variant 
proteins S240A, S307A and H401A were isolated using the same protocol and are presented 
in lanes 7 to 9. All PA0919 proteins were purified to apparent homogeneity as judged from 
SDS-PAGE analysis.  
To unambiguously identify the isolated protein and to verify the loss of the PelB secretion 
signal, the N-terminal amino acid sequence of the PA0919-Strep protein was determined 
according to the method of Edman, 1950 (section 2.10.4). The observed N-terminal amino 
acid sequence (MAK35LEALDLDDGGHA47, PA0919 amino acids underlined) indicated the 
efficient cleavage of the signal sequence and also verified the PA0919 protein. This result 
indicates the efficient secretion of the recombinant PA0919 protein in the periplasm of 
E. coli.  
 
3.7.3 Initial characterization of the PA0919 protein 
The recombinant PA0919-Strep protein was initially characterized by native molecular 
weight determination and by absorption and fluorescence spectral analysis.  
The native molecular mass of the PA0919-Strep protein was determined by analytical gel 
permeation chromatography (section 2.10.6). The protein and a number of standard 
proteins employed for calibration were loaded onto the Superdex 200 5/150 GL 
chromatography column (GE Healthcare, Munich, Germany) using a flow rate of 
0.45 mL/min. By comparing the specific elution volumes, the native molecular mass of 
PA0919-Strep was calculated to 57 kDa (see appendix, Figure 37). By comparison with the 
calculated molecular weight of PA0919-Strep after the cleavage of the PelB leader sequence 
(44’626 Da), it was concluded that PA0919 possesses a monomeric architecture under the 
employed conditions. 
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In some cases, proteins contain organic and/or metal cofactors which might be co-purified 
with the target proteins (Schmid, 2001; Lakowicz, 2006; Waldron et al., 2009). To determine 
if PA0919 provides an organic cofactor like NADH/NADPH (nicotinamide adenine 
dinucleotide/nicotinamide adenine dinucleotide phosphate), FADH2 (flavine adenine 
dinucleotide) or heme, the protein was analyzed by absorption and fluorescence 
spectroscopy (section 2.10.7). The obtained spectra did not indicate the presence of any 
cofactor (data not shown). For the identification of metal cofactors, an ICP-MS analysis was 
performed (section 2.10.8) and no metal cofactor was detected.  
Since PA0919 influences the overall A-PG content in P. aeruginosa (see chapter 3.5), an 
interaction of the enzyme with membrane lipids was assumed. In an initial approach, a 
protein lipid overlay assay was performed employing a Membrane Lipid StripTM (Echelon 
Biosciences, Salt Lake City, UT, USA) providing several standard membrane lipids like PG, PE 
and DPG immobilized on a hydrophobic membrane. The membrane was incubated with 
purified PA0919-Strep wild-type protein and after extensive washing, the lipid bound protein 
was detected via its Strep-tag II (section 2.10.9). However, an interaction between the 
PA0919 protein and the provided membrane lipids was not detectable (data not shown). Of 
note, the Membrane Lipid StripTM did not provide any aaPG derivatives and consequently, an 
interaction with this class of phospholipids was not investigated. 
It was suggested that PA0919 hydrolyzes A-PG to alanine and PG (section 3.7.1). For this, 
PA0919 might have the ability to bind alanine. To analyze this, purified Strep-tagged PA0919 
protein was immobilized on the Strep-Tactin® affinity chromatography matrix and incubated 
with 14C-labeled alanine. After extensive washing, the protein was eluted and analyzed by 
scintillation counting. For control, the PA0919 S307A variant protein mutated within the 
potential active site and a sample treated in the absence of any protein were employed 
(section 2.10.10). With this experimental setup, identical radioactivity values were obtained 
for all samples (data not shown). This result indicated that PA0919 does not bind to alanine.  
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3.7.4 PA0919 substrate specificity using artificial p-nitrophenol ester 
derivatives 
For the analysis of the PA0919 substrate specificity, an in vitro activity assay using artificial 
p-nitrophenol derivatives as substrates was performed. During the assay, the substrates 
were hydrolyzed by the purified PA0919-Strep protein and product formation was 
monitored by measuring the p-nitrophenolate absorption at 400 nm. For control, the 
spontaneous hydrolysis of the respective substrate was quantified in the absence of the 
PA0919 wild-type protein (section 2.11.1). 
The employed artificial chromogenic substrates mainly representing p-nitrophenol esters of 
amino acid derivatives or aliphatic acid compounds are displayed in Figure 22. Most of them 
were commercially available, whereas Lys-ONp was synthesized de novo and kindly provided 
by Dr. J. S. Dickschat (compare section 2.11.1). 
 
 
The specificity analysis of the PA0919-Strep protein revealed that the employed amino acid 
p-nitrophenyl esters Ala-ONp, Gly-ONp and Lys-ONp (1 – 3) were accepted as substrates. The 
specific activity of PA0919 for each compound was calculated (spontaneous autohydrolysis 
subtracted): for Ala-ONp (1) a specific activity of 11 ± 3 nmol/(min*mg) was determined and 
Figure 22: Chromogenic compounds employed for the PA0919 substrate specificity analysis 
A. Amino acid p-nitrophenyl ester compounds hydrolyzed by PA0919. 
B. p-Nitrophenyl derivatives not hydrolyzed by PA0919. 
1: Ala-ONp (L-alanine 4-nitrophenyl ester), 2: Gly-ONp (glycine 4-nitrophenyl ester), 3: Lys-ONp 
(L-lysine 4-nitrophenyl ester), 4: 4-NP acetate (4-nitrophenyl acetate), 5: 4-NP butyrate (4-nitro-
phenyl butyrate), 6: Ac-Gly-ONp (acetyl-glycine 4-nitrophenyl ester), 7: Boc-Ala-ONp (tert-butyl-
oxycarbonyl alanine 4-nitrophenyl ester), 8: Ala-pNA (alanine p-nitroanilide), 9: 4-NP phosphate 
(4-nitrophenyl phosphate). 
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13 ± 4 nmol/(min*mg) were obtained for Gly-ONp (2). Additionally, a specific activity of 
16 ± 4 nmol/(min*mg) was calculated for Lys-ONp (3). These values are in the same order of 
magnitude and might indicate a minor importance of the respective amino acid side chain. 
Interestingly, artificial substrates lacking the amino group like 4-NP acetate or 4-NP butyrate 
(4 and 5) were hydrolyzed by PA0919. Amino acid derivatives with amino groups bound to 
acetyl or Boc residues like Ac-Gly-ONp or Boc-Ala-ONp (6 and 7) were not accepted as 
substrates. These results indicate that the amino group of the artificial substrates is highly 
important for the substrate recognition. Furthermore, compounds like Ala-pNA (8) carrying 
an amide instead of an ester bond or 4-NP phosphate (9) were not hydrolyzed and therefore 
not accepted by the PA0919 protein.  
In summary, these in vitro assay results indicate that the PA0919 protein does neither cleave 
the ester bonds linking the fatty acids to the glycerol backbone of the putative native 
substrate A-PG nor the phosphodiester linkages between the glyceroldiester moiety and 
glycerol (see Figure 23). Instead, it was proposed that PA0919 cleaves the aminoacyl bond 
linking alanine to PG in the native substrate A-PG by recognizing the amino group of the 
alanine moiety.  
 
 
The in vitro activity assay was also employed to analyze the specific activity of the PA0919 
variant proteins S240A, S301A and H401A. Due to the assumption that A-PG is the native 
PA0919 substrate, Ala-ONp was employed as substrate.  
Figure 23: Structural formula of aminoacylated PG 
The results obtained by the PA0919 substrate specificity analysis using chromogenic compounds 
are indicated: The aminoacyl ester bond linking the amino acid to PG (highlighted gray) is 
hydrolyzed. The amino group (dotted rectangle) is important for substrate recognition, whereas 
the amino acid side chain (R) is of minor importance for the PA0919 substrate specificity. The fatty 
acyl ester bonds and the phosphodiester linkage might not be hydrolyzed (gray circles) by 
PA0919.  
aaPG: aminoacyl-phosphatidylglycerol, PG phosphatidylglycerol.  
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For the active site mutant S307A and for the H401A variant protein, no Ala-ONp hydrolysis 
was detectable. Instead, a reduced activity of 45 % (± 15 % standard deviation) was obtained 
for the S240A variant when compared to the wild-type protein. Thus, this in vitro activity 
assay indicates that the amino acid residues serine 307 and histidine 401 are important for 
PA0919 catalysis. 
 
3.7.5 PA0919 activity is reduced by PMSF and TLCK 
The well-established in vitro activity assay was employed to analyze the inhibition of the 
PA0919 protein by specific compounds. PMSF is known to inhibit serine proteases (Gold and 
Fahrney, 1964; Gold, 1965) and TLCK specifically inactivates trypsin-like proteases by 
exclusively binding to active site histidines (Shaw and Springhorn, 1967). The metal ion 
chelating EDTA (Diermayr et al., 1987) was employed to investigate the PA0919 activity 
dependency of metal ions. The experiments in the presence of inhibitory substances were 
performed to initially characterize main principles of the PA0919 catalysis. The purified 
PA0919-Strep protein (chapter 2.9) was pre-incubated with the respective inhibitor and 
subsequently, the PA0919 activity was determined using the in vitro activity assay employing 
Ala-ONp as the substrate (section 2.11.2; see Groenewold, 2013).  
The utilization of 1 mM PMSF did not result in any detectable PA0919 activity indicating a 
serine dependent catalytic mechanism. Interestingly, experiments in the presence of 60 µM 
and 1 mM of the histidine-specific TLCK revealed reduced PA0919 activities of 90 % and 10 % 
compared to the enzyme activity in the absence of TLCK. Therefore, the involvement of an 
active site histidine residue in the catalytic mechanism must be taken into account. Instead, 
in the presence of the metal chelating agent EDTA, no reduction of PA0919 enzyme activity 
was observed (Groenewold, 2013). This result is in good agreement with the previously 
described ICP-MS analysis by which no metal ions were detected in the purified PA0919-
Strep protein (see sections 2.10.8 and 3.7.3).  
In conclusion, the results of the inhibitor study indicate a serine and/or histidine dependent 
PA0919 catalysis in the absence of any metal ion cofactor. 
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3.7.6 PA0919 in vitro activity analysis using the putative native A-PG substrate 
The PA0919 protein was analyzed employing an in vitro activity assay in the presence of the 
putative native substrate A-PG. Since A-PG was not commercially available, a coupled 
PA0919 in vitro activity assay was established (section 2.11.3) which is based on the 
previously described A-PGS in vitro activity assay (Hebecker et al., 2011). The principles of 
the employed in vitro procedure are summarized in Figure 24. 
 
 
For the synthesis of 14C-labeled A-PG, the [1-14C]-L-alanine substrate was mixed with an 
E. coli crude cellular extract providing the PG substrate, the alanine-specific tRNAAla and the 
recombinantly overproduced Ala-tRNAAla synthetase (PA0903 from P. aeruginosa PAO1) 
coupling alanine to the tRNAAla. During the A-PGS assay, the purified A-PGS543-881 (from 
P. aeruginosa; see Hebecker et al., 2011) transferred the [1-14C]-L-alanine from its tRNA to 
an hydroxyl group of PG yielding [1-14C]-A-PG (compare section 1.4.2). The polar lipid 
fraction containing [1-14C]-A-PG was isolated from reaction mixtures and the lipids were 
solubilized by TritonTM X-100. Purified PA0919-Strep protein variants were mixed with 
solubilized lipids and the reaction products PG and [1-14C]-L-alanine were detected by one-
dimensional TLC and autoradiography (section 2.11.3). The obtained results are presented in 
Figure 25.  
Figure 24: Basic principle of A-PG synthesis and the PA0919 protein in vitro activity assay 
For A-PG synthesis, [1-14C]-L-alanine was mixed with crude cellular extracts of E. coli Rosetta 
(λDE3) pLysS pET28b(+)PA0903 overproducing the recombinant P. aeruginosa Ala-tRNAAla 
synthetase (PA0903) and providing tRNAAla and PG. During incubation, the synthetase transferred 
the 14C-labeled alanine to its tRNAAla. [1-14C]-A-PG was synthesized by the purified P. aeruginosa 
A-PGS543-881 (catalytic A-PGS domain, compare Hebecker et al., 2011) by transferring the activated 
[1-14C]-L-alanine from its tRNAAla to PG.  
Polar lipids containing [1-14C]-A-PG were extracted, solubilized by TritonTM X-100 and subjected to 
the PA0919 in vitro assay. Lipid mixtures were mixed with PA0919 proteins and incubated. 
Product formation was observed by TLC and autoradiography analysis.  
For detailed protocol, see section 2.11.3. 
A-PG: alanyl-phosphatidylglycerol, PG phosphatidylglycerol, TLC: thin-layer chromatography.  
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In the absence of any PA0919 protein, a dominant spot with an Rf of 0.7 was observed by 
autoradiography analysis (lane 2) representing the 14C-labeled A-PG substrate. This spot was 
also detected by ninhydrin staining (data not shown) indicating the presence of an amino 
group containing compound. For assays containing the PA0919 wild-type protein, a second 
radioactively labeled spot with an Rf of 0.46 was detected (lane 3). This spot exhibited 
identical migration characteristics to the L-alanine reference spot visualized by ninhydrin 
staining (lane 1). Hence, the hydrolysis of A-PG to alanine and PG by PA0919 was concluded.  
Likewise, the PA0919 variant proteins S240A, S307A and H401A were also subjected to the 
[1-14C]-A-PG in vitro activity assay. The exchange of the conserved serine 240 to alanine did 
result in a reduced hydrolysis as indicated by a minor spot with alanine migration 
characterristics (lane 4). Instead, no A-PG hydrolysis was observed for the S307A mutant 
protein representing the active site mutant (lane 5). Analogously, in experiments performed 
with the H401A mutant protein (highly conserved histidine 401 changed to alanine), no 
alanine was determined (lane 6). These results indicate that serine 307 and histidine 401 are 
key residues for the enzymatic hydrolyzation of A-PG by PA0919. 
 
Figure 25: Autoradiography analysis of the PA0919 in vitro activity using 14C-labeled A-PG 
The synthesized substrate [1-14C]-A-PG (section 2.11.3) was solubilized by TritonTM X-100 
treatment and mixed with 40 µM of PA0919 variant proteins. A sample without protein was 
prepared for control. Samples were incubated at 37 °C under vigorous shaking for 30 min. A-PG 
hydrolysis was observed by separating amino acids and lipids by one-dimensional TLC using 
n-butanol, acetic acid and water (5:3:2, v/v/v; Qiu et al., 2010). 1 µL 10 mM L-alanine was loaded 
onto the TLC plate for reference. TLC plates were stained with ninhydrin and radioactive spots 
were detected by autoradiography analysis (section 2.5.4).  
1: L-alanine reference, stained with ninhydrin; lanes 2 to 6 present autoradiography results: 
2: negative control in the absence of protein, 3: PA0919 wild-type protein, 4: S240A mutant, 
5: S307A mutant, 6: H401A mutant. 
A-PG: alanyl-phosphatidylglycerol, Ala: alanine.  
1 2 3 4 5 6
Ala / [1-14C]-Ala
[1-14C]-A-PG
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3.8 Localization of the PA0919 protein in P. aeruginosa 
The previously presented results of the PA0919 in vitro characterization were obtained using 
a recombinant Strep-tagged PA0919 protein fused to an N-terminal PelB secretion signal that 
had been heterologously produced in E. coli cells. After protein production, the mature 
protein was secreted and the PelB leader sequence was removed yielding a soluble PA0919-
Strep fusion protein localized in the E. coli periplasm. 
Previous studies indicated a periplasmic localization of PA0919 in P. aeruginosa by a 
screening approach using PhoA-fusion proteins (compare Lewenza et al., 2005). Of note, the 
updated version of the secretion signal prediction program SignalP specifically developed to 
distinguish between N-terminal secretion signal sequences and transmembrane domains 
(SignalP 4.1 used with SignalP-TM networks; Petersen et al., 2011) did not identify a 
secretion signal sequence at the N-terminus of PA0919 (see appendix, Figure 38). Instead, 
the transmembrane protein topology prediction program TMHMM (Krogh et al., 2001) 
identified a transmembrane helix formed by amino acids 12 – 31 and predicted an 
periplasmic localization of the C-terminus represented by amino acids 32 – 427 (see 
appendix, Figure 39). Although the PA0919 protein had been predicted previously to contain 
an N-terminal secretion signal by several bioinformatics programs (Lewenza et al., 2005), 
these newly obtained prediction results indicate that PA0919 is anchored to the cytoplasmic 
membrane of P. aeruginosa by the N-terminal transmembrane helix. Nevertheless, the 
predicted periplasmic direction of the soluble protein part had been proven by the PhoA 
fusion experiment before (Lewenza et al., 2005). 
To identify the cellular localization of the PA0919 protein in its native host P. aeruginosa, the 
PA0919 encoding sequence was C-terminally fused to a Strep-tag II sequence. This construct 
was introduced into the P. aeruginosa PAO1 ΔPA0919 deletion mutant strain for 
complementation either by chromosomal integration or by employing an appropriate 
plasmid. For control, a construct devoid of the proposed N-terminal PA0919 secretory signal 
(encoded by amino acids 1 to 34) was designed and employed analogously. Since a 
stationary growth phase phenotype and an elevated A-PG content were observed for the 
ΔPA0919 deletion mutant strain under acidic conditions, the obtained strains were analyzed 
concerning their growth behavior and lipid composition.  
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After establishing an appropriate strain expressing the PA0919-Strep fusion protein, this 
strain was employed for PA0919 localization. For this, the respective cells were fractionated 
using different strategies and the PA0919 protein was detected within these fractions via its 
C-terminal Strep-tag II. 
 
3.8.1 Complemented ΔPA0919 mutant strains for PA0919 localization 
To unambiguously localize the PA0919 protein in P. aeruginosa, variants of the PA0919 
encoding sequence were fused to a C-terminal Strep-tag II and transferred into the PAO1 
ΔPA0919 deletion mutant strain (sections 2.4.15 and 2.4.19). The constructs employed for 
the complementation of the ΔPA0919 strain are summarized in Figure 26.  
 
Figure 26: Complementation variants of PAO1 ΔPA0919 for PA0919 localization 
A. Chromosomal complementation of PAO1 ΔPA0919. A construct consisting of the PPA0919 
promoter and the PA0919-Strep fusion protein (PPA0919-PA0919-Strep) was inserted into the 
attB locus of the PAO1 ΔPA0919 chromosome. A second construct devoid of the PA0919 
secretory signal sequence (PPA0919-PA091935-427-Strep) was employed analogously.  
B. pUCP20T-based complementation of PAO1 ΔPA0919. The previously designed constructs 
PPA0919-PA0919-Strep and PPA0919-PA091935-427-Strep were cloned into the pUCP20T plasmid 
(E. coli – P. aeruginosa shuttle vector) and transferred into PAO1 ΔPA0919, respectively. The 
empty pUCP20T vector was used for control. 
Construction details are presented in sections 2.4.15 and 2.4.19. 
attB: attachment site B locus, PPA0919: native promoter of orf PA0919, trrnB: rrnB terminator 
sequence, Strep: Strep-tag II. 
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The PAO1 ΔPA0919 deletion mutant strain was complemented by Strep-tagged PA0919 
variant proteins controlled by its native promoter PPA0919 using two different approaches 
(Figure 26, A and B): First (A), the complementing construct was inserted into the 
chromosomal attB locus of PAO1 ΔPA0919 using the well-established mini-CTX2 technique 
(section 2.4.19; Hoang et al., 2000) resulting in a markerless complemented mutant strain 
(named Δ19 19). For control, a construct devoid of the PA0919 secretion signal sequence 
(amino acids 1 – 34) was applied equally (strain Δ19 1935-427). Second (B), a complementation 
strategy based on the E. coli – P. aeruginosa shuttle vector pUCP20T (Schweizer et al., 1996) 
was employed. The complementing construct consisting of the PPA0919 promoter and the 
PA0919-Strep fusion protein encoding sequence was cloned into pUCP20T and transferred 
into PAO1 ΔPA0919 (strain Δ19 pUC/19). A construct lacking the PA0919 secretion signal 
sequence was employed in analogy to the chromosomal complementation strategy 
(Δ19 pUC/1935-427). For control, the empty pUCP20T vector was introduced into PAO1 
ΔPA0919 (Δ19 pUC). The resulting five complemented variant strains were subjected to 
further analyses. 
 
3.8.2 The PA0919 secretion signal peptide is essential for A-PG dependent 
lipid homeostasis 
The PAO1 ΔPA0919 strain showed a specific late stationary phase growth phenotype and an 
increased A-PG level of 200 % under acidic conditions when compared to the PAO1 wild-
type. In contrast, neither a growth nor an A-PG associated phenotype was observed under 
neutral pH conditions. Complementation experiments clearly attributed the observed 
phenotypes to the presence of PA0919 (compare section 3.5.3). 
The strains generated for PA0919 localization (section 3.8.1) were analyzed concerning their 
growth and A-PG content to investigate the effects of the employed Strep-tag II on PA0919 
function. Phenotype analyses of strains Δ19 19 and Δ19 pUC/19 were expected to indicate 
the secretion of PA0919 into the periplasm. In contrast, strains Δ19 1935-427 and 
Δ19 pUC/1935-427 were expected to show a ΔPA0919 deletion mutant phenotype since the 
putative N-terminal secretion signal sequence was absent in the respective complementing 
construct.  
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The growth analysis revealed an almost identical growth behavior for all strains under 
neutral conditions (pH 7.3; see appendix, Figure 40) as observed before for other comple-
mented ΔPA0919 variant strains (compare section 3.5.3). The growth curves obtained by 
cultivating the strains under acidic conditions (pH 5.3) are presented in Figure 27. 
 
 
The chromosomally complemented strain Δ19 19 encoding a full-length PA0919-Strep fusion 
protein showed a growth behavior almost identical to the wild-type (Figure 27, A) indicating 
the expression of a functional secreted PA0919 protein. Instead, for the corresponding 
Δ19 1935-427 strain lacking the putative PA0919 N-terminal secretion sequence, the deletion 
mutant phenotype was obtained. It was concluded that the Strep-tagged PA091935-427 
protein is not secreted. 
The PAO1 ΔPA0919 variant strains carrying a pUCP20T derivative exhibited an extended lag 
phase which might be attributed to the application of Cb for vector maintenance (Figure 27, 
B). The observed growth phenotypes of the plasmid-based complemented strains were in 
good agreement with the results obtained for the chromosomally complemented mutants: 
Figure 27: Growth of complemented PAO1 ΔPA0919 strains for PA0919 localization 
PAO1 ΔPA0919 variant strains were grown in AB medium pH 5.3 (supplemented with Cb for 
pUCP20T harboring strains) at 37 °C and 200 rpm. Growth was monitored by measuring the OD578 
(section 2.3.5). For strain designation and construction details, see Figure 26 and section 2.4.19.  
A. Chromosomally complemented PAO1 ΔPA0919 variant strains. Rhombus: PAO1 wild-type, 
square: PAO1 ΔPA0919 deletion mutant, triangle: Δ19 19, cross: Δ19 1935-427. 
B. PAO1 ΔPA0919 variant strains complemented with pUCP20T derivative plasmids. Star: Δ19 
pUC/19, dot: Δ19 pUC/1935-427, plus: Δ19 pUC. 
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Strain Δ19 pUC/19 showed a phenotype identical to the PAO1 wild-type and the Δ19 19 
strain. In analogy to the ΔPA0919 deletion mutant and to strain Δ19 1935-427, a stationary 
growth phase phenotype was observed for strain Δ19 pUC/1935-427 devoid of the PA0919 
secretion signal and for strain Δ19 pUC harboring the empty vector.  
Lipid compositions of the employed PAO1 ΔPA0919 derivative strains were analyzed by 
extracting and separating the polar lipid fractions of the cells (sections 2.3.5, 2.5.1 and 
2.5.3). Under neutral growth conditions, no A-PG was detected for all strains (see appendix, 
Figure 41). TLC plates obtained after cultivation in under acidic conditions (pH 5.3) are 
summarized in Figure 28.  
 
 
For strain Δ19 19 expressing the full-length PA0919-Strep protein, an A-PG level of 120 % 
was observed almost reflecting the wild-type A-PG content of 100 %. An increased A-PG level 
of 200 % was determined for the Δ19 1935-427 strain harboring the truncated PA0919-Strep 
protein which is comparable to the A-PG content observed for the ΔPA0919 deletion mutant 
(Figure 28, A). The complementation of the ΔPA0919 deletion mutant strain employing the 
pUCP20T-based constructs resulted in analogous lipid phenotypes: For strain Δ19 pUC/19, 
A B
PAO1
100 %
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A-PG
ΔPA0919
Δ19 19 Δ19 1935-427
200 %
200 %120 %
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Δ19 pUC
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Figure 28: Lipid composition of complemented PAO1 ΔPA0919 variants for PA0919 localization 
Various P. aeruginosa mutant strains were cultured in AB medium pH 5.3 (supplemented with Cb 
for pUCP20T carrying strains) at 37 °C for 24 h (section 2.3.5). After harvesting, polar lipids were 
extracted, analyzed by two-dimensional TLC and stained with molybdatophosphoric acid (sections 
2.5.1 and 2.5.3). Relative A-PG amounts were quantified and related to the wild-type strain A-PG 
level (defined as 100 %). For strain designation and construction details, compare Figure 26 and 
section 2.4.19. A-PG position is indicated by an arrow. 
A-PG: alanyl-phosphatidylglycerol, PE: phosphatidylethanolamine. 
A. Chromosomal complementation variants of PAO1 ΔPA0919.  
B. pUCP20T-based PAO1 ΔPA0919 complementation strains.  
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an A-PG amount of 90 % was observed which reflects almost the A-PG level of the wild-type 
strain. Furthermore, the introduction of the PA0919-Strep protein devoid of the secretory 
signal sequence (strain Δ19 1935-427) or the empty pUCP20T vector (strain Δ19 pUC) resulted 
in an elevated A-PG level of 200 % also observed for the ΔPA0919 deletion mutant. 
In conclusion, the growth analysis and the determination of the A-PG content of the various 
complemented strains revealed that the constructs encoding the full-length Strep-tagged 
PA0919 protein were able to complement the deletion mutant and almost restore the wild-
type phenotype. Hence, the PA0919 protein was expressed, secreted and the employed 
C-terminal Strep-tag II did not influence the activity of the protein in vivo. In contrast, strains 
harboring the PA0919-Strep fusion protein lacking the predicted N-terminal PA0919 
secretion signal sequence exhibited phenotypes characteristic for the ΔPA0919 deletion 
mutant strain. These results indicate that the N-terminal secretion signal peptide consisting 
of amino acids 1 – 34 of the entire PA0919 protein is necessary for the localization and 
function of the PA0919 protein in P. aeruginosa.  
 
3.8.3 Localization of the PA0919 protein in cellular fractions of P. aeruginosa 
The PA0919 protein was localized in P. aeruginosa using the Δ19 pUC/19 strain expressing a 
PA0919-Strep fusion protein (compare sections 3.8.1 and 3.8.2). Cells were grown under 
acidic conditions, when PA0919 expression was induced by the PPA0919 promoter (compare 
section 3.6). After harvesting, different cellular fractions (periplasm, cytoplasm, total 
membrane fraction, inner and outer membrane fractions) were isolated by various methods 
(chapter 2.12). SDS-PAGE and Western Blot analyses were performed and the PA0919 
protein was detected within the obtained fractions via its Strep-tag II (Groenewold, 2013).  
The P. aeruginosa strain Δ19 pUC/19 was selected for the PA0919 localization study based 
on several initial experiments (M. Groenewold, not shown). The cells were grown under 
acidic conditions (pH 5.3) to the early stationary growth phase. After harvesting, the cells 
were subjected to different fractionating procedures. To isolate periplasmic and cytoplasmic 
fractions (section 2.12.2), the cells were treated with polymyxin B for outer membrane 
permeabilization. After removing the periplasmic fraction by centrifugation, the spheroblasts 
were lysed, cell debris was sedimented and the cytoplasmic fraction was received.  
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The total membrane protein fraction of Δ19 pUC/19 cells was isolated by disrupting 
harvested cells, removing cell debris and sedimenting the total membrane fraction by high-
speed centrifugation. Additionally, the membrane proteins were solubilized by TritonTM 
X-100 treatment and lipids were removed by a second high-speed centrifugation step 
(section 2.12.3).  
To specifically locate the PA0919-Strep fusion protein to the inner or the outer membrane of 
P. aeruginosa, the respective membrane fractions were isolated by two different methods: 
First, the isopycnic sucrose gradient procedure according to Magnowska, 2010, was 
employed (section 2.12.4). After harvesting, cells lysis and cell debris removal, the 
membrane containing supernatant was loaded onto an isopycnic three-step sucrose gradient 
and subjected to ultracentrifugation. The inner and the outer membrane fractions were 
enriched at the interphases of the sucrose layers and were carefully isolated. The second 
protocol (section 2.12.5) employed for the isolation of P. aeruginosa membranes made use 
of the selective solubilization of the inner membrane by sarcosyl (Filip et al., 1973). For this, 
the employed cells were lysed and cell debris was removed. The total membrane fraction 
was sedimented by high-speed centrifugation and suspended in a sarcosyl-containing 
solution. After an additional ultracentrifugation step, the inner membrane proteins resided 
in the supernatant while the outer membrane fraction was sedimented. The inner 
membrane fraction proteins were concentrated to increase the protein concentration. The 
outer membrane sediment was purified by a second sarcosyl solubilization and a subsequent 
ultracentrifugation. The obtained purified outer membrane sediment was suspended for 
further analysis. 
Samples of the isolated protein fractions were analyzed by SDS-PAGE (section 2.10.2) and 
Western Blot (section 2.10.3). The PA0919 protein was detected within the samples via its 
Strep-tag II employing a Strep-Tactin® alkaline phosphatase conjugate (section 2.10.5). The 
obtained membrane is presented in Figure 29 (Groenewold, 2013). 
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The PA0919 protein was detected in the whole cell fraction prior to the isolation of the 
periplasm and cytoplasm (A, lane 1). After polymyxin B treatment, soluble periplasmic and 
cytosolic proteins were isolated. However, the PA0919-Strep fusion protein was neither 
detected in the periplasmic nor in the cytoplasmic fraction (A, lanes 2 and 3). 
The total membrane protein fraction was isolated to identify a general membrane 
association of PA0919 (B). PA0919 was detected in the whole cell fraction (B, lane 4). After 
cell lysis, the PA0919-Strep fusion protein was present in the membrane containing 
supernatant (B, lane 5) and residual amounts were observed in sedimented cell debris and 
unbroken cells (B, lane 6). The membrane containing supernatant was centrifuged to 
sediment the total membrane fraction. Minor amounts of PA0919 were observed in the 
supernatant after high-speed centrifugation (B, lane 7), whereas most of the protein was 
sedimented in the total membrane fraction (B, lane 8).  
Figure 29: PA0919 protein localization in P. aeruginosa 
Strain P. aeruginosa Δ19 pUC/19 expressing the Strep-tagged PA0919 protein was grown in 
AB medium pH 5.3 for 6 h (early stationary phase). After harvesting, the cells were fractionated 
into the periplasm, the cytoplasm and the inner and the outer membrane fractions. Samples were 
analyzed by SDS-PAGE and transferred to the PVDF membrane by Western Blot procedure. The 
PA0919 protein was detected via its C-terminal Strep-tag II (for details, see chapter 2.12).  
M: PageRulerTM Prestained Protein Ladder, relative molecular masses (*1000) as indicated. 
A. Periplasm and cytoplasm isolation. 1: whole cells, 2: soluble periplasmic fraction, 3: soluble 
cytoplasmic fraction. 
B. Total membrane protein preparation. 4: whole cells, 5: supernatant after cell debris removal, 
6: cell debris and unbroken cells, 7: supernatant after membrane sedimentation, 8: TritonTM 
X-100 solubilized total membrane fraction. 
C. Separation of the inner and the outer membrane by isopycnic sucrose gradient centrifugation. 
9: inner membrane fraction, 10: outer membrane fraction. 
D. Separation of the inner and the outer membrane by sarcosyl solubilisation. 11: inner 
membrane proteins, 12: outer membrane proteins. 
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The separation of the inner and the outer membrane employing the isopycnic sucrose 
gradient method (C) indicated that PA0919 is associated to the inner membrane of 
P. aeruginosa as demonstrated by the detection of major amounts of the PA0919-Strep 
fusion protein in the inner membrane fraction (C, lane 9) compared to the outer membrane 
sample (C, lane 10). This result was verified by the second technique employing sarcosyl for 
membrane fraction separation (D). Here, the PA0919-Strep protein was detected exclusively 
in the inner membrane (D, lane 11), whereas no PA0919 was detectable in the outer 
membrane fraction (D, lane 12).  
This investigation clearly localized the PA0919 protein to the inner membrane of 
P. aeruginosa. Interestingly, the recombinant Strep-tagged PA0919 protein heterologously 
produced as a soluble variant protein in the E. coli periplasm was enzymatically active in 
several in vitro analyses (compare chapter 3.7). Therefore, it was concluded that PA0919 is 
associated to the inner P. aeruginosa membrane by an N-terminal transmembrane helix and 
the C-terminal part of the protein is directed into the periplasmic space as indicated by the 
previous study (Lewenza et al., 2005). This orientation would allow for the specific 
interaction with the hydrophilic alanine residue of the A-PG substrate present within the 
outer leaflet of the inner membrane of P. aeruginosa. 
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4 Discussion 
4.1 A diverse evolution is responsible for the aaPGS substrate specificity 
Prior to this work, the amino acid substrate specificity of 14 aaPGS enzymes had been 
investigated (compare Table 10). Due to the limited number of A-PGS enzymes, the 
identification of determinants responsible for the amino acid substrate specificity was not 
possible. In this study, the amino acid specificity of three L-PGS and six A-PGS enzymes was 
elucidated (compare Table 11) resulting in an overall number of 23 characterized aaPGS 
enzymes. The amino acid sequence comparison of enzymes specific for alanine or lysine did 
not result in the identification of determinants characteristic for the employed amino acid 
substrates Ala-tRNAAla and Lys-tRNALys. In a phylogenetic study, A-PG or L-PG synthesizing 
organisms do not cluster together. Instead, the utilization of alanine or alternatively of lysine 
is widely distributed in prokaryotes (compare Figure 8). 
A previous study analyzing the determinants for the Ala-tRNAAla recognition by the 
P. aeruginosa A-PGS enzyme had revealed that only five terminal base pairs of the tRNA 
acceptor stem are recognized by the enzyme (Hebecker et al., 2011). Another study dealing 
with the tRNA substrate recognition by C. perfringens aaPGS enzymes had identified the 
tRNA acceptor stem as necessary for PG aminoacylation (Roy and Ibba, 2008b). Interestingly, 
both studies had revealed that the amino acid moiety is the most important determinant for 
the aaPGS substrate recognition (Hebecker et al., 2011; Roy and Ibba, 2008b).  
Due to the results obtained in the present study, a diverse evolution of the respective 
alanine or lysine specific enzyme was proposed. It seems reasonable that the aminoacyl-
tRNA substrate specificity is determined by the architecture of the substrate binding pocket. 
The successive exchange of minor conserved amino acid residues forming the binding pocket 
might have slightly altered the pocket architecture leading to a successive change of the 
substrate specificity of the individual aaPGS. AaPGS enzymes with broadened substrate 
specificity may represent intermediate stages of such processes and it was proposed that 
they enable the respective bacterial host to effectively fine-tune their membrane lipid 
homeostasis by the simultaneous incorporation of different aaPG molecules. 
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Taken together, these considerations imply that even the application of an increased 
number of aaPGS enzymes might not result in the identification of determinants for 
aminoacyl-tRNA recognition. Moreover, the amino acid sequence of an aaPGS enzyme might 
not be sufficient for the prediction of its substrate specificity. Perhaps, the structural analysis 
of several aaPGS enzymes might provide further insights into the aminoacyl-tRNA substrate 
specificity determination.  
 
4.2 Bacterial adaptation strategies by A-PG and L-PG synthesis 
In this study, the formation of A-PG in P. aeruginosa was correlated with increased 
resistances against selected antimicrobial compounds like β-lactams, CAMPs, cationic 
disinfectants and the lipopeptide daptomycin (see Table 12). The complementation of the 
A-PGS deficient deletion mutant strain PAO1 ΔPA0920 with aaPGS homologs from different 
organisms resulted in the synthesis of A-PG, L-PG or L-PG together with A-PG in the identical 
genetic background. This experimental setup allowed for the in vivo analysis of the 
physiological impact of aminoacylated PG in the gram negative model organism 
P. aeruginosa. The formation of altered aaPG levels resulted in increased susceptibilities to 
most antimicrobials compared to the deletion mutant (compare Table 12).  
Previous studies analyzing the resistance of S. aureus against several positively charged 
antimicrobials had resulted in the ‘charge repulsion’ mechanism hypothesis which relates 
the resistance against several CAMP molecules to the synthesis of the positively charged 
L-PG (see section 1.4.3; Peschel et al., 2001). A previous study dealing with the synthesis of 
A-PG and L-PG in the gram positive model organism S. aureus clearly indicated that the 
formation of both aaPG variants resulted in comparable resistance phenotypes in the 
presence of the lipopeptide daptomycin (Slavetinsky et al., 2012). Based on these and 
further results, the susceptibility of bacteria to CAMPs was correlated rather to the content 
of PG than L-PG (compare section 1.4.3; Bayer et al., 2013). It was concluded that the type of 
amino acid employed for PG modification is of minor importance for antimicrobial resistance 
but might be relevant for membrane fluidity or lipid homeostasis in S. aureus synthesizing 
high levels of aaPG (Slavetinsky et al., 2012; Bayer et al., 2013). 
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Based on the ‘charge repulsion’ hypothesis, an increased resistance against positively 
charged antimicrobial compounds was expected for the P. aeruginosa strains synthesizing 
L-PG and therefore providing an altered membrane surface charge in this study. Additionally, 
elevated amounts of the zwitterionic A-PG resulted in slightly altered membrane surface 
charges. However, for these strains, increased susceptibilities were obtained for all applied 
cationic antimicrobial compounds (protamine sulfate, poly-L-lysine, polymyxin E, benze-
thonium chloride and domiphen bromide) with phenotypes comparable rather to the aaPG 
deficient ΔPA0920 deletion mutant than to the A-PG synthesizing PAO1 wild-type strain. In 
certain cases, the complemented variant exhibited an increased susceptibility when 
compared to the deletion mutant strain (e.g. ΔSacomp for poly-L-lysine or ΔPacomp for 
polymyxin E; compare Table 12). The PG levels of all employed mutant strains synthesizing 
artificial aaPGs were found constant and comparable to the wild-type amount (compare 
Figure 10) and therefore the obtained phenotypes cannot be related to the PG level. 
Furthermore, the transcription level of the PPA0920 promoter was found mainly determined 
by the environmental pH value but was modulated in the presence of specific antimicrobials 
indicating a fine-tuning of the membrane lipid composition in response to specific 
compounds. 
These observations clearly elucidate that neither the postulated ‘charge repulsion’ 
mechanism nor the ‘PG reduction’ hypothesis can explain the aaPG mediated antibiotic 
resistance observed for the gram negative model organism P. aeruginosa in this study. 
Instead, it seems reasonable that the aaPG mediated resistance mechanisms differ from 
each other in gram positive and gram negative organisms and might depend on the overall 
aaPG amount. Other physical aspects like hydrophobic interactions of cationic compounds 
with membranes (Pogliano et al., 2012; Zasloff, 2002) have to be considered beside the 
electrostatic effects described by the ‘charge repulsion’ and ‘PG reduction’ mechanisms. 
Additionally, membrane characteristics like homeostasis, permeability, fluidity and potential 
might be responsible for the observed phenotypes (Klein et al., 2009; Roy et al., 2009; Ernst 
and Peschel, 2011). The formation of microdomains might dramatically change local 
membrane characteristics and the activity and conformation of membrane proteins might be 
influenced by alterations in their lipid environment (Dowhan and Bogdanov, 2002; 
Matsumoto et al., 2006; Barák and Muchová, 2013).  
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It seems reasonable that the resistance against different antimicrobial compounds, which is 
correlated to the synthesis of aaPG molecules, is mediated by different mechanisms in one 
organism. In this study, such a variety of mechanisms might be responsible for the 
susceptibility of P. aeruginosa to ampicillin and to oxacillin. Additionally, the specific cell 
envelope architecture of gram positive and gram negative bacteria might also result in 
different aaPG-dependent resistance mechanisms. However, the present study does not 
allow for the elucidation of the molecular mode of antimicrobial resistance.  
Taken together, the analysis of A-PG and L-PG formation in P. aeruginosa and the PPA0920 
promoter activity study revealed that the amino acid employed for PG modification and, 
additionally, the level of modified PG within the membrane maintaining the membrane lipid 
homeostasis are important for the susceptibility of P. aeruginosa to antimicrobial 
compounds. However, the precise molecular mechanism remains to be identified.  
 
4.3 PA0919 is an alanyl-phosphatidylglycerol hydrolase (A-PGH) 
AaPGS homologs are often chromosomally encoded together with an AcvB/PA0919 
homologous protein in gram negative organisms. To elucidate the function of orf PA0919 
located directly downstream of the A-PGS encoding gene in P. aeruginosa, orf PA0919 was 
deleted. The resulting PAO1 ΔPA0919 deletion mutant strain showed a stationary growth 
phase phenotype, an elevated A-PG level and was found susceptible to several antibiotic 
compounds (compare Table 14). In complemented variants of strain ΔPA0919 expressing orf 
PA0919, the wild-type resistance phenotype was restored. These results clearly indicate that 
the accurate fine-tuning of the cellular A-PG content and therefore the maintenance of 
membrane homeostasis are of prime importance for the resistance of P. aeruginosa to 
several antimicrobial compounds. 
Due to the elevated A-PG content of the ΔPA0919 mutant strain and the identified 
LIPASE_SER motif in the PA0919 amino acid sequence, it was assumed that the PA0919 
protein hydrolyzes A-PG (compare section 3.7.1). To analyze the protein in vitro, it was 
recombinantly produced in E. coli and the substrate specificity of the purified protein was 
investigated using artificial p-nitrophenol derivative substrates. The PA0919 protein was 
found to hydrolyze ester bonds linking amino acids to p-nitrophenol depending on the 
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presence of the amino group. Taken into account that PA0919 homologous proteins are also 
detected in L-PG synthesizing organisms, these findings might indicate that PA0919 
homologs are generally involved in aaPG dependent lipid homeostasis in gram negative 
bacteria. The hydrolysis of the artificial lysine substrate by PA0919 in vitro might either be a 
general feature of PA0919 homologs or an evolutionary relict. The future analysis of PA0919 
homologous proteins might confirm this hypothesis.  
In a second in vitro approach, the PA0919 activity was analyzed in the presence of 
radioactively labeled A-PG representing the putative native substrate. The observed 
hydrolysis of A-PG into alanine and PG indicated first, that A-PG represents the native 
PA0919 substrate and second, that PA0919 modulates the A-PG content in P. aeruginosa 
membranes. Consequently, the PA0919 protein was named alanyl-phosphatidylglycerol 
hydrolase (A-PGH). 
The enzymatic hydrolysis of ester bonds is catalyzed by three key amino acid residues 
(serine, aspartate/glutamate and histidine) forming a catalytic triade e.g. in esterases, lipases 
or phospholipases (Jaeger et al., 1999; Aloulou et al., 2012). After binding of the ester 
substrate, the active site serine is activated by a histidine (promoted by an aspartate/ 
glutamate) located in an appropriate position. Subsequently, the serine nucleophile attacks 
the substrate ester bond and a covalent enzyme-substrate intermediate is obtained while 
the alcoholic moiety of the ester substrate is liberated. Finally, the carboxylic residue of the 
ester substrate is released from the serine residue (Jaeger et al., 1999; Aloulou et al., 2012). 
An analogous mechanism and active site architecture are proposed for the A-PGH due to the 
identified LIPASE_SER motif. For the analysis of the enzymatic mechanism of A-PGH, the 
protein was treated with serine- and histidine-specific inhibitors and the protein activity was 
found reduced in the presence of the respective compound. This indicates the involvement 
of a serine and a histidine residue in the enzymatic mechanism. To substantiate this 
hypothesis, the A-PGH protein was analyzed by site-directed mutagenesis. The in vitro 
activity analysis of the obtained A-PGH mutant proteins S307A (putative active site serine 
mutated) and H401A (conserved histidine mutated) clearly indicated the importance of 
these amino acid residues for the enzymatic mechanism due to the lack of enzyme activity of 
both mutant proteins. Instead, the third A-PGH mutant protein S240A (conserved serine 
mutated) exhibited a residual activity in all in vitro analyses and therefore, it was concluded 
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that serine 240 is not essential for PA0919 catalysis. To unambiguously elucidate the 
enzymatic mechanism, the PA0919 protein and its derivatives should be analyzed by X-ray 
crystallography in the presence and absence of inhibitory compounds. 
Bioinformatic and experimental analyses performed in a previous study had predicted the 
presence of an N-terminal secretion signal for the A-PGH enzyme and identified the A-PGH 
protein in the periplasm of P. aeruginosa using a PhoA fusion protein (Lewenza et al., 2005). 
To unambiguously localize the A-PGH in its native host in this study, the full-length A-PGH 
protein was fused to a Strep-tag II and produced in an A-PGH deficient P. aeruginosa strain. 
The bacterial cells were fractionated and the A-PGH fusion protein was localized within the 
cytoplasmic membrane fraction by two different experimental approaches.  
Based on all obtained results, an A-PGH topology and reaction mechanism model is 
proposed (Figure 30).  
 
Figure 30: Model of the topology and the proposed enzymatic mechanism of the A-PGH 
The domain structure model was developed based on bioinformatic and experimental results 
presented in this study. It is proposed that the A-PGH is anchored to the inner membrane of 
P. aeruginosa by one transmembrane helix located near the N-terminus (amino acids 12 to 31). 
The N-terminus providing several positively charged amino acid residues faces the cytoplasm and 
the active site containing C-terminal protein domain (characterized by serine 307 and histidine 
401) is directed to the periplasm. 
For the reaction, the alanine residue of A-PG is recognized by the membrane anchored A-PGH 
enzyme based on its ester linkage and its amino group. The active site serine attacks the 
aminoacyl bond between alanine and PG (dark gray lipid head group) and promoted by the active 
site histidine, a covalent enzyme-alanine intermediate is obtained and PG is liberated. In the 
second step, alanine is released into the periplasm. 
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It is concluded that the A-PGH is anchored to the inner membrane of P. aeruginosa by its 
uncleaved N-terminal sequence and that the catalytic active site containing domain is 
located in the periplasmic space. Four N-terminal located amino acids, which are proposed 
to be located at the cytoplasmic surface of the inner membrane, provide positively charged 
amino acid side chains (compare Figure 30). This is in good agreement with the ‘positive 
inside rule’ describing membrane protein topologies (see section 1.3.3; Dalbey et al., 2011; 
Bogdanov et al., 2009). The membrane spanning helix formed by amino acids 12 to 31 was 
predicted using TMHMM (compare appendix, Figure 39). Due to this proposed A-PGH 
topology, the catalytic active site containing the identified key amino acid residues serine 
307 and histidine 401 would be positioned at the membrane surface next to the alanine 
residue of the A-PG substrate located in the outer leaflet of the inner membrane of 
P. aeruginosa. The catalytic mechanism of the A-PGH is proposed based on the enzymatic 
mechanism of lipases (Jaeger et al., 1999): The A-PG substrate is recognized by the A-PGH 
enzyme due to its ester bond and the amino group provided by alanine. The A-PG ester bond 
linking the alanine moiety to PG is attacked by the nucleophilic hydroxyl group of serine 307 
resulting in a covalent enzyme-substrate intermediate while the PG residue is liberated. 
Subsequently, alanine is released from the active site serine completing the A-PG hydrolysis. 
The active site histidine 401 is proposed to be involved in both reaction steps.  
The functions of the A-PGH homologous enzymes AcvB and VirJ from A. tumefaciens and 
AtvA from R. tropici had been analyzed in previous studies: The respective A-PGH homolog 
deficient strains had shown an increased acid sensitivity (Vinuesa et al., 2003) and 
A. tumefaciens virulence had been reduced in the absence of AcvB/VirJ (Wirawan et al., 
1993; Pan et al., 1995). Based on the identified LIPASE_SER motif in AtvA, Vinuesa and 
coworkers had proposed a lipolytic activity of AtvA homologs (Vinuesa et al., 2003). After the 
characterization of several aaPGS enzymes had been published, Sohlenkamp and coworkers 
speculated that AtvA hydrolyzes L-PG in R. tropici (Sohlenkamp et al., 2007). However, this 
present work represents the first characterization of an A-PGH-type enzyme hydrolyzing 
A-PG, thus mediating the aaPG membrane lipid homeostasis in gram negative bacteria.  
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4.4 A-PG-dependent lipid homeostasis in P. aeruginosa 
In former studies, the A-PG synthesis in P. aeruginosa had been elucidated and first hints 
concerning the role of A-PG in antibacterial resistance had been obtained (Klein et al., 2009; 
Hebecker et al., 2011). The present study provides new insights into the A-PG homeostasis 
of P. aeruginosa, summarized in Figure 31.  
The A-PG homeostasis in P. aeruginosa is mediated by the A-PGS and the A-PGH located in 
or at the inner membrane. An alanine residue is transferred from its corresponding tRNA to 
a hydroxyl group of the phospholipid PG by the C-terminal catalytic A-PGS domain (Hebecker 
et al., 2011). The N-terminal A-PGS transmembrane domain is proposed to translocate the 
synthesized A-PG to the outer leaflet of the inner membrane as it had been described for 
homologous enzymes (Slavetinsky et al., 2012). Subsequently, the cellular A-PG level, which 
was identified to be of relevance for antimicrobial resistance in this study, is fine-tuned by 
the A-PGH enzyme identified and characterized in this work. A-PG is transferred to the inner 
leaflet of the outer membrane (Klein et al., 2009) by an as yet unidentified mechanism. 
Although the molecular basis remains unclear, the accurate A-PG level seems to be 
responsible for the resistance of P. aeruginosa against a wide variety of antimicrobial 
compounds (this work; Klein et al., 2009). Furthermore, the A-PG level is controlled by 
regulating the transcription of the A-PGS and the A-PGH: The formerly identified promoter 
PPA0920 induces the A-PGS transcription under acidic conditions (Klein et al., 2009), but the 
overall induction level was found modulated in the presence of specific compounds (this 
work). Additionally, the PPA0920 promoter is induced under neutral conditions by certain 
antimicrobials (this work). The A-PGH regulating PPA0919 promoter newly identified in this 
study induces the transcription of the A-PGH enzyme under acidic conditions. 
From these results it becomes clear that the inhibition of the A-PGS and/or the A-PGH might 
be a promising strategy to overcome the high resistance of P. aeruginosa against several 
antibiotics of clinical relevance. This is of special interest considering the presence of aaPGS 
enzymes (in some gram negatives in combination with A-PGH homologous enzymes) in many 
pathogens causing serious infections. 
 
 
 -157- Discussion 
 
Figure 31: A-PG homeostasis in P. aeruginosa 
A-PG is synthesized by the C-terminal A-PGS domain (dark gray) located in the cytoplasm of 
P. aeruginosa. An alanine residue is transferred from its tRNA to a hydroxyl group of the 
phospholipid PG (dark gray lipid). The product A-PG proposed to be translocated to the outer 
leaflet of the inner membrane by the A-PGS transmembrane domain (light gray) exhibiting a 
potential flippase activity. A-PG is transported to the inner leaflet of the outer membrane by an as 
yet unidentified pathway. The A-PGH enzyme hydrolyzes A-PG to maintain A-PG homeostasis 
mediating antimicrobial resistance against a wide variety of compounds. 
The cellular A-PG level is also influenced by regulating the expression of the A-PGS and the A-PGH 
enzymes: Both promoters are induced under acidic conditions and A-PGS expression is 
additionally modulated by several antimicrobial compounds. 
A-PG: alanyl-phosphatidylglycerol, A-PGH: A-PG hydrolase, A-PGS: A-PG synthase, PG: phospha-
tidylglycerol, PPA0919: promoter upstream of orf PA0919, PPA0920: promoter upstream of orf PA0920. 
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5 Summary 
Bacteria are able to adapt their cell envelope to changing environmental conditions. Several 
bacterial pathogens modify their membrane lipid component phosphatidylglycerol (PG) by 
the addition of lysine or alanine. This modification is mediated by aminoacyl-
phosphatidylglycerol (aaPG) synthases and confers resistance against several antimicrobial 
compounds. The inhibition of aaPG synthases was proposed as a promising strategy to 
defend bacterial infections. At the beginning of this work, it was not clear how the 
aminoacyl-tRNA substrate specificity of the synthases is determined. In this work, the 
specificity of nine aaPG synthesizing enzymes was elucidated. The subsequent analysis of the 
phylogenetic distribution and the amino acid sequence-based comparison of all as yet 
characterized aaPG synthases indicate a diverse evolution for the aminoacyl-tRNA substrate 
specificity of the respective enzymes. 
Most aaPG synthases are specific either for the lysyl-tRNA or the alanine-tRNA substrate. Up 
to now, only three enzymes with broadened substrate specificity have been identified 
resulting in the concomitant synthesis of at least two aaPG variants in the same organism. 
Furthermore, the observed aaPG amount in the bacterial membranes was found to vary in a 
wide range. To date, it is not clear if alanyl-PG and lysyl-PG provide complementary or 
differing functions in different bacteria. To address this question, strains of the gram 
negative model organism Pseudomonas aeruginosa with artificially altered aaPG contents 
were generated and analyzed phenotypically. It was shown that the amino acid employed 
for PG modification but also the overall level of aaPG incorporated into the membrane are of 
importance for the antimicrobial resistance of P. aeruginosa. Furthermore, the adaptation of 
the alanyl-PG content to antimicrobial stresses in P. aeruginosa was investigated. For this, 
the PPA0920 promoter which is located upstream of the aaPG synthase in P. aeruginosa was 
analyzed. The pH value was identified as the prominent determinant for aaPG synthase 
expression in P. aeruginosa. Besides this, the overall induction level of the PPA0920 promoter 
is modulated in the presence of specific antimicrobial compounds. 
In several gram negatives, aaPG synthases are encoded in an operon with a second protein. 
The function of this PA0919 protein from P. aeruginosa was investigated in this study in vivo 
and in vitro. A PA0919 deficient P. aeruginosa strain exhibited an increased alanyl-PG 
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content, a stationary growth phase phenotype and an increased susceptibility to specific 
antimicrobial compounds. The PA0919 protein expression was found upregulated under 
acidic conditions by the PA0919 specific promoter PPA0919. 
The PA0919 protein was recombinantly produced in Escherichia coli and characterized 
concerning its substrate specificity in vitro. It accepts p-nitrophenol esters of several amino 
acids as artificial substrates. The in vitro hydrolysis of the native substrate alanyl-PG was 
observed and consequently, PA0919 was termed A-PGH for alanyl-phosphatidylglycerol 
hydrolase. The analysis of site-directed mutant proteins and an inhibitor study indicated that 
the hydrolysis of alanyl-PG depends on the active site amino acid residues serine 307 and 
histidine 401 of the A-PGH in a lipase-like mechanism. A localization study identified the 
A-PGH in the inner membrane of P. aeruginosa. Based on theoretical observations it is 
proposed that the A-PGH is anchored to the cytoplasmic membrane by one N-terminal 
transmembrane helix and its catalytic domain is directed to the periplasmic space of 
P. aeruginosa. This investigation elucidated the regulatory circuit that maintains the 
alanyl-PG dependent membrane lipid homeostasis in P. aeruginosa. 
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6 Outlook 
 Elucidation of the three-dimensional structure of the A-PGS 
 Analysis of A-PG function using artificial membrane models 
 
 Organic synthesis of A-PG 
 Direct in vitro A-PGH activity measurement using A-PG containing liposomes 
 
 Elucidation of the three-dimensional structure of A-PGH in the presence of a 
substrate molecule 
 Characterization of A-PGH homologous enzymes 
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8 Appendix 
8.1 P. polymyxa aaPGS encoding nucleotide sequence 
The aaPGS encoding gene of P. polymyxa ATCC 842 was amplified using random primers 
since the genome sequence of this specific strain was not available (compare section 2.4.15). 
The elucidated nucleotide sequence is presented in Figure 32. 
ATGAATTCAA ATCACAAACC GATCCAATCC TTTAAAATCG TACAGTACAT CATGACCATC TATAGGCAGC   70 
GATTAACGCG TATTTTGCTA CCGCTGGCTG TACTGGCTTT TATTATATGG GAGGCTGGAC GAGAGCTAAA  140 
AGACTTTAAT CTGGCACGGA TGCTTCATGA GCTGCGGCGA ATGGATGCCA CGTTTCTCAT CGAAATTGGC  210 
TTGTTCTCAC TGGTAGCCGT AGCTGCTATG AGTGCTTACG ATTATGTAAT CAGGCATCAT TTCAAGCTTC  280 
AGGTTATGCC TGGAACGACA TTCCGGTACG CCTGGATCTC CAATACCTTC AATAATGTCT TCGGCTTCGC  350 
CGGCTTTACA GGAGCTGGAC TGCGCACTGT GCTGTATAAA AAGAGCGGTG TGCCATTGGG TGTCATTACC  420 
TCGGCAGTCG TATTTCTTTC GCCTGTCGTC ATTACCGGAC TATCTTTGCT AGCTTGGGGT GCTATTGTCC  490 
ATCTGTATCC GGTGCAGCCT GTGCTGGATG CTCACCCATG GCTTCATTGG GCGCTATGGG GAATGGCACT  560 
TTACCTGCCT CTATTTCTGA TCATGCAGCG CTCCAAAAGG TATGCCACAT GGTTCAACAA GGGAGAAGGA  630 
CAGCTCTCCT GGTTCACCAT CTCTGCCTCC ATTGGCGCCT CTCTGCTGGA ATGGCTGCTG GCTGGTCTTA  700 
CCTTTGCATG GATCGGCTCG CACTTGCTCC ATGAGCTGCC GCTCCATGCT GTGTTCGGTA TTTATGTAAT  770 
AGCCGCAATT GCGGGGTTAA TCAGTCTTGC ACCCGGAGGC GTCGGCGCAT TCGATATTAT CGCCCTGCTC  840 
GGGCTGCAAA TGGCAGGAGC CAACTCGGAC CGGGCGCTGG CTGTGCTGCT GGTCTTTCGC GTCTTTTATT  910 
ACATCATTCC GTGGCTCATC GGCTTGGTAT TAGCGGCGCT GGAAATGATT CCGCGTAATG AGCGCTTGAG  980 
CCAGCTCGCT GAGACAGGCT GGGATTACTC CCTTAATGCC TGGCAGAAGG TATGGGGCTG GCCTGGTCAA 1050 
TTCCGGTTTT TGGCCGATCT GGGGGTATGG GCACTTGGGA AACTGGTACT CATCTCCGGC GTGGTGCTTC 1120 
TGTTGTCGGC CGCTACGCCT GGTCTGTTGT ATCGGCTCCG TTTTGCTGAA CATTTGCTCA GCCTGCCCGT 1190 
TATGCGCTTA TCGCACGAAA TCTCGGTCAT CATCGGAATT ATGCTTGTCG TTCTGTCCCA CGGAATCTCT 1260 
CTGCGTATTC GCAGAGCATT GCGGCTGACC TTGATACTGC TGCTGACAGG AGCCATTTTC ACCTTCACTA 1330 
AAGGTCTGGA TTTTGAAGAA GCCTTTTTCC TGCTGTTCGT GGCATTAATG CTGTGGATTT CGCGTTCACG 1400 
GTTTTATCGG GTCAGTGCGC CGCTGAATCG GCACAACATT TTAATATGGG GCGGATTATC TCTACTCGTA 1470 
ACTGGTGCTT ATTTTATAAT CGGGGCAGGC TCCAATACTC CATTTATGCG TCATTTGCAT GCCAAGGTCC 1540 
ACCTGGACTT TTTTATGAAC CGCAGCGATT ACGGAGTTAC AGCCGTATTT AGTTTGATTT TGGCATGGGT 1610 
ATTCTTGACG GTGTATTTCT TTCTTCGTCC TCAACGTAGC ATCAGCAATC TACCCGACGC ACAGGAACTG 1680 
GTTAAGCTAA AAGAATTTTT GGAACGACAG GGTGGTAATC TCGTTTCTCA TATGCTTTTT CTCGGCGATA 1750 
AATATCTGTA TTGGACCAAG GACGAACAGG TAGTTCTCCC CTATGCTCGC AGTCGGGACA AACTGATTGT 1820 
ATTAGGTGAC CCCCTCGGTC CAAAGGAACG TGTGAGTGAA GCCATTCAGG AATTCCAACG GTTCGCGGAT 1890 
CGCTATGCTT TGACGGCTGT ATTTTATCAA GCATCACCGG AATATTTGTC CATCTATCAC GAGAACGGCT 1960 
ATCGCTTTTT TAAGTTGGGC GAGGAAGCGC TCGTGCCGCT GGAGTCCTTT ACACTAACGG GCAAAAGCAA 2030 
TCAGGCGCTG CGAAGCGCCA AAAATCGCTT TGGCCGCGAA GGCTATTCAT TCGAAATGAT CCAGCCTCCT 2100 
CTAGAGGCGT CATTGATTGA GGAGATGCGT CATATTTCGG ATATTTGGCT GGACGGGCGC AAGGAGAAGG 2170 
GATATTCACT CGGCTGGTTC AAGGAATCTT ACCTTCAGTT GGCTCCAATT GCATTGCTGA AAGACTCTGA 2240 
AGGTAAGGTT ATTGCTTTCG CCACGATGGC CCCTGCCTAT GATCATGGGC AGACGGTCTC TATCGATCTG 2310 
ATGCGTCACC TGCCTGACAC ACCCAATGGA ACGATGGATT ACTTATTCAC ACGGGTCATC GAGTGGGCCA 2380 
AGGAGAGTGG ATATACGACA TTTAATCTGG GCATGGCACC GCTGTCCCAG GTAGGACAAA GCGAAAAGGC 2450 
ACTGCGCGAG GAAAAGCTGG CTCGACTCGT TTTTCAATAC GGGGGACATT TTTACGGCTT CCAGGGGCTC 2520 
CGACGCTTCA AGGATAAGTT CAAGCCGCAG TGGGAGCCGC GCTATCTAGC CTATCCAGCT TCTGTTTTTC 2590 
TACCGATCCT GACGCTGGAA CTGGTGTATC TCGTGTCCAA ACGCTCGGAC TAA                   2643 
 
Figure 32: Nucleotide sequence of the P. polymyxa ATCC 842 aaPGS encoding gene 
The aaPGS encoding nucleotide sequence from P. polymyxa ATCC 842 was amplified using 
random primers and the sequence was elucidated after cloning into vector pBAD-His-A (compare 
section 2.4.15). 
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8.2 Sequence identity determination of aaPGS enzymes 
The C-terminal domains of aaPGS enzymes were defined based on a sequence alignment 
with the C-terminal domain of the A-PGS of P. aeruginosa (Hebecker et al., 2011). Sequence 
identity values were calculated using the Lasergene® software package (DNASTAR, Madison, 
WI, USA) and are summarized in Figure 33. 
 
 
 
 
Figure 33: Identity analysis of C-terminal aaPGS domains  
Sequence identity values were obtained by comparing the C-terminal catalytic domains from all 
enzymes with characterized amino acid substrate specificity (see Table 10 and Table 11) using the 
Lasergene® software package (DNASTAR, Madison, WI, USA). Results were grouped according to 
their aminoacyl-tRNA substrate specificity. 
Light gray: comparison of the L-PGS group, dark gray: comparison of the A-PGS group, black: 
cross-comparison of L-PGS and A-PGS sequences, white: enzymes showing broadened substrate 
specificity. The initial character(s) of each sequence name indicates the amino acid substrate 
specificity of each enzyme.  
PAO1: P. aeruginosa PAO1, Bph: B. phymatum, Cpe: C. perfringens, Kra: K. radiotolerans, Mba: 
M. barkeri, PA14: P. aeruginosa PA14, Ppoly: P. polymyxa, Pput: P. putida, Bsu: B. subtilis, Efm: 
E. faecium, Efs: E. faecalis, Atu: A. tumefaciens, Ban: B. anthracis, Bli: B. licheniformis, Bthu: 
B. thuringiensis, Ccre: C. crescentus, Lmo: L. monocytogenes, Rtr: R. tropici, Sa: S. aureus, Sth: 
S. thermophilus, Msm: M. smegmatis, Mtb: M. tuberculosis. 
L_Mtb -
L_Msm 79.6 -
L_Sth 16.9 17.2 -
L_Sa 19.9 19.3 31.9 -
L_Rtr 20.7 19.8 27.8 31.3 -
L_Lmo 17.7 16.9 39.8 37.2 32.0 -
L_Cpe 16.3 16.9 38.5 36.9 34.4 43.8 -
L_Ccre 18.5 18.2 31.2 27.6 41.9 28.0 29.6 -
L_Bthu 18.4 18.4 37.3 41.4 35.5 44.5 40.4 28.6 -
L_Bli 18.9 19.8 44.2 45.2 37.6 44.6 47.0 31.4 63.6 -
L_Ban 18.5 18.5 37.3 41.1 34.9 44.6 40.1 28.8 97.3 63.7 -
L_Atu 21.3 19.2 27.8 30.1 66.4 28.2 32.3 41.3 34.3 36.7 33.7 -
ALR_Efs 19.5 20.1 49.3 36.8 30.7 45.2 43.4 31.5 41.7 45.5 42.4 29.2 -
ALR_Efm 18.6 19.1 47.7 38.3 31.3 44.7 41.5 28.1 41.2 48.8 41.3 31.6 67.8 -
AL_Bsu 19.0 18.7 41.5 42.9 36.5 43.0 41.8 31.0 64.8 76.2 64.7 35.0 43.4 44.8 -
A_Pput 23.8 23.2 27.9 30.9 43.0 30.1 30.4 43.0 32.1 33.8 31.8 41.8 30.0 30.0 32.8 -
A_Ppoly 20.7 21.3 36.4 36.6 34.9 41.9 40.4 31.8 43.2 43.7 43.7 32.8 39.8 40.8 42.2 37.6 -
A_PA14 22.6 21.7 29.7 30.9 44.8 30.4 30.7 44.5 30.9 32.0 30.3 42.7 29.7 30.3 32.5 85.3 37.0 -
A_Mba 17.2 17.8 31.8 31.5 38.3 27.6 33.6 41.8 32.4 32.6 32.7 40.7 31.8 29.7 33.0 45.1 35.5 45.1 -
A_Kra 22.5 21.9 26.3 32.2 41.4 30.3 30.3 39.3 35.5 35.2 36.4 41.1 31.5 30.1 35.5 40.5 36.7 39.6 41.8 -
A_Cpe 19.1 18.2 37.7 36.6 35.4 38.3 40.4 28.4 42.4 43.7 41.9 32.1 38.3 43.2 40.4 33.5 43.9 33.2 34.3 31.2 -
A_Bph 23.7 23.7 26.7 30.1 45.5 26.8 28.6 37.4 28.7 31.2 29.1 42.8 26.4 29.1 30.4 44.6 34.3 44.9 38.6 39.2 31.0 -
A_PAO1 22.9 21.7 29.7 30.6 45.1 30.1 30.7 44.5 31.2 32.0 30.6 43.3 29.7 30.3 32.8 84.7 37.0 99.1 45.4 40.2 33.5 45.2 -
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8.3 Antimicrobial compounds employed for MIC determination 
The chemical structures of antimicrobial compounds used in this study for MIC 
determination and the PPA0920 promoter activity analysis are given in Figure 34. 
 
Figure 34: Chemical structures of antimicrobial compounds employed in this study 
The antimicrobial peptides were used for MIC determination and PPA0920 promoter activity 
analysis. Positively charged amino acid residues of protamine are highlighted in gray. 
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8.4 Growth curves and lipid composition of ΔPA0919 complemented 
strains employed for the functional analysis of PA0919 
Several strains were constructed for the analysis PA0919 in vivo (Δ19 P20-19, Δ19 P19-19, Δ19 
P20 and Δ19 P19) and cultivated under neutral conditions (pH 7.3). The corresponding growth 
curves and the lipid compositions of the strains are presented in Figure 35. For strain 
construction strategy, see section 3.5.2. 
 
 
 
 
 
 
 
Figure 35: Growth curves (A) and lipid composition (B) of ΔPA0919 complemented strains for 
PA0919 function analysis 
The various P. aeruginosa strains were cultured in AB medium pH 7.3 at 37 °C and 200 rpm 
(section 2.3.5). Culture turbidity was measured at 578 nm. After 24 h, polar lipids were 
extracted, separated by two-dimensional TLC and visualized by molybdato-phosphoric acid 
staining (sections 2.5.1 and 2.5.3). A-PG position is indicated by a circle. 
Rhombus: PAO1 wild-type, square: PAO1 ΔPA0919, triangle: Δ19 P20, cross: Δ19 P20-19, star: 
Δ19 P19, dot: Δ19 P19-19. 
A-PG: alanyl-phosphatidylglycerol, PE: phosphatidylethanolamine. 
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8.5 Sequence alignment of PA0919 homologous proteins 
PA0919 homologous proteins were identified by BLAST analysis. Selected sequences were 
aligned using ClustalW2 (section 2.13.1). The obtained alignment is presented in Figure 36. 
 
 
 
 
PA0919          ------------------------------------------------------------ 
PP_1201         ------------------------------------------------------------ 
Atu_AcvB        ------------------------------------------------------------ 
Atu_VirJ        ------------------------------------------------------------ 
Rtr_AtvA        ------------------------------------------------------------ 
Bphy_4018       ------------------------------------------------------------ 
Rpic_3994       MSWQAPRTQEARHRGVLRKGLRLAGHVGAVGMVLAASWAIAADAPAPTSKPTPVQGAVLV  60 
XAC1368         ------------------------------------------------------------ 
XAC2411         ------------------------------------------------------------ 
Phep_2436       ------------------------------------------------------------ 
Phep_2437       ------------------------------------------------------------ 
Phep_2737       ------------------------------------------------------------ 
XF0754          ------------------------------------------------------------ 
XF2679          ------------------------------------------------------------ 
CJA_1309        ------------------------------------------------------------ 
 
 
PA0919          ------------------MSVVKRHWRR-----------FLVAALVLIVG--AALLLWSR  29 
PP_1201         --------------------MTRRFLLY-----------LLVPLLLAALGGALAFWLWTR  29 
Atu_AcvB        --------------------MMKRNLIG---------AFIAAST---LLSSSVAFSQDKP  28 
Atu_VirJ        -------------------MAIKLVLIL---------VFTLFLA------ADAAYANDR-  25 
Rtr_AtvA        -------------------MILKYAMSL---------AFACVLSTGLLMSGQARAEADDT  32 
Bphy_4018       --------------------MIMQKFYR---------LAALASVSLCSLAGVAPTAHAYE  31 
Rpic_3994       PPVGMTGASGVVAVPPRGDMPPRLQMSGPAVTANKAANGGVLSLPVVAPATPAAAPGAVE 120 
XAC1368         --------------------MRRLEMWS-----------ALCGAAMLTLSGMAAAQA-PE  28 
XAC2411         ---------------------MGMGIKM---------FRWMIAILLIGGSSYAVARHLQD  30 
Phep_2436       --------------------MANKNLYL------------LIVTSLLSLSGCSLLKRERV  28 
Phep_2437       ------------------------------------------------------------ 
Phep_2737       --MKGLMIRGLAQFMNKTLSMVKAGLTS-----------VFICLFLMLFYIKPALAIKEE  47 
XF0754          --------------------------------------------MLLGG-SVAVCSHAYG  15 
XF2679          --------------------MKQFKIRS-----------VLQSIALLVLAGTAAAEPKPE  29 
CJA_1309        ------------------------------------------------------------ 
 
 
PA0919          PAAQAKLEALDLDDGGHATLAEPGEKP--------RSRVVVIAAPEQQLNDAQMLNLAHD  81 
PP_1201         PAPEARLEQLSINDT-SITRVTPGVHP--------KARVAIGVPQDQALTGKQLLDLSQA  80 
Atu_AcvB        AYETGMIPADHIMVPDGDIQASIFLISDANGWTEADETRAKALVEKGAAVVGIDFKEYLK  88 
Atu_VirJ        --------ANGVMWSNG-------------------------------------------  34 
Rtr_AtvA        KYDLGMIPAPHIMRPHGKVSNEVVLISDLAGWGDKEKAVADKLVANGSLVIGIDYPSFLA  92 
Bphy_4018       TLPGGRYGNVTVTKPVADVRGFVVLFSRESGWNPADQQAADALAKNGAMVVGVDTAKYAA  91 
Rpic_3994       FVTHGRFRDVPVYKPKGEIRSVVLMLSGDLGWTPAASRMAESLAQQGALVAGLSTPALFA 180 
XAC1368         PVSHGRFEQVPVLMPKGEPQRVVIWLA-GAGNAATRQAQAESLRADGAMVAVVDTAHLYA  87 
XAC2411         SNTAGHYGSVEVIRPEGTPKAMVILLP-DGDHPQDSQKLADMLSNDGALVAVVDTANYRE  89 
Phep_2436       TRHNG-------------------------------------------------------  33 
Phep_2437       ------------------------------------------------------------ 
Phep_2737       VISHKTFGKTVIYIPQTIPTSVALFVSGDGGWQAGVINMAKNLALQGALVAGIDARQYMA 107 
XF0754          DASDGRD-----------------------------------------------------  22 
XF2679          KITHGRFEQIPVLRPDGEPQRVVIWFS-DAGHVDQRTRQAEILRQDGAMVALVDTTHLYK  88 
CJA_1309        ------------------------------------------MSQHGNLSAVLNIDNYLS  18 
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PA0919          SAARVIQYFPPENGDCRAQQSRLEAVIARLGGKPNLVAGIGPGSTTAWRWLASQDDDK-A 140 
PP_1201         GEAQLVQVILPP-GDCSKQQQAMDQALNQLQEKPTLVAGIGPGAVQAWRWLASQNDDK-A 138 
Atu_AcvB        ALEADDDECIYMISDIESLSQQIQRTAGTGSYRLPIVTGIGKGGTLALAMIAQSPVSTVR 148 
Atu_VirJ        ----------------------------------------GEAG----------------  38 
Rtr_AtvA        ALDSKNDGCIYIVSDLESLSQQVQRSFADSTYQLPVIAGVGAGGAMALTIAAQTPDATVA 152 
Bphy_4018       NLAAKKEACHQLVGDAEAVSHQLERQVQSNRYFMPIVAGTGQGATLAMQVLKQAPENTVA 151 
Rpic_3994       SLEADPGDCAFPDGDLENFSRFLQAYEKVPGYYPPILVGDNEGGALAYAMIAQARPNIFA 240 
XAC1368         VLRKAGGTCTFSVGDVENFSRYVQAFYHIPTYRLPLLVGDGEGAALAYAIAAQAKPHVLA 147 
XAC2411         RVRSHQAACSSLADDAERLGKKLLRAEHVDAFLPPVLVGQGDGAVLARQAVASAAPDVLG 149 
Phep_2436       ------------------------------------------------------------ 
Phep_2437       ------------------------------------------------------------ 
Phep_2737       FLSRSSSSCYYPAGDFEQLSMMLQKKYKFNSYTKPVLVGYSYGATLVYGLLAQAPAGTFK 167 
XF0754          --------------------------------------GWG-----AMERLPSAS----S  35 
XF2679          VLAADSNHCTFSVGDVENLSRYLQAYYRDKTYRLPLLVGDGDGSGLVYAVAAQATENILA 148 
CJA_1309        NIKARGATCFDAATPLSVYAQDIQQHHQFTHFTQAFITGFGTAGSYLFAMLTQIPKGIFR  78 
 
 
PA0919          KALSVGFDIALAERDCDAP----------------------------------------- 159 
PP_1201         RAISVGF--TLEQPDCQAP----------------------------------------- 155 
Atu_AcvB        EAVAVDPKAGLPLEKILCTPATKD---------------------------KVDGETVYG 181 
Atu_VirJ        ------------------------------------------------------------ 
Rtr_AtvA        GTLAVDPTAGVGLKQELCTPAEK----------------------------KTDGDMVFG 184 
Bphy_4018       GAVSVAAQGNLDKRFNPC------------------------------------------ 169 
Rpic_3994       GAMSMEFCPVLELRKPLCKGEGVHFSRRMSESRTTAKRVKPPENAGVVLLPATKLSAPWV 300 
XAC1368         GVLTDGLCPATVSNQAICQ-------------------------PGVRPGTNTLLPVPLQ 182 
XAC2411         GAVVADAG---------------------------------------------------- 157 
Phep_2436       ------------------------------------------------------------ 
Phep_2437       ------------------------------------------------------------ 
Phep_2737       GAIALGFCPDITLKKPLCKGNGLKS---------------------HVLVPGKSYYLERT 206 
XF0754          GVAITDP-----------------------------------------------------  42 
XF2679          GVVSDGLCPVVVPTQAVCG-------------------------AGVAS-DQHLKPAPVA 182 
CJA_1309        GAYSLG------------------------------------------------------  84 
 
 
PA0919          ----LPHQASHGQWLLAWNDNPDDDTAVFVRKQSSAETSISDYDTPLS-----------3 
PP_1201         ----LPKSAAHGHWNVAWNDNPDDASAAFVRDQANAETSISDYDIHLP------------ 199 
Atu_AcvB        LTDGALPAPVSVIFTPDADQKGRDHVNALVKLHSDIEVTDVTDKAD-------------- 227 
Atu_VirJ        ------------------------------------------------------------ 
Rtr_AtvA        LQEGALPNPILVTFTANAPKDGRDHVADIQKDHPEVQTTD-SDNADT------------- 230 
Bphy_4018       --------------------APDPTVTHGPGLPGFAETDAN-PSAGT------------- 195 
Rpic_3994       ALQSAMPTSFARRSGPLCDARATQAFIDTISGAQSVALPAMATGANAPP---VTASEPFK 357 
XAC1368         IPWVLAASQDKR-----CPAAAEEGFLKQVPQARTFRRSAQGDILPG-----------LR 226 
XAC2411         --------------------TKDPGLACSRDLPNASQGFLDDLADAS------------- 184 
Phep_2436       ------------------------------------------------------------ 
Phep_2437       ------------------------------------------------------------ 
Phep_2737       EKLAAPFIALNGIKDETCPFQATKTFLTGMPFAELVTLPKVGHGFSIADNWLPQFYQSYK 266 
XF0754          ----------------------DAGAAGLPPLPEKVQ------SHRA-------------  61 
XF2679          APLLVMTVSSAH-----CPAQLTSGFVRKVALGREIRLAASADLLPR-----------LR 226 
CJA_1309        ------------------------------------------------------------  
 
 
PA0919          ---DVLAHQLRLQLQG---NAEALPVLEVP----AAQPSDIVTLFYSGDGGWRDLDKDSA 253 
PP_1201         ---QVLKAQLTQALVGRDGNALAIPVVEVP----AGQTTDTVTLFLSGDGGWRDLDRDVA 252 
Atu_AcvB        -EVLTQTLSDKVDAAGDSGNPLGLPITVL----EAKPVMDTMAVIYSGDGGWRDLDEEVG 282 
Atu_VirJ        ---------------------VRLPLRVF----NAKPAKNTVAIIYSGDAGWQNIDEVIG  73 
Rtr_AtvA        YATLEASLADLMKTIDSSKSPLGLPLDIM----ETTPTEDTLAIVYSGDGGWRDIDKEVG 286 
Bphy_4018       QRIVELTTPHLRVAVMKEEDVSDLPLIEL----PAAHPTGLMAIVISGDGGWRDLDKTIA 251 
Rpic_3994       TAFAKLVAQRKPPPPPPPAAVSDLPIIEVPAQPGSSSE--LFAVLLSGDGGWAGLDKEVA 415 
XAC1368         AAVRSLGEQKGVALPPPPGGLADLPVVELPAKPDGDSDDDTFVIFVSGDGGWAGLDEEVA 286 
XAC2411         SPMQIAAATRGHFLAAQSQGLGDLPLVEM----HAPG-SDRLVVMLSGDGGWRELDKGIA 239 
Phep_2436       ----------------IARSDFDLPVFAYP--AADSNKTGTLIVMLSGDGGWLDFEDSLS  75 
Phep_2437       MKFKILLFLLILTYQDYTQAQTAYPTHPLF-----KSSHKPLVLFLTGDGGWNTFSMQVA  55 
Phep_2737       KIIASPSAIKQKNAASVQRMPDKLITTLPLNLLPAPSSDQPLIFMMSGDGGWTSFDQSLA 326 
XF0754          TPIQ-------------SSGVSALPLVEY----HAPG-SDRLAIMISGDGGWRTLDRNLS 103 
XF2679          AALRVLGAQKGVSLPPPPADLDGLPVVEVPSKAQKKSD--TFAIFVSGDGGWAEIDKKVA 284 
CJA_1309        -----------------------------------WQDDITLPIPPCHNNSALEWKERCS 109 
                                                         . .    : .    .   . 
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PA0919          EHMASMGYPVVGIDTLRYYWQHKSPEQSAADLSKLMQHYREKWGAKRFVLAGYSFGADIL 313 
PP_1201         GEMAKLGYPVVGIDTLRYYWQHKTPEQSAADLSELMHHYRQKWGTKRFVLTGYSFGADVL 312 
Atu_AcvB        SALQKQGVPVIGVDALRYFWKEKDPKEVAGDLARIIDTYRKEWKVKNVVLIGYSFGADII 342 
Atu_VirJ        TYLQTEGIPVIGVSSLRYFWSERSPSETAKDLGHIIDVYTKHFGVQNVLLIGYSFGADVM 133 
Rtr_AtvA        SYLQDQGIPVVGVDTLHYFWTEKDPQQTANDLGRIIDFYTKRFKVKHVVLVGYSFGADVL 346 
Bphy_4018       EELQKDGVSVIGWDSLRYFWSEHSPQQTSHDLARVLQTYATRWHADHVALIGYSFGADVM 311 
Rpic_3994       AALSKSGVPVVGIDSLRYFWTPRTPASAAADMDRLVRFYASRWKKQKALLIGYSQGADVL 475 
XAC1368         DALAAQGIPVVGLDSLRYFWTERTPQGFADDLDRIARIYAQRWDRQRVVLIGFSQGADVL 346 
XAC2411         AQLQQQGVSVVGWNSLRYFWGSRTPQQVGADLDRVIASYRQRWHIQHVALVGYSFGADVL 299 
Phep_2436       VQFSKAGFNTVGFNCRDYFWERKTPRQTAEDLSMLLHVYIQQYNSTKIVLCGYSFGADVV 135 
Phep_2437       DELGKNGYPVISLDTRKYFWEQKTPAGFAADVNTIVSKYLNQWNKDEFCVVGYSFGAEVG 115 
Phep_2737       ESFAEKGMAVVGLDAQKYFWNAKTPQQTAAAIADAISYYMQNWKKKKFILAGYSFGACIA 386 
XF0754          KELQRRGISVVGWNSLRYFWKLRTPEQLGDDLSRVIADYQRRWGAHQVILIGYSFGADVM 163 
XF2679          GHLADADIPVVGLDSLRYFWSERTPEGFAKDLDRIARFYAHHWKRNRLLLVGFSQGADVL 344 
CJA_1309        ELILHT----YPLPSTPWRLFNTHP---LKDLQAAIDYYTQAWAKSELLLIGFSMGADVM 162 
                  :              :      *      :      *   :   .  : *:* ** :  
 
PA0919          PAIYNRLPGKDQQQVKAMLLLALARTGSFEIEVEGWLGK--AGEEAATGPEMARLPAAKV 371 
PP_1201         PAIYNRLPVEDQQRIDAVMLLAFARSGSFEIEVEGWLGK--EGQEAPTGPEMAKLPASKV 370 
Atu_AcvB        PATYNLLPDRVKSSVAQLSLLGLSNEVDFEISVQGWLGVAGEGKGGKTVDDIAKIDPKLV 402 
Atu_VirJ        PASFNRLTLEQKNRVKQISLLALSHQVDYVVSFRGWLQLETEGKGGNPLDDLRFIDPAIV 193 
Rtr_AtvA        PASYNRLPQAEKDKIVQMSLLSLSQKVDYVISVMGWLGASSQGKGGDPVNDLKSINPKMV 406 
Bphy_4018       PFAYNRLPDGLRAKVSLISLLGFAPSADFQIRVTGWLGMPASDKALPVKPEFERLPPRIV 371 
Rpic_3994       PFIVNRLPAASREHVALAVMMGLGKRADFEFHMTNWVSS--SASGLLILPEVQKLPAGLG 533 
XAC1368         PAAINKLPAATKQNLRMTALLSVGKLADYEFHVSNWLGS--DDEGLPIAPEVQRLPAGTT 404 
XAC2411         PFAYPGLSPQQRASVQFVSLLGLGHEADFKVRVGGWLGW-HNDAERDVEPAIQALDAHRL 358 
Phep_2436       PFIYNRLRPHLKSRITALGMLSPFATTDFKVHTSDLLNIAKDNRKYKVKAEIDRIRIP-V 194 
Phep_2437       AFLPTHLPAATLEKFKSLVLLSPGYSNSFEVRFINMIATKNTNKDKYKVYPELLKSKIPV 175 
Phep_2737       PFIANRLPENLQHNLSAVCMLSPDERADFEIHVADMLSIDGQDEPYNVLAEMKKARTFKL 446 
XF0754          PFAYAHLMPTQRNGVDFISLLALGRKADFKARIFGWLGW-GEHGTRDVLTALGALDLHRV 222 
XF2679          PAAINKLSPNTRQIIRMTALLSLGKYAHYEFHVSNWIST--DDEGIPIAPDMVKLRSTRT 402 
CJA_1309        PFMVNRLDANTKHKIRSVNLLNPANTVDFVFHVSGWFST-AGELPYKLYPEMKDWTQWPV 221 
                .     *       .    ::       :     . .  
 
PA0919          FCIYGAEEKDESGCTQSQAVG-------EKLELPGGHHFDE-DYLSLAKKMLQAIRDREN 423 
PP_1201         VCVYGVEETDESGCTEKTAVG-------ERLKLPGGHHFDE-NYPALAKRLIGEIETRQG 422 
Atu_AcvB        QCVYGTEEEDEDPCPGLKAKGV------ETIGIEGGHHFDE-DYEALAKRIVTSLKTRLA 455 
Atu_VirJ        QCMYGREDRNN-ACPSLRQTGA------EVIGFSGGHHFGN-DFKKLSTRVVSGLVARLS 245 
Rtr_AtvA        QCVYGKDDDEDVACPLLKGTGA------EVIAMDGGHHFDD-DYEALANHIINGLKSRLG 459 
Bphy_4018       QCFYG-EHEDETLCPTLTKTGI------EVIRTTGDHHFGH-DYVALEKRILNALKKQAN 423 
Rpic_3994       MCIYG-KEEKDTNCPGLDPKQV------QLVKLPGGHHFDG-DYAKLARISLEGARAPGN 585 
XAC1368         VCIYG-QDDDDALCPSLPANVA------RRVALPGDHHFKG-DYATLAKTIMDQLHALSK 456 
XAC2411         QCIYG-DEEKDTLCPELRARGV------QVLARPGGHHFDH-DPVVLANLLMQGWQHAAQ 410 
Phep_2436       FCFYG-KDEEPKAQENILKPGF------YLKLLAGDHRYEESTYQEIVNTLTNTINQK-- 245 
Phep_2437       WCIFGEEEKTDISQELKETNKI------RKITIPGSHHYND-DVQLVVSGAIKGLVN--- 225 
Phep_2737       IVLFG-DDEDPATTKQFRQETS------RVITLPGGHHYNN-DYTGIVNYVIKSL----- 493 
XF0754          QCIYG-QNDKDAVCPELRERIF------DVVMRPGGHHFDG-DTVKLADAILQGWQRRIE 274 
XF2679          VCIYG-VDDQETLCPSLPQ-QN------RRVALPGTHHFNG-DYETVAKTILAQMEAAP- 452 
CJA_1309        NCFYS--ETQDSLCETIKANLPQKPDNQQLFYLSGDHHFNG-NYQQLIKWILANSKVPVR 278 
                  .:.  .                          * *::       :  
 
PA0919          APDA------- 427 
PP_1201         KSSVAEQN--- 430 
Atu_AcvB        K---------- 456 
Atu_VirJ        HQYSSGPAPL- 255 
Rtr_AtvA        E---------- 460 
Bphy_4018       GV--------- 425 
Rpic_3994       ASR-------- 588 
XAC1368         P---------- 457 
XAC2411         TPIAETASRS- 420 
Phep_2436       ----------- 
Phep_2437       ----------- 
Phep_2737       ----------- 
XF0754          LREPRNADSPR 285 
XF2679          ----------- 
CJA_1309        ----------- 
Appendix -184-  
 
8.6 Native molecular mass determination of the PA0919 protein 
The native molecular mass of recombinant PA0919-Strep protein was determined by 
analytical gel permeation chromatography (section 2.10.6). The obtained chromatogram is 
given in Figure 37. The calculated native molecular mass of 57 kDa indicated a monomeric 
architecture of the recombinant PA0919-Strep protein. 
 
Figure 36: Sequence alignment of PA0919 homologous proteins (see previous pages) 
PA0919 homologous proteins were identified by BLAST analysis and selected sequences were 
aligned by ClustalW2 (section 2.13.1). Conserved serines and histidines are indicated in bold 
letters and amino acid positions mutated by site-directed mutagenesis in PA0919 are highlighted 
gray. Conservation degrees are indicated: period (.): semiconserved, colon (:): conserved, asterisk 
(*): identical. 
Gene names/locus tags: PA0919: P. aeruginosa PAO1, PP_1202: P. putida KT2440, Atu_AcvB: 
A. tumefaciens C58, Atu_VirJ: A. tumefaciens octopine-type Ti-plasmid pTiA6, Rtr_AtvA: R. tropici 
CIAT 899, Bphy_4018: B. phymatum STM815, Rpic_3994: R. pickettii 12J, XAC1368 and XAC2411: 
X. axonopodis 306, Phep_2436, Phep_2437 and Phep_2737: P. heparinus DSM2366, XF0754 and 
XF2679: X. fastidiosa 9a5c, CJA_1309: C. japonicus Ueda107. 
Figure 37: Analytical gel permeation chromatography of the recombinant PA0919-Strep protein 
50 μg of purified recombinant PA0919-Strep protein were loaded onto a Superdex 200 5/150 GL 
column and eluted using a flow rate of 0.45 mL/min. Protein elution was monitored by measuring 
the absorption at 280 nm.  
Protein standards: carbonic anhydrase (Mr = 29’000), bovine serum albumin (Mr = 66’000), yeast 
alcohol dehydrogenase (Mr = 150’000) and β-amylase (Mr = 200’000).  
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8.7 Topology analysis of the PA0919 protein 
The PA0919 amino acid sequence was analyzed by the programs SignalP 4.1 and TMHMM 
for the identification of secretion signal sequences and transmembrane helices (section 
2.13.5). The obtained output data are presented in Figure 38 (SignalP 4.1) and in Figure 39 
(TMHMM). The analyses revealed the presence of one N-terminal transmembrane helix 
formed by amino acids 12 – 31 of the entire PA0919 protein. A secretion signal sequence 
was not predicted. 
 
Figure 38: SignalP 4.1 output data for PA0919 
The PA0919 amino acid sequence was analyzed by SignalP 4.1 to predict a potential secretion 
signal (Petersen et al., 2011). Calculated scores were plotted against the specific amino acid 
position.  
The obtained output data are presented: C-score (red): raw cleavage site score, S-score (green): 
signal peptide score, Y (blue): combined cleavage site score, D-score: discrimination score 
(distinguishes signal peptide sequences from non-signal sequences).  
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Figure 39: TMHMM output data for PA0919 
The TMHMM online tool (Krogh et al., 2001) was employed to detect transmembrane helices 
using the PA0919 amino acid sequence for query. Calculated probabilities for the location of 
specific amino acid residues were plotted against the specific amino acid moiety. The obtained 
output data are presented. One N-terminal located transmembrane helix was predicted by 
TMHMM consisting of PA0919 amino acids 12 to 31 and the program indicated the possibility of 
an N-terminal secretion signal sequence. 
Protein sequences predicted to face the cytoplasm are indicated blue and fragments proposed to 
be located within the periplasm are given in magenta. Putative transmembrane helices are 
indicated in red.  
AAs: amino acids, THMs: transmembrane helices. 
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8.8 Growth phenotype and lipid composition of ΔPA0919 complemented 
strains employed for PA0919 localization 
Several P. aeruginosa strains (Δ19 19, Δ19 1935-427, Δ19 pUC/19 and Δ19 pUC/1935-427) were 
constructed based on the ΔPA0919 deletion mutant strain for the localization of PA0919 
within its native host. The stains were analyzed together with their reference strains (PAO1, 
ΔPA0919 and Δ19 pUC) concerning their growth and lipid composition under neutral 
conditions. The obtained results are presented in Figure 40 and Figure 41. For strain 
designation and construction strategy, see section 3.8.1. 
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Figure 40: Growth curves of complemented ΔPA0919 for PA0919 localization 
P. aeruginosa strains were cultured in AB medium pH 7.3 at 37 °C and 200 rpm (section 2.3.5). 
Culture turbidity was determined at 578 nm. For strain designation and construction details, see 
Figure 26 and section 2.4.19. 
Rhombus: PAO1 wild-type, square: PAO1 ΔPA0919 deletion mutant, triangle: Δ19 19, cross: Δ19 
1935-427, star: Δ19 pUC/19, dot: Δ19 pUC/1935-427, plus: Δ19 pUC. 
Figure 41: Lipid composition of complemented ΔPA0919 strains for PA0919 localization 
Various P. aeruginosa strains were grown in AB medium pH 7.3 at 37 °C and 200 rpm for 24 h 
(section 2.3.5). Polar lipids were extracted, separated by two-dimensional TLC and detected by 
molybdatophosphoric acid staining (sections 2.5.1 and 2.5.3). A-PG position is indicated by a 
circle. For strain designation and construction details, see Figure 26 and section 2.4.19. 
A-PG: alanyl-phosphatidylglycerol, PE: phosphatidylethanolamine. 
PAO1
Δ19 19 Δ19 pUC/19
Δ19 pUC
Δ19 1935-427 Δ19 pUC/1935-427
ΔPA0919A B
PE
A-PG
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